VSID	CONTIG	START	STOP	REF	ALT	HGVSg	HGVSc/HGVSn	HGVSp	Alias for Report - From Clinical team	ClinVar	HGMD	dbSNP	DISEASES	MARKET NAME	GNOMAD POPMAX	GNOMAD AF POPMAX	GENE	GENE ID
VSC5MWS4IU	chr1	21564138	21564139	G	A	NC_000001.11:g.21564139G>A	NM_000478.5:c.571G>A	NP_000469.3:p.Glu191Lys		28709	CM920019	rs121918007	Hypophosphatasia	571G>A	FIN	0.0176915	ALPL	249
VS2DC9M7M9	chr1	21573780	21573781	T	C	NC_000001.11:g.21573781T>C	NM_000478.5:c.979T>C	NP_000469.3:p.Phe327Leu		28712	CM960047	rs121918010	Hypophosphatasia	979T>C	EAS	0.0010436	ALPL	249
VSMF1AN98L	chr1	21575735	21575736	G	A	NC_000001.11:g.21575736G>A	NM_000478.5:c.1001G>A	NP_000469.3:p.Gly334Asp		28711	CM930017	rs121918009	Hypophosphatasia	1001G>A			ALPL	249
VSXFND2QV4	chr1	21575867	21575868	A	T	NC_000001.11:g.21575868A>T	NM_000478.5:c.1133A>T	NP_000469.3:p.Asp378Val		28710	CM920022	rs121918008	Hypophosphatasia	1133A>T	NFE	8.95E-06	ALPL	249
VSPUAGXR3Q	chr1	21577630	21577632	CT	C	NC_000001.11:g.21577632delT	NM_000478.5:c.1559delT	NP_000469.3:p.Leu520fs		28713	CD941570	rs387906525	Hypophosphatasia	1559delT	EAS	0.00011868	ALPL	249
VSI3F5KDW4	chr1	23810734	23810735	C	T	NC_000001.11:g.23810735C>T	NM_000191.2:c.561+1G>A				CS066285		3-hydroxy-3-methylglutaryl CoA lyase deficiency	561+1G>A			HMGCL	3155
VSK25QZ9C5	chr1	23820531	23820532	C	T	NC_000001.11:g.23820532C>T	NM_000191.2:c.122G>A	NP_000182.2:p.Arg41Gln		26996	CM980987	rs121964997	3-hydroxy-3-methylglutaryl CoA lyase deficiency	122G>A	EAS	0.000115955	HMGCL	3155
VSVRI5KYN4	chr1	23820544	23820545	C	A	NC_000001.11:g.23820545C>A	NM_000191.2:c.109G>T	NP_000182.2:p.Glu37*		192195	CM970742	rs763494292	3-hydroxy-3-methylglutaryl CoA lyase deficiency	109G>T	AMR	0.000208445	HMGCL	3155
VSFEJMLGR1	chr1	26438227	26438228	A	G	NC_000001.11:g.26438228A>G	NM_024887.3:c.124A>G	NP_079163.2:p.Lys42Glu		39666	CM110930	rs147394623	Retinitis pigmentosa 59	124A>G	ASJ	0.00467005	DHDDS	79947
VSAA1QMT1V	chr1	40089494	40089495	G	A	NC_000001.11:g.40089495G>A	NM_000310.3:c.451C>T	NP_000301.1:p.Arg151*		23943	CM981629	rs137852700	"Neuronal ceroid lipofuscinosis, PPT1-related"	451C>T	NFE	0.00051949	PPT1	5538
VSR9XVG27H	chr1	40091397	40091398	T	A	NC_000001.11:g.40091398T>A	NM_000310.3:c.364A>T	NP_000301.1:p.Arg122Trp		23938	CM950975	rs137852695	"Neuronal ceroid lipofuscinosis, PPT1-related"	364A>T	FIN	0.00641889	PPT1	5538
VSYWHKLHJJ	chr1	40092408	40092409	T	G	NC_000001.11:g.40092409T>G	NM_000310.3:c.223A>C	NP_000301.1:p.Thr75Pro		23939	CM981626	rs137852696	"Neuronal ceroid lipofuscinosis, PPT1-related"	223A>C	AFR	6.53E-05	PPT1	5538
VSEFD4489D	chr1	43337928	43337929	T	A	NC_000001.11:g.43337929T>A	NM_005373.2:c.79+2T>A			139302	CS061304	rs146249964	Congenital amegakaryocytic thrombocytopenia	IVS1+2T>A	ASJ	0.00822231	MPL	4352
VSJ99LJVR9	chr1	45507543	45507544	T	TA	NC_000001.11:g.45507545dupA	NM_015506.2:c.271dupA	NP_056321.2:p.Arg91fs		16460	CI055013	rs1060499568	"Methylmalonic aciduria, cblC type"	271dupA	ASJ	0.00243803	MMACHC	25974
VSAVMLI4IW	chr1	45508265	45508266	C	T	NC_000001.11:g.45508266C>T	NM_015506.2:c.331C>T	NP_056321.2:p.Arg111*		16463	CM060058	rs121918242	"Methylmalonic aciduria, cblC type"	331C>T	AFR	0.000130873	MMACHC	25974
VSS9I5LFV1	chr1	45508328	45508329	C	T	NC_000001.11:g.45508329C>T	NM_015506.2:c.394C>T	NP_056321.2:p.Arg132*		16462	CM060051	rs121918241	"Methylmalonic aciduria, cblC type"	394C>T	SAS	0.000747238	MMACHC	25974
VSJ1JSKCSY	chr1	46192096	46192097	C	T	NC_000001.11:g.46192097C>T	NM_017739.3:c.1539+1G>A			71221	CS014770	rs138642840	Muscle-eye-brain disease	1539+1G>A	FIN	0.00188476	POMGNT1	55624
VSW2F93R6K	chr1	53197091	53197092	C	A	NC_000001.11:g.53197092C>A	NM_000098.2:c.149C>A	NP_000089.1:p.Pro50His		23993	CM950325	rs28936375	Carnitine palmitoyltransferase II deficiency	149C>A	FIN	0.0015896	CPT2	1376
VSTXKXBPMT	chr1	53202426	53202427	C	T	NC_000001.11:g.53202427C>T	NM_000098.2:c.338C>T	NP_000089.1:p.Ser113Leu		23992	CM930171	rs74315294	Carnitine palmitoyltransferase II deficiency	338C>T	ASJ	0.00690355	CPT2	1376
VSDG7IZ8ZR	chr1	53210032	53210033	A	G	NC_000001.11:g.53210033A>G	NM_000098.2:c.359A>G	NP_000089.1:p.Tyr120Cys		24007	CM001108	rs121918528	Carnitine palmitoyltransferase II deficiency	359A>G	AMR	0.000268033	CPT2	1376
TP2016013	chr1	53210043	53210044	C	T	NC_000001.11:g.53210044C>T	NM_000098.2:c.370C>T	NP_000089.1:p.Arg124*		199958	CM980445	rs201065226	Carnitine palmitoyltransferase II deficiency	370C>T	NFE	8.95E-06	CPT2	1376
VS6BPLQVII	chr1	53210125	53210126	G	A	NC_000001.11:g.53210126G>A	NM_000098.2:c.452G>A	NP_000089.1:p.Arg151Gln		136314	CM983397	rs515726177	Carnitine palmitoyltransferase II deficiency	452G>A	EAS	5.80E-05	CPT2	1376
VSIQCCSANU	chr1	53210193	53210194	G	A	NC_000001.11:g.53210194G>A	NM_000098.2:c.520G>A	NP_000089.1:p.Glu174Lys		23996	CM960421	rs28936674	Carnitine palmitoyltransferase II deficiency	520G>A	EAS	0.000115955	CPT2	1376
TP2016049	chr1	53210207	53210232	GAACCCTGCAAAAAGTGACACTATC	T	NC_000001.11:g.53210208_53210232delinsT	NM_000098.2:c.534_558delinsT	NP_000089.1:p.Leu178_Ile186delinsPhe		136310		rs515726173	Carnitine palmitoyltransferase II deficiency	p.Leu178_Ile186delinsPhe			CPT2	1376
VSN3L4NREG	chr1	53210353	53210354	C	T	NC_000001.11:g.53210354C>T	NM_000098.2:c.680C>T	NP_000089.1:p.Pro227Leu		24003	CM990437	rs74315298	Carnitine palmitoyltransferase II deficiency	680C>T	AFR	0.000787505	CPT2	1376
VSGYW1P724	chr1	53210656	53210657	A	G	NC_000001.11:g.53210657A>G	NM_000098.2:c.983A>G	NP_000089.1:p.Asp328Gly		136312	CM030824	rs515726175	Carnitine palmitoyltransferase II deficiency	983A>G	AMR	2.98E-05	CPT2	1376
VSBSN9ADIR	chr1	53210818	53210819	G	A	NC_000001.11:g.53210819G>A	NM_000098.2:c.1145G>A	NP_000089.1:p.Arg382Lys		136313	CM993448	rs515726176	Carnitine palmitoyltransferase II deficiency	1145G>A			CPT2	1376
VSEJHASKB8	chr1	53210821	53210822	T	A	NC_000001.11:g.53210822T>A	NM_000098.2:c.1148T>A	NP_000089.1:p.Phe383Tyr		23997	CM960422	rs74315295	Carnitine palmitoyltransferase II deficiency	1148T>A	EAS	0.000289956	CPT2	1376
VSTDPJGH1A	chr1	53210910	53210913	CAG	C	NC_000001.11:g.53210913_53210914delGA	NM_000098.2:c.1239_1240delGA	NP_000089.1:p.Lys414fs		98339	CD991686	rs397509431	Carnitine palmitoyltransferase II deficiency	1239_1240delGA	ASJ	0.00467005	CPT2	1376
VSX7XCXIVC	chr1	53211180	53211181	C	T	NC_000001.11:g.53211181C>T	NM_000098.2:c.1507C>T	NP_000089.1:p.Arg503Cys		23998	CM990440	rs74315296	Carnitine palmitoyltransferase II deficiency	1507C>T	AMR	3.00E-05	CPT2	1376
VSSCZ5KJPS	chr1	53213263	53213264	G	A	NC_000001.11:g.53213264G>A	NM_000098.2:c.1646G>A	NP_000089.1:p.Gly549Asp		136315	CM990441	rs186044004	Carnitine palmitoyltransferase II deficiency	1646G>A	AMR	5.96E-05	CPT2	1376
VSCF5VRNE3	chr1	53213500	53213501	A	C	NC_000001.11:g.53213501A>C	NM_000098.2:c.1883A>C	NP_000089.1:p.Tyr628Ser		23995	CM960423	rs28936673	Carnitine palmitoyltransferase II deficiency	1883A>C			CPT2	1376
VS1VL9ZTQ1	chr1	53213508	53213509	C	T	NC_000001.11:g.53213509C>T	NM_000098.2:c.1891C>T	NP_000089.1:p.Arg631Cys		23991	CM920217	rs74315293	Carnitine palmitoyltransferase II deficiency	1891C>T	SAS	0.000129946	CPT2	1376
VSB6UD2K9P	chr1	54999186	54999187	A	T	NC_000001.11:g.54999187A>T	NM_057176.2:c.1A>T	NP_476517.1:p.Met1?		19419	CM013300	rs74315284	"Bartter syndrome, type IV"	1A>T	NFE	8.96E-06	BSND	7809
VS5522FSP8	chr1	54999213	54999214	G	A	NC_000001.11:g.54999214G>A	NM_057176.2:c.28G>A	NP_476517.1:p.Gly10Ser		19424	CM013303	rs74315287	"Bartter syndrome, type IV"	28G>A	SAS	3.25E-05	BSND	7809
VSQLUUA35X	chr1	75733602	75733603	C	T	NC_000001.11:g.75733603C>T	NM_000016.5:c.362C>T	NP_000007.1:p.Thr121Ile		18638	CM012321	rs121434283	Medium-chain acyl-CoA dehydrogenase deficiency	362C>T	FIN	4.49E-05	ACADM	34
VSJC83EQ59	chr1	75740093	75740094	G	A	NC_000001.11:g.75740094G>A	NM_000016.5:c.583G>A	NP_000007.1:p.Gly195Arg		18633	CM940001	rs121434278	Medium-chain acyl-CoA dehydrogenase deficiency	583G>A	NFE	7.17E-05	ACADM	34
VSD1CIGC4G	chr1	75749508	75749509	G	A	NC_000001.11:g.75749509G>A	NM_000016.5:c.799G>A	NP_000007.1:p.Gly267Arg		18627	CM910003	rs121434274	Medium-chain acyl-CoA dehydrogenase deficiency	799G>A	SAS	0.000487298	ACADM	34
VSDZCZKI8C	chr1	75761160	75761161	A	G	NC_000001.11:g.75761161A>G	NM_000016.5:c.985A>G	NP_000007.1:p.Lys329Glu		18625	CM900001	rs77931234	Medium-chain acyl-CoA dehydrogenase deficiency	985A>G	NFE	0.00625974	ACADM	34
VSIM7W2VPR	chr1	97450057	97450058	C	T	NC_000001.11:g.97450058C>T	NM_000110.3:c.1905+1G>A			15471	CS961553	rs3918290	Dihydropyrimidine dehydrogenase deficiency	1905+1G>A	FIN	0.0238159	DPYD	1806
VSCICWETNI	chr1	99851057	99851058	C	T	NC_000001.11:g.99851058C>T	NM_000642.2:c.16C>T	NP_000633.2:p.Gln6*		16134	CM960015	rs113994126	"Glycogen storage disease, type III"	16C>T	NFE	3.58E-05	AGL	178
VSI6C4JHCW	chr1	99851057	99851060	CAG	C	NC_000001.11:g.99851060_99851061delGA	NM_000642.2:c.18_19delGA	NP_000633.2:p.Gln6fs		192258	CD961746	rs113994127	"Glycogen storage disease, type III"	18_19delGA	NFE	8.06E-05	AGL	178
VSFGY7NP8X	chr1	99875393	99875394	C	T	NC_000001.11:g.99875394C>T	NM_000642.2:c.1222C>T	NP_000633.2:p.Arg408*		16145	CM011271	rs113994128	"Glycogen storage disease, type III"	1222C>T	NFE	3.58E-05	AGL	178
VSSAIXQHJV	chr1	99881328	99881329	G	A	NC_000001.11:g.99881329G>A	NM_000642.2:c.2039G>A	NP_000633.2:p.Trp680*		16135	CM960016	rs113994129	"Glycogen storage disease, type III"	2039G>A	NFE	1.80E-05	AGL	178
VSFX1FL5MC	chr1	99884611	99884612	C	T	NC_000001.11:g.99884612C>T	NM_000642.2:c.2590C>T	NP_000633.2:p.Arg864*		34067	CM960017	rs113994130	"Glycogen storage disease, type III"	2590C>T	FIN	0.0002693	AGL	178
VS3Y14XIGM	chr1	99902775	99902776	C	T	NC_000001.11:g.99902776C>T	NM_000642.2:c.3682C>T	NP_000633.2:p.Arg1228*		34068	CM960018	rs113994131	"Glycogen storage disease, type III"	3682C>T	EAS	5.81E-05	AGL	178
VSHP99AQFU	chr1	99913540	99913542	GT	G	NC_000001.11:g.99913542delT	NM_000642.2:c.3965delT	NP_000633.2:p.Val1322fs		16142	CD004089	rs113994132	"Glycogen storage disease, type III"	3965delT	NFE	1.80E-05	AGL	178
VSCDLH41U8	chr1	99916397	99916398	A	G	NC_000001.11:g.99916398A>G	NM_000642.2:c.4260-12A>G			16138	CS982059	rs369973784	"Glycogen storage disease, type III"	4260-12A>G	AFR	0.000263505	AGL	178
VSLFC7U8CE	chr1	99916702	99916704	CT	C	NC_000001.11:g.99916706delT	NM_000642.2:c.4456delT	NP_000633.2:p.Ser1486fs		16137	CD972873	rs113994134	"Glycogen storage disease, type III"	4456delT			AGL	178
VS2KKUFHD2	chr1	100011412	100011413	C	T	NC_000001.11:g.100011413C>T	NM_012243.2:c.514C>T	NP_036375.1:p.Gln172*		94575	CM1310456	rs398122524	"Arthrogryposis, mental retardation and seizures"	514C>T			SLC35A3	23443
VS9KCSW8PY	chr1	119415447	119415448	C	A	NC_000001.11:g.119415448C>A	NM_000198.3:c.29C>A	NP_000189.1:p.Ala10Glu		27227	CM001196	rs28934880	"3-beta-hydroxysteroid dehydrogenase deficiency, type II"	29C>A	NFE	1.79E-05	HSD3B2	3284
VSJM3H24LA	chr1	119422012	119422013	G	A	NC_000001.11:g.119422013G>A	NM_000198.3:c.512G>A	NP_000189.1:p.Trp171*		27223	CM920363	rs80358216	"3-beta-hydroxysteroid dehydrogenase deficiency, type II"	512G>A			HSD3B2	3284
VSXP4T9NE5	chr1	119422276	119422277	C	T	NC_000001.11:g.119422277C>T	NM_000198.3:c.776C>T	NP_000189.1:p.Thr259Met		27231	CM993171	rs80358221	"3-beta-hydroxysteroid dehydrogenase deficiency, type II"	776C>T	AFR	6.54E-05	HSD3B2	3284
VSAM4DC9IJ	chr1	119743905	119743906	G	A	NC_000001.11:g.119743906G>A	NM_006623.3:c.1468G>A	NP_006614.2:p.Val490Met		18906	CM003043	rs121907987	3-phosphoglycerate dehydrogenase deficiency	1468G>A	ASJ	0.00172694	PHGDH	26227
VSMQSJH3DU	chr1	146018398	146018399	C	A	NC_000001.11:g.146018399C>A	NM_213653.3:c.959G>T	NP_998818.1:p.Gly320Val		17404	CM040081	rs74315323	"Hereditary hemochromatosis, HFE2-related"	959G>T			HFE2	148738
VSRB78Q7NW	chr1	150796862	150796863	A	G	NC_000001.11:g.150796863A>G	NM_000396.3:c.926T>C	NP_000387.1:p.Leu309Pro		23465	CM001110	rs29001685	Pycnodysostosis	926T>C	NFE	8.95E-06	CTSK	1513
VSA34464LS	chr1	154275164	154275165	C	T	NC_000001.11:g.154275165C>T	NM_006118.3:c.568C>T	NP_006109.2:p.Gln190*		19689	CM070157	rs74315322	"Congenital neutropenia, HAX1-related"	568C>T	NFE	6.27E-05	HAX1	10456
VSEC7CF7DE	chr1	155235001	155235002	C	T	NC_000001.11:g.155235002C>T	NM_001005741.2:c.1604G>A	NP_001005741.1:p.Arg535His		19350	CM930293	rs75822236	Gaucher disease	p.R496H	ASJ	0.0022673	GBA	2629
VSF9A013ED	chr1	155235251	155235252	A	G	NC_000001.11:g.155235252A>G	NM_001005741.2:c.1448T>C	NP_001005741.1:p.Leu483Pro	p.L444P	19327	CM870010	rs421016	Gaucher disease	p.L444P	ASJ	0.00268207	GBA	2629
VS20160217	chr1	155235725	155235726	T	A	NC_000001.11:g.155235726T>A	NM_001005741.2:c.1343A>T	NP_001005741.1:p.Asp448Val		19333	CM940816	rs77369218	Gaucher disease	p.D409V			GBA	2629
VSF4B788F1	chr1	155235726	155235727	C	G	NC_000001.11:g.155235727C>G	NM_001005741.2:c.1342G>C	NP_001005741.1:p.Asp448His		19332	CM900106	rs1064651	Gaucher disease	p.D409H	AMR	0.000209193	GBA	2629
VS65DB188E	chr1	155235771	155235772	C	A	NC_000001.11:g.155235772C>A	NM_001005741.2:c.1297G>T	NP_001005741.1:p.Val433Leu		19331	CM890054	rs80356769	Gaucher disease	p.V394L	ASJ	0.000710804	GBA	2629
VSD771E4D5	chr1	155235842	155235843	T	C	NC_000001.11:g.155235843T>C	NM_001005741.2:c.1226A>G	NP_001005741.1:p.Asn409Ser	p.N370S	19329	CM880036	rs76763715	Gaucher disease	p.N370S	ASJ	0.0271066	GBA	2629
VS8DB8382E	chr1	155240628	155240629	C	T	NC_000001.11:g.155240629C>T	NM_001005741.2:c.115+1G>A			99352	CS920754	rs104886460	Gaucher disease	IVS2+1G>A	ASJ	0.000203046	GBA	2629
VS52697618	chr1	155240659	155240660	G	GC	NC_000001.11:g.155240661dupC	NM_001005741.2:c.84dupG	NP_001005741.1:p.Leu29fs		19341	CI910569	rs387906315	Gaucher disease	p.L47X	ASJ	0.000913706	GBA	2629
VS396CAB61	chr1	169549810	169549811	C	T	NC_000001.11:g.169549811C>T	NM_000130.4:c.1601G>A	NP_000121.2:p.Arg534Gln		15681	CM940389	rs6025	F5	R506Q			F5	2153
VSCYVD3TBY	chr1	170539514	170539515	G	T	NC_000001.11:g.170539515G>T	NM_152281.2:c.442G>T	NP_689494.2:p.Glu148*		17689	CM086922	rs119455951	Geroderma osteodysplastica	Glu123Ter	NFE	2.74E-05	GORAB	92344
VSVPY88MZQ	chr1	179561326	179561327	C	T	NC_000001.11:g.179561327C>T	NM_014625.3:c.413G>A	NP_055440.1:p.Arg138Gln		20399	CM000581	rs74315342	Steroid-resistant nephrotic syndrome	413G>A	NFE	0.00121868	NPHS2	7827
VSUQZTY7KZ	chr1	179561327	179561328	G	A	NC_000001.11:g.179561328G>A	NM_014625.3:c.412C>T	NP_055440.1:p.Arg138*		20400	CM000582	rs74315343	Steroid-resistant nephrotic syndrome	412C>T	AFR	6.54E-05	NPHS2	7827
VS5ITBPMW9	chr1	209625720	209625721	G	A	NC_000001.11:g.209625721G>A	NM_000228.2:c.1903C>T	NP_000219.2:p.Arg635*		29578	CM941034	rs80356682	"Junctional epidermolysis bullosa, LAMB3-related"	1903C>T	NFE	0.00105712	LAMB3	3914
VSJYT5FNGI	chr1	209632677	209632678	G	A	NC_000001.11:g.209632678G>A	NM_000228.2:c.727C>T	NP_000219.2:p.Gln243*		33855	CM960920	rs80356681	"Junctional epidermolysis bullosa, LAMB3-related"	727C>T	NFE	2.69E-05	LAMB3	3914
VSKLZBE9ID	chr1	209650022	209650023	G	A	NC_000001.11:g.209650023G>A	NM_000228.2:c.124C>T	NP_000219.2:p.Arg42*		29580	CM950743	rs80356680	"Junctional epidermolysis bullosa, LAMB3-related"	124C>T	FIN	8.97E-05	LAMB3	3914
VSI1PLNBU4	chr1	235716747	235716749	AT	A	NC_000001.11:g.235716749delT	NM_000081.3:c.9590delA	NP_000072.2:p.Tyr3197fs		18851	CD972137	rs80338667	Chediak-Higashi syndrome	9590delA			LYST	1130
VSLW8R5C8K	chr1	235806050	235806051	G	A	NC_000001.11:g.235806051G>A	NM_000081.3:c.3085C>T	NP_000072.2:p.Gln1029*		18853	CM970311	rs80338651	Chediak-Higashi syndrome	3085C>T			LYST	1130
VSHAZYABGB	chr1	235806511	235806513	TA	T	NC_000001.11:g.235806516delA	NM_000081.3:c.2623delT	NP_000072.2:p.Tyr875fs		18854	CD992261	rs80338649	Chediak-Higashi syndrome	2623delT			LYST	1130
VSZXL27DTV	chr1	235809349	235809351	GC	G	NC_000001.11:g.235809351delC	NM_000081.3:c.1467delG	NP_000072.2:p.Glu489fs		18847	CD961888	rs80338644	Chediak-Higashi syndrome	1467delG			LYST	1130
VSBKV3KEV1	chr1	235830269	235830270	G	A	NC_000001.11:g.235830270G>A	NM_000081.3:c.148C>T	NP_000072.2:p.Arg50*		18852	CM970310	rs80338643	Chediak-Higashi syndrome	148C>T			LYST	1130
VS65DIE7L6	chr1	235830298	235830299	G	GC	NC_000001.11:g.235830301dupC	NM_000081.3:c.118dupG	NP_000072.2:p.Ala40fs		18849	CI962241	rs80338642	Chediak-Higashi syndrome	118dupG			LYST	1130
VS42F39FA5	chr1	241497926	241497927	A	ATTT	NC_000001.11:g.241497930_241497932dupTTT	NM_000143.3:c.1431_1433dupAAA	NP_000134.2:p.Lys477dup		51261	CI983099	rs367543046	Fumarase deficiency	1431_1433dupAAA	ASJ	0.00507924	FH	2271
VSE8B5191W	chr10	14934460	14934461	G	T	NC_000010.11:g.14934461G>T	NM_001033855.2:c.597C>A	NP_001029027.1:p.Tyr199*		19712	CM023908	rs121908157	Omenn syndrome	597C>A			DCLRE1C	64421
VSFEBEBD15	chr10	54317413	54317414	G	A	NC_000010.11:g.54317414G>A	NM_033056.3:c.733C>T	NP_149045.3:p.Arg245*		19972	CM030933	rs111033260	"Usher syndrome, type IF"	p.R245X	ASJ	0.00406421	PCDH15	65217
VSLV8ZHH33	chr10	54317448	54317449	G	A	NC_000010.11:g.54317449G>A	NM_033056.3:c.706-8C>T			55676		rs10740579	fingerprint variant		ASJ	0.750609994	PCDH15	65217
VS4B1G2SUK	chr10	71779315	71779316	G	A	NC_000010.11:g.71779316G>A	NM_022124.5:c.5237G>A	NP_071407.4:p.Arg1746Gln		19955	CM010013	rs111033270	"Usher syndrome, type ID"	5237G>A	NFE	0.000116402	CDH23	64072
VSI8PMAG5D	chr10	71793369	71793370	G	A	NC_000010.11:g.71793370G>A	NM_022124.5:c.6442G>A	NP_071407.4:p.Asp2148Asn		19961	CM021546	rs111033271	"Usher syndrome, type ID"	6442G>A	NFE	0.000188145	CDH23	64072
VSAJ3LHL3L	chr10	89225167	89225168	A	G	NC_000010.11:g.89225168A>G	NM_000235.3:c.599T>C	NP_000226.2:p.Leu200Pro		15116	CM930478	rs121965086	Cholesteryl ester storage disease	599T>C	NFE	2.69E-05	LIPA	3988
TP2016039	chr10	89228367	89228368	C	A	NC_000010.11:g.89228368C>A	NM_000235.3:c.260G>T	NP_000226.2:p.Gly87Val		94353	CM960943	rs587778878	Cholesteryl ester storage disease	p.G87V	AMR	2.98E-05	LIPA	3988
VST5S5FCZJ	chr10	102832531	102832532	T	A	NC_000010.11:g.102832532T>A	NM_000102.3:c.1118A>T	NP_000093.1:p.His373Leu			CM930182	rs760695410	17-alpha-hydroxylase deficiency	1118A>T	EAS	0.000174054	CYP17A1	1586
VSMETMLRK4	chr10	102837198	102837202	TGAA	T	NC_000010.11:g.102837204_102837206delAAG	NM_000102.3:c.160_162delTTC	NP_000093.1:p.Phe54del		16817	CD890143	rs121434319	17-alpha-hydroxylase deficiency	160_162delTTC	SAS	0.000194919	CYP17A1	1586
VSZ46X4R7A	chr10	102837223	102837224	G	A	NC_000010.11:g.102837224G>A	NM_000102.3:c.138C>T	NP_000093.1:p.His46His		314018		rs6162	fingerprint variant		EAS	0.56795001	CYP17A1	1586
VS8YLR2QMJ	chr11	5225677	5225678	C	T	NC_000011.10:g.5225678C>T	NM_000518.4:c.364G>A	NP_000509.1:p.Glu122Lys	Hb O	30331	CM930381	rs33946267	"Hemoglobinopathy, Hb O"	364G>A	AFR	6.53E-05	HBB	3043
VSTBNS55L2	chr11	5225677	5225678	C	G	NC_000011.10:g.5225678C>G	NM_000518.4:c.364G>C	NP_000509.1:p.Glu122Gln	Hb D	30191	CM900124	rs33946267	"Hemoglobinopathy, Hb D"	364G>C	SAS	0.00497044	HBB	3043
VS2ELQPW8Y	chr11	5225727	5225728	T	G	NC_000011.10:g.5225728T>G	NM_000518.4:c.316-2A>C			34042	CS860020	rs33914668	Beta-thalassemia	316-2A>C			HBB	3043
VSPMEJV8VQ	chr11	5225727	5225728	T	C	NC_000011.10:g.5225728T>C	NM_000518.4:c.316-2A>G			34043	CS840009	rs33914668	Beta-thalassemia	316-2A>G	AFR	0.000130685	HBB	3043
VSJWDSDDUU	chr11	5226575	5226576	C	T	NC_000011.10:g.5226576C>T	NM_000518.4:c.315+1G>A			30477	CS820006	rs33945777	Beta-thalassemia	315+1G>A	AFR	0.000196027	HBB	3043
VSYIG695E2	chr11	5226755	5226757	AG	A	NC_000011.10:g.5226758delG	NM_000518.4:c.135delC	NP_000509.1:p.Phe46fs		30454	CD820008	rs80356820	Beta-thalassemia	135delC	NFE	2.69E-05	HBB	3043
VSDBJQ4WJN	chr11	5226761	5226766	CAAAG	C	NC_000011.10:g.5226765_5226768delAGAA	NM_000518.4:c.126_129delCTTT	NP_000509.1:p.Phe42fs		30456	CD830011	rs1235072590	Beta-thalassemia	126_129delCTTT	EAS	0.00203134	HBB	3043
VS6NYSUMLR	chr11	5226773	5226774	G	A	NC_000011.10:g.5226774G>A	NM_000518.4:c.118C>T	NP_000509.1:p.Gln40*		30441	CM810001	rs11549407	Beta-thalassemia	118C>T	NFE	0.000671826	HBB	3043
VSSPZIJ9BD	chr11	5226799	5226800	C	T	NC_000011.10:g.5226800C>T	NM_000518.4:c.93-1G>A			30485	CS900251	rs33943001	Beta-thalassemia	93-1G>A			HBB	3043
VS9QGSZ6YB	chr11	5226819	5226820	C	T	NC_000011.10:g.5226820C>T	NM_000518.4:c.93-21G>A			30493	CS810003	rs35004220	Beta-thalassemia	93-21G>A	NFE	0.000278456	HBB	3043
TP2016011	chr11	5226923	5226924	A	G	NC_000011.10:g.5226924A>G	NM_000518.4:c.92+6T>C			30489	CS820004	rs35724775	Beta-thalassemia	92+6T>C	NFE	0.000224014	HBB	3043
TP2016010	chr11	5226924	5226925	C	G	NC_000011.10:g.5226925C>G	NM_000518.4:c.92+5G>C			30486	CS830004	rs33915217	Beta-thalassemia	92+5G>C	SAS	0.0049061	HBB	3043
TP2016009	chr11	5226928	5226929	C	T	NC_000011.10:g.5226929C>T	NM_000518.4:c.92+1G>A			30475	CS991412	rs33971440	Beta-thalassemia	92+1G>A	NFE	0.000161276	HBB	3043
VS6P5Z374F	chr11	5226942	5226943	C	T	NC_000011.10:g.5226943C>T	NM_000518.4:c.79G>A	NP_000509.1:p.Glu27Lys	Hb E	30200	CM820002	rs33950507	"Hemoglobinopathy, Hb E"	79G>A	SAS	0.00113703	HBB	3043
VSRJAK4EUT	chr11	5226946	5226947	A	T	NC_000011.10:g.5226947A>T	NM_000518.4:c.75T>A	NP_000509.1:p.Gly25Gly		30498	CS830005	rs33951465	Beta-thalassemia	75T>A	AFR	6.54E-05	HBB	3043
VSQJJGLDGM	chr11	5226962	5226963	T	C	NC_000011.10:g.5226963T>C	NM_000518.4:c.59A>G	NP_000509.1:p.Asn20Ser		30297	CM890058	rs33972047	Beta-thalassemia	59A>G			HBB	3043
VSHNULBX6Z	chr11	5226969	5226971	TG	T	NC_000011.10:g.5226971delG	NM_000518.4:c.51delC	NP_000509.1:p.Lys18fs		30453	CD951723	rs35662066	Beta-thalassemia	51delC	SAS	0.000292379	HBB	3043
VSMDW5BD54	chr11	5226969	5226970	T	A	NC_000011.10:g.5226970T>A	NM_000518.4:c.52A>T	NP_000509.1:p.Lys18*		30440	CM790002	rs33986703	Beta-thalassemia	52A>T	EAS	0.000522345	HBB	3043
VSXSL6K7CH	chr11	5226974	5226975	C	T	NC_000011.10:g.5226975C>T	NM_000518.4:c.47G>A	NP_000509.1:p.Trp16*		30442	CM840003	rs63750783	Beta-thalassemia	47G>A	SAS	0.000649773	HBB	3043
VS9J7U41JK	chr11	5226993	5226994	A	AC	NC_000011.10:g.5226995dupC	NM_000518.4:c.27dupG	NP_000509.1:p.Ser10fs		44972	CI931090	rs35699606	Beta-thalassemia	27dupG	SAS	0.00204678	HBB	3043
VSNX3CFA7G	chr11	5226994	5226997	CTT	C	NC_000011.10:g.5226996_5226997delTT	NM_000518.4:c.25_26delAA	NP_000509.1:p.Lys9fs		30452	CD890152	rs35497102	Beta-thalassemia	25_26delAA	SAS	6.52E-05	HBB	3043
VS44V8MHW3	chr11	5226996	5227000	TCTC	T	NC_000011.10:g.5227001_5227003delCTC	NM_000518.4:c.22_24delGAG	NP_000509.1:p.Glu8del		30286	CD800001	rs63750928	Beta-thalassemia	22_24delGAG			HBB	3043
VSZDANWLNW	chr11	5227001	5227002	T	A	NC_000011.10:g.5227002T>A	NM_000518.4:c.20A>T	NP_000509.1:p.Glu7Val	Sickle Cell (Hb S)	30372	CM880038	rs334	Sickle cell anemia (Hb S)	20A>T	AFR	0.047771499	HBB	3043
VS1ECXWW4C	chr11	5227002	5227003	C	T	NC_000011.10:g.5227003C>T	NM_000518.4:c.19G>A	NP_000509.1:p.Glu7Lys	Hb C	30165	CM930366	rs33930165	"Hemoglobinopathy, Hb C"	19G>A	AFR	0.0130065	HBB	3043
VSY76CQRBM	chr11	5227098	5227099	T	C	NC_000011.10:g.5227099T>C	NM_000518.4:c.-78A>G			30510	CR830009	rs33931746	Beta-thalassemia	-78A>G/-28A>G			HBB	3043
VS5AKT5PBG	chr11	5227099	5227100	T	C	NC_000011.10:g.5227100T>C	NM_000518.4:c.-79A>G			30508	CR840011	rs34598529	Beta-thalassemia	-79A>G/-29A>G			HBB	3043
VSIJHNC33V	chr11	5227158	5227159	G	A	NC_000011.10:g.5227159G>A	NM_000518.4:c.-138C>T			30499	CR840012	rs33944208	Beta-thalassemia	-138C>T			HBB	3043
VS48F1843A	chr11	6391975	6391976	T	C	NC_000011.10:g.6391976T>C	NM_000543.4:c.911T>C	NP_000534.3:p.Leu304Pro		18028	CM920624	rs120074124	"Niemann-Pick disease, type A and B"	p.L302P	ASJ	0.000406091	SMPD1	6609
VS3DEAE250	chr11	6392054	6392056	TC	T	NC_000011.10:g.6392061delC	NM_000543.4:c.996delC	NP_000534.3:p.Phe333fs		18029	CD931053	rs1408292116	"Niemann-Pick disease, type A and B"	fs330	ASJ	0.00132033	SMPD1	6609
VS5E1E8675	chr11	6394203	6394204	G	T	NC_000011.10:g.6394204G>T	NM_000543.4:c.1493G>T	NP_000534.3:p.Arg498Leu		18019	CM910355	rs120074117	"Niemann-Pick disease, type A and B"	p.R496L	ASJ	0.00274614	SMPD1	6609
VS1BEA9F5F	chr11	6394535	6394539	TGCC	T	NC_000011.10:g.6394540_6394542delGCC	NM_000543.4:c.1829_1831delGCC	NP_000534.3:p.Arg610del		195254	CD910554	rs120074118	"Niemann-Pick disease, type A and B"	delR608	ASJ	0.000406669	SMPD1	6609
VSISBKBVEB	chr11	6616695	6616696	C	A	NC_000011.10:g.6616696C>A	NM_000391.3:c.851G>T	NP_000382.3:p.Gly284Val		17686	CM003658	rs119455957	"Neuronal ceroid lipofuscinosis, TPP1-related"	851G>T	NFE	1.79E-05	TPP1	1200
VS2C3DNGU9	chr11	6617039	6617040	G	A	NC_000011.10:g.6617040G>A	NM_000391.3:c.622C>T	NP_000382.3:p.Arg208*		17682	CM970326	rs119455955	"Neuronal ceroid lipofuscinosis, TPP1-related"	622C>T	NFE	0.000439454	TPP1	1200
VSB3DNYMDG	chr11	6617153	6617154	C	G	NC_000011.10:g.6617154C>G	NM_000391.3:c.509-1G>C			17683	CS971663	rs56144125	"Neuronal ceroid lipofuscinosis, TPP1-related"	509-1G>C	NFE	0.00085101	TPP1	1200
VS21VNLAUR	chr11	17387489	17387490	C	T	NC_000011.10:g.17387490C>T	NM_000525.3:c.602G>A	NP_000516.3:p.Arg201His		23705	CM040764	rs80356624	"Familial hyperinsulinism, KCNJ11-related"	602G>A			KCNJ11	3767
VSQCCN1E2Y	chr11	17387490	17387491	G	A	NC_000011.10:g.17387491G>A	NM_000525.3:c.601C>T	NP_000516.3:p.Arg201Cys		23707	CM040763	rs80356625	"Familial hyperinsulinism, KCNJ11-related"	601C>T			KCNJ11	3767
VS3H5BQTH6	chr11	17387592	17387593	T	G	NC_000011.10:g.17387593T>G	NM_000525.3:c.499A>C	NP_000516.3:p.Ile167Leu		23719	CM074293	rs80356620	"Familial hyperinsulinism, KCNJ11-related"	499A>C			KCNJ11	3767
VSTADRW5VV	chr11	17387915	17387916	A	C	NC_000011.10:g.17387916A>C	NM_000525.3:c.176T>G	NP_000516.3:p.Val59Gly		23708	CM040761	rs80356617	"Familial hyperinsulinism, KCNJ11-related"	176T>G			KCNJ11	3767
VSLZMMCVKX	chr11	17387916	17387917	C	T	NC_000011.10:g.17387917C>T	NM_000525.3:c.175G>A	NP_000516.3:p.Val59Met		23706	CM040762	rs80356616	"Familial hyperinsulinism, KCNJ11-related"	175G>A			KCNJ11	3767
VSS8DU2QUY	chr11	17387933	17387934	C	T	NC_000011.10:g.17387934C>T	NM_000525.3:c.158G>A	NP_000516.3:p.Gly53Asp		23724	CM045416	rs80356615	"Familial hyperinsulinism, KCNJ11-related"	158G>A			KCNJ11	3767
VS3FCF8F9D	chr11	17395886	17395890	GAGA	G	NC_000011.10:g.17395890_17395892delAAG	NM_000352.4:c.4160_4162delTCT	NP_000343.2:p.Phe1387del		194041	CD962164	rs1213140867	"Familial hyperinsulinism, ABCC8-related"	delF1388	ASJ	0.000336097	ABCC8	6833
VS0DE990ED	chr11	17397054	17397055	C	T	NC_000011.10:g.17397055C>T	NM_000352.4:c.3989-9G>A			24127	CS951534	rs151344623	"Familial hyperinsulinism, ABCC8-related"	c.3992-9G>A	ASJ	0.00568528	ABCC8	6833
VSGPYR51AZ	chr11	17531407	17531408	C	CG	NC_000011.10:g.17531414dupG	NM_005709.3:c.238dupC	NP_005700.2:p.Arg80fs		20180	CI002571	rs397515359	"Usher syndrome, type IC"	238dupC	ASJ	0.00162833	USH1C	10083
VSY17AV2IE	chr11	17531430	17531431	C	T	NC_000011.10:g.17531431C>T	NM_005709.3:c.216G>A	NP_005700.2:p.Val72Val		20182	CS002472	rs151045328	"Usher syndrome, type IC"	216G>A	NFE	8.07E-05	USH1C	10083
VSLZJ2F873	chr11	36573558	36573561	TAA	T	NC_000011.10:g.36573560_36573561delAA	NM_000448.2:c.256_257delAA	NP_000439.1:p.Lys86fs		269282	CD982919	rs772962160	"Severe combined immunodeficiency, RAG1-related"	256_257delAA	NFE	5.39E-05	RAG1	5896
VSD7Y21MVJ	chr11	36573933	36573935	CT	C	NC_000011.10:g.36573935delT	NM_000448.2:c.631delT	NP_000439.1:p.Cys211fs			CD127374		"Severe combined immunodeficiency, RAG1-related"	631delT			RAG1	5896
VSWSCL5ZDD	chr11	36574489	36574490	C	T	NC_000011.10:g.36574490C>T	NM_000448.2:c.1186C>T	NP_000439.1:p.Arg396Cys		28183	CM981692	rs104894289	"Severe combined immunodeficiency, RAG1-related"	1186C>T	NFE	1.80E-05	RAG1	5896
VSFIBQQKJI	chr11	36574869	36574870	G	T	NC_000011.10:g.36574870G>T	NM_000448.2:c.1566G>T	NP_000439.1:p.Trp522Cys		45371	CM010075	rs193922461	"Severe combined immunodeficiency, RAG1-related"	1566G>T	NFE	0.000224602	RAG1	5896
VSY66AUBUX	chr11	36574984	36574985	C	T	NC_000011.10:g.36574985C>T	NM_000448.2:c.1681C>T	NP_000439.1:p.Arg561Cys		28187	CM981695	rs104894285	"Severe combined immunodeficiency, RAG1-related"	1681C>T	NFE	3.60E-05	RAG1	5896
VSPLGWD5VG	chr11	36574985	36574986	G	A	NC_000011.10:g.36574986G>A	NM_000448.2:c.1682G>A	NP_000439.1:p.Arg561His		28182	CM981694	rs104894284	"Severe combined immunodeficiency, RAG1-related"	1682G>A	AMR	2.98E-05	RAG1	5896
VS77ED889A	chr11	46739504	46739505	G	A	NC_000011.10:g.46739505G>A	NM_000506.4:c.*97G>A			28349	CR961726	rs1799963	F2	G20210A			F2	2147
VSCC683A1A	chr11	61393964	61393965	G	T	NC_000011.10:g.61393965G>T	NM_001173990.2:c.218G>T	NP_001167461.1:p.Arg73Leu		15236	CM100170	rs201108965	Joubert syndrome 2	p.R12L	ASJ	0.0035533	TMEM216	51259
VSB7VUCEQC	chr11	64746795	64746796	A	G	NC_000011.10:g.64746796A>G	NM_005609.2:c.2392T>C	NP_005600.1:p.Trp798Arg		17351	CM001321	rs119103258	"Glycogen storage disease, type V"	2392T>C	AMR	5.96E-05	PYGM	5837
VSGGVVDFNJ	chr11	64750421	64750425	TGAA	T	NC_000011.10:g.64750427_64750429delAAG	NM_005609.2:c.2128_2130delTTC	NP_005600.1:p.Phe710del		143234	CD941765	rs527236147	"Glycogen storage disease, type V"	2128_2130delTTC	EAS	0.000231911	PYGM	5837
VSILKZDJU6	chr11	64751596	64751597	C	T	NC_000011.10:g.64751597C>T	NM_005609.2:c.1827G>A	NP_005600.1:p.Lys609Lys		17352	CS032423	rs119103259	"Glycogen storage disease, type V"	1827G>A	AMR	2.98E-05	PYGM	5837
VS897PGB18	chr11	64752063	64752064	T	G	NC_000011.10:g.64752064T>G	NM_005609.2:c.1628A>C	NP_005600.1:p.Lys543Thr		17339	CM930631	rs119103252	"Glycogen storage disease, type V"	1628A>C			PYGM	5837
VSX944PV6U	chr11	64752064	64752065	T	A	NC_000011.10:g.64752065T>A	NM_005609.2:c.1627A>T	NP_005600.1:p.Lys543*			CM063079		"Glycogen storage disease, type V"	1627A>T			PYGM	5837
VSX1IPASQM	chr11	64757825	64757826	C	T	NC_000011.10:g.64757826C>T	NM_005609.2:c.613G>A	NP_005600.1:p.Gly205Ser		17338	CM930630	rs119103251	"Glycogen storage disease, type V"	613G>A	NFE	0.000206089	PYGM	5837
VSGP5E4SDS	chr11	64758692	64758693	G	T	NC_000011.10:g.64758693G>T	NM_005609.2:c.255C>A	NP_005600.1:p.Tyr85*		143233	CM030270	rs527236146	"Glycogen storage disease, type V"	255C>A			PYGM	5837
VSHFZCLYJ4	chr11	64759750	64759751	G	A	NC_000011.10:g.64759751G>A	NM_005609.2:c.148C>T	NP_005600.1:p.Arg50*		17337	CM930629	rs116987552	"Glycogen storage disease, type V"	148C>T	NFE	0.00242653	PYGM	5837
VSZRA6E2NS	chr11	65720384	65720385	G	A	NC_000011.10:g.65720385G>A	NM_032193.3:c.205C>T	NP_115569.2:p.Arg69Trp		16299	CM063107	rs78635798	"Aicardi-Goutieres syndrome, RNASEH2C-related"	205C>T	SAS	0.000682217	RNASEH2C	84153
VSYTJEVGV8	chr11	66526180	66526181	T	G	NC_000011.10:g.66526181T>G	NM_024649.4:c.1169T>G	NP_078925.3:p.Met390Arg		27182	CM021489	rs113624356	"Bardet-Biedl syndrome, BBS1-related"	1169T>G	NFE	0.00273209	BBS1	582
VSQ6MT46YR	chr11	68760237	68760238	C	T	NC_000011.10:g.68760238C>T	NM_001876.3:c.2129G>A	NP_001867.2:p.Gly710Glu		24110	CM993447	rs80356780	Carnitine palmitoyltransferase I deficiency	2129G>A	EAS	5.85E-05	CPT1A	1374
VS848T8C2H	chr11	68760240	68760241	C	T	NC_000011.10:g.68760241C>T	NM_001876.3:c.2126G>A	NP_001867.2:p.Gly709Glu		24108	CM033598	rs28936374	Carnitine palmitoyltransferase I deficiency	2126G>A			CPT1A	1374
VS1QDFED3V	chr11	68775397	68775398	T	C	NC_000011.10:g.68775398T>C	NM_001876.3:c.1493A>G	NP_001867.2:p.Tyr498Cys		24105	CM021572	rs80356791	Carnitine palmitoyltransferase I deficiency	1493A>G	SAS	3.25E-05	CPT1A	1374
VSSWEEBXSU	chr11	68780661	68780662	G	A	NC_000011.10:g.68780662G>A	NM_001876.3:c.1436C>T	NP_001867.2:p.Pro479Leu		76552	CM016082	rs80356779	Carnitine palmitoyltransferase I deficiency	1436C>T	AMR	5.96E-05	CPT1A	1374
VSLQW2F8Y5	chr11	68780736	68780737	T	C	NC_000011.10:g.68780737T>C	NM_001876.3:c.1361A>G	NP_001867.2:p.Asp454Gly		24100	CM983369	rs80356778	Carnitine palmitoyltransferase I deficiency	1361A>G			CPT1A	1374
VS8VJWZ1A2	chr11	68781881	68781882	G	A	NC_000011.10:g.68781882G>A	NM_001876.3:c.1241C>T	NP_001867.2:p.Ala414Val		24104	CM021571	rs80356790	Carnitine palmitoyltransferase I deficiency	1241C>T			CPT1A	1374
VSMFG1CWZS	chr11	68784898	68784899	T	C	NC_000011.10:g.68784899T>C	NM_001876.3:c.1079A>G	NP_001867.2:p.Glu360Gly		24101	CM042966	rs80356787	Carnitine palmitoyltransferase I deficiency	1079A>G			CPT1A	1374
VS20160212	chr11	71435839	71435840	C	G	NC_000011.10:g.71435840C>G	NM_001360.2:c.964-1G>C			99628	CS982160	rs138659167	Smith-Lemli-Opitz syndrome	IVS8-1G>C	ASJ	0.0117546	DHCR7	1717
VSI9876IM3	chr11	77142782	77142783	C	A	NC_000011.10:g.77142783C>A	NM_000260.3:c.93C>A	NP_000251.3:p.Cys31*		26898	CM961009	rs35689081	"Usher syndrome, type IB"	93C>A	NFE	8.26E-05	MYO7A	4647
VSH2LETGBA	chr11	77156068	77156069	C	T	NC_000011.10:g.77156069C>T	NM_000260.3:c.448C>T	NP_000251.3:p.Arg150*		26886	CM950826	rs121965079	"Usher syndrome, type IB"	448C>T			MYO7A	4647
VSNNUU5CIB	chr11	77156903	77156904	G	A	NC_000011.10:g.77156904G>A	NM_000260.3:c.635G>A	NP_000251.3:p.Arg212His		26889	CM950827	rs28934610	"Usher syndrome, type IB"	635G>A	NFE	2.69E-05	MYO7A	4647
VSK33AM53Z	chr11	77156968	77156969	C	T	NC_000011.10:g.77156969C>T	NM_000260.3:c.700C>T	NP_000251.3:p.Gln234*		26887	CM950829	rs41298133	"Usher syndrome, type IB"	700C>T	AMR	8.93E-05	MYO7A	4647
VS7AST6PYA	chr11	77156999	77157000	G	C	NC_000011.10:g.77157000G>C	NM_000260.3:c.731G>C	NP_000251.3:p.Arg244Pro		26892	CM971012	rs121965081	"Usher syndrome, type IB"	731G>C			MYO7A	4647
VS68MQPXZ6	chr11	77174815	77174816	C	T	NC_000011.10:g.77174816C>T	NM_000260.3:c.1996C>T	NP_000251.3:p.Arg666*		26899	CM990896	rs121965085	"Usher syndrome, type IB"	1996C>T	NFE	3.62E-05	MYO7A	4647
VSFSRZ43N9	chr11	94476317	94476318	C	G	NC_000011.10:g.94476318C>G	NM_005591.3:c.630G>C	NP_005582.1:p.Trp210Cys		23825	CM050004	rs137852763	Ataxia-telangiectasia-like disorder	630G>C			MRE11A	4361
VSTQS4CI8K	chr11	108141687	108141688	C	T	NC_000011.10:g.108141688C>T	NM_000019.3:c.814C>T	NP_000010.1:p.Gln272*		17879	CM940006	rs120074144	Beta-ketothiolase deficiency	814C>T	NFE	8.98E-06	ACAT1	38
VSUM547QE7	chr11	108227805	108227806	C	T	NC_000011.10:g.108227806C>T	NM_000051.3:c.103C>T	NP_000042.3:p.Arg35*		18064	CM960096	rs55861249	Ataxia-telangiectasia	103C>T	AMR	8.93E-05	ATM	472
VSKQUPSJQ9	chr11	108248986	108248987	C	T	NC_000011.10:g.108248987C>T	NM_000051.3:c.1120C>T	NP_000042.3:p.Gln374*		545967	CM980135		Ataxia-telangiectasia	1120C>T			ATM	472
VS63PNJGZ9	chr11	108251024	108251027	CAG	C	NC_000011.10:g.108251029_108251030delGA	NM_000051.3:c.1564_1565delGA	NP_000042.3:p.Glu522fs		132797	CD961794	rs1374409941	Ataxia-telangiectasia	1564_1565delGA	NFE	9.86E-05	ATM	472
VSF7SGSVUY	chr11	108257470	108257471	T	G	NC_000011.10:g.108257471T>G	NM_000051.3:c.2251-10T>G			180411	CS982069	rs730881346	Ataxia-telangiectasia	2251-10T>G	NFE	1.79E-05	ATM	472
VSU5QBHU5B	chr11	108268574	108268575	C	CGCTA	NC_000011.10:g.108268577_108268580dupCTAG	NM_000051.3:c.2806_2809dupCTAG	NP_000042.3:p.Glu937fs		408108	CI983032	rs1064794235	Ataxia-telangiectasia	2806_2809dupCTAG			ATM	472
VSNNY4J4L3	chr11	108281167	108281168	G	A	NC_000011.10:g.108281168G>A	NM_000051.3:c.3576G>A	NP_000042.3:p.Lys1192Lys		18074	CS961477	rs587776551	Ataxia-telangiectasia	3576G>A	NFE	3.59E-05	ATM	472
VSPFMTET1L	chr11	108284369	108284370	A	AT	NC_000011.10:g.108284374dupT	NM_000051.3:c.3894dupT	NP_000042.3:p.Ala1299fs		151248	CI991965	rs1169704167	Ataxia-telangiectasia	3894dupT	NFE	8.97E-06	ATM	472
VSJAHVRFHI	chr11	108292688	108292689	C	T	NC_000011.10:g.108292689C>T	NM_000051.3:c.4507C>T	NP_000042.3:p.Gln1503*		421079	CM980139	rs1131691164	Ataxia-telangiectasia	4507C>T	AMR	8.94E-05	ATM	472
VS6TAM5ZVX	chr11	108295001	108295002	C	T	NC_000011.10:g.108295002C>T	NM_000051.3:c.4852C>T	NP_000042.3:p.Arg1618*		183303	CM983653	rs762083530	Ataxia-telangiectasia	4852C>T	SAS	3.25E-05	ATM	472
VSV2RKSQJ9	chr11	108310304	108310305	C	T	NC_000011.10:g.108310305C>T	NM_000051.3:c.5908C>T	NP_000042.3:p.Gln1970*		151118	CM980146	rs587781722	Ataxia-telangiectasia	5908C>T	AMR	0.000208731	ATM	472
VSI2N8T56I	chr11	108312423	108312424	G	T	NC_000011.10:g.108312424G>T	NM_000051.3:c.5932G>T	NP_000042.3:p.Glu1978*		132871	CM980147	rs587779852	Ataxia-telangiectasia	5932G>T	NFE	9.86E-05	ATM	472
VSJ5I8QJQ5	chr11	108315910	108315911	G	A	NC_000011.10:g.108315911G>A	NM_000051.3:c.6095G>A	NP_000042.3:p.Arg2032Lys		180483	CM990215	rs139770721	Ataxia-telangiectasia	6095G>A	NFE	6.27E-05	ATM	472
VSF7459H76	chr11	108327676	108327679	ATG	A	NC_000011.10:g.108327679_108327680delGT	NM_000051.3:c.7010_7011delGT	NP_000042.3:p.Cys2337fs		222108	CD961809	rs864622416	Ataxia-telangiectasia	7010_7011delGT			ATM	472
VSCVH4H7GE	chr11	108330232	108330233	C	T	NC_000011.10:g.108330233C>T	NM_000051.3:c.7327C>T	NP_000042.3:p.Arg2443*		18075	CM960104	rs121434220	Ataxia-telangiectasia	7327C>T	NFE	8.98E-06	ATM	472
VSDSVXT5WP	chr11	108330354	108330355	G	A	NC_000011.10:g.108330355G>A	NM_000051.3:c.7449G>A	NP_000042.3:p.Trp2483*		244641	CM980148	rs773516672	Ataxia-telangiectasia	7449G>A	AMR	8.93E-05	ATM	472
VSXAX4W2D6	chr11	108331440	108331445	TAGAG	T	NC_000011.10:g.108331445_108331448delGAGA	NM_000051.3:c.7517_7520delGAGA	NP_000042.3:p.Arg2506fs		151361	CD961811	rs1484059922	Ataxia-telangiectasia	7517_7520delGAGA	SAS	3.26E-05	ATM	472
VSZPLPB212	chr11	108331883	108331893	CTCTAGAATT	C	NC_000011.10:g.108331887_108331895del	NM_000051.3:c.7638_7646del	NP_000042.3:p.Arg2547_Ser2549del		18058	CD961812	rs587776547	Ataxia-telangiectasia	7638_7646delTAGAATTTC	AFR	6.54E-05	ATM	472
VSIST524LA	chr11	108332898	108332899	A	C	NC_000011.10:g.108332899A>C	NM_000051.3:c.7926A>C	NP_000042.3:p.Arg2642Ser		212910	CM960106	rs863224440	Ataxia-telangiectasia	7926A>C			ATM	472
VSDKJ4TP5R	chr11	108335893	108335904	TGTGTAATACA	GACCTG	NC_000011.10:g.108335894_108335904delinsGACCTG	NM_000051.3:c.8201_8211delinsGACCTG	NP_000042.3:p.Met2734fs			CX057621		Ataxia-telangiectasia	8201_8211delTGTGTAATACAinsGACCTG			ATM	472
VSFZUHGASP	chr11	108335955	108335961	TATAAG	T	NC_000011.10:g.108335957_108335961delATAAG	NM_000051.3:c.8264_8268delATAAG	NP_000042.3:p.Tyr2755fs		180515	CD982467	rs730881294	Ataxia-telangiectasia	8264_8268delATAAG	AMR	5.96E-05	ATM	472
VSAZKITHZE	chr11	108345817	108345818	C	T	NC_000011.10:g.108345818C>T	NM_000051.3:c.8494C>T	NP_000042.3:p.Arg2832Cys		132916	CM980159	rs587779872	Ataxia-telangiectasia	8494C>T	AFR	0.000130753	ATM	472
VSEYAW3I11	chr11	119025269	119025272	CAG	C	NC_000011.10:g.119025271_119025272delAG	NM_001164277.1:c.1042_1043delCT	NP_001157749.1:p.Leu348fs		21965	CD982664	rs80356491	"Glycogen storage disease, type IB"	1211delCT	AMR	0.000330887	SLC37A4	2542
VSPKICA3M4	chr11	119025298	119025299	C	A	NC_000011.10:g.119025299C>A	NM_001164277.1:c.1015G>T	NP_001157749.1:p.Gly339Cys		21960	CM970551	rs80356490	"Glycogen storage disease, type IB"	1015G>T	NFE	0.000128403	SLC37A4	2542
VSKZ637XYT	chr11	119028222	119028223	A	G	NC_000011.10:g.119028223A>G	NM_001164277.1:c.352T>C	NP_001157749.1:p.Trp118Arg		21962	CM980796	rs80356489	"Glycogen storage disease, type IB"	352T>C			SLC37A4	2542
VSSUAMCIKC	chr12	48131393	48131394	G	A	NC_000012.12:g.48131394G>A	NM_000289.5:c.237+1G>A			187120	CS930857	rs202143236	"Glycogen storage disease, type VII"	237+1G>A	ASJ	0.00223396	PFKM	5213
VSCI4MZQ18	chr12	48145037	48145039	GC	G	NC_000012.12:g.48145041delC	NM_000289.5:c.2003delC	NP_000280.1:p.Pro668fs			CD941757	rs767095759	"Glycogen storage disease, type VII"	2003delC	ASJ	0.00243704	PFKM	5213
VSG1I85HFM	chr12	53308050	53308051	C	T	NC_000012.12:g.53308051C>T	NM_015665.5:c.1331+1G>A			260025	CS003065	rs150511103	Achalasia-addisonianism-alacrima syndrome	1331+1G>A	AMR	0.000148889	AAAS	8086
VS29XZ1KZ9	chr12	53309623	53309624	A	G	NC_000012.12:g.53309624A>G	NM_015665.5:c.787T>C	NP_056480.1:p.Ser263Pro		20084	CM010150	rs121918550	Achalasia-addisonianism-alacrima syndrome	787T>C	FIN	0.000718714	AAAS	8086
VSAI7CXN6W	chr12	57766129	57766131	AC	A	NC_000012.12:g.57766131delC	NM_000785.3:c.262delG	NP_000776.1:p.Val88fs		16703	CD982587	rs387906260	"Vitamin D-dependent rickets, type I"	262delG	NFE	9.71E-05	CYP27B1	1594
VSRMGSL4QU	chr12	76347712	76347713	C	CA	NC_000012.12:g.76347716dupA	NM_024685.3:c.271dupT	NP_078961.3:p.Cys91fs		16367	CI064666	rs549625604	"Bardet-Biedl syndrome, BBS10-related"	271dupT	NFE	0.00104503	BBS10	79738
VS84HCWX6E	chr12	101753408	101753409	G	A	NC_000012.12:g.101753409G>A	NM_024312.4:c.3565C>T	NP_077288.2:p.Arg1189*		17803	CM053911	rs137852897	"Mucolipidosis, type II/III alpha/beta"	3565C>T	EAS	0.000115955	GNPTAB	79158
VSQIJZ4FEP	chr12	101753468	101753471	TGA	T	NC_000012.12:g.101753472_101753473delGA	NM_024312.4:c.3503_3504delTC	NP_077288.2:p.Leu1168fs		17810	CD060604	rs34002892	"Mucolipidosis, type II/III alpha/beta"	3503_3504delTC	SAS	0.000714703	GNPTAB	79158
VSAPMRU3PI	chr12	101770184	101770185	A	G	NC_000012.12:g.101770185A>G	NM_024312.4:c.1120T>C	NP_077288.2:p.Phe374Leu		17814	CM090831	rs137852900	"Mucolipidosis, type II/III alpha/beta"	1120T>C			GNPTAB	79158
VS6151NJB3	chr12	102840398	102840399	C	T	NC_000012.12:g.102840399C>T	NM_000277.1:c.1315+1G>A			15615	CS860021	rs5030861	Phenylalanine hydroxylase deficiency	1315+1G>A	NFE	0.000823664	PAH	5053
VSN6AQ38XK	chr12	102840491	102840492	C	T	NC_000012.12:g.102840492C>T	NM_000277.1:c.1223G>A	NP_000268.1:p.Arg408Gln		15651	CM920562	rs5030859	Phenylalanine hydroxylase deficiency	1223G>A	EAS	0.000289922	PAH	5053
VSCHBETGL6	chr12	102840492	102840493	G	A	NC_000012.12:g.102840493G>A	NM_000277.1:c.1222C>T	NP_000268.1:p.Arg408Trp		15616	CM870016	rs5030858	Phenylalanine hydroxylase deficiency	1222C>T	NFE	0.00149516	PAH	5053
VSKWZ118XY	chr12	102843789	102843790	C	T	NC_000012.12:g.102843790C>T	NM_000277.1:c.1066-11G>A			15646	CS910455	rs5030855	Phenylalanine hydroxylase deficiency	1066-11G>A	NFE	0.000404393	PAH	5053
VSCQUSH6FT	chr12	102851742	102851743	C	T	NC_000012.12:g.102851743C>T	NM_000277.1:c.856G>A	NP_000268.1:p.Glu286Lys		108616	CM040236	rs62508739	Phenylalanine hydroxylase deficiency	856G>A	EAS	0.000116036	PAH	5053
VS4WE85PHP	chr12	102852935	102852936	G	A	NC_000012.12:g.102852936G>A	NM_000277.1:c.721C>T	NP_000268.1:p.Arg241Cys		108539	CM930548	rs76687508	Phenylalanine hydroxylase deficiency	721C>T	EAS	0.00133535	PAH	5053
VSQF5XCN9H	chr12	109557080	109557081	G	A	NC_000012.12:g.109557081G>A	NM_052845.3:c.700C>T	NP_443077.1:p.Gln234*		200226	CM061122	rs369296618	"Methylmalonic aciduria, cblB type"	700C>T	NFE	6.27E-05	MMAB	326625
VSXEQ9MBA5	chr12	109561051	109561052	C	T	NC_000012.12:g.109561052C>T	NM_052845.3:c.572G>A	NP_443077.1:p.Arg191Gln		216056	CM061120	rs746219370	"Methylmalonic aciduria, cblB type"	572G>A	AMR	2.98E-05	MMAB	326625
VSZT7X6Y55	chr12	109561052	109561053	G	A	NC_000012.12:g.109561053G>A	NM_052845.3:c.571C>T	NP_443077.1:p.Arg191Trp		215031	CM023191	rs376128990	"Methylmalonic aciduria, cblB type"	571C>T	AFR	6.56E-05	MMAB	326625
VSUIKV11CC	chr12	109561054	109561055	C	T	NC_000012.12:g.109561055C>T	NM_052845.3:c.569G>A	NP_443077.1:p.Arg190His		200228	CM061118	rs756414548	"Methylmalonic aciduria, cblB type"	569G>A	NFE	8.98E-06	MMAB	326625
VSFG6BLJ3X	chr12	109561055	109561056	G	A	NC_000012.12:g.109561056G>A	NM_052845.3:c.568C>T	NP_443077.1:p.Arg190Cys		102138	CM061117	rs398124434	"Methylmalonic aciduria, cblB type"	568C>T	NFE	2.69E-05	MMAB	326625
VS663H8FPN	chr12	109561067	109561068	G	A	NC_000012.12:g.109561068G>A	NM_052845.3:c.556C>T	NP_443077.1:p.Arg186Trp		18134	CM023190	rs28941784	"Methylmalonic aciduria, cblB type"	556C>T	NFE	0.000206371	MMAB	326625
VSA57T5VGF	chr12	109565176	109565177	C	T	NC_000012.12:g.109565177C>T	NM_052845.3:c.291-1G>A			216058	CS023222	rs199971687	"Methylmalonic aciduria, cblB type"	291-1G>A	AFR	6.54E-05	MMAB	326625
VS2PUV4EFX	chr12	109568772	109568773	A	G	NC_000012.12:g.109568773A>G	NM_052845.3:c.287T>C	NP_443077.1:p.Ile96Thr		215030	CM050665	rs864309509	"Methylmalonic aciduria, cblB type"	287T>C			MMAB	326625
VSUNKR5VYK	chr12	109568863	109568864	C	A	NC_000012.12:g.109568864C>A	NM_052845.3:c.197-1G>T			216059	CS023221	rs763935916	"Methylmalonic aciduria, cblB type"	197-1G>T	SAS	0.000259909	MMAB	326625
VSIHGA8GSR	chr12	131932300	131932301	C	T	NC_000012.12:g.131932301C>T	NM_025215.5:c.430C>T	NP_079491.2:p.Arg144Trp		17575	CM041423	rs104894371	Mitochondrial myopathy and sideroblastic anemia 1	430C>T	AFR	6.54E-05	PUS1	80324
VSRGMLR36C	chr13	20189312	20189313	A	G	NC_000013.11:g.20189313A>G	NM_004004.5:c.269T>C	NP_003995.2:p.Leu90Pro		32055	CM990691	rs80338945	"Nonsyndromic hearing loss, GJB2-related"	269T>C	NFE	0.00123647	GJB2	2706
VSS6K6E4ZL	chr13	20189345	20189347	AG	A	NC_000013.11:g.20189349delG	NM_004004.5:c.235delC	NP_003995.2:p.Leu79fs		32053	CD991730	rs80338943	"Nonsyndromic hearing loss, GJB2-related"	235delC	EAS	0.00614564	GJB2	2706
VSAEY6NTKZ	chr13	20189352	20189353	A	G	NC_000013.11:g.20189353A>G	NM_004004.5:c.229T>C	NP_003995.2:p.Trp77Arg		32042	CM970682	rs104894397	"Nonsyndromic hearing loss, GJB2-related"	229T>C	AMR	0.000208445	GJB2	2706
VSV4A776QF	chr13	20189413	20189415	CA	C	NC_000013.11:g.20189415delA	NM_004004.5:c.167delT	NP_003995.2:p.Leu56fs		32049	CD972241	rs80338942	"Nonsyndromic hearing loss, GJB2-related"	167delT	ASJ	0.0165239	GJB2	2706
VSHAXX8N9U	chr13	20189510	20189511	C	T	NC_000013.11:g.20189511C>T	NM_004004.5:c.71G>A	NP_003995.2:p.Trp24*		32041	CM970678	rs104894396	"Nonsyndromic hearing loss, GJB2-related"	71G>A	SAS	0.00445065	GJB2	2706
VS7KJP9IDU	chr13	20189545	20189547	AC	A	NC_000013.11:g.20189552delC	NM_004004.5:c.35delG	NP_003995.2:p.Gly12fs		32043	CD972240	rs80338939	"Nonsyndromic hearing loss, GJB2-related"	35delG	NFE	0.00932669	GJB2	2706
VS51SPA3IR	chr13	23331715	23331716	G	A	NC_000013.11:g.23331716G>A	NM_014363.5:c.12160C>T	NP_055178.3:p.Gln4054*		47016	CM087684	rs281865120	Spastic ataxia of Charlevoix-Saguenay (ARSACS)	12160C>T	NFE	3.61E-05	SACS	26278
VSH539NDRK	chr13	23335030	23335032	TA	T	NC_000013.11:g.23335032delA	NM_014363.5:c.8844delT	NP_055178.3:p.Ile2949fs		20551	CD000613	rs281865117	Spastic ataxia of Charlevoix-Saguenay (ARSACS)	8844delT	NFE	0.000125734	SACS	26278
VSBAYR8H5F	chr13	23336371	23336372	G	A	NC_000013.11:g.23336372G>A	NM_014363.5:c.7504C>T	NP_055178.3:p.Arg2502*		20552	CM000568	rs281865118	Spastic ataxia of Charlevoix-Saguenay (ARSACS)	7504C>T	EAS	5.80E-05	SACS	26278
VSLIDZ647W	chr13	40799095	40799096	C	G	NC_000013.11:g.40799096C>G	NM_014252.3:c.95C>G	NP_055067.1:p.Thr32Arg		21039	CM064277	rs121908536	Ornithine translocase deficiency	95C>G			SLC25A15	10166
VSHIRN8FQQ	chr13	40807375	40807376	C	T	NC_000013.11:g.40807376C>T	NM_014252.3:c.535C>T	NP_055067.1:p.Arg179*		21033	CM001338	rs104894429	Ornithine translocase deficiency	535C>T	EAS	0.000637755	SLC25A15	10166
VS47C5ISHE	chr13	40807392	40807396	TTTC	T	NC_000013.11:g.40807403_40807405delTTC	NM_014252.3:c.562_564delTTC	NP_055067.1:p.Phe188del		21031	CD991827	rs1292727868	Ornithine translocase deficiency	562_564delTTC	NFE	0.000125318	SLC25A15	10166
VSZNNSA8U2	chr13	51937569	51937570	T	C	NC_000013.11:g.51937570T>C	NM_000053.3:c.3809A>G	NP_000044.2:p.Asn1270Ser		18898	CM930060	rs121907990	Wilson disease	3809A>G	AMR	0.00083378	ATP7B	540
VSWI18ACT1	chr13	51941193	51941194	A	G	NC_000013.11:g.51941194A>G	NM_000053.3:c.3443T>C	NP_000044.2:p.Ile1148Thr		18902	CM990276	rs60431989	Wilson disease	3443T>C	EAS	0.000405844	ATP7B	540
VSPH4H4DI8	chr13	51944144	51944145	G	T	NC_000013.11:g.51944145G>T	NM_000053.3:c.3207C>A	NP_000044.2:p.His1069Gln		18887	CM930059	rs76151636	Wilson disease	3207C>A	ASJ	0.00528133	ATP7B	540
VS7TAK2UZ6	chr13	51946437	51946438	C	T	NC_000013.11:g.51946438C>T	NM_000053.3:c.2906G>A	NP_000044.2:p.Arg969Gln		18899	CM950116	rs121907996	Wilson disease	2906G>A	SAS	9.75E-05	ATP7B	540
VSHLM1RX5J	chr13	51958332	51958333	C	A	NC_000013.11:g.51958333C>A	NM_000053.3:c.2333G>T	NP_000044.2:p.Arg778Leu		18891	CM950111	rs28942074	Wilson disease	2333G>T	EAS	0.00202922	ATP7B	540
VS1DB17RKD	chr13	51961848	51961849	A	C	NC_000013.11:g.51961849A>C	NM_000053.3:c.1934T>G	NP_000044.2:p.Met645Arg		18901	CM970138	rs121907998	Wilson disease	1934T>G	ASJ	0.00243655	ATP7B	540
VSHELRGN7B	chr13	77000916	77000919	CAT	C	NC_000013.11:g.77000920_77000921delAT	NM_006493.2:c.1175_1176delAT	NP_006484.1:p.Tyr392fs		17603	CD982542	rs1341468352	"Neuronal ceroid lipofuscinosis, CLN5-related"	1175_1176delAT	FIN	0.000827434	CLN5	1203
VSP5N6AGU2	chr13	100155089	100155090	G	A	NC_000013.11:g.100155090G>A	NM_000282.3:c.412G>A	NP_000273.2:p.Ala138Thr		47472	CM991016	rs202247814	"Propionic acidemia, PCCA-related"	412G>A			PCCA	5095
VS9FG4ENSW	chr13	100209353	100209354	T	C	NC_000013.11:g.100209354T>C	NM_000282.3:c.491T>C	NP_000273.2:p.Ile164Thr		47473	CM991017	rs202247815	"Propionic acidemia, PCCA-related"	491T>C	AMR	2.98E-05	PCCA	5095
VSQZ483ZNQ	chr13	100268730	100268731	A	G	NC_000013.11:g.100268731A>G	NM_000282.3:c.862A>G	NP_000273.2:p.Arg288Gly		47474	CM103692	rs121964957	"Propionic acidemia, PCCA-related"	862A>G	NFE	8.96E-06	PCCA	5095
VSHJHT449U	chr13	100273217	100273218	C	T	NC_000013.11:g.100273218C>T	NM_000282.3:c.937C>T	NP_000273.2:p.Arg313*		47475	CM991019	rs138149179	"Propionic acidemia, PCCA-related"	937C>T	SAS	0.000162538	PCCA	5095
VSKYC753TP	chr13	100368512	100368513	C	G	NC_000013.11:g.100368513C>G	NM_000282.3:c.1685C>G	NP_000273.2:p.Ser562*		47471	CM991023	rs202247816	"Propionic acidemia, PCCA-related"	1685C>G			PCCA	5095
VS20160224	chr14	24259812	24259813	T	C	NC_000014.9:g.24259813T>C	NM_000359.2:c.877-2A>G			264584	CS951536	rs142634031	"Lamellar ichthyosis, type I"	c.877-2A>G	NFE	0.000641408	TGM1	7051
VSMVTYSFEM	chr14	24261774	24261775	C	T	NC_000014.9:g.24261775C>T	NM_000359.2:c.428G>A	NP_000350.1:p.Arg143His		27520	CM951204	rs121918719	"Lamellar ichthyosis, type I"	428G>A	AMR	2.98E-05	TGM1	7051
VSZZ1YH85P	chr14	24261777	24261778	C	T	NC_000014.9:g.24261778C>T	NM_000359.2:c.425G>A	NP_000350.1:p.Arg142His		27524	CM951202	rs121918718	"Lamellar ichthyosis, type I"	425G>A	FIN	8.97E-05	TGM1	7051
VSTCTMWR4W	chr14	24261778	24261779	G	A	NC_000014.9:g.24261779G>A	NM_000359.2:c.424C>T	NP_000350.1:p.Arg142Cys		27522	CM951203	rs121918716	"Lamellar ichthyosis, type I"	424C>T			TGM1	7051
VSSQ81M5WX	chr14	67729335	67729341	CGCCCT	C	NC_000014.9:g.67729338_67729342delCCCTG	NM_152443.2:c.806_810delCCCTG	NP_689656.2:p.Ala269fs		17086	CD042224	rs1420329578	"Leber congenital amaurosis, RDH12-related"	806_810delCCCTG	NFE	0.000328623	RDH12	145226
VSFSG69YT3	chr14	67782839	67782840	G	A	NC_000014.9:g.67782840G>A	NM_015346.3:c.4312C>T	NP_056161.2:p.Arg1438*		15788	CM081474	rs118204049	"Spastic paraplegia, ZFYVE26-related"	4312C>T	AMR	5.96E-05	ZFYVE26	23503
VS31MB7CMI	chr14	67802240	67802241	G	A	NC_000014.9:g.67802241G>A	NM_015346.3:c.1477C>T	NP_056161.2:p.Gln493*		15791	CM081475	rs118204050	"Spastic paraplegia, ZFYVE26-related"	1477C>T			ZFYVE26	23503
VSREGGUX4T	chr14	74484425	74484426	C	A	NC_000014.9:g.74484426C>A	NM_006432.3:c.352G>T	NP_006423.1:p.Glu118*		23519	CM013309	rs80358266	"Niemann-Pick disease, type CII"	352G>T	NFE	8.95E-06	NPC2	10577
VSRTYENYPQ	chr14	74484482	74484483	A	G	NC_000014.9:g.74484483A>G	NM_006432.3:c.295T>C	NP_006423.1:p.Cys99Arg		34310	CM052292	rs80358264	"Niemann-Pick disease, type CII"	295T>C	EAS	5.80E-05	NPC2	10577
VSJQ8DAEDQ	chr14	74484578	74484579	A	G	NC_000014.9:g.74484579A>G	NM_006432.3:c.199T>C	NP_006423.1:p.Ser67Pro		23521	CM013308	rs11694	"Niemann-Pick disease, type CII"	199T>C			NPC2	10577
VSQXU6RLD1	chr14	74486323	74486324	C	T	NC_000014.9:g.74486324C>T	NM_006432.3:c.190+5G>A			23518	CS013321	rs80358268	"Niemann-Pick disease, type CII"	190+5G>A	FIN	0.000105485	NPC2	10577
VS8X6SWELU	chr14	74486377	74486378	G	T	NC_000014.9:g.74486378G>T	NM_006432.3:c.141C>A	NP_006423.1:p.Cys47*		34308	CM052291	rs80358263	"Niemann-Pick disease, type CII"	141C>A	SAS	3.51E-05	NPC2	10577
VSGURTW1K2	chr14	74486385	74486386	G	A	NC_000014.9:g.74486386G>A	NM_006432.3:c.133C>T	NP_006423.1:p.Gln45*		34307	CM052290	rs80358262	"Niemann-Pick disease, type CII"	133C>T			NPC2	10577
VS555QTP6P	chr14	74493216	74493217	C	A	NC_000014.9:g.74493217C>A	NM_006432.3:c.58G>T	NP_006423.1:p.Glu20*		23516	CM003177	rs80358260	"Niemann-Pick disease, type CII"	58G>T	NFE	0.00016525	NPC2	10577
TP2016GALC	chr14	87925158	87956831	GATAGTTGCATTAGCCTGTAGCTGGCAAAATCATTTCAAAAAACACAGGCAACACAGTACACTATAGAATATCTGTTGTTTACCCTCAGGATCACATGGCTGATAGGAGATACTGCTTGCTGCCACTGCCCAGTGTCAGGAGAGAGTATTGTACCATATATCACTAGCCCAGGAAAAGGTCAAAATTTGAAGTATAGTTTCTACTGAATGTGTATCATTTTTGCAGCATCATAAAGTTGAAAAATCATTAAGTTGAACCATCATAAGTTGGGGACTATCTGTCTTAGTGTCAAAATATTTCAGAAAAGGACACCATCTCTACAAAAAAAAATTAAAAATTAGCCAGGTGTGGTAGCACATGCATGTAATTCCTAGCTACTCAGGAGGCTGAGGCAGGATAACTGCCTGAGCCTAGGGGTTCGAGGCTGCAGTGAGCTATGATGGTGCCATTCCACTCCAGCCTAGGTGACAGAATGAGACTCTGTCTCTAAAAAATTAAAAAAGGCTCATGATGGCCAGATATTCAAGTAAATGAATGGAGAGTTCCATGTCCAGCCTTGAGGGAATAAAAACTAAAACTGGACCAGTCCTCCCACTGTAAACAACAGTTTCAGAGAGTAGACAGCAGGAAGCCCAGTACTGTGATCAGAGAAAAACAGAGAAATCAGTGAGGTGCATTTTGTGATCCCCCATTTCTGTCTGGAGCCACTTACCAGATTCCAGGGCAGAGAGGGGAAATACAGAGTATATGGGTCTTGTGGAGCTGTGGAGATAAAGATCAGAGTTCAAAGAGGCTGCAGCACCTGAAATTTGCAGTGCAGAGTATCTGAGAGAAGGGTGCTATGCAGAAAAAGAGGTTCAGAAATCTCAGAGGGGGGTCTATTTGTGTCTTTAGCCCTAAACTAAGCTAAACATTCACAGTGTGAAAGCCCTTGGGCCAGACAAAGAATAATCAGGAAAGTGTTAGCTGAACAACTATCAAAATTATCAGAGGACTAGAAGATATTTAAGATGTGAACAAATATAGTGGAGAGAACTCATTTAGCTCCCAGGGAATTCCACGCCTTAAGAACAGGGCTAGACTAGAGCTAGAATGCCCCAGGAGAATCAACCTCTCAGACTGAACCTGAACAGGGAAATAGAAAACACATATTTTCTGTATTTGGAGAGCTTAACTCTTCTCACTCAGTAATTAACAGTAAATGTAGAGAGAAAATCAGTAAGTCATAGACATCAACACGATCAACTAACACGACCTAATTAATATTTGTAATACATTACAGCCAGTCACTGCAGAAGGCAAATTATTTTTATGGGTACACTAAGATAAATTGGGTCATAAAACAAGTCTAAATACATTTAAGATAGTTGAAATGAAACACAACATATTTTCTAATCACAACAGAATTAAGTTTCAATATCAATGACAAAAAGTTACCTGGAAAATCTTCAAATACTTAGAAATTAAACATTGACCTTCTACAATAATTAGCACAAAGGTCAAAAAAGTACAAGACAACTTAGAAAACATTCTGAACTGAATGAAAATTAAAACATAGATATTAAAATATGTGAGATGCAACTAAATAAATGTTTAAATTTTAGTGTTAAATGTTTACATACTTAAAAAAAGTCTAAAATCAAAGATCTAAGCTTGCATCTTAAGAAACTAGAATAAGAGTAAATTTAATCTGAAAGTAGGCTAAATAATAAAGGTACAAGCAGCAATTAGTGAAACAGAAAAAAAAAATCTAAGAAATTTAGAACTGGTTCTTTGAAAAATAAATAAAATTGACAAAATATTAATTAGACCAATAAAGATAAAAAGAAAGCACAAATTGGCCATATCAGGAATGTCTTATTGATATTAAAATAAAGGAATATTTTAAACAATGTTATGCCAATAAATTAGACAATTTAGATGAAGTTGACAAATTCCTTAAAAGACAAATTGTCAAAACTGACATAAGAAATAGAAAAATTGGCCAGGAGCAGTGGCTCACGCCTGTAATCCCAGCACCTTGGGAGGCCAAGGTGGGTGGATCACGAGGTCAGGAGATCGAGACCATCCTGGCCAACATGGTGAAACTCCGTCTCTACTAAAAATACAAAAATTAGCTGGGCATGGTGGTGCGCACCTGTAATCCCAGCTACTCGGGAGGCTGAGGCAGGAGAATCACTTGAACCCGGGAGGCAGAGGTTGTAGTGAGCTGAGATTGCGCCACTGCACTCCAGCCTGGAGATAGAGCAAGACTCTTAAAAAAAATAAAAAAAAAAAAGAAAGAAAAATTGGAATAGCCCTGTATCTGTTAAATCTTCTCAGCCTCAAACCCACTCGTTTGACCTGCTTTATGATACTGGAGCTGGGTCCTGCCAACATTTCTCCTGTGTCAGATGGCATACTTAAGCTTTATCAGTGAAGGTTATAAAGACACTGCAGGAGGAAGCAGCTTCTCTTCTCTGTCCCAGTGTGCTTTTTCCTTCCTGCTTCTGTGGCATGTGGCTACTAGCAAGCAGCATTTGGGACACCCAGTGAAGCACCTCTTCCAGTAGGAGTTGGAACAACCAGTGGCACTTACTTTGCCGGGATTTTCACCAACAATCCTACAGGTGGTTTCCCAGAAAGTTTCACCAGCACCACAAAGGGTGGTTTCCTAGTGAGTTTCAGCAGCGCCTTAGGAGGAGCTTCCCCAGGAGTCTGACACATACCCCAGAAGACAGTTTCCCACTTGCCAGCCCCAGCACACAGCATCTCAGCAAACTCTAGGCCATTCCAGGGTCACACTATATCAACACTATATCATCTGCAGTTGAGATCTGAGCCTCAGCCATGTAAGGAGGATCTCTTCCGAGTTTGTTCCCGCTGTGAGTACTCTGCCCCGGCCTAGGAAGTGGCTGGTCTCTACATCTGCTCTTCCTGTATTCTTTGGAGTTCTCTCTACCCCTTAGCTGCTAATCTCATTACTGTTAATAATTCTTAAGATTAGATTGGTCCTGGCATGGTTTCTGTCTCCTGACTGGACCCTGACTGATACAACTGATGAATTCTAAGATTTAAGAACCTCACAAACTTTCAGAGAATAAAGAAGGAGGCAGCATTTCCAAACTGAATTTATGAGGTATCACCCTGCCACCAAACCAGATAAAGACATTAGGAGAAAATAAAACTAGATCAATATTCCACAGGAACACAGACACAAACACTTTTAGCCAAATATTGGCAGATTGAATTCACCAGTACATAAACAGGGTAACAAACCCCACTTCGTCATGACATATCTCACAAATGCAAAGTTGCTTTAATATCTGAAAATCAAACCATGTGATATATCACATTAACGTAATAAAGAAGATAGTATAACTATCTCATTAGATGTAGAAAAAAAGCATTTAACATTCAGTACTCATTCATAAGCAAGCAGGAAGTATGAAAAAAATTCCCTAAAGGGAATCTAAAAAAGAAAAAAAGAAAGAAAACTCTAGAACTAACTTCACACTTAATGGTGAAAGAGACTCTTCCTAAGATGAGGAACAAGGCTGATACATCTGTTCTTACCACTTCTCAACATTGTACTTGAAGTCCGGGTCAGTGTAATAAGGCAACAAAAGCATCAGAAACACAGCAGAAATATTGAAAAGGAAGAAGCAGAATTGTCTATATTCACAGATGACATAATTATATATGTAGAAAATTCTAAAGAATTTACCCAAAAAAAGCTAAACTAAAAAGTGAATTTCGCAAGGCAGCAGGATTGCAGGTCAATATACAAAAACCAACTGTATTTCTATGTATGAGTAACAAATAATAAACACTATTTACAATAGCATCAAAAACATAAACTATTTAAGGATACATTTAATAAAAAACATCTTCAAGATCTGTATGCTGAAAACTACAGAAACTGCTGAGAGAAATTACAGACTTAATGTATGAAAAGGTGTCACTGCTCCTCAGCAAATGCCAAAGAACTGAAATCATAGTCTCTCAGACCACAGTGCAATCAAATTAGAACTCAGGATTATGAAACTCACTCAAAACTACACAATTACATGGAAATTGAACAACCTGCTCCTGAATGACTCCTAGGTAAATAATGTAATTAAGGCAGAAATCAAGAAGTTCTTTGAAACCAATGAGAACAAAGAGAACATACGAGAATCTGGGGAACACAGCTAAAGCAGTGTTAAGAGGGAAATTTATACCACTAAATGCCCACATCAGAAAGTGAGAAAGATCTCAAATTGACATTTTAACATCACAATTAAAAGAGCTAGAGAAGCAAGAGCAAACTAATCCAAAAACTAGCAGAAGACAAGAAATAACATCAGAGAAGAATTGAAGGAGATAGAGACACGAAAAGCCCTACAAAAAAATCAATGAATCAAGGAGCTAGTTTTTTGAAAAAAATAATAAAATGGATAGACCACTAGCTAGACTAATAAAGAAGAGGGAAGAATCAAATAGACACAATAAAAAATGATAAAGGGGTATCACCGCTGACCCCACAGAAATACAAACTACCATCACAGAATACTATAAACATTTCTATGCACATAAACTAGAAAATCTAGCAGAAACGGATAAATTTCTGGACACATATACCTTCCCAAGACTAAACTAGGAGGAAGTCGAATCCCTGAATAGACCAATAACAAGTTCTGAACTTGAGGCAGCAATTAATAGCCTACCAACAAAAAAGCCCAGGACAAGATGGATTCACAGCCAAATTCTACCAGAGGTATAAAGAGGAACTGGTATCATTCCTTCTGAAACTATTCCAAACAATTGAAAAGGAGAGACTCCTCCCTAACTCACTGTACAACACATCATCCTGATACCAAAAACTGGGAAGAGACATAACAAAAAAAGAAAACTTCAGGCCAATATCCCTGATGAACATCAACATGAAAATCCTCAATAAAATACTGGCAAACCGAATCCAGCAGCACATCAAAAAATTCATCCACCACGATCAAGTTGGCTTCATCCCTGGGATGCGAGGCTGGTTCAACCTATGCAAATCAATAAACACAATCCATCACATAAACAGAACCAAAGACAAAAACCACATGATAATAGAGGCAGAAAAGGACTTTGATAAAATTCAACATCTCTTTATGTTAAAAACTGTCAATAAACTAGGTATTGATGGAACATATCTCAAAATAAGAAGAGCTATTTATGACAAACCCACAGCCAATATCATATTGAATGGGAAAAAACTGGAAGCATTCCCTTTGAAAACCAGCACCAAGGCAAGGATACCCTCTCTCAACAATCCCATTCAACATAGTATCAGAAGTTCTGGCCAGGGCAATCAGGCAAGAGAAAGAAATAAAGGGTATTCAGATAGGAAGAGAGAAAGTCTAATTGTCTCTGTTTGCAGATAACATGATTCTAAATTTAGAAAACCCCATCATCTCAGTCCAAAAACTCCTTAAGCTGATAAGCAACTTCAGCAAAGTTTCGGGATACAAAATAAATGTGGAAAAATCACAAGCATTCCTTTACACCAACAATAGACAAGCAGAGAGCCAAATCATGAATGAACTCTCATTCACAATTGCTACACAGAGAATAAAATACCTACGAATACAGCTAACAAGGGATGTGAAGGACCTCTTCAAGGACAACTACAAACCACTGCTCAAGGAAGTAACAGAGGACACAAACAAATGGAAAAACATTCCATCCTCATGGATAGGAAGAATCAATATCATGAAGATGGCCACACTGCCCAAAGTAATTTATAGATTCAATGCTATTCCCATCAAACTACCCTTGACATTTTTCACAGAATTAGAAAAAACTACTTTAAATTTCATATGAAATCAAAGAAGACCCCATATAGCCAAGAAAATCCTAAGCAAAAAGAACAAAGCTGGAAGCATCATGTTAGCTGATGTCAAACTATACTATAAGACTACAGTAACCAAACCAGCATGGTACTGGTACCAAAACAGACATATAGATCAATGGAACAGAACAGAGACTTCAGAAATAACACCACACATCTACAACCATCTGCTCTTCGACAAACCTGACAAAAACAAGCAGTGGGAAAAGGATCTCCTATTCAATAAATGGTGCTGGGAAAACTGGCTAGCCATATGCAGAAAACTGAAACTGGACCCCTTCCCTACACCTTATAGAAAAATTAACTCAAGATGAATAAAAGACTTAAATGTAAAACCCAAACCATAAAAACCCTAGAAGAAAATCTAGGCAATACCACCAAGGACATAGGCATAGGCAAAGACTTCATGATGAAAATGCCAAAAGCAATTGCGAAACAGCCAAAATTGACAAACGGGATCTAATTAAACTAAAGAGCTTCTGCACAGCAAAAGAAACTATCATCACATTGAACAGGCAACCTACAGAATGAGAAAACATTTTTGCAGTCTATCCATCTGACAAAGGTCTAATATACAGAATTTACAAAGTACTTAAATGTACAAGAAAAAAACAACTCCATCGAAAAGTGGGCAAAGAATATGAACAGACACTACTCAAATAGAAGACATTTACCTACCCAACAAACATGAAAAAAAGCTCAACATCACTAATCATTAGAGAAATGCAAATCAAAACCACAATGAGATACCATCTCATGCCAGTCAGAATGGCAATTATTAAAAAGTCAAGAAAGAACAGATGCAGGTGAGGCTGTGGAGAAATAGAAGTGCTTTTACACTGTTGGTGGGAATGTAAATTAGTTCAACCATTGTGGAAGACAGTGTGGTGATTCCTCAAGGATCTAGAACCAGAAATACCATTTGACCCAGCAATCCCATTACTGGGTATACACCCAAAGGAATATAAATCATTCTGATATAAAGACACATGCACACATAAGTTTACTGCAGCACCATTTACAATAGCAAAGTTATGGAACCAACCCAAATATCCATCAACCATAGACTGGATAAAGAAAACATGATACATATACACCATGGAATACTACGCAGCCATAATAAAGAATGAGATCATTTCCTTTGCAGGGACATGGATGAAGCTGGAAGCCGTCATGCTCAGCAAACTAACACAGGAAGAGAAAATCAAACACTGCATGTTCTCACTCATAAGTGGGAGCTGAACAATGAGAACACAAGGACACAGGGAGGGGAACAACACATACCAGGGGCTGTTGGGGGGTGGGGGGCGAGGGGAGGGAACTTAAAAGAATGGGTCAATAGGTGCAGCAAACCACCATGGCACACATATACCTATGTAACAAACCTGCACCTTCTGCACATGTATCCTGGAACTTAAAGTAAAATAAAATTTTTAAAAAGGTGTAACTGCTCATGGATTTGAAGGGTCCATATTAGTCAGATATCAGTTCTCTCCAGATTTATCTATAATTTAAATGCAATCACAATGAAAATTCCATCAGGCTCTTTGCAGAAATAGAGAAAATAATTTTCAAAACTTTTTTTTTTTAAAAAAACATGTATCTGGAAGATGTAAAGAGCTCTTAAAACTCAATGGAAAAAACAGAATTTTTTAGATGAGCAAAATATTTGAATAGATATTACATAAAACAAAGTACATAAATGTCCATTAAGTCCATGACATCTGCTCAATAGCTTTAGTCATCAGAGAAATGTACATACTATACACCCACAATTAAGGGTTAAAATTAAAAAGAATGACAACATGAAGCACTGACAAGAATGCAGAGTAACTGGAACTTTTAAACATTGTTGATAGAAGTGTAAAACCATACAATCATTTTGGAAAACAGTTTGGTAGTTTCTTATAAAGTTAAACATACAATTAACATAAGACCCAGGAATTTCACTCCTCAGTATTCATCCAGAAGAAATAAAAATATATTTGACACAAAGATTGTAAATGTAGACAGTTTTAATTGTAGTATCAGAAACTGGTGGGGAGGAAACAAATTGTGGTATATTCATACAATGGAAAACTCTTCAGAAATAAGAAGGAACAAACCACTGAATCACACAACATGGACAAATCTCAAATCATTATGCTGATGGAAAGAAACCATTCATAAGAATACACAGTACATGACGCCGCTTTCATGATGTTCTGGAACAAAGAAAACTAACCTATAGTGATAGAATTCCTATCAATGGCTGCCAACAATTGGGAGTGAAAGGAACTGACTGAGCAGGTATACAAGAGAACCTTCTGGGGTGATGGAAATATTCTGAAGCTTGACTGGAGTGTTGGTTACATGGGTATATCAATTTATCAAAACTCACTGAATTGTATATTTAAAGTAGGAACATTTTATTGTAAATAAATTACACCTCTATAATGTTCGTTTTAAAAAATATTAGATACATCAGCTGGAAATCACTTGGTTTTAACAAAAAATTTTCTCTGTAATCTTATTTATTCTAGCACTTATCTTCTTGTCTTCAAAAGCAATGCAAAACTTCACTGTAGCTAAGCCTATGTTAGACTCTTACAAATTCCTAAATAGTAGAATTAGTTCAATGAGTAATTCTTATAAATAATTCTAGATTTACTTTACCTACATGAATAACTGATTTGCTACATAGAGCCACATTAATGCTTAGTATAAATCATACAACATGATGAACACGCTCACGTATATTTAAATATAAACATATTTGGACTTTAAAAAGTAAGTACATCTTAGGAGATGATCCAATTCTGGGAGTTAGCAAATGTCTAAGTGCTCCCCTCCTTCCACACATAAGGAGAGAAAAGCATTCATCAGCTGTGTGAGTCTGTTACCAGTGCACATGTGAGGACAGACCACAGCACAGTGAGATGAGGCTGAGGAAACGACTACAACAGCATTGGCTATATCAGGTTTTCTTCCTTCTTCCAGCCACCTGGAAAAACGTTCACAGAGAGTTATAGTGGTTACAAGACCAAAACTTGGAATCAAAAAAATTAAATAATGCAAATAACCCAATTAATCTGCTAATATCTATTACTGCAGAAATAGTGTTAGAGGTAGTTTATTAAAGAGGCATTTTTAAAATCATCCCACTCATCATATCCTGCATTTCAAAAGTATCATCTTAAAAAGGAAAATAAAAAAATACTTTTTAGAGCATAAAGCATAACAGGTTGAAGTGGTTTTCAAAAAGCTACTTCTAGTGTTCTTCAGCTTTCTATTATGGCAGCATCATCTTGTGATGAAGACACTGGCTCACTTGGACACACGGTCAGCATGCATAAATACATCTCAGTGATGATCAAGTTACTGCCATCTACAGGACCGCTTGCAAATAAGATGAAGAGAGCTACCTCAGTGTTAGCAGCAAGGCTTCGAGGTCTGTACTACTCAAACCACTCCTAAGGGTATGGCCAATGCACAGTTTGAATGTTAGGGAACACACCAGGTAATGTTAAAGATTCACCAGTTTTCCCCTTGGAATTAATTCTAATAAAATCTTCCACAGGGTAAATTAAAAATAAATTTCTCTCCCCTTTTACTCTTCATTATTTTTAGTCTCAAAAGCCTCATATACTGTTCCAATGAAACAAGAATTGGCTCTGAACCAAAACCAAAAAGAAGGGAAGAAAATCCAGAGTATTCTATGATGCCCTGTTAAGTATTAGCGTGTGGCTTCCACAAGAAAGTTGTCAAACTGTGCAAATTCAAAGGAGTGAGTTCCAATTGCAGCCCAGCCATTCTTTGGAAAATTCACAGGGATGTCTGTCCACAGAGACTTGTCATTCAGCATGCCAGAGGTGAAATGACCCTAGAGTAGAAAGAAACACATTCCTTGAAACCATATGAAAATGGTCCTCTGAAGTCTGTTTCTTGATCATGTATGGCCCACTACTTAGTGGAGCAAATGTACTACTCACTCAAGACTTAACCACAGCAAAACACAATTCCACAAGTTTGAGCAAAAGTTTAAAATACAGGAAAAAACTCTAGGAAGAAATTCTTATCTACCTACTTAAATCGTTCCCAAAGTACAAGGAATACCTCAATATTTCCTGTGCTCCACCAAAATTTAAAACCAACAAAATGCAAAACTTTTCAGGCATTATTATAAAGTTTTAGAAAAAAGCTCATTAAAATTTAACAAAAGTTATTTATAAGTAGTCACATGTACAAGTGGTGTGGCTAACAGCCACCAGCTCTTCAGACATGACTGCTGGAGTCAAAACATCTGCTTCTACCTCATTGCTTCCTTAAGGTTTTCATTAAGGAGCCTCTGCCCAGCCAGAAGAAAAATAATTAACCTTAGTTTTTGTGTTTTGTTGCCATGAATAGAATATCACTTCAAAGCCATATGAAGCTCCTACCCTTAAGTTGGAAAAACAGTAACCATCAGTTAAAGTGATGCTGGAGTAGGGTGCAGCGGGTGGAAGAAGGGAGGCATCTATAAGGTGTGACTTACTGGTCACTGACAGTGAAAGAAAAAATTACACCTTCCTCCGAATGTTGCCATTCTACTTAGCTCAGTGCCTGGCACATGGTAAACAATAAATCTCAGCTCTTATTATCTTTATGATAGTACATTTATGAGCACATATTCACAGCATACTAACTACAGTCAATCATATAAAACTAGCTACTCTCAGAAGGTGAAGAGCTCAAAACTCAAAGCACTGGGCCAAGAACCAGAATAAATCTGCTTTTAAGTCTTGGAAGTATAACGTAATGGGCCTTAATTTAGTTCTTTTATTTTATGCGTGGAAACACTGAGGCTTAATAGATTAAAGCTCAAAGTCACAGGTTTTCACTCCAAGTTACCTAGCTCCAAATTCAGAGCCACATTCCTATTACTACAGACTTGCACAGCTATCTTCAGCTCTAGAAGTGCTTACTGAACATCTTCTGCTGCCATCAAACACTCAATATTAACACCGAGCCAAGGGACTCAAATCACAGATCACATTAAGCACAAAACCTGTCTAACAGGACCTTATCTCTCCTGACTCCCCAGACTTCAGCCACCCCAGCCTCCAGGCTGCTCTTCACACAATGTCAGCTACACCTGCCTTTTGCACCTGCCACTTGGTCTGCTCAAATTGTTCTTCCCAGCATTCAGGTCTGCACTCAAGTACTACCCACTCAGTGAGGTCTTTCCTCACCTCCCTGGTTAGAGAATCAGGGTAACAGAGCTACTTTATCTCATGACTCTATTTTTTCTTCATAATCATTTATAAACTTATTTACAAGTTTATTATCTCAGGATAGGGCTCAGCAAACTATGACCTACATGCCAACCGCCCTTTTTTTAATAAATAAAATCTTACTGAAACACAGCCACATCCATTGTCTATGGCTTTTTTTCTCATTATTGTCTATTGTCTATGGCTTTTTTACTCATTACAATAGCCGAACTGGGTAGCCACAGCAGAGACCACATGGCCCACGAAGTCTAAAATATTTACTATCTGGCCCTTTACAGAAAAAGTTGCCAACCCCTGTCCTAGAAGAATATATGCTCTAAGAGAGCAGGAATCTTGTCTGTTTCGTTCGCTGCTGTATCCCTAGGACTTAGTAAAGTGCATACAGTAGGGGCTTAATAAAAATGTGTTGAATATAAGAATGAAACACATTTAACCCTCAAAACAACCTCACAGAAGTTATCTCCATTTTGCAGATAAGGAAATGGATACTCAAAGAGGTGGAATAACTTGCTAGAAGTCTCAGCATGTGTTAGTGAGGAAATACGAATGCTGGTCTGTCTGGTTCCAAACACTCCTACTCCTAAAAATATTAACTTGACTCATTAAGTGCTTACCACATATCAGGTACTATATATATATATATATTTATTTATTTTCTCATTGAATCTTCATAAGAAAAGTGTTCTTCATGATATCATGGATGGGAAAATTGAAGCTGTGCAATATAAAATACTTGCAAGTAGAATATAGTAGACTTCAAAGTCCATTGTGCTACCCACCATGCAACAGAACTGGGACAAGTCACCTGACAAGTGCTGAGAAGAATTCAACAGGTGGCTGATAGTCAGTGACAAAATCCTCACATTAGCTGTAATTTGGAATATGGGCAACATAGAAGATGATGTTTTGTTTTTTTTATTTACGCAAAGAAGATTTATATGTCAAATACTGTTTAATGCACTGGGAATTTAAGATGAACAAGAAAGACAAGGTCCCTGCTCTTATGGAGCTTATATTCTAGTAGGAGATGGACAGATATGCACACACACACAAAATGAGAGCTAAAAGATAAGTAGCATGTAAAAATTAAGCCAGGTCAAGGTGACAATGGGTGCCTGACAGACTACTTTAGTGCAGATAGTTACAGAAGACCCTCAGAGTATGTGGCAAAAGCTGAGATTCAAGAGGAAACAGAATGCCCATAGTTGATGAAACACAAAATAACAGGAGTAGGGGAGTGAGGTGGGTGCAAGCCAGCAAAGTCCTATCCATCCTAGTAGCAAGACAAGAGCCAATTTTTAAAAGTAATGAATCACATTGTATTAAAGACACACCAGAAGAAACAGCTAAAATAGTGAAGAGTGGCTGTATCAGAAGTACAAGACACAGAATGGGGTCAAGAAGAAGGAACAGGATGTGAGGCAAGATGCCTCACATCCTATTGATATTTTAACCAGGTATGCAAAGTACCTGAAAAAAATTAAGAAAATTTTTAAAATCTCATTCATGATTTCAAAAAAACTCATAAAATTACTAAAACAAACCTAATCAAAAGTTTGCAAAAATAAAACTGAAGGACATAGTGGCAAATCTTAATAAATGGTGAAATATAGCATGCTTTTGTTCCTGTGTTCTCTCATGGGGAAACACATTATTGTTAAAAAAAAAAAAGTCATTTTTTCCTAAATTGATGTGTAAATTTAATGTAATACCAGCACCATTTTTCAAGTAACTGAAAGTTTGTTTTTTAAAAGTCAAATCGAATAATATATATAGTGGAATAGCAAAGATAATTTTGAAAAAGAAACAATGAGGAAGTTGCCCCACCAGATATCCATTCATTCATTTACCAAGTATTATTCGGACTCTTGCTCTGCCTGGCTGTCAGGCACTTTTCTAGGTGCTACAGAGCCAGCAGTGAGGAATATGGAGAAAAGCCTGTCACTAAAGGAGCTATGTGCTAGTGAAGGGAGTAGGAAAACACATGAACAATTAACAGAATATGTGTGATGTCAGCTTGGGATAAAACTTTTGGAGAAAAATAAAGCAACAGAAAGGAGTTAGAGAGTGAGATGGGGCGCTGTTTTCTATCAGGTGGTCAGGTAAGAAAACTCTGAAGGAAGCAAGGGAGTAGCTGTATCATCAAAGCTTTTAGAATGTGAACACCAATTAAAAGCGTGATTTTGGATAATAATAGACAAACATCAATATGGAGAACAGAAAAAAGTTCAGAAACAAGCATGTGCACATGTGCTGATTTGTTACATCAAAAAGGTAGCCTTTAAATTATGGGCAAAAGGATAGTCCATTGTAATAAATGATGGCTATCCATTTTTTAAAAAATTATATTCAGTACTTCCCCTTACAATTCACAAGTAAATTTCTGACGTATTAAAGACTTACACATAAAAATAAATCCTAAACTTTGTTTAGCTTGGGGGAAAAATGTTCCTAACCTTGAGAAACAAGAAGGCCTTATTTAAAACATGAAACATAAAAGCAATGAATAAAAAGTGAAATATTTGACAGTATCAAAATGTAAAACTTATAATCATCAAAAATACCATAAGCAAAATTAGAATACACATGAAGGAAGAGCATAGTTGTGACGTATGTAACAGACAATGGGTTACTATCCAGAATACATATTAAATTCACACAAATTTGCCAGAAAAAGACAACATGATAGAAAAATGAAGAAAGAAGTGAACAGGCAACTTCAGAGAAGAGAAAATACAAATAGCCAGTAAACATTAGATGTGCAAGCTCCCTAATTATCAAGGAAATACAAATCATATCTATGAGTTTGGAAAAAATCTTCAAATTCAATAATAGTGAATATTATTATAATTGCTATAAAATGGCTACAATTTGGCTAGTGTGGTATAGTTAAATAATCTATGCTACATCCAAACCAAATCTTCAATATACATATTGTTAATGCTAAAAAATAATTAGTGCTGTCATTTTTGGTGGTTGAGAGAACAAATTCCAAAGTTATTGGAATCTGATTTTTAATTTCTACTGCACTCTAAACAAAATTGTGAGAGAGCTATCTTGGGAGAGACCAACACATTATACACAAAAATTTATCTGCACAGCATCCCTTGGAAGCACTGTCGAGCAGTAACTCATGATCACCCAGTGATTCTCAGGAACATTTTTATATTTCTATTATACTAAAATTAATCTGGTATTTTCTCTGACTAAAATATTCATGGAAACCAATTTCTAAAAATTATGCTTATAATTGAAAACCAAATTATTCTTAACCATCAAAAATAAATGCATATGGCTTTGCTTACATCTATAAGCTCCATGTACAGTCTTGGTTCAAGCAAACTTGAAAAAAATAGTTCAATTATTGACTCTATCAATTATGCCTCAGTTTAAAAAACAAAATAAAATTTTTTAAAAAAATAGTGACCTGATAAAGTCAACTGCTGATGGTTCTCACATAGGTTACCCTCACACATGTAACTATCCTAGGGATGAGTGGCTTCCCGGCACCAAGGCAGATTCTTTGTCTCTCTTCATTATATGTCACACTTTCCCCCTCCTATTTTATAACAGAAAATTATAGAAATGCACAACAAAAGAGCATTTTACCTCCAGACTCCAATCAGCAATACTTACCTTAATAGTTAACGTGAGTGTATACCATTTTTTTGCTGTAACTTCAACACGTCCTAAAGCATATATAATCCATCCAGCTGTAACACAAAAATATTATCCCAATAGATATAATTTTGAGATCTCAATCACAGAATCATATAATTCAGTGGGGTTCTTGAGTGGCATCTGTATGTAGTAAAGTCAGCCTCAACAGAGAGCTATGTCCCTTCATTCCCAGATCTACAACTGAGTTAAGCCAAAACATTTTTCATTTAGCCATGCATTTAATAGCATATACTGAGATCCTACTCTGAGCCATATACTATATGTGAGCTCACAACAGAACCAGTGAAATAAACTTAAAAACCAGTGATAGTATGAGGTGTTAGCATCTGTAGTTCAAGTACACATTTATACATGACTGGATTGAATATGGAAGACAAGAGAGACAGAATATAAAATTTCCAGCCAGTCTAATTGGTCACATGGTAATAGTATTAACTTAGAGGGAGAAAATAGTAAGTTAATTTTTGGAATTAGTGTTATTTGAATGCCTATGAGAAACCCAGGACAAAATTTCAAGTAGGCGGTTTAAAACAGACAATAGGGACTGCAGACACAGATTTAAATTCCTAGTTCCAGTTCTGCCACTAACTAGCTTTGAGTCATTAGGCCACTCAATTAACCTCACTGGTTCTATGTTTTCGATTTCAGTATCACTGAGGTAAGTTCAGATTGGTAATGCTATGAATATGTAACTCTTGTTCTAATATCCTTACTACCTACTTCCTCTTTAATTTTTATTTTATTTATGGAGTCAAAGCAAAGAGCAGAAAACTATAAAAGAGATATTTTTAAATTAAGGTAAGACGAAAGTCAAGAGACTGAGAATCAAGAAAAGTCACTACCAGTAAGGTCTAGCTTCAAAGGAGTGGTGTGTATCAAAACCAATCTGAAGTGGACACAGTTCAATCTGAACATATTTGAAGCACCTATTCTGGATAAAATATTATCCTACCTAACACAAGGGCTGTAAAGATGACTGAGAAAAGTCAAGCTATTTTCAAGTATTAACTAAATTCAAAAATGAGATTTTTCCATTTTAAGCCGATCAATTCCCCTCCTTATATTTCTATAGGTACAGCAGCAACAGTCGTATACTCTTGCTTTTATTTATGGTGCCTCCTGAGCATTCTCTCCCTACCACCACTACCTCAGATGGTTTTGATACTATCTATGCAAATCCTATCCTCACAGCCCAGTTCAACTCTACAATACCCTTAAAAGCTTTGTACAATTATTTTCCCTTCCACAGAGCTGCCCCCATCTCTAGGAATTAAATAACTTTCTATAATTGTAAACTATTTGGTATTTGCTTACATCCCTTCCCAATTAGATGTCCAAACACCTTGGGTTGAATTCTTTTTATCACTCCCACAAATAACAAGTAGGTGCTCAAAGTAACATAGCCCATAAGTCATATGCTATTAAAAAAAAAAAAAGTCAGTTACCTAAATCACCTGTAACCCTGTAAGATCCATTTGCAAAAATCCAGAAGAAAATTCCTCTGGCACTTCTAATCAAAATACCACCTTTATTTACTCTTCCTGCAATGAACACACCTCCTGTGTCAGGGGTCTCTATGTATACATCACACTTTATAGTCAGATTGGTCCTGCAAAATAAAACGGTTGATTAGTACTCTTTAAAATATGCCCTTTGTAACATAGTACAGATATGTCATTTCACAGCACATGCTTCCAAACTTCTAATTGAGGTGAGAATGTGATTTGCTAAGTCTAAGCCTGTAGCAGAGATGGGCTTCAAGAATCTTTATTGACAACAGTTTTAAATGTTACATGACTTAAGTCATTTCATTGCCTCTTTAAATGATTACTGGACAATAATAGTTATGATTTTTAAGTTTCCTGAGAAAATTTTTTTTCTACAATAAAACAACTTCTCATCTTAAGAATACAATATTTTAAAATGCTACTATTGTCTATGAACACATTAAAAAGTAAAAAGTTCCACACAATTCTGAGGGAAAATGTTTATTCAAACTTCCATCAACAAAGAGAGGCAATGAAGGCAATGCTAGGAGCCTTTGAGAGAACACAAGCTATTCCGGGGCCAACTTTTACATTTAAATCTAACAAAACTTTAAAACTCCAGGAGAAAAGATCTAAAATTATTTTTCTGCAAAGACCACAGAGTTGACTCTCTAGGAGGGCTTCTCACACCTGAACAGCACTGAAATCACCTGGAGGGCTTCTTAAACTCAGTTCACTGGCCCTACCCCACAGCGTGATTCAGTACATCTGGGGCAGCCCCTTGAATGTGCATGTCTAACAAGTTCCCAGGTGATGCTGATGCTGCTCGTCCAGGAATGCCACTTGGAGGACCATTTTCCCCTATGAAGTATCTGTCTATAAGGAAGCAATAAAATCCTGGTTCTAGGCTCACTGATCCACAGCAGTCTATCAAAGATGGGAAAAGATTCAGCTGTCCAGGGACTACCAGAGCTTTTACAGTGAGCTCTCCTCCAGGTTTCCTCTTACAAATGCTACCAGGTACAACACTTTCCTTCTGGAATGCTACAACCACCCCAAACCAACATGATCTCTGAAAATATTTCACTTCCTACTCAGTATCTAACTGCAAGTGGGAAGAAAAAGAAAGCCTGCACATAACCAAGTCATAAATCAAGCAATATATCTCACATAAAACTGGAAACACCAAGAAATCCATTCTGGAAATGGGCTGGGGGGAATGAGATCTAGAATTATGTGGCTTTTACATTTCTGTGTCTTATCAGTGAATTTTGCACAGTGAAATTTTACTACATAAAGGAAAATATTACAGAAGTACCTACATCAGCTACACAGGGAGGACAATCCACACTTAATTATCTAAGCAGAGCTGGACTACTTTACAGGAAGATAAATGCTAAGTAACTCAAGCCCAGTCTCTCTTGTATGTCCTCTGACATCAGAGGGAGTTTTCTCTCCATAGATTATCACCAGCATGAAACCACTGGCAATCAACACTGGTACTTACATCCCTTACCTCCTTTCTGGTTCATCAGAAGTTTGAAAGTGCTACAAATACCATCAGCACCATAAAATTATTCTATTTAGAGTTGGAATGAGAGAAGATCAAACTTTCCTTTTCTATATACCACATTCCAGAATAAGTGATTCTTGCATCAGAACTTGCCAGGCAATTTCACAGATAATGAATGAAATGGAATAAAAGTGTGGTTTATTCTTCCACAGCCACAATCTCTCAGTAATGCTGAAAGAACAAAAACTAGCCAATACATAAGGCAAATTTGATCCAAGAGAGTTCATCTGTGTGCAGGGAAAGGTAATTTTGTGATTGTCTTTAAAGGATTCCAACCAATGCTCACTATCAAGATAGAAGTAGCCAGTTATAGTACAATCTATCCCATATAATCAAATTACTGTGCTGGTAAATGACTAAATCTAGGTATAAGAGAGGAAGTTCTACTCAAAACACAAGTCTAAAAACTGTGAGTAGTGTGCACTCATTGAGAGCAGATTTACTAAAATAGCACTACAGATAAACTAAACAAATTTCTCATTTCCTACCTTTAGGAAGAAGATGATTAAAATGAGGCTGTGAGATGTACTCCAAAGAGAATGGGCTACTCAGTCACACAGACCCGGCTTCTAGCCCTTGTTCTGCCACTTACAAGTGAAATATTGGGTAAATCTTATTCCAAAGATGCAGTTTCTCAGTCTGCAAGGTGGGGACGATGATATCTCCACCATAAAGTGGTTGTGTGGGAAATCCATCAAAGTGCCTACTATTACCCAATTTTTATTCCCTCCTTTTCCCACAATAAGTGGGCACAGCAGCCAGACAACAGAAATGAACAAGGGATTTGTGTGGATCTCTGAGCAGATCTGGCTGCCTCAAATAGAGGGTGGAATACTGGAAAATAACACATAATAGATGAGACCAAATTATAAAGGGTCTTGGAAATCAAGCCTAGAAGTGGAAAACACAGGTAGCAGGACAGAGTCACTGCATCTTCCTGAGCAGGGGAATAACATGATGAAAACAGGGCTTCAGAAAGATGAAGGCAGGCCTTTCTTGACACGCAAAATTGCAACTTCCCGGTTCCTTTCCTTTCAGAATATGTCACTCTCTTCCCTTCTACACCCTTCCCCATCCCTCGTCCCCACCTCCTTACCCACTGCAATAGATCCTAGTAAAAACTGAGTATTGCTATTTAAATTGTGAAGATGTATATGAAGATTCAAATATATGAAGATCTGGGGGAGTAAATCTTTGGATGGTGCTATATCTCACTTCTATACTACAATTAAGGGGCTTCTCAATCTTTTTGGAGTCCCAGCCAGAAATAAGATTGAGTTTGAGTTTAGAAAGAGCCCTCTATGGTATTCAAGTGCATGGGGTATAGGGGATGTCACAGAAAAAAAAGTTTCCTATACGGCGACTTCAAAACTGGAGATCAAAACAATGGGACCCAGGCCTTGGACACTTAAACCCAGCCACTGGACTTAAAATAAGACCATCAGTCACAAATAAGGATGCCAAGAACTCCACTACCATAACTGGAAAATCTAGGTAAAGTTTCCACCTCAGAGACAATGGGACAAGCAGAAATTCTGCGTAAAAACACAAGCCACAAATGTCATCCTAAATTAGGAAGGAATTCTTCACTGCACCTCAATAACTCTTCATAGTGTTATAAGGGTTCCAGGGGCTCTGGATAACTAAAAGTTTCTTAAGACTTATGTCAGAGCTTGGGACTAGAATCAGGATTTCTAACTGGGAGTAAGGCACTTCAGGAGGGATAAACACTTTCTGCACACTCCATAGACAGGCAATTCAAGGCTCTTTTCAGAATTCTTTTCTCTTCCCTCTCCAGTTTCCAAGCTTCGGATATGGCTTTTTGGTGGCTTGGTATTACTAGTACTAGCTCTAAACCTGGAATGTGTATGTGTTTCTTTTCCCACAGTGGAATCATACTAGTTATAGGAAAAAATGAAAAAGAAACACATGACAGGTGGAATAAGTCAGCACATAGAAATTCTGTAACTAAAGAGGAAGGGAAAGTTTTAGTTTGGCATTATATTTTATGTGAATAATATAACTTGTCTCTTTACCAGATGACTAAATAAAAAGTTAAATTCACTAGGCGACTAAAGCTGATTAGCTTTTTACTATTGCCATCTACTGTCACCTGGTAAATCTTTTAATAAGGCTAAGACGGTGTAATTCTAAGATTGGTCCACTAGATGGCAACACCAGATCAACAAATCAACTCTCCAGCAAAACAAAAACTTAAAAATACCTCACAAATCCGTCTATTTATAAACAAATATTAAATTATAATTGGGTCCAAAAGTCCTTAGTTTTTATACTGGAATCAAATTGCTCCTGTAATAATCACTATTAAATAGGGCAAAAATGAGGGAAGGACACTGGGGCAGCAAAACAATTTGCAGCTTTGTGGTCATCACCATACTATTCAACAACCCTTAATATTACATATTACACATCTATTAGGTTCTTGAAATAGGAGGACCATTGAAAACTCTTCACTTCAAAATGTACCTGACAATATTACAAGGGTATTTCAGCCAGATCCACATTGAGAACATCAATCTTACCAGTTGTAGTCTCCTATAATACTGATTGTGTTGGATGCATCGGCAGCCCATGTAATGGGTCTCTGGTTGAGAACTTGGCGTAGCGTGAAGTGATGCTCGCCAGGGTCTTCAATATTTGTAAAATATTCAAATACACCAGTTTGATCAGCAAAGTTTGGAGCTTCACTAAAAAATGGGTAATCTGTTCAGAATGTAAGAAATTCTCTGTTTAGTATCAAATCCTTCAGAAGCTCTCCTTGCTGATATTTTATAGTATGTCTGAAACACTTCTGAAAGCTTTTAAATAAATAAATAAAATCTAAACCAAAGTTTAGGGCCTAGGTCTAATAAAGATACATTAATTTTTGTATCATCATTACTAAATATCAAGATGATGAGTTCGACATATAGATGCTGCATAATATTTAATCCAGGCATCTGGTGTAGAGGAAAGGTCATGAGTTTTGAAGTAAGACCTAGATTCAAATTCGAGTTCAGTCTGTCGCCCTGGACAAGCTATTTAACTGCCCTGCATCTAAAGTTTCTTCATTTCCAGGTTTGCAGGAGGACAAGAGAATTAAAGAAAAGATAACAGGTACATAAGCCAGCACCTGGCAAGGGCTCAATAAGGGATAGCTTTATTATTTCTAATATCTGTCAAGCAAGGTTCCAAATCATGCGTCACAATCATCTGCCAAAAGAGCATAAGAAAGGTTTACTATATCAAGCATAAAATTTACAAATTTTCTTCTACTTCTAAACTGCAGCAAAAACCAGTTTTGGGCCTAAGTTATCAATCCCTTTTTAGTTTTACTAAATTAAATTATAGTCTTACAATAATGAATGCTGTAGAGGAGAAATTTTACATATCTTATAGCTCTTATACCTCATGCTTTTCCAAGTGTTTTTGCATTCATTACCTCATTTGAGACATTTAGAACCCTAACAAGTATCTCCAGAGCCTAGCTTATAATATTTAACTTAGTTTTAAATTTATATTGTAGCTCATAAAGTATTACATTTTATATTTGAAGGTTTGAAATTGCCTCTTAGTCTTCAGGGTCACAAAATATTGGTCTTGGTGCTGGCAGTTCTTCAATCTCATTATCTAGGCCATATCCCACACAGATTCCTCACTTACTGAAGGCAAAAGTCACTTTTGCTAACAGAGAACCAAGCGAGCAACAGATTTTAAAGACCCTGTGTTTCACAAAATTAATGGGTTTATCTAAGAGGCCATTTCAAAGAGTTGCAGAAAAACAAACCACCAAGCTCCCCCTGAGGATCACTGTTGTCTGTATTATAGTTGAGAGGACTCCATTACACAGTCCAAAAGGCCTTATACTCCAGCCAACTAGATCATTTCCTGAGAAAGGGAGGCGAGACCCTGTAGCAGTGACTGGGAAAGGGTGATAGGAGTGTCCATCTTTGGTGGAACAAGCAGCTCTGCAGCAAACAGGAGCTTCAAGTGATGCTCCAGCAATGCCAGCTCCCTCCCTATTACTCTCCTGCTGCTACAGATTTTAGGAGCAGATTACAAAGCCACCTGACCCTGTCTGTGAGACCCATAAACCTACAGAACACCACCAAGCAGTCAACAAATTTTGTTACTTACTCACTAGGAATATAACTACAATGACCATGTCTTCTAACTTTTTTCCAAGTGGTTTTCCTAAATCACCTATAACCAAAAACTTTTCTAACAACTTTAGGACAGATCTTCCTAGAAAACCAAGAAAGCTCAATTAAAAAAAAAGCACGGGATGGTATATAATGAGTTGGATCAGCCAAGGACAACATAACTGCCCATAAGCACTCAGTTCACTAGCACTGCAGAAAGACAGATATGAATGTGTCTTAACCTCCACACAGAAGGAAGATGTCAGTAATGGCTAATGGGGCAGTAGCAAAGTTACAAAGTTTAAGTTTCACCAAAAACAAATCAGAACTATAACTTTCATTCTAACAATGAACCCTATATTTTTTTCTGAAACTGAAAAATACAGGGTCCTCAAATTTAGATTTACCATAAAGTAATGCAAAAAATTAGCCCTCCTTTTACCGCATATGAGATGTAGGAGGTAAATGAATGTGCTTTTGACAGCCACTCCATCATGCACCCAGTTTGACAGGTAGAAATCAACACACTACTGTTAAATATAGAGACCAAGTTAAGTTTTAGTGAAAAATACTCACCAACATTGAAATCATCCTTATAGGTACTTGGGAAGGGCTGGGATTTTGGAGGAAGCGGGTAGCTGCCTTTGCGACCAGTGGTGAGAGTGGTGAGTGTGAACAGCTCATCTTCATGCAGGCTCAGTGTGAAACTGCCATCGCTGTCAAGGAGCTGAAAAAGAAGACACTACTGTATTCAGGACCAGGTACTATAGCTCATCTCATGTGGACAGAATAGCTTTAAAAAAATTAGCTTAAAGAAAAGTCCAAATCATTTCTGTTAGAACTTCCTAAACATTTGTGGAAAACTCACCAATATCAAGGCCCTTGGAATCTTTTTTTCCTAAGTATTTTAGAAAACTTTATAAAATTATGCTTTATAATTTTAAACAACCTTACTTCATGGAAGGAAGGACTAAATAATCTCAAAATCTATTTCTATTAGCCTATTCTTTTCCACTACACAGTAAGCTCCTTAAAGCTTGGATATATTCGATACATGCAACTAAGAGACCTGCTTTTTTCTCTCAGTAATTTACTAAGGTAAAAAAATTCATAAAATATCACTGTCGACCCAGCTGTTAATCACAGAAATCCTTTTACAATTAAGAGAGAAAAATCCTGCTCATTTTATGATCAATATATATTTCAACTAGCAAGTTAGGCTTATGTCACACTTACGATCTTGGCAACTTAATCTCTTTAAGTCACAATCTCCTCATCTACAAAATGAGGAAAAAATACATACCTTATAGACTGCTGTGAGGATTAAACCAGATAATGCTTTTAAAGTGCTAAGCTTAGTGTGTGACCAATGGAAAACGCTCCCAGTATCAAAGTTGTTCTATGCTAAATGTAGATCTCTGAAGACACTGGAATCCTTTTATGAAATTTGAACAGTTTTTTTCTATTTTGAATAAAAGGAGTTATTATCCTTGTTTTAATGGTAAATTGATGATCAGATCTATGAAATACCTGACCGTTATATTCAGGTTGAAGAATAACCCCAAATGACATTATTTTTCTTATGAGGAAAATCAATTTTATTATGCCATTCCTAGCAATTTGTTACACAAAAAGTATGAACTTTTTTTTCAGAACTTAATACATAATAAGGTGTTTTATCACTGTTAGTGACTAGTTGGTTATCAGAACATTAATAATAACCAGAAAAAGTGGTAGACTTGTGTCAATTAAGTGAAATAATGTGCTTGTTTGGGCCAATTCGTTCTTTGAAACCTTTCCCCAGAAAGCACCATGGATGAGGCACTGTGGGAAGCACCTGGGATATAAAGCTAAATAAGGCAAGGCTCAGTCTTCAAGGTGTCCAGTGGTGCAGGAAAAGCATTTAACTAGGTAAGCACATGGCCCTAGGTGAATATGAGCTAAGACTGGTGAGGAAGCGTCAGAGGAAAAGACACTTGAATTGAGTCTCAAAAGATGACAAAGTTGAGGAGAGGCCATTCTAGGTGAAGAACACAGTATGTGCAAAGTCACAGAGGTAAATAAACAGGCATGCTATGCTTTGAAAAATGTAAGTTTAGTATGTGAAGAGAGGCCAGTTTAGTAGGACACATCTCTAGGAAGAAGACCAGTCTTCTACCTTCTGGGAGGATAATGAGGGCCATGTGCTACACTAAGGAATGTTAACTTCTAAGAAAATAATCACTGAGGTCCTCTGAGCACAGTGGTCACAAAAATCAGATCTGCATTTTTGACATTTCACTCTGTAGCAGTGTGATGGGTGACCTGGAAAGTCAGACTGGAAAAACAAGAGGCAGTTTCTGAAATCCAGGAGAGCGATAATGAAGAACTGAAACAAGAAGTAACGGTGGTAATGGAGAATAAGGAGTGAGTAAGAGAAATGTGTGGATACAACTGTCTATACTTGACCACTGGCGGGATACAGAGGGTGAGTGGGAAAGACAGAGAGTCTCAAATGGGACTTAAATTTCCAACCTGGGAAGCCAGGTGATGGCGTCACCATCCACCAAGACAAACTAAATGTCTAAGAGCTAAACACATCTATAAACACACAAACTTATAAAAATAAAAATTCTTAATTAATGACATTTCTGTGCCCTTTTACTGTTTTACTGTTGGAATACCCAAAATATAAGAATTTACTTTAAAATTACCCATAGAGAATCCAGCTGCTTAAAAAGAAATCTTTCGGATGTTTTTCCAAGTTTGGTATACCATACCTGTAGCTCTGGTATTTCACTCTGTAAAGAAAAGACAAAAAAGCATGGCTGAGTAATTCATCACATCCTCTTTGAGGATTTCCAAAATCAGTACCAGCAAGAATGTACCAATGACAATATTATCTCTATTTATCAAGAGAAACACCTCAAATATTAAATAATAATATTTTTAAAAATAGGAAAACACTGTTCAAGCAAATACTTTATTCTCTAAACACTAAAGAATTTTGGCAAATGATAAAAAAATTACAGTGTCTTTGCTTCAAAAACATTCATTACTGTACCTGTGTAATAACTTCTAAATTAAAATAACTTTCTGGTATTAAAAAACAATTCTTATGCCATTAGTAATCAGAAAGGGTACTGCAGTTTGTCAATTCAAACCTAACAATTCACAGAAATAGCAAGTATCTGGTACTTTTAAACAATATTTTTGGCATAGTATACTGTAAATATCAATGCTTGAAAGTTCCCTAGACCATAAAATGCTTCTACCACCAAGAACAACTTTCTTGCAAGTGACTTTTGTAAGTGTTCCTCAAAGTCACAGAGCATTTTACCTCCTACTGGCTTCTGTCCTGCTAGATTAAAGCAAGTCGGAAGACAGAAGACACCAGGGCCTCTGTCAATTCATATGCAAACTGTTAAAAGTTCATAATATAAGGCTTCACTTAAGAACTACTGGCCTGTGACAGAATATATAAATTCTTAAATCAAAACTAAAATAAAGTTAAACATATTTACTTACAAAAGATCCCTTAAGAACAAAGGTGGCAAATTGTTGTGACACATTGAAATAAGGAAGAAATGGCCGTATGCACTTAGAATGTTTATGACTCTGAAAAAAAAAAATCACATACATTATCCAAATGATGTATAAGCTACCTTAGGGGAAAAAAAGTTCAACAGTTAATGCCCAAGATTAACAGAAATTTACATATACTAGATAACAAATATGAGTTTATTTCACATTTTTAAAGACTTTTTTACAATATAATATTTACTGAATGTGTATTGTATGTTCCTAGTCAAATACAAAGGTCAATGGCGTTTCAACTGGATCAAATTTTGAATTCGTAGCTAAACTGTAGAGACATATATGGCATACAGATTAATTTTTTGTTATAACTGTTTTCCAACTAAAATACATCAAATAAAAAGCAAAAGTAAGGATGTTTTCACTGAAAAGACATCTCATCTAAATATAACTTTCGTTCTCATGTAAGAAGTAAAAAATATATATATATATGTATGGGTGTGTGTATATATAGTATATATAGATATCAAATACACACTAAGGTCAGCTAAATATATGTAACATAGTTCTCACATTGCCATCACTGTTTACTAAATAGTCACAACTATGGGCTGGGATCAAAAGAAGTATGAGACATAATCCCTACTTTAAGAGATTCCACAGTCACAGAATACTTATAGTACACAGTTCTATTTCAGGCTTTGCAGACCATTAAAAAATTACTTTCATAATCAGAGATTTCAATATCCATCTCTTAGTAATTGATAGTACAACTAGATGGACAATCAGCAAGGATATAAGAGATTTGAACAACACTACCAAACAACATGCCATCTATAAATGCCTCCATCTAGCAACAGCAGGATGCACATTCTTTTCAAGCGCACATGGAACACTGACCAAACTACACCATACTCTGATCCATAAAGCAAGTCCTCATAAATACAGGAAGATTCAAGTCACACAAAGTACTTTTTTAACCACTATAGAATTAAATCAGAAATGAATAACTGAAAACCTTCTGGAAAAGTCAAAAATATTTACAAACTATCAAATTTCTAAATAATCAATAGATCAAAGGAAAAATAAAAAGAGAAATTAGAATTTTCAGCTTTATGAAAATGAAAACACAACATATCACAATTTGTGGTATGCCACTAAAGCAATACTTAGGAGGACATTTACAGCACTAAATACCTAGATTAGAAACCAAGAAAGGATTTGAGAGTTCAGCTTCTGTCTTGAGATACTAGAAAAATAGGAGCAAATTTTAAAAGATTACAAATTGGGTTCAATGTATACTGCTCGGGGATGGGTGAACCAAAATCTCACAAATCACCACTAAAGAACTTATGTAACCAAATACCACTTGTTCCCCAAAAAACTGTGGAAATAAAATTTTTTTAAAAAGTAAAAATAAAAATAAAGAAAAAACCAAAATAGGCAAAGAAAATAATAATGAGCAAAGAAGAATTAAACAAAAACAAATTTAAAAACCACAAGAAAATAATAAAACCAAAAGCTGATTCTTCGAGAAGATCAATACAGTTGAAAAACTTCTAGCCAGACTAATAAAAAATCAGGTTAAGAGAAAACATACACTTCAACAATAAGAAAGGTGACATTACTAGAGATTAGAGATTTACCTAGGGGGAGAGGCAAGGCATGAAATAGCTTCAAACCTTTTCTTAAAGGAATTGATATTTGACACAGAGCATAGAGAGGTTTAAGACTAATGTTGTTCTAAAAAATAATGGAGGTTTTGGTGAAAAGAAAAAAGAAACCAGTGGCTTCACTATAGGCATAAGCTAAACCACAACCCTGCCTAATATCCTGTTGAGAACCACCCAGCCTAGTATCCTGTTGCTCCACTAAAAATGACAGTATCACAACACACAGTTTCTTTAATGTCCGTTGCTGACCCCCGGAAAAAAATTCAGCTTTTATACAGTCAACATTCTTTATATCTGAAGGATGAAAAACAGCACAAAAATCTTGAAAACTATGAAGTCCCAGAATCTATTGGTCTCCAGATCTTAGTGGTCATTTCTTACTTAGCAAACTGTATGAATAGACATGTTCATGTGAAAGATTACTTTGTACATTCTGTTTCTGAAACACAGAATATAGAATCCCAGAAGATTCACTCCTCTAGACTGAGTGAGGTAACGAGCTCTAATATGCAAATATGTGGATTTGAAAGCATAGTTCTGCATTTAACTGAAAAGTATCAAAAGCTTCTCAGTGAAAATAAAATTATAGATGAACAGCCTAAACATCAGTCAGATATCTGTGGTCAGAACTTTCACTCAAATTTGTTTCAGTTAGACCACAAATGTGCAGCTATGTTGGATTTGGTTTGTAGTACTAAACAAATTAATATAGGGCCTGAAGTGGTACAAAGAGAGTGTGTGCCAACAGAATATCATGAAATACAAAACCAGTGTTTGGGATTATTTTCCTTGAACACAGTAGATAAGCCAAGGTCTGAAGTCTGAAGCAGCAGTTAGGAAGGTCTCAGACCTTAAAATGTCAACTGATACGGAATTTCTCTGTATAATTACCTCCAGCCAGGTTGCTTTTTTAGCTCAAAAGAAAGATAAAGGGCGGAGTCCTATAAATAAAGGGAATGTAAACATGGAGACTGAACCAAAGGCAAGTTACGGGAAGATAAGAATATCTGAAGAGAATTCCATTCAACTTGATGATTTTACAGAAGCATATGAAAGTGGACAAAACCAAGCATATTCTCTTGAACATTTTAGTCCTGTTTTTCCTAAAACAGAAAATAGCCACATTCACATAAACTCTGACAAAGGTCCTGAAGAAAATACAGGATCTCAAGAACTTTTCAGTTCTGAAGATGAACTGCCACCAAATGAGATACGTATTGAGTTGTGTAGCTCAGGAATACTGTGTTCCCAACTAAACACCTTCCACAAAAGTGCTATTAAAAGAAGCTGCACCTCTGAAGATAAAGTGGGCCAGTCTGAAGCTCTATCTAGAGTCCTTCAAGTAGCTAAGAAAATGAAGTTGATTTCTAATGCAGGAGATTCTGTTGTAGAAATGGATCAGAGGAATGTGTCTGAATTTAAGGGTATTAAAAAAAGTCATTAATAAAAAACTGTGATTCTAAAAGCCAGAAGTATGATTGTTTAGTCATGGTGCTATCTCCATGTCATGTGAAGGAAATAAACATAAAATTCGGACCAAATTCTGGCTCTAAAGTGCCTTTAGCAACAGTTACAGTAATTGATCAATCAGAAACTAAGAAGGTTTTTCTGTAGAGGACTGCAGCATTTTGGGCATATACAGTGTTTCTTGGAGATATAATTTTACTCGCAGATGTTGTTATTCATGAGGACCAATGGGTTGGCGAGACAGTACTACAATCAACATTTAGCAGTCAGTTATTAAATCTTGGGAGTTATTCATCTATTCAGCCTGAAGAATATTCCAGTGTAGTTAGTGATGTTGTACTTCAAGACCTACTGGCACAGGTGTCCTCAAAACATTCCTACCTCAGAGATCTTCCTCCGAGGCAGCCTCAGAGGGTGAACAGTATAGACTTTATAGAATTGGAGCACCTTCAGCCTGATGTATTAGTCCACACAATACTAAGAGTTGTTGATTTCACTATACTGACAGAGGCAGTATACAGTTATAGAGGACAGAAGCAGAAAAAGTTATGTTAACAGTGGAACAGGCCCAAGATCAACATTATGTGCTTGTATTATGGAGTCCTGGAGCAGCCTGGTACCCTCAACTGCAAAGGAAAAAAGGTTATATTTGGGAATTTAAATATCTTTTTGTTCAGCGCAATTACACACTAGAAAACCTAAAATCGCATACAATGCCTTGGTCATCCTGTGAGTGCTTGTTTGATGATGATGTAAGGGCAATTACATTTAAAGCAAAATTTCAAAAAAGTGCACCTTCCTTTTGGAAGATATCAGACTTAGCAACCCACCTAGAGGATAAATGTTCAGGAGTGGTTCTAATTAAAGCCCAGATTTCAGAGCTGTCATTTCCTATTACGGCAGCTCAGAAGATAGCTCTAAATGCTCACAGTTCTCTGAAGAGTATTTCTTTTCTTCTCTTCCCAACATCATATATACTGGCTGCGCAAAATATGGATTGGAACTAGAAACAGATAAGAACAGGATCTACAAACAATGTTTTAGCTGCTTGCCATTTACTATGAAGAAAATATACTATAGGCCAGCTTTAATGACTGTAGTTGATGGAAGACATGATGTTTACATCCGTGTAGACTCAAAGCTGATAGAGAAGATTCTTCTCAACATTTTTGCAGACTGCCTCAACAGAGTGATAGTTACTTCCTCAGAGATCACCTATGGGATGGTCATGGCAGACCTGTTACACTCCTTGTCGGCAGTCAGCGCAGAACCTTGTGTATCAAAGATTCAGAGCCTTTTTGTGTTAGATGAAAGCAGCTATCCATTACAACAAGATTTCTCCCTCCTGGATTTTTATCCTGACACTGTAAAGCATGGAGCCGATGCCCTTTTCTGAGGCCAGAGGAAGAAATGGCAGGCATTTCAAGGAAGAAGTACTGAAATGATTTGTCTTTTGAAGTAAATAAACGATAGGGTTTTTGCTTTGGATTTTTTATTAAATACATTTTACAAAGAGAATTTCAATTAAAACTTTTTTCTAAGAAAATCCTGTGAGGTTTAAAAAGATTATTTTTGTTTTTTGGTTTCTTCCTTTCTTCTGGAGAAATGATCTACCAGTCAAGGCAATATGTAGCAGATCCCTGGGAATTAAAGGTTTGCCCATTTGTTCACTGTATTTAGTCCCTGCTACGTTCCAGGCATTGTACTAAGTATGAGGAACCACAGGGAAGACATTCCCTCAGAAACTGCTGCAGTGCTTTTACTTATCCCTACCTAAAAACCGTCAATGTGAAATCATTTCCTTGATTACAACTATACATGATAATGGATTAGTTTATATAAACCTCTGTTTAGACAAGTTCAAGACAAGCGTGTCTTTCTATAAAAAGCATTGAAAACGAAGGAAATGAGATCATGTTTCAATTTATTAAAGCGGGGAAGAGCGTTCTGTGGTTAGTTCGTGTCTAGGATTTGAGTGCCTTACTGAATGTATTTAGCAAACATGTAGCAATCTGTTCTCTCACTGTGATTGTAGAAGAAGCTCATGTAAAATGATAGTCATTAATGAGGAAGTATAGAGTGGTACTTATTCTGTAAGTTCAGAGTATGCCGAGTATTAATAGATTATCATACTGCCTGAAAATAAATTTATGATGAAATGAAAAAAAAAAGTGACAGTTTAAAAAAAAAAATCTCCTGTGGTCAGAAGAAAACTAAAACACTAACTTCAAACCACCCCTGAAAATGAGCTGGAATTTAATTGGATCAGTCTTTGGAACAATTTAAGTCCCCAGGGCATTGTTTAAAACAATACAGAAATCCACCAGCAATTAGTGTAACTTACAGTGAGGTGTGATCAAGGAACCAGACAGAGTCCTGGAAAAACAAATCCCAGGGTGACTGTGGATATGCCCAAAACCACATTCTCCAAGGAGCAACATTTCAGGCTTTACAGTGTGTGGAGGGGAAGAAGGAGGGAACAGAGTTAACTAAAATACTCCAGCAAATCACTAAGTAAATAAATAAACAACAACAAGCCTCAAGGGGGAGAGGATCAATGCCCAGAGTTGATAGCATATATTATATACGAGTTGCTACCATATATTATATATAAGGTCCAGTTTCCAACAACACACACAAAAAATGAGACATTCAAAGAAATAGGCATTATTTCATTCTTTCTATGCTGAAGAGTATTTCATGATGTGTGTGTGTATATGTATATACATACACCATATATATATACACGCACCATATATATATATATACACACACACCATATATATACACACACACACACACACACACACACACCATATATATATGGTATATATATATTTCCTTTATCCACTCATCAGTTGATGGGCACTTAGGTTGATTCCATATGTTTCAATTGTGAATTGTGCTACATAAACATATGTGTGCAGGTGACTTTCTGATACAGTGACTTCTTTTCTTTTGGGTAGATATCCAGTAGTAGGATTGCAGGAATGAATGGCAGATCAATCAATTTAGTTCTTTGAT	G	NC_000014.9:g.87925161_87956832del	NM_000153.3:c.1162-6083_*9572del		30kb deletion				Krabbe disease	c.1161+6532_polyA+9kbdel			GALC	2581
VSV3HMGZE3	chr14	87941432	87941433	A	C	NC_000014.9:g.87941433A>C	NM_000153.3:c.1796T>G	NP_000144.2:p.Ile599Ser		39572	CM960686	rs387906953	Krabbe disease	1796T>G			GALC	2581
VSYTTZP91R	chr14	87941528	87941529	T	G	NC_000014.9:g.87941529T>G	NM_000153.3:c.1700A>C	NP_000144.2:p.Tyr567Ser		186914	CM970567	rs752537626	Krabbe disease	1700A>C	NFE	0.000108093	GALC	2581
VSLU4IJRML	chr14	87941543	87941544	A	G	NC_000014.9:g.87941544A>G	NM_000153.3:c.1685T>C	NP_000144.2:p.Ile562Thr		98406	CM140252	rs398607	fingerprint variant		AFR	0.611532986	GALC	2581
VS9WLG4EYI	chr14	87945565	87945566	C	T	NC_000014.9:g.87945566C>T	NM_000153.3:c.1657G>A	NP_000144.2:p.Gly553Arg		186915	CM990621	rs748573754	Krabbe disease	1657G>A	NFE	1.80E-05	GALC	2581
VS4EWG6PSG	chr14	87945592	87945593	C	T	NC_000014.9:g.87945593C>T	NM_000153.3:c.1630G>A	NP_000144.2:p.Asp544Asn		39571	CM960685	rs387906952	Krabbe disease	1630G>A	NFE	1.80E-05	GALC	2581
VS82EYWK1A	chr14	87945636	87945637	G	A	NC_000014.9:g.87945637G>A	NM_000153.3:c.1586C>T	NP_000144.2:p.Thr529Met		358254	CM970565	rs200960659	Krabbe disease	1586C>T	NFE	0.000179714	GALC	2581
VST4XTHXH3	chr14	87947743	87947745	CT	C	NC_000014.9:g.87947746delT	NM_000153.3:c.1472delA	NP_000144.2:p.Lys491fs		186917	CD972223	rs771489305	Krabbe disease	1472delA	AMR	0.000358166	GALC	2581
VSUPDU2CHC	chr14	87968385	87968386	C	T	NC_000014.9:g.87968386C>T	NM_000153.3:c.857G>A	NP_000144.2:p.Gly286Asp		39576	CM970558	rs199847983	Krabbe disease	857G>A	NFE	4.49E-05	GALC	2581
TP2016038	chr14	87976360	87976361	A	G	NC_000014.9:g.87976361A>G	NM_000153.3:c.749T>C	NP_000144.2:p.Ile250Thr		260060	CM960682	rs886039569	Krabbe disease	c.749T>C	NFE	1.79E-05	GALC	2581
TP2016037	chr14	87976415	87976427	ACTCCCAGAGAT	GAG	NC_000014.9:g.87976416_87976427delinsGAG	NM_000153.3:c.683_694delinsCTC	NP_000144.2:p.Asn228_Ser232delinsThrPro			CX952009		Krabbe disease	c.683_694delATCTCTGGGAGTinsCTC			GALC	2581
TP2016033	chr14	87993043	87993044	C	T	NC_000014.9:g.87993044C>T	NM_000153.3:c.121G>A	NP_000144.2:p.Gly41Ser		39578		rs387906955	Krabbe disease	c.121G>A			GALC	2581
VS8A2ED5WJ	chr14	94378609	94378610	C	T	NC_000014.9:g.94378610C>T	NM_000295.4:c.1096G>A	NP_000286.3:p.Glu366Lys	Z allele (or PI*Z)	33006	CM830003	rs28929474	Alpha-1 antitrypsin deficiency	1096G>A	NFE	0.018153001	SERPINA1	5265
VS9UAUZRYA	chr14	94383007	94383011	GAGA	G	NC_000014.9:g.94383015_94383017delAGA	NM_000295.4:c.227_229delTCT	NP_000286.3:p.Phe76del	M (Malton) allele	321860	CD890161	rs775982338	Alpha-1 antitrypsin deficiency	227_229delTCT	EAS	0.000405985	SERPINA1	5265
VSBLD6GMVQ	chr14	96876032	96876033	C	T	NC_000014.9:g.96876033C>T	NM_003384.2:c.1072C>T	NP_003375.1:p.Arg358*		22536	CM094869	rs137853063	"Pontocerebellar hypoplasia, type IA"	1072C>T	ASJ	0.00142479	VRK1	7443
VSWPLQQ3TA	chr15	34236718	34236719	G	A	NC_000015.10:g.34236719G>A	NM_133647.1:c.3031C>T	NP_598408.1:p.Arg1011*		20365	CM022673	rs121908427	Andermann syndrome	3031C>T	NFE	8.96E-06	SLC12A6	9990
VS93LGTXXY	chr15	34236746	34236747	G	A	NC_000015.10:g.34236747G>A	NM_133647.1:c.3003C>T	NP_598408.1:p.Leu1001Leu		169108		rs4577050	fingerprint variant		FIN	0.715164006	SLC12A6	9990
VSJERDPCBU	chr15	34240658	34240660	AC	A	NC_000015.10:g.34240661delC	NM_133647.1:c.2436+1delG			429644	CD022746	rs1436424652	Andermann syndrome	2436+1delG	NFE	8.96E-05	SLC12A6	9990
VSV6GQKYB5	chr15	40415453	40415454	C	T	NC_000015.10:g.40415454C>T	NM_002225.3:c.941C>T	NP_002216.2:p.Ala314Val		18607	CM983435	rs28940889	Isovaleric acidemia	941C>T	NFE	0.00124472	IVD	3712
VS728YI389	chr15	42387801	42387803	CA	C	NC_000015.10:g.42387804delA	NM_000070.2:c.550delA	NP_000061.1:p.Thr184fs		32660	CD951640	rs1333478151	"Limb-girdle muscular dystrophy, type 2A"	550delA	NFE	0.000420875	CAPN3	825
VS2T1MI21T	chr15	42401754	42401755	G	A	NC_000015.10:g.42401755G>A	NM_000070.2:c.1469G>A	NP_000061.1:p.Arg490Gln		32661	CM970217	rs121434548	"Limb-girdle muscular dystrophy, type 2A"	1469G>A	AFR	0.000130753	CAPN3	825
VS3QQSF9QP	chr15	42410925	42410926	G	A	NC_000015.10:g.42410926G>A	NM_000070.2:c.2306G>A	NP_000061.1:p.Arg769Gln		32652	CM950197	rs80338802	"Limb-girdle muscular dystrophy, type 2A"	2306G>A	SAS	6.50E-05	CAPN3	825
VSR7J1PXVK	chr15	51211009	51211010	C	T	NC_000015.10:g.51211010C>T	NM_031226.2:c.1310G>A	NP_112503.1:p.Cys437Tyr		32855	CM930184	rs78310315	Aromatase deficiency	1310G>A	NFE	8.99E-06	CYP19A1	1588
VSNA4UZ1CL	chr15	51211016	51211017	G	A	NC_000015.10:g.51211017G>A	NM_000103.3:c.1303C>T	NP_000094.2:p.Arg435Cys		32854	CM930183	rs121434534	Aromatase deficiency	1303C>T	EAS	5.81E-05	CYP19A1	1588
VS8RLSZ3HZ	chr15	51212357	51212359	TG	T	NC_000015.10:g.51212362delG	NM_031226.2:c.1224delC	NP_112503.1:p.Lys409fs		32858	CD972160	rs786205108	Aromatase deficiency	1224delC			CYP19A1	1588
VSL82YQ9SY	chr15	51212459	51212460	G	A	NC_000015.10:g.51212460G>A	NM_000103.3:c.1123C>T	NP_000094.2:p.Arg375Cys		32857	CM950332	rs121434536	Aromatase deficiency	1123C>T	NFE	1.80E-05	CYP19A1	1588
VSHU711VN6	chr15	51212488	51212489	C	T	NC_000015.10:g.51212489C>T	NM_000103.3:c.1094G>A	NP_000094.2:p.Arg365Gln		32860	CM973297	rs80051519	Aromatase deficiency	1094G>A			CYP19A1	1588
VSS8GIC16K	chr15	51218504	51218505	T	A	NC_000015.10:g.51218505T>A	NM_031226.2:c.743+36A>T				CS066630	rs1143704	fingerprint variant		ASJ	0.524733007	CYP19A1	1588
VSCMSXR3HT	chr15	51218538	51218539	A	G	NC_000015.10:g.51218539A>G	NM_031226.2:c.743+2T>C			32856	CS920749	rs786205107	Aromatase deficiency	c.858+2T>C			CYP19A1	1588
VSV8KT1W64	chr15	51218657	51218658	G	T	NC_000015.10:g.51218658G>T	NM_031226.2:c.629-3C>A			32862	CS024713	rs786205110	Aromatase deficiency	629-3C>A			CYP19A1	1588
VS7CPV5K4L	chr15	51222348	51222349	C	T	NC_000015.10:g.51222349C>T	NM_000103.3:c.628G>A	NP_000094.2:p.Glu210Lys		32865	CS033116	rs121434538	Aromatase deficiency	628G>A	EAS	5.80E-05	CYP19A1	1588
VSCUYK18LH	chr15	51222506	51222508	AG	A	NC_000015.10:g.51222509delG	NM_031226.2:c.469delC	NP_112503.1:p.Val158fs			CD993257		Aromatase deficiency	469delC			CYP19A1	1588
VSDB4AV11B	chr15	51227777	51227778	C	T	NC_000015.10:g.51227778C>T	NM_031226.2:c.451+1G>A						Aromatase deficiency	c.451+1G>A			CYP19A1	1588
VS1YUTJELT	chr15	68211696	68211700	TTGA	T	NC_000015.10:g.68211703_68211705delATG	NM_017882.2:c.461_463delTCA	NP_060352.1:p.Ile154del		19122	CD020221	rs121908080	"Neuronal ceroid lipofuscinosis, CLN6-related"	461_463delTCA	AMR	2.98E-05	CLN6	54982
VS20160209	chr15	68211843	68211844	C	CG	NC_000015.10:g.68211850dupG	NM_017882.2:c.316dupC	NP_060352.1:p.Arg106fs		19120	CI020252	rs397515352	"Neuronal ceroid lipofuscinosis, CLN6-related"	c.316dupC	SAS	0.000194932	CLN6	54982
VSAS4Y14CB	chr15	68214372	68214373	C	A	NC_000015.10:g.68214373C>A	NM_017882.2:c.214G>T	NP_060352.1:p.Glu72*		19116	CM020103	rs104894483	"Neuronal ceroid lipofuscinosis, CLN6-related"	214G>T	AMR	0.000476446	CLN6	54982
VS3ECLY26T	chr15	71813572	71813573	G	A	NC_000015.10:g.71813573G>A	NM_014249.3:c.932G>A	NP_055064.1:p.Arg311Gln		20571	CM000538	rs28937873	Enhanced S-cone syndrome	932G>A	ASJ	0.00494321	NR2E3	10002
VS13D35E48	chr15	72346233	72346234	C	G	NC_000015.10:g.72346234C>G	NM_000520.5:c.1421+1G>C			18929	CS880074	rs147324677	Tay-Sachs disease (DNA)	IVS12+1G>C	ASJ	0.00244848	HEXA	3073
VS23EFA9E3	chr15	72346578	72346579	G	GGATA	NC_000015.10:g.72346580_72346583dupGATA	NM_000520.5:c.1274_1277dupTATC	NP_000511.2:p.Tyr427fs		18928	CI880091	rs387906309	Tay-Sachs disease (DNA)	1278+TATC	ASJ	0.0135025	HEXA	3073
VS1278TATC	chr15	72346583	72346584	T	G	NC_000015.10:g.72346584T>G	NM_000520.5:c.1273A>C	NP_000511.2:p.Ile425Leu					Tay-Sachs disease (DNA)	1278+TATC			HEXA	3073
VSBDCADE52	chr15	72348046	72348047	C	T	NC_000015.10:g.72348047C>T	NM_000520.5:c.1073+1G>A			18959	CS910444	rs76173977	Tay-Sachs disease (DNA)	IVS9+1G>A	NFE	0.000412238	HEXA	3073
VS9EB2A855	chr15	72350516	72350517	C	T	NC_000015.10:g.72350517C>T	NM_000520.5:c.805+1G>A			18977	CS920759	rs121907980	Tay-Sachs disease (DNA)	IVS7+1G>A	NFE	8.95E-06	HEXA	3073
VSDB1E9396	chr15	72350517	72350518	C	T	NC_000015.10:g.72350518C>T	NM_000520.5:c.805G>A	NP_000511.2:p.Gly269Ser		18937	CM890061	rs121907954	Tay-Sachs disease (DNA)	p.G269S	ASJ	0.00071066	HEXA	3073
VS455D36EF	chr15	72350577	72350578	G	A	NC_000015.10:g.72350578G>A	NM_000520.5:c.745C>T	NP_000511.2:p.Arg249Trp		132034	CM930396	rs138058578	Tay-Sachs disease (DNA)	p.R249W	EAS	0.000695733	HEXA	3073
VS22AE0C4A	chr15	72350583	72350584	G	A	NC_000015.10:g.72350584G>A	NM_000520.5:c.739C>T	NP_000511.2:p.Arg247Trp		18961	CM920335	rs121907970	Tay-Sachs disease (DNA)	p.R247W	NFE	0.00324042	HEXA	3073
VSBF2D9E05	chr15	72353104	72353105	C	T	NC_000015.10:g.72353105C>T	NM_000520.5:c.533G>A	NP_000511.2:p.Arg178His		18935	CM880041	rs28941770	Tay-Sachs disease (DNA)	p.R178H	AFR	0.00013077	HEXA	3073
VCB7AFA16A	chr15	72370591	72378536	ATCAGTGAGGCGGGAAGACTGCTTGAGTCCTGGAGTTCGAGGTTGCTGTAAGCCGTGATCACACCACTGCACTCCAGTCTGAATGACAGAGAAAGACCTGTTTCTTAAAAAAAAAAAGAAAGAAAAGAAAAGAAAAAAACAGGGCTGTGAGAAGAGAGGCTGGTGGAAGACTGCAGGCCAAGCTAATCTAGGCCCTGGGATTCAAAATGAAATATGACACTTATTTTGCCCTTCAACTAAAAACTGTGCTTCTGCCATCACCTTCTTTCTAAAGACAATTTATTCATCACTGTATTTCTCCTATGTATCCCTCGTTCTCCAGAAACCCCTTCATGAGAAAAAGTAATTCTACTACAAAACCTTCTTCCCGTGTTGTTTTCTTCCTCTTTGCTTTTAAAACAATAAACTTAGTGGCAATCATCTTTGGCAGGAATATGCCTTGTCTTTGCCGTGGGAAAGGTTAAAGTATAGTTAGCCGCTAGCCCAATTAAAGTGGAGAGAACTAATCGGCCTTATTCTTTCTCCCCAGCCCAGCTGCTTGACCTTATCTGTTTCCCTCCTAGATGCAATCCCAATGCATCTCTCACTGCATGCTGAGTTAAGAGCAGCACGAGTTGGGATCACACAATAAGCAGCATAGTGTGATTATCCTTTGCCTGGAATCACACACTTACACTCCAAATTGGTAACCTGAAAGGAAAGGTAATCCTCAATGAAAACCTGCAAATCATATCTTTTTGATGATCTTCTCAGACCTGTAATCCCAACACTTTGGGTGGCTGAAGCAGGCAGAGTGGTTGAGCCCAGGGGTTCGAGACCAGCTGGGGCAACATGGTGGTACTCCATCTCTACAAAAATTAGCTATGCACCTGTAGTCCCAGCTACTCAAGAGGCTGAGATGGGAGGACAGCTTGAGCCTCGGAGGTCGAGGCTGCAGTGGGCTGTGTTTGTGCCACTGCACTCCAGACTGGGTGACAAAATAAGACCCTGTCTCTAAAAGAAAAAAAAAAAAAAAAAAAAAAGAAAACAAAACCCAAACCCATAAAGCCTTCTTACAAATGTTTACACAAAGTAGCTCTTTAACGTTAATATATTTTACAAATAATTACTACATATCTACAACGTTCCAGATACAGAAGAAATGGCCAAAGAAGGTATTTTAGGAGATCCAGATTATAATGAACTATGCCATTTATTAATTTAGTCACTTCTTTAATATCTGAGGATGAGCAAATCAAATACTGATAATGGCTGCAGAAGGACACAGGCTCTTATATAATAATCTTACTTCCATTCCAGAATAAAAGGGCTGGAGAAGGGGGGCAGGATTATTCTGTTGAAGGACAATGGCATCCTCAGCAACTCACAGGGATGTGCAGGTGAACATCAGACCAGGATGGGAACCTTATAATATCTATGATATACTATGGCTTCTATCAACCAGTTTCAGGAAAAGCAAAGAAGAATGCAGTCATGGCCAGGTGCAGTGGCTCACACCTGTAATCTTGAGGTGGGCAGATCACATGAGGCCAGGAGTTCGAGACCAGTCTGGCCAACGTGGTGAAACCCCATCGCTACTAAACCCCGTCTCTACTAAAAAATAAAAAATTAGCCAGGCATGGTGGTGGGTGCCTGAATTCCCAGCTACTTGGGAGGCTGAGGCAGGATAATCACTTGAACCCAGGAGGTGGAGGTTGCAGTGAGTCAAAATCACACCACTGCATTCCAGCCTGGGCAACAGAGCAAGACTCCATCTCAAAAAAAAAAAAAAAATGCAGTCTAATGGCAGAATTAGACTTAGCCACTTTACTTGGAAAAATTTGGACTTTATCAGCTCCATCAAGCACCATGCTCCACACCATGCTTATTAAATGTCTGGAGCAACATTAGATGGGTGCCATTCCAAATTCCAAATAATCACATCTTTGCTTTGCAAACAGGATGTGGCTTAATAATCAAACAGGGAACTAGATTCATTCAAGTATCTAGTTCCTAAAATAAGTCTATTTAACAGGTTCAACAACATGCAACACACACCCTCCAATTGGTAGAAACACCTCTCAATGACAAAGAAAGGTGGCAAATACTAAACACCTTCACAGACCATTTAGCAACTGGTGGGACTAACCCTTGAAGGTGAATTCAAAATAGAACTGAACCTCAATACCAGACTTCTTTTTCAGAAAAGGGAGTATGAATTCTTAGTTTCAGGTTCAGACAAAAACCAGAAGTTGTATTGCATTAGGAAAAACACTGGGCTGGTCAGGTGGCTCATTCCACCCTGTAATCCCAGGACTTTGGTAGGCCAAAGCAGGGGGATCACTTGAGCTCAGGAATTGGAGACCAGCTTGGGCAACATGGCGAAACCCCATCTACAGAAAATACAAAAATTAGCCAGGTGTGGTGGCATGCTCCTGTGGTCCCAGCTACTCAGGAGGCTGAGGTGGGAGAATTGCTTGAGACCGGGAGGCAGAGGTTGCAGTGAGCCAAGATTGTGCCACTGAACTCCAGCCTAGGTGACTAAGCAAGATTCTGTCTCAAAAAAACAAAAACAAACAAACAAACAAAACCTACTGGCCCAGAGCCTACAAATAAGTTGTTTGGAGGAAGAGGATGGAAATCTGTTAGTTAAGATTTAACCTGCATATGTTGCCTTCTTTACTAAAATCAGACTCATAAAGAAATGTATTCTGGCTTCAGCCTTGTTGGTATTGCTCTACCTCTATTTGTTTCCCATGCTATTGCTTCATCCTTGTTTCTGCAGAACTAGGATTTTAGCTCAAAGTCACCTAAAAGCCTCCACAGGAAACTACATTCCAAAGGGAAGACTCCATGGGAAGAGCAATAGAGAAAGAAGTTACTTTTAAGTCTTTGGTAATGTTCACCCAACCCAGTTTTCATTTTCTCTCAATGGACAAGAACCCTCAACTAATAAAGCTAATGAACTTACAGGAAGGTAATATATGGAAATAAACATCTTATTGAATTTATCTGGCTCTAAATCTCTTTTGTTAGGGAATTTATAGTATTCCATTATCTTACAATCTCTCCATTTCTATCTACTTGATTAAACTATGGTGCTATAGCAATGGAGGTGAAGGCCTAATTTAGAAGTATAGGAATTAGGTATGGCGCGGTGGCTCATGCCTGTAATCTCAGCACTTTGGGAGGCTGAGGTGGGTGGATCACTTGAGGCCAGGAGTTTGAGACCAGCCTGGCCAACATGGTGAAACCCCATCTCTACTAAAAATACAAAAATTAGCTGGGCGTGGTGGCAAGCACGTGTAGTCCCACCTACTCGGGAGGCTGAGGCAGGAGAATCGCTTGAACCCAGGAGGCGGAGGCTGCAGTGAGCCAAGATCGTATCACTGCACTCAGCCTCAGTGTAGGCTGAGTGATAAAGCGAGACTCCGTCTCAAAAAAAAAAAAAAAAAGGAAAGGAATTATTCTCATGTATACAATAGTAGGAAACAACCTATAAAGCTTTTGAGAATCTTATAATTCACTGTGTACCTCCCTCTGTTTCATATTTTCGCAATTGAACTATAGAGCCTAGGCCTAGGTCTTAAGACTTTTCTTGTAACCTTCAGAGTGCCCAGCACTGGGATTGACATATACCAGTTAGACGGATTTTTTTTTCCATAAACCAGGCTCAAACTCTTCTAAACCAAAATCAACATATTCTGAGTGCCAATCTTGGGTAAGGCACTCTATTATTTGTCATGAAGGATTCAGAGGAAAATGTGATCTACCACACTCAACAGCAGGCCTCTTATCCTCTCCAGCTTAATGCATTTTACCAGTTAAGGACTACCCTGATGCTGAGATTGTGTTTCTTTCCCCAAATCAAATGTCACTCTCTAAGGGTCATCTGTATAATTAAATGCTTTTAATTCTATATATCAAATGATAACTTTTGTGAAAGTAATTTAAACACACTTGAAACATCATATAAAATATTACTACAAGACTTAACCGTAAATGTGGCTCCCACCCCCATAACATCTATACAATATAACCAAAGAGCTAGATTCCAGATTATCAAGAAACTTCTAAATTTTGAACCCATGCAGCAGAATTGTATTCCTTTACATTGTTGGCTCGACTTACAAATGTGCTGTGGAATAATTATCCTCAAATACAATTTTCAGTACTGATTACATAGCTGCCTAAAAGAAAACTGTTAGCCCCTTCCATTTTATGTGAAACCAATGTCTAAAGCGCTCTTGACTCTTCAACCCCACATTTTCCCCACCCTCATCCCTCCTCAATCCCCAGCCCCCACTCATCACATCCACTAGACCTGAACTTTGAACTCAATCATAATTCTTTGTGCCTCTGCTCAAGCCCTTCTTCCTGCCTGGAATACCCTCTTTTCAGTCCCGGCTAATTACATCTACCATCCCATTCCAAGTGGCCGCTGGAAACTCACTTCCTTATGTTCTATGATTTCTTTCACAATTTACACTTTTTTTGTTTTGTTTTGTTTTGTTTGGGGGGGGGGGTTGTTTTTCTGAGAGGGAGTCTTGCTCTGTTGCCCAGGCTGGAGTGCAGTGGCGCGATCTCAGCTCACCACAACCTCCACCTCATGGGTTCAACCGATTCTCCTGCCTCAGCATCCCGAGTAGCTGGGACTACAGGCGCGCGCCGCCACGCCTGGCTAATTTTTTGTGTTTTTGGTAGAGACGGGGTTTCACTATGTTGGCCGGGCTGGTCTCGAACTCCTGACCTCGTGATCCGCCCGCCAAACATTCTATGTGCCAGAAACTTGTATGTAACTTTGCATAGTTCTTGTATTATGTCTCCCCAATTTTGAGTGTTTTCTCTGGTCTCTACTCAGCCCTTGCTCACAGTCTCACTAGGACCCTGGCTAGCTTGAACACGGTCAGAAGGATCACCTTAGATTTCTGCTGGCACAGTATTTTCCATAAATTAATCTCCTGATTGAACCGTAGTCCTATAGTAGTTATCTTTGGATGAAAACCTAATGCAGCTCGAGGAGGAAGTGGAGTGCCTGTGATCAGAGGGCTGGACAAAAGCCCATAGGGCGTCTCTGGAGCCCTGGGGGAACTGTCCCCAGGCAGGCACTCTCAGGGCCCAGGAACAGGGCGGGACAAGTCCGACTCACCTGTGAGGTAAGGACGGGGCCAAGACCCGGAACCGAAAAGCAGGTCACGATAGCGCTGGAAGGCCTCGTCGAGGACTGAGCAGCCGGGCTGCGCGGCCGAGCTGACATCGTACTGGAATTGAAAGTTGTTCGGGTAAAGGACGTAGCGCTGGTCGGAGGTTTGGAAGTTCTGAGGCCAGGGCCAGAGGGCCGTCGCCCGTCCTGCGAACGCTGCCGCCAGCAGCAGCGAAAACCAAAGCCTGGAGCTTGTCATGGCCCGCTGGTCTCCCCTCTCGGAGGGGGCTGGCCACGTGAGACCCTGGTCAGGTGAGCGGCGCCCCCGTGACTTATCGGCGAATCACGTGACCAGAGGCGGCTCTGCGCCTGCGACCCCAGGAGGACCCACACCCTGCCCTTTCACTTCCGGCCTGGACCTGAGGCTCCTGCTACGTGCAGCGGATTGTGCCGGGCGTCGGCAACTGCTCGGCTCGCCAGACTGTTCACGGGCCCAGTAGAGCAGTAAATAACCGGCCACCCCTGCGGCCGTGCCGGCCGTGATGGAACTAGACAGCTCACCCGACTCGAGAAGAACGGGGTGGGGAGGCGAGGACGCAGGGCGACCTGGAGAAGAAAGTTTCCCAGATGGCTCTAGGGTGAATCTTGAATGTTGTGATGCAGCTCGCCAGGCCTACGGGGAGGTAAAGGACTTGCCAGGCTGAAGTAACTTCAGAAGCAGAAAAACGGAGGATTAAAACCACAAGTCGTTGTGATGTGAAATTTCGTGGGGCAAGAAAGGGCCGGAAGTAGGTAGTCTGCACGGCTCTGCTAGAGAGAGGATCACAAGATCACACAAATGTGATCTACTTATGACTGGAAAAAATGTGTACTTTCAGAGCCAGCTTGAGGCATTCCATTGCCTCCAATATGAGCTCTTCCCTTCAAGATTGACTATAAATCTCTTAGTTACAACTCACATCCCCTTTCCCCAGACAAAACCCCACATAGCCCGGTGTGTATTTACTGAAAGCAGTAAGATATTGCTGGGGCTTTGGGTGCAAGATGGAGAGTGCTCAGAGATAATGACAGGGGCCTGGTCCTGCAGGGCCTTACGTAGAAAGTCAAGGAATTTATTCTCTGAGCAATTGAAAATCATCCCGAAAGATCTGCATTTTAGAAATACCATGTTGAGTAGTTGCATAAGAAACCAGTTAGGAGGCCCCTTTTTATTGGAGGTAGAGAATAATGAGAGACTGAACTACAGAAGTGGGGAAGGAAGACAGCTGTAGATCCAAGAAATAGTATCCGGAAGAGAGGCTTGAGAAGTGATCAAGGAGAATTCCACAGTTATCAGAGACCCTGTCTTCCTTGTTCACCACTATATTACCAGAACATAATACAAATAATGCTATTGTTATTGGGTGGCATTATTTGGTTAGTAGGTACTTTTTAAAATTTTTAAATTTAATTTTAGTATTAAAATACATGTAAAGATCAGGAAAATGAACTTTTAAAAATAAAGGGCTTTCACTGGGCATGATAACACATCCCTGTAGTCCCAGCTACTCCCAGCTATTCAGGAGGCTGAGGCGGCAGGATCACTTGAACCAAGGAGTTCAAGTTTAGCCTGGGCAGTATAGTGAAACCCTTTCTCAAAAACAAATAAAGGGCTACTGAAATAATGATAATTTATATTCAGGTCGTAGGTACCTAATTACTAGTTACACATACATGGCTTTGATGGGAAATCAAAGAAACATTCTGACAATACAGAGATTCATCAAGCAATTTGTCTTTGAAAGTTGATTATTCAAAAACAGAGCTTGTAGCAAAAGAAGCAGAAATTAGATCCCACAGTCATCAAGTTTCAGATCCTAAGGCTTGCATTCTTACACCAATTTCTTCTTTGCTTAAATCTTAATTTTCATCAGCATTAATTAAGTGTCTGGGTACTCTGCCAGTCAGGAGAGATGTTACCAAAGGTACAGGATTTGAGAAGTATTGTCAGAAGAGCCAAGTTCATAATCAGGCCCACAGGATCAATAATTTGGGGGAGTGTTTAGAGCAGTTTCAAAGATGAGAGCAGTAGATCAAAGTAGAATTTCAGGACTGAGCACATGCCAAGGCACCCTTTTATGGATATTCAACCTGTACCAGAAGGGAGGAGTCATTTACTTAAAAGAGTTACACAAGATGAAAGAGCTAGATCCAAATAAAGACGCTATAAAAATTACTAATGGGGCTGAGCATGGTGGATTACAGGGATTCAGTTATTTAATTATTACTGAAAGAGCTCTTTTAGACTTAACCAGATTTTTAAACCAAATATTCTTATGCATACATAAAAGTAAGTTACACAAGATAAATTTGTTGATCTTCCAAAATATCCCCCCTTACTATACACTAGAGTGGGGTTTTGGCATAATGGCAGACAAATAGATGGAACGGAATAGAGGGTCCAGGAAAAGAGCCATTTGATTATTACTCCATTTCAATGAAGACACCAATTTAATTTAGTGGGGAAGGCAAGTTATTTTCAATAAAAGGTGATGAAGAAAATAGATATCCCTATGTGGGAAAAATGAACTATGATCCCCTACCTCACAGCATACACAAACTTAATTAAAAATGGATCACAGGCTGGGGATGGTGGCTCACACCTGCAATTCCAGCACTGTGGAAGGCCAAGATGGGAGGATCACTTGAGCCCAGGAGTTCAAGATCAGCATGGGTAATACGAGGAAATCCCATCTCTCTTTATTTTTTTCTTTTTTGAGATGGGGGTGGTTAATGGGTACAAAAAAAGTAGCCTGAATAAGACATACTATTCGAGAGCACAAT	C	NC_000015.10:g.72370592_72378536delinsC	NM_000520.5:c.-2564_253+5128delinsG						Tay-Sachs disease (DNA)	del7.6kb			HEXA	3073
VSHR2D9AH4	chr15	74897049	74897050	G	A	NC_000015.10:g.74897050G>A	NM_002435.2:c.884G>A	NP_002426.1:p.Arg295His		29388	CM023097	rs28928906	"Congenital disorder of glycosylation, type IB"	884G>A	NFE	6.27E-05	MPI	4351
VSHYWQUAD4	chr15	80180229	80180230	G	A	NC_000015.10:g.80180230G>A	NM_000137.2:c.1062+5G>A			26909	CS930802	rs80338901	"Tyrosinemia, type I"	1062+5G>A	FIN	0.000670601	FAH	2184
VSD09ED03F	chr15	90766922	90766928	ATCTGA	TAGATTC	NC_000015.10:g.90766923_90766928delATCTGAinsTAGATTC	NM_000057.3:c.2207_2212delATCTGAinsTAGATTC	NP_000048.1:p.Tyr736fs		20493	CX952002	rs113993962	Bloom syndrome	2281Del6/Ins7			BLM	641
VS2EE60EBF	chr15	90769436	90769437	G	GT	NC_000015.10:g.90769438dupT	NM_000057.3:c.2407dupT	NP_000048.1:p.Trp803fs		51343	CI073737	rs1385729266	Bloom syndrome	2407dupT	ASJ	0.000101564	BLM	641
VSX3J9IRE8	chr16	3243204	3243205	C	T	NC_000016.10:g.3243205C>T	NM_000243.2:c.2282G>A	NP_000234.1:p.Arg761His		17588	CM981247	rs104895097	Familial Mediterranean fever	2282G>A	EAS	0.00185529	MEFV	4210
TP2016019	chr16	3243256	3243257	C	A	NC_000016.10:g.3243257C>A	NM_000243.2:c.2230G>T	NP_000234.1:p.Ala744Ser		17587	CM981246	rs61732874	Familial Mediterranean fever	2230G>T	ASJ	0.0126904	MEFV	4210
VSTXQBFS71	chr16	3243309	3243310	A	G	NC_000016.10:g.3243310A>G	NM_000243.2:c.2177T>C	NP_000234.1:p.Val726Ala		17579	CM970914	rs28940579	Familial Mediterranean fever	2177T>C	ASJ	0.040203001	MEFV	4210
VS55GA9TY7	chr16	3243402	3243403	T	C	NC_000016.10:g.3243403T>C	NM_000243.2:c.2084A>G	NP_000234.1:p.Lys695Arg		17586	CM981245	rs104895094	Familial Mediterranean fever	2084A>G	FIN	0.0165934	MEFV	4210
VSI299ASI5	chr16	3243404	3243405	C	T	NC_000016.10:g.3243405C>T	NM_000243.2:c.2082G>A	NP_000234.1:p.Met694Ile		17578	CM970912	rs28940578	Familial Mediterranean fever	2082G>A	AMR	0.000506224	MEFV	4210
VSLBGIE5ZK	chr16	3243406	3243407	T	C	NC_000016.10:g.3243407T>C	NM_000243.2:c.2080A>G	NP_000234.1:p.Met694Val		17577	CM970913	rs61752717	Familial Mediterranean fever	2080A>G	NFE	0.000474434	MEFV	4210
VSEE12HLDB	chr16	3243407	3243411	CATT	C	NC_000016.10:g.3243411_3243413delTAT	NM_000243.2:c.2076_2078delAAT	NP_000234.1:p.Ile692del		103377	CD982752	rs104895093	Familial Mediterranean fever	2076_2078delAAT			MEFV	4210
VSNPGQI6Q1	chr16	3243446	3243447	C	T	NC_000016.10:g.3243447C>T	NM_000243.2:c.2040G>A	NP_000234.1:p.Met680Ile		17589	CM990839	rs28940580	Familial Mediterranean fever	2040G>A			MEFV	4210
VS8FG9M6CY	chr16	3243528	3243529	C	T	NC_000016.10:g.3243529C>T	NM_000243.2:c.1958G>A	NP_000234.1:p.Arg653His		17592	CM014209	rs104895085	Familial Mediterranean fever	1958G>A	AFR	0.000130685	MEFV	4210
VS25WEN9KN	chr16	8806397	8806398	C	T	NC_000016.10:g.8806398C>T	NM_000303.2:c.338C>T	NP_000294.1:p.Pro113Leu		22762	CM971224	rs80338700	"Congenital disorder of glycosylation, type IA"	338C>T	SAS	9.75E-05	PMM2	5373
VS4TKAWJ5L	chr16	8811087	8811088	C	A	NC_000016.10:g.8811088C>A	NM_000303.2:c.357C>A	NP_000294.1:p.Phe119Leu		22750	CM971225	rs80338701	"Congenital disorder of glycosylation, type IA"	357C>A	NFE	6.99E-05	PMM2	5373
VSAPNCHB92	chr16	8811152	8811153	G	A	NC_000016.10:g.8811153G>A	NM_000303.2:c.422G>A	NP_000294.1:p.Arg141His		22745	CM971228	rs28936415	"Congenital disorder of glycosylation, type IA"	422G>A	FIN	0.00821273	PMM2	5373
VSU99R3RB5	chr16	8811196	8811197	T	C	NC_000016.10:g.8811197T>C	NM_000303.2:c.447+19T>C			98709		rs11074924	fingerprint variant		FIN	0.572171986	PMM2	5373
VSP662AW6P	chr16	8847774	8847775	G	A	NC_000016.10:g.8847775G>A	NM_000303.2:c.691G>A	NP_000294.1:p.Val231Met		22758	CM971231	rs80338707	"Congenital disorder of glycosylation, type IA"	691G>A	EAS	0.000115996	PMM2	5373
VS6S6G9FB8	chr16	16154898	16154899	G	A	NC_000016.10:g.16154899G>A	NM_001171.5:c.4015C>T	NP_001162.4:p.Arg1339Cys		21615	CM001604	rs28939702	Pseudoxanthoma elasticum	4015C>T	SAS	0.000233567	ABCC6	368
VSE7RYGXT7	chr16	16163077	16163078	G	A	NC_000016.10:g.16163078G>A	NM_001171.5:c.3421C>T	NP_001162.4:p.Arg1141*		21598	CM001043	rs72653706	Pseudoxanthoma elasticum	3421C>T	FIN	0.0029148	ABCC6	368
VS7JIEUYN4	chr16	16163085	16163086	C	T	NC_000016.10:g.16163086C>T	NM_001171.5:c.3413G>A	NP_001162.4:p.Arg1138Gln		21600	CM001041	rs60791294	Pseudoxanthoma elasticum	3413G>A	NFE	0.000134368	ABCC6	368
VS8LAH98N5	chr16	56878161	56878162	G	T	NC_000016.10:g.56878162G>T	NM_000339.2:c.1180+1G>T			430987	CS040559	rs749098014	Gitelman syndrome	1180+1G>T	NFE	4.50E-05	SLC12A3	6559
VSLRDG6411	chr16	57656243	57656244	T	A	NC_000016.10:g.57656244T>A	NM_005682.6:c.1036T>A	NP_005673.3:p.Cys346Ser		20869	CM045046	rs121908463	Bilateral frontoparietal polymicrogyria	1036T>A			GPR56	9289
VSAGZFH53N	chr16	89746839	89746841	GT	G	NC_000016.10:g.89746841delT	NM_000135.2:c.3398delA	NP_000126.2:p.His1133fs			CD015307		"Fanconi anemia, type A"	3398delA			FANCA	2175
VSW5F6ZZQL	chr16	89792032	89792037	GCCAA	G	NC_000016.10:g.89792039_89792042delCAAC	NM_000135.2:c.1115_1118delTTGG	NP_000126.2:p.Val372fs		18479	CD962003	rs397507552	"Fanconi anemia, type A"	1115_1118delTTGG	NFE	0.000134271	FANCA	2175
VSH2TQ8Z97	chr16	89811059	89811060	G	A	NC_000016.10:g.89811060G>A	NM_000135.2:c.295C>T	NP_000126.2:p.Gln99*		358391	CM050255	rs1057516430	"Fanconi anemia, type A"	295C>T			FANCA	2175
VSCF50A51C	chr17	3483496	3483497	A	G	NC_000017.11:g.3483497A>G	NM_000049.2:c.433-2A>G			48619	CS941422	rs63751297	Canavan disease	IVS2-2A>G			ASPA	443
VS4C58962E	chr17	3494407	3494408	C	A	NC_000017.11:g.3494408C>A	NM_000049.2:c.693C>A	NP_000040.1:p.Tyr231*		17648	CM940123	rs12948217	Canavan disease	p.Y231X	ASJ	0.00121852	ASPA	443
VS1EDDF157	chr17	3498999	3499000	A	C	NC_000017.11:g.3499000A>C	NM_000049.2:c.854A>C	NP_000040.1:p.Glu285Ala		17644	CM930046	rs28940279	Canavan disease	p.E285A	ASJ	0.00873096	ASPA	443
VSB0E24D8B	chr17	3499008	3499009	A	G	NC_000017.11:g.3499009A>G	NM_000049.2:c.863A>G	NP_000040.1:p.Tyr288Cys			CM034717		Canavan disease	p.Y288C			ASPA	443
VS40889C42	chr17	3499059	3499060	C	A	NC_000017.11:g.3499060C>A	NM_000049.2:c.914C>A	NP_000040.1:p.Ala305Glu		17646	CM940124	rs28940574	Canavan disease	p.A305E	NFE	0.000385685	ASPA	443
VS6R3ETGJI	chr17	3656571	3656599	GTGCCCTACATCAAGGTACGGCCTTGCC	G	NC_000017.11:g.3656584_3656610del	NM_004937.2:c.559_561+24del	NP_004928.2:p.Lys187del		34294		rs113994211	Cystinosis	deletion 27 bp nt. 898-IVS8+24	NFE	8.07E-05	CTNS	1497
VSZ8GFQ57U	chr17	7222202	7222203	C	T	NC_000017.11:g.7222203C>T	NM_000018.3:c.779C>T	NP_000009.1:p.Thr260Met		33876	CM960002	rs113994168	Very long chain acyl-CoA dehydrogenase deficiency	779C>T	SAS	3.25E-05	ACADVL	37
VSVS99UKEJ	chr17	7223864	7223865	G	A	NC_000017.11:g.7223865G>A	NM_000018.3:c.1322G>A	NP_000009.1:p.Gly441Asp		33868	CM960010	rs2309689	Very long chain acyl-CoA dehydrogenase deficiency	1322G>A	NFE	5.37E-05	ACADVL	37
VS8Y4LYMQ4	chr17	7224039	7224040	C	T	NC_000017.11:g.7224040C>T	NM_000018.3:c.1405C>T	NP_000009.1:p.Arg469Trp		33869	CM990104	rs113994170	Very long chain acyl-CoA dehydrogenase deficiency	1405C>T	EAS	0.000115969	ACADVL	37
VSN36ED6DB	chr17	19663334	19663335	C	T	NC_000017.11:g.19663335C>T	NM_000382.2:c.943C>T	NP_000373.1:p.Pro315Ser		16679	CM970080	rs72547571	Sjogren-Larsson syndrome	943C>T	NFE	0.000232891	ALDH3A2	224
VS4E8ENR1Z	chr17	19671803	19671806	AAG	A	NC_000017.11:g.19671810_19671811delGA	NM_000382.2:c.1297_1298delGA	NP_000373.1:p.Glu433fs		16680	CD971972	rs1399724851	Sjogren-Larsson syndrome	1297_1298delGA	NFE	8.06E-05	ALDH3A2	224
VS16B98F5D	chr17	42903946	42903947	C	T	NC_000017.11:g.42903947C>T	NM_000151.3:c.247C>T	NP_000142.2:p.Arg83Cys		27037	CM930261	rs1801175	"Glycogen storage disease, type lA"	p.R83C	ASJ	0.00680203	G6PC	2538
VS92D66C44	chr17	42911390	42911391	C	T	NC_000017.11:g.42911391C>T	NM_000151.3:c.1039C>T	NP_000142.2:p.Gln347*		27039	CM940797	rs80356487	"Glycogen storage disease, type lA"	p.Q347X	NFE	0.000404109	G6PC	2538
VSX1RSIIP6	chr17	42911448	42911449	T	C	NC_000017.11:g.42911449T>C	NM_000151.3:c.*23T>C			256175		rs2229611	fingerprint variant		FIN	0.810934007	G6PC	2538
VSSC48B4IY	chr17	50167652	50167653	C	T	NC_000017.11:g.50167653C>T	NM_000023.3:c.229C>T	NP_000014.1:p.Arg77Cys		24476	CM951152	rs28933693	"Limb-girdle muscular dystrophy, type 2D"	229C>T	FIN	0.00198574	SGCA	6442
VSC4ZCMH3C	chr17	59028458	59028460	TC	T	NC_000017.11:g.59028461delC	NM_015294.4:c.2212delG	NP_056109.1:p.Glu738fs		71207	CD001909	rs386833416	Mulibrey nanism	2212delG	FIN	0.000315799	TRIM37	4591
VS5CKS8IX5	chr17	59064354	59064355	C	T	NC_000017.11:g.59064355C>T	NM_015294.4:c.860G>A	NP_056109.1:p.Ser287Asn		20285	CS065628	rs386834008	Mulibrey nanism	860G>A	NFE	9.93E-06	TRIM37	4591
VS57KZPZZJ	chr17	59079878	59079879	T	C	NC_000017.11:g.59079879T>C	NM_015294.4:c.493-2A>G				CS001838	rs186251998	Mulibrey nanism	493-2A>G	FIN	0.00845096	TRIM37	4591
VS6WB7SHGK	chr17	75758090	75758091	G	A	NC_000017.11:g.75758091G>A	NM_000154.1:c.1144C>T	NP_000145.1:p.Gln382*		20670	CM001700	rs111033608	Galactokinase deficiency	1144C>T	AMR	0.000328476	GALK1	2584
VSSD6GYLTI	chr17	75764013	75764014	C	A	NC_000017.11:g.75764014C>A	NM_000154.1:c.238G>T	NP_000145.1:p.Glu80*		20668	CM950523	rs104894577	Galactokinase deficiency	238G>T			GALK1	2584
VS6W24DXD2	chr17	75765042	75765043	C	T	NC_000017.11:g.75765043C>T	NM_000154.1:c.94G>A	NP_000145.1:p.Val32Met		20667	CM950522	rs104894576	Galactokinase deficiency	94G>A	NFE	1.97E-05	GALK1	2584
VS4BNW7RFJ	chr17	75765054	75765055	G	T	NC_000017.11:g.75765055G>T	NM_000154.1:c.82C>A	NP_000145.1:p.Pro28Thr		20669	CM992892	rs104894572	Galactokinase deficiency	82C>A	NFE	2.06E-05	GALK1	2584
VSJ7SEMT3K	chr17	78993856	78993857	C	T	NC_000017.11:g.78993857C>T	NM_138793.3:c.899G>A	NP_620148.1:p.Arg300His		15319	CM097771	rs267606699	"Desbuquois dysplasia, type I"	899G>A	SAS	3.34E-05	CANT1	124583
VS5WM8U4K5	chr17	78995176	78995177	C	T	NC_000017.11:g.78995177C>T	NM_138793.3:c.676G>A	NP_620148.1:p.Val226Met		39975	CM110019	rs377546036	"Desbuquois dysplasia, type I"	676G>A	EAS	0.000115982	CANT1	124583
VSV45NNCGG	chr17	80104541	80104542	T	G	NC_000017.11:g.80104542T>G	NM_000152.4:c.-32-13T>G			19066	CS941489	rs386834236	"Glycogen storage disease, type II"	-32-13T>G	NFE	0.00534808	GAA	2548
TP2016027	chr17	80105109	80105111	CT	C	NC_000017.11:g.80105111delT	NM_000152.4:c.525delT	NP_000143.2:p.Glu176fs		19072	CD941680	rs386834235	"Glycogen storage disease, type II"	525delT	NFE	0.000199464	GAA	2548
VS20160214	chr17	80112921	80112922	C	A	NC_000017.11:g.80112922C>A	NM_000152.4:c.1935C>A	NP_000143.2:p.Asp645Glu		19068	CM940801	rs28940868	"Glycogen storage disease, type II"	c.1935C>A	EAS	0.00158488	GAA	2548
VSB9Z5V3KA	chr17	80118270	80118271	C	T	NC_000017.11:g.80118271C>T	NM_000152.4:c.2560C>T	NP_000143.2:p.Arg854*		19073	CM930288	rs121907943	"Glycogen storage disease, type II"	2560C>T	AFR	0.00203385	GAA	2548
VSUIYB63S3	chr17	80118709	80118713	CAGA	C	NC_000017.11:g.80118713_80118715delAAG	NM_000152.4:c.2707_2709delAAG	NP_000143.2:p.Lys903del		19067	CD951716	rs121907939	"Glycogen storage disease, type II"	2707_2709delAAG			GAA	2548
VSRW4ADWKC	chr18	23536735	23536736	A	G	NC_000018.10:g.23536736A>G	NM_000271.4:c.3182T>C	NP_000262.2:p.Ile1061Thr		18006	CM990946	rs80358259	"Niemann-Pick disease, type CI"	3182T>C	NFE	0.000393898	NPC1	4864
VS20160216	chr19	1399792	1399793	C	T	NC_000019.10:g.1399793C>T	NM_000156.5:c.327G>A	NP_000147.1:p.Lys109Lys		33917	CS961593	rs80338735	Guanidinoacetate methyltransferase deficiency	c.327G>A	NFE	0.000440658	GAMT	2593
VS20160215	chr19	1399807	1399808	T	TGGGGCCCAGTCCC	NC_000019.10:g.1399811_1399823dup	NM_000156.5:c.299_311dup	NP_000147.1:p.Arg105fs		23341	CI962286	rs1376622112	Guanidinoacetate methyltransferase deficiency	c.299_311dupGGGACTGGGCCCC	NFE	0.000132118	GAMT	2593
TP2016006	chr19	1401417	1401418	C	G	NC_000019.10:g.1401418C>G	NM_000156.5:c.59G>C	NP_000147.1:p.Trp20Ser		23342	CM041007	rs80338734	Guanidinoacetate methyltransferase deficiency	59G>C	NFE	0.00010868	GAMT	2593
VCD92E745E	chr19	7521734	7528169	TCAAGCGATCCTCCCACCTTAGCCTCCCGAGTAGCTGGGATTGCCGGTGCATGCCACCGCCCACTGCGCTCAGCTTGGAGTTGAAGGGACTCTGGAAGATGTAGAAGTGGCATTGTCAGTGCCTAGATTTAAATCCCAATTGCCCTCCAGGGTCCAAATTCTTAACCATTACGCTCCAGGGCAAAAGTATGCAAAGGCTCTGGGGCTATAGAAAGATGAGCTTTGGATGGAGGTAGGAGCCAGATCAGAGGGCCCTGATAGACGAGAGTGGGGACTCTGCCTGTCATTACAGAGCAATGGGAAGCCGAGGGCAGGTTCTCGCAGGAAGGATAGGAATTATTCTTTGAAGATGCTTGTGGCTGCTGGGTAGAGAGTGGAGTGGAGGGAGGCTGAGATCGGGGAGGAGGTTGCTGCAAAGATCCAGGCCAGGAATGTTGGAAGACTCTGGGCTGGGGGCCATGGGGTGGGGATAAGTGGTTCTATTTGATACATAATTAGGAAATCGTGTTTGCTGAAGATGCGCAGGAGAAGGGTAAAAGGAGTTTCTGGGAGAAAGAGGAAGACAGCGTTGAGATAGTAGGCAGGGTCATCACCAGGCACCAAGGAGGATAAGGGGTCAAGCTCTGGACATGGAAGTCACAAGCCTGGCACCGGATTCGGGGCATGGCCGGGAGCCAGGGCAGAGCTCGTCGTTGCCAAACTCAGAGTCAGCCCATCCCCCGCCACCCAGAGCGCGTCGGCGCTAGGACCTAGCGACTGCCTTCGACCCAGAGGGCGCCGGCAGAGGCACGCATGCGCGCTGTTCCGGCAGGGGTTGTCGTGGCGCAGGGGGCGGGACCAGAGGCGGTCACGTGAGGGGCTCTGGGCTACCGGGTCACGTGACCGAGGCACAGATCAGCTGATGCCGGAGGGTTTGAAGCCGCGCCGCGAGGGAGCGAGGTCGCAGTGACAGCGGCGGGCGATCGGACCCAGGCTGCCCCGCCGTACCCGCCTGCGTCCCGCGCTCCCGCCCCAGCATGACAGCCCCGGCGGGTCCGCGCGGCTCAGGTGAGGGCGCGGGCGGCACCGTGGGGCCCCGAACTCAGGCGGGCGGGCTGTGTCTCCCACCTGGGGCGGCGGAGCTCCTAGTCTCTTTTTTTCTAAGCTCCAGCGCTGACTTTTCACGGTGGAGAAAAGGGCAGACGGCTCCTAGAACTTGGGCGGCGGGTGGGCACCAGCCTCTCCAATTCTTCCTCCTGAACCCAGGCTCTGCTGGGTTCCCAAACTCAGGCAGGGATCGCGCCGGGCCGCCAGCTTCTCCCTCTGGGGCGGCGAGGTTCCTGGGATTCCCACTGGGAGCCTAGGTTCCGATTGCTCAACTTCGTCTGGAACTCAGACAGCGGGCACCAGCTTCTCCAACCCGCACGTGAGACTCCCAGGCTTCCCCTCCTGATTCCAGGGGACAAATGCTCAGCTTCCCTAAGCTCAAGCCTGGAGAGCTGGAGGGATTGCCCCCAGGCGATTAACTCAGTTTTAGCTTTCCAAACCGCTGGAAGCGCAGCCTTCTTAAATTCGGGCTTCTAGCCAATTCTGATGCCACCCCTCCTCGGGGAGGCTGGAGGAAGACCCCTTGTGTTAGCTTCCCCTTCTGGAGCTAGCTGGGGACCCCTACCTGATAGATGTCCCGGTGTCCCAGCTAGTAGGGTCTGGGGTGGGTTAGCTGTAATCTCAGCTCTGTAAGCGGGCCCTGCCCTCTGGCTTTGTCGTAAACAGCCACAGCAGCATCTCATTGCAAAGGGAGGGGCCGGGAACTTGTCCCTCTCTGCAAGGGAGGTTCTGACAGTGCACACATTTATCCTGACTGCTTTGCTAGGCAGGAGGCCAGGCCCTAGAAAGCAGCACGGGGCCAGGCCCTAGAAAGCACATCCCCATGGGGGTGTGACAGGGACAGTTTTGGGCTACTGTGACTGGTTTTGACTCCAGCAGTTGCTGAAAGCTTAGATCTAACCATTAGGCTGGAAAAAAATAAACAGTGATTAGAACAGCTTGTGTTTGCTGAAGAGGTCTTTATCTGCTGTGTCTCACTGAATTCTCAGAGCAGCTTCAGGATCTCAACCTCAAGGCTCAGGGAGAGGGTGGACTTTTTTTTTTTTTAATAAACTTTTTTTTGTTGCCCAGGCTGTAGTGCAGTGGCATAATCCTAGCTCATTGTAACATCGAACTCCTGGGCTCAAGTGATCCTCCCAACTCAGCCTCCCGGGTAGATGGGGTCCCAGCTACTAACTACGGGCATGAGCCGTCACACCTGACTATTTAAAAAAAATGTTTTTTTTTTGTAGACAGGGAGGTCTCGCTGTATTACCTAGGCTGGATCCTCCCACCTTGGCCTCCCAAAGCCGTTGGGATAACAGGCATGAGCCACTGAGCCCAGCCAAGGGGTCGCCTTTTTAAAATTTCCACTCTTCAGATGAGGAGATGGAGGCTCAGGGAGGTACCTGGAGTCAACCTACTGTAAAGTGGCAGGTCTGGGATTTGATGCTAGGGCTGCATGATTTCTAGGAGCTGGTGCTTTTCAGGGAGATAAAATGAGTCTTTAGCGAATGTGTTCCATTATTATTACTTATGTTGTCAATTACCTCTTCTCCAGGTCCTTGGCTTCTGAGAGTGTCAGCTGATGGGCCAGGTTATAATGAACCCAGAGGTCATCTTTTGGGTATTTGTCCAGACAAACCTAGAATACAGGCTGAGTTCTATGCTCATGTCTGGAAGCTGGAGTTGGGATAAGCCCAGCAGGCTTGAACGCCCAGTGAAAAGCCAGTGGGAGCAGTTCATTCTCTCCCCACTGATCAATAACGGGAACATTGATGAAATGTTCTGACATTCACCATGGACCAGCCCCTGTGATCAATGCTTCATAAGCATCCAGTCCTTAGCGTTCCCATGAGACATATTATTGCCCCATTTCGCAGATGAGGAAACTGAGGCTCAGAGAGCTGGTGAGCAGGAGGGGCAGGAATCAGCCCAGGCCCTGTACCTCCCAAACCCAAACTCATAACCTCTGAGCAGGACGGGTGCATAGATACCTACAATGTCACAGGTTTTCTGGTTTTCTTTAGACCTCTCAGAGCTCTTCCTTGGCAGGAGCATGGGGACATGAAGATAGGGCGTGTGCTGCCTTCCTGGTTGGAGAAAGGGGAAAAGGGGAGTTGCCCAGGCCTCACCCCAGTGCCCTCTCCTATTCCCACAGAGACCGAGCGGCTTCTGACCCCCAACCCCGGGTATGGGACCCAGGCGGGGCCTTCACCGGCCCCTCCGACACCCCCAGAAGAGGAAGACCTTCGCCGTCGTCTCAAATACTTTTTCATGAGTCCCTGCGACAAGTTTCGAGCCAAGGGCCGCAAGCCCTGCAAGCTGATGCTGCAAGTGGTCAAGATCCTGGTGGTCACGGTGCAGGTGAGGCCAGCCAAGCAGGGGCCCCAGCTGAAGGCCACCTGTGGCTGCTGTGCTCCTTGAAGAGAGTCTTAAAGCAGCACTTTGGAAGGCCGAGGCCGGTGGATCGCTTGAGGCTGGGAGTTCAAGACCAGTCTGGCCAGCATGGTGAAACCCCATCTCTACTAAAAATACAAAAAAATTAGCCGTGCGTGGTGGCGGGTGCCTGTAATCCCAGCTACTTGGCAGGCTGAGGCAGGAGAATCGCTTGAATTGGGAGGCGGAGGTTGCCGTGAGCTGAAATCATGCCACTGCACTCCAGCCTGGGCAACAGAGCAAGACTGTCTCAAAAAAAAAAAGAAGCCGACTCTGAGGCTCAGAGAGGTTAGGAGACTTGCCCAAAGTCACACAGCAATAGAACATTGGGAGCTGGGATTTGAACCCAGGCAGTCTGACACCATGTTGACCCAATGGCTGCACAGATAGTTCTCCCTCCCCCATGCCAGACCCTGTGCTGGGCTCTGGGAACCCCAAGATGAATCAGACCCAGCCACTGCCCTAAGTGCTTACTTCATGTTTTGGGCTGACTTTAGCATGTCACCATGCCTCTAATTTTCCCTCTGAAAAGGGACCCAATTGTCCAGGCATGGTGGCTCATGCCTGTAATGCCAGCACTTTGGGAGGCTGAGTTGGGTGGATCATTTGAGGCCAGGAGTTTGAGACCAGCCTGGCCAACATTGCAAAACCCCGTCTCTACTAAAAATACAAAAATTAGCTGGGTTTGGTGGCAGGTACCTGTAACTCAGCTACTCAGGAGGCTGAGACAGGAGAATTGCTTGAACCCAGGGGGTGGAGGTTGTAGTGAGCTGAGATCATACCATGGCACTCCAACTTGGGCAACAGAGTGAGACTCTGTCTCAAAAAAGAAAAGAAAAGGGACCCAGTCATGGTACTTACCCTGAAAGTTTGGGTTTAACACAGAATCGGACATCCAGTAAACATTTAATGAACGTTAGTCCCTGCAGTGAGATAGATGAGTCCCCACCCTGTGTTGTACGGGGGAGGACACAGTGGTGGGCGTGGCATGGAGCTTATGCCAGGAGGTGGGGTGAAATTAATCAAAGCAAAGAAATGCACAAGTGAAATCCGTGTTTGTGGCCCAAGTTAGCAGGGCCCTGCCCCACCCCAGTGGACATCTGCAGGGCCCTCCCTGTCCTCTTCCAGGGCCTGTGCCCTGAGGGAGATACACCCCAACCCCCATCCTAGCCATGCCAACCTCTACTACCCTCTCCCCAGCTCATCCTGTTTGGGCTCAGTAATCAGCTGGCTGTGACATTCCGGGAAGAGAACACCATCGCCTTCCGACACCTCTTCCTGCTGGGCTACTCGGACGGAGCGGATGACACCTTCGCAGCCTACACGCGGGAGCAGCTGTACCAGGCCATCTTCCATGCTGTGGACCAGGTGCTGGTGGGCGGGCAGGTGCTGGTGGGCAGGCAGGTGCAGGTGGGCGGGCAGGTGCAGTTGGGCGGGCAGGTGCTGGTGGGCGGGCAGGTGCAGGTGGGTGGGCTGCAGAGAGCGGGCCGGACTCACAGGCCCTCCCCTTCTCTGCCCACAGTACCTGGCGTTGCCTGACGTGTCACTGGGCCGGTATGCGTATGTCCGTGGTGGGGGTGACCCTTGGACCAATGGCTCAGGGCTTGCTCTCTGCCAGCGGTACTACCACCGAGGCCACGTGGACCCGGCCAACGACACATTTGACATTGATCCGATGGTGGTTACTGGTGAGTGGGCAGGACGAGGCTTCACTGTTGGGAGCCTGAGCTGCTGGGATTAAAATCAACAGCTGTGGCTGGGCACGGTGGCTCACGCCTATAATACCAGCACTTTGGGAGGCTGAGGAGGAAGGATTGCTTGAGGCCAGAAGTTTGAGACCAGCCTGGGCCACGTAGGAAGACCTTGTCTCTACGCACAAACAAATTAGCTGGGCGTGGTGGCGTGCCCCTGTGGTCCCAGCTACTCAGGAGGCTGAGGCAGGAGGATCGCTTGAGTCCGGGAGGTTGAGGCTGCAGTAAGCTATGACCACGCTGCTGCACTCCACCCTGGGTGACAGAGTGAGACCCTGTCTCAAAAAAAAAAAAAAAAAAAAAAAACAAGTATGCTTAGTGTGAGTGTGACTCTTGCCACGTAGAAAGCACCAGATGTTATATTTTAATATGGCTCATTCAGTAAAACATCCGCAGGCCCAGAGAGTGCCAGGCCTGTAGGAATGACCCAACCCTGGGGAAGCACAGGGAAGAAGGCCACTGGGGACTCTGGGGAGACCAGCCTGGCCTCCCCGGCCCCCTGAGGCCCTTCCCTGACTCCCTGTCCTTAGACTGCATCCAGGTGGATCCCCCCGAGCGGCCCCCTCCGCCCCCCAGCGACGATCTCACCCTCTTGGAAAGCAGCTCCAGTTACAAGAACCTCACGCTCAAATTCCACAAGTACTGCCTGCTCACTCGAGGGGGGCCCAGGGTGGGGGAGGCAGCACACTAGGCACTCTCACCCCAGCAACTACTTCCCTAAGGTGGGGACAGGGCCCCCCCGCCCGCGCTGGTGCCTGCTGGGTGAGCACTTCCCCTGCCAGCTGCAGAGTCAGCACGTGGCAGGGGACGCTGGCACTTGGGGCCGGAAGGGACCCGAAGACGCCCCTGACCCTCACCCGAGCCTCCTGCCTAGGCTGGTCAATGTCACCATCCACTTCCGGCTGAAGACCATTAACCTCCAGAGCCTCATCAATAATGAGATCCCGGACTGCTATACCTTCAGCGTCCTGGTGAGGCCCCCCGGGAACCCACAGGGCTCCTGAGTTCCAGGGCAGGGACCTGGTCAGGGAGTGTCTTGGGAGCACTGGCCAAGGGCAAGCGTGCGGGTGATGAGGGAGGGAGCCCGGGGTCTGTCAGGCCACCTGTCATGTGGACCTTGGGGCTTGGGGCTGCCAAGGTTTACTCTGCCCCCAACTGGCCCCCACAGATCACGTTTGAC	T	NC_000019.10:g.7521736_7528169del			NG_015806.1:g.4127_10560del6434				"Mucolipidosis, type IV"	del6.4kb			MCOLN1	57192
VS3A215F29	chr19	7526758	7526759	A	G	NC_000019.10:g.7526759A>G	NM_020533.2:c.406-2A>G			20170	CS002473	rs104886461	"Mucolipidosis, type IV"	IVS3-2A>G	ASJ	0.00426569	MCOLN1	57192
VS57HCJW3P	chr19	7629835	7629836	G	C	NC_000019.10:g.7629836G>C	NM_001171155.1:c.3G>C	NP_001164626.1:p.Met1?		130979	CM140903	rs587777839	Mitochondrial complex IV deficiency	3G>C	NFE	1.87E-05	PET100	100131801
VSGE71B6JV	chr19	12649145	12649146	A	G	NC_000019.10:g.12649146A>G	NM_000528.3:c.2426T>C	NP_000519.2:p.Leu809Pro		34062	CM990829	rs80338681	Alpha-mannosidosis	2426T>C	NFE	0.000143413	MAN2B1	4125
VSK1KYNY32	chr19	12649931	12649932	G	A	NC_000019.10:g.12649932G>A	NM_000528.3:c.2248C>T	NP_000519.2:p.Arg750Trp		16726	CM981231	rs80338680	Alpha-mannosidosis	2248C>T	FIN	0.00107623	MAN2B1	4125
VSFV9S6LFU	chr19	12655692	12655693	C	G	NC_000019.10:g.12655693C>G	NM_000528.3:c.1830+1G>C			34059	CS991442	rs80338677	Alpha-mannosidosis	1830+1G>C	FIN	0.000316256	MAN2B1	4125
VSJ9C2P52J	chr19	12896248	12896249	G	C	NC_000019.10:g.12896249G>C	NM_000159.3:c.680G>C	NP_000150.1:p.Arg227Pro		17128	CM960711	rs121434373	"Glutaric acidemia, type I"	680G>C	NFE	0.000340502	GCDH	2639
VSP4G58LCS	chr19	12897823	12897824	C	T	NC_000019.10:g.12897824C>T	NM_000159.3:c.1204C>T	NP_000150.1:p.Arg402Trp		17124	CM960719	rs121434369	"Glutaric acidemia, type I"	1204C>T	FIN	0.000717489	GCDH	2639
VSSIYIQ6KT	chr19	12899485	12899486	C	T	NC_000019.10:g.12899486C>T	NM_000159.3:c.1262C>T	NP_000150.1:p.Ala421Val		17121	CM960722	rs121434367	"Glutaric acidemia, type I"	1262C>T	NFE	0.000233012	GCDH	2639
VS269TKKD4	chr19	33401861	33401862	C	T	NC_000019.10:g.33401862C>T	NM_000285.3:c.826G>A	NP_000276.2:p.Asp276Asn		15247	CM900178	rs121917721	Prolidase deficiency	826G>A	FIN	0.00013544	PEPD	5184
VS5HTZT8BB	chr19	33464005	33464006	G	A	NC_000019.10:g.33464006G>A	NM_000285.3:c.605C>T	NP_000276.2:p.Ser202Phe		15257	CM061164	rs267606943	Prolidase deficiency	605C>T			PEPD	5184
VSP9116H2Z	chr19	35831357	35831358	G	A	NC_000019.10:g.35831358G>A	NM_004646.3:c.3325C>T	NP_004637.1:p.Arg1109*		21906	CM981391	rs137853042	"Nephrotic syndrome, type I"	3325C>T	FIN	0.000627915	NPHS1	4868
VSH4C4EIE6	chr19	35846152	35846154	CG	C	NC_000019.10:g.35846154delG	NM_004646.3:c.1481delC	NP_004637.1:p.Ser494fs		71080	CD994099	rs386833883	"Nephrotic syndrome, type I"	1481delC	NFE	1.09E-05	NPHS1	4868
VST22TLDL6	chr19	35851607	35851610	CAG	C	NC_000019.10:g.35851609_35851610delAG	NM_004646.3:c.121_122delCT	NP_004637.1:p.Leu41fs		71070	CD982836	rs386833873	"Nephrotic syndrome, type I"	121_122delCT	FIN	0.0111913	NPHS1	4868
VS2CCBE93C	chr19	41424581	41424582	T	A	NC_000019.10:g.41424582T>A	NM_000709.3:c.1312T>A	NP_000700.1:p.Tyr438Asn		17414	CM890022	rs137852870	"Maple syrup urine disease, type IA"	p.Y438N	NFE	0.000145717	BCKDHA	593
VSIJXHMTSG	chr19	43511435	43511436	C	A	NC_000019.10:g.43511436C>A	NM_014297.4:c.505+1G>T			496126	CS040543		Ethylmalonic encephalopathy	505+1G>T			ETHE1	23474
VS2XZ6U6EH	chr19	43511454	43511455	G	A	NC_000019.10:g.43511455G>A	NM_014297.4:c.487C>T	NP_055112.2:p.Arg163Trp		17356	CM040420	rs28940289	Ethylmalonic encephalopathy	487C>T	AFR	6.53E-05	ETHE1	23474
VS5W4IJWJY	chr19	43526518	43526519	A	AT	NC_000019.10:g.43526520dupT	NM_014297.4:c.221dupA	NP_055112.2:p.Tyr74fs		211894	CI040628	rs863223955	Ethylmalonic encephalopathy	221dupA	NFE	9.07E-06	ETHE1	23474
VSQUQKMHJH	chr19	45553911	45553912	C	G	NC_000019.10:g.45553912C>G	NM_025136.3:c.143-1G>C			19278	CS013828	rs80356523	"3-methylglutaconic aciduria, type III"	143-1G>C			OPA3	80207
TP2016007	chr19	46756275	46756276	C	A	NC_000019.10:g.46756276C>A	NM_024301.4:c.826C>A	NP_077277.1:p.Leu276Ile		19260	CM013805	rs28937900	"Limb-girdle muscular dystrophy, type 2I"	826C>A	NFE	0.00224724	FKRP	79147
VSG2YE1RI5	chr2	26195183	26195184	C	G	NC_000002.12:g.26195184C>G	NM_000182.4:c.1528G>C	NP_000173.2:p.Glu510Gln		23767	CM940884	rs137852769	Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency	1528G>C	FIN	0.00426009	HADHA	3030
VSXIF1ZXLL	chr2	27309944	27309945	G	T	NC_000002.12:g.27309945G>T	NM_002437.4:c.498C>A	NP_002428.1:p.Asn166Lys		31200	CM061855	rs121909722	"Hepatocerebral mitochondrial DNA depletion syndrome, MPV17-related"	498C>A			MPV17	4358
VSLYHN84YK	chr2	27312509	27312510	C	T	NC_000002.12:g.27312510C>T	NM_002437.4:c.359G>A	NP_002428.1:p.Trp120*		31203	CM083824	rs121909724	"Hepatocerebral mitochondrial DNA depletion syndrome, MPV17-related"	359G>A	NFE	8.95E-06	MPV17	4358
VSKT4W2WKX	chr2	27312684	27312688	CCAA	C	NC_000002.12:g.27312691_27312693delACA	NM_002437.4:c.271_273delTTG	NP_002428.1:p.Leu91del		46916	CD1010132	rs267607264	"Hepatocerebral mitochondrial DNA depletion syndrome, MPV17-related"	271_273delTTG	AFR	0.000130685	MPV17	4358
VS53VXSJQX	chr2	27313030	27313031	C	T	NC_000002.12:g.27313031C>T	NM_002437.4:c.149G>A	NP_002428.1:p.Arg50Gln		31199	CM061857	rs121909721	"Hepatocerebral mitochondrial DNA depletion syndrome, MPV17-related"	149G>A	NFE	2.69E-05	MPV17	4358
VSXS151YDL	chr2	27313031	27313032	G	A	NC_000002.12:g.27313032G>A	NM_002437.4:c.148C>T	NP_002428.1:p.Arg50Trp		31201	CM061856	rs121909723	"Hepatocerebral mitochondrial DNA depletion syndrome, MPV17-related"	148C>T	NFE	2.69E-05	MPV17	4358
VS6IBSF4FC	chr2	27322447	27322448	C	A	NC_000002.12:g.27322448C>A	NM_002437.4:c.70G>T	NP_002428.1:p.Gly24Trp		31204	CM083825	rs121909725	"Hepatocerebral mitochondrial DNA depletion syndrome, MPV17-related"	70G>T			MPV17	4358
VSYFZP2YAS	chr2	38070948	38070949	G	A	NC_000002.12:g.38070949G>A	NM_000104.3:c.1405C>T	NP_000095.2:p.Arg469Trp		22772	CM980505	rs28936701	Primary congenital glaucoma	1405C>T	NFE	7.16E-05	CYP1B1	1545
TP2016024	chr2	38071086	38071087	T	A	NC_000002.12:g.38071087T>A	NM_000104.3:c.1267A>T	NP_000095.2:p.Asn423Tyr		22782	CM033366	rs104893629	Primary congenital glaucoma	1267A>T	NFE	2.69E-05	CYP1B1	1545
VS2F4ZPJXJ	chr2	38071143	38071144	T	TGGTGGCATGA	NC_000002.12:g.38071147_38071156dup	NM_000104.3:c.1200_1209dup	NP_000095.2:p.Thr404fs		79358	CI983071	rs587778873	Primary congenital glaucoma	1202_1211dupATGCCACCAC	AMR	0.000595699	CYP1B1	1545
VS4VJX41T7	chr2	38071194	38071195	C	T	NC_000002.12:g.38071195C>T	NM_000104.3:c.1159G>A	NP_000095.2:p.Glu387Lys		22774	CM980502	rs55989760	Primary congenital glaucoma	1159G>A	AMR	0.000506616	CYP1B1	1545
VS5BKSPN1S	chr2	38071233	38071234	C	T	NC_000002.12:g.38071234C>T	NM_000104.3:c.1120G>A	NP_000095.2:p.Asp374Asn		22773	CM980500	rs104893622	Primary congenital glaucoma	1120G>A			CYP1B1	1545
VSXI2BRXBK	chr2	38071250	38071251	C	T	NC_000002.12:g.38071251C>T	NM_000104.3:c.1103G>A	NP_000095.2:p.Arg368His		22778	CM000137	rs79204362	Primary congenital glaucoma	1103G>A	SAS	0.0306642	CYP1B1	1545
VSJWFWETS7	chr2	38074852	38074854	GC	G	NC_000002.12:g.38074855delC	NM_000104.3:c.535delG	NP_000095.2:p.Ala179fs		514468	CD022282	rs771076928	Primary congenital glaucoma	4339G 1 bp del	AMR	0.000158203	CYP1B1	1545
VSM1W6EJFB	chr2	38075147	38075148	A	T	NC_000002.12:g.38075148A>T	NM_000104.3:c.241T>A	NP_000095.2:p.Tyr81Asn		22783	CM042334	rs9282671	Primary congenital glaucoma	241T>A	FIN	0.0141567	CYP1B1	1545
VSNBUZW39L	chr2	38075206	38075207	C	T	NC_000002.12:g.38075207C>T	NM_000104.3:c.182G>A	NP_000095.2:p.Gly61Glu		22769	CM980497	rs28936700	Primary congenital glaucoma	182G>A	NFE	0.00049023	CYP1B1	1545
TP2016023	chr2	38075213	38075215	GT	G	NC_000002.12:g.38075215delT	NM_000104.3:c.174delA	NP_000095.2:p.Leu59fs			CD033534		Primary congenital glaucoma	174delA			CYP1B1	1545
TP2016025	chr2	38075217	38075218	C	T	NC_000002.12:g.38075218C>T	NM_000104.3:c.171G>A	NP_000095.2:p.Trp57*		22776	CM011311	rs72549387	Primary congenital glaucoma	171G>A	NFE	0.00035735	CYP1B1	1545
VSV1WJ3J8W	chr2	43974243	43974244	G	A	NC_000002.12:g.43974244G>A	NM_133259.3:c.1061C>T	NP_573566.2:p.Ala354Val		18149	CM034438	rs119466000	"Leigh syndrome, French Canadian"	1061C>T	NFE	0.000107521	LRPPRC	10128
VS1PGKKIE2	chr2	48688019	48688020	C	G	NC_000002.12:g.48688020C>G	NM_000233.3:c.1777G>C	NP_000224.2:p.Ala593Pro		29427	CM950783	rs121912520	Luteinizing hormone resistance	1777G>C			LHCGR	3973
VS3G246WRF	chr2	48688136	48688137	G	A	NC_000002.12:g.48688137G>A	NM_000233.3:c.1660C>T	NP_000224.2:p.Arg554*		29431	CM960940	rs121912524	Luteinizing hormone resistance	1660C>T	NFE	8.97E-06	LHCGR	3973
VSAWM5YTBL	chr2	48688736	48688737	C	T	NC_000002.12:g.48688737C>T	NM_000233.3:c.1060G>A	NP_000224.2:p.Glu354Lys		29437	CM981202	rs121912529	Luteinizing hormone resistance	1060G>A			LHCGR	3973
VS9XPV2WWT	chr2	71551083	71551084	C	G	NC_000002.12:g.71551084C>G	NM_003494.3:c.1566C>G	NP_003485.1:p.Tyr522*			CM994323		"Limb-girdle muscular dystrophy, type 2B"	1566C>G			DYSF	8291
VSQ6YSZ2DY	chr2	71564073	71564074	C	G	NC_000002.12:g.71564074C>G	NM_003494.3:c.2372C>G	NP_003485.1:p.Pro791Arg		21710	CM990491	rs121908956	"Limb-girdle muscular dystrophy, type 2B"	2372C>G			DYSF	8291
VSH7MNPEQH	chr2	71569883	71569884	C	T	NC_000002.12:g.71569884C>T	NM_001130978.1:c.2875C>T	NP_001124450.1:p.Arg959Trp		268491	CM033373	rs202218890	"Limb-girdle muscular dystrophy, type 2B"	2875C>T	NFE	7.16E-05	DYSF	8291
VSCF9R3JI5	chr2	71570299	71570300	G	T	NC_000002.12:g.71570300G>T	NM_003494.3:c.2997G>T	NP_003485.1:p.Trp999Cys		21713	CM994325	rs28937581	"Limb-girdle muscular dystrophy, type 2B"	2997G>T	EAS	0.000173933	DYSF	8291
VSDLU7Z6K7	chr2	71570703	71570704	G	A	NC_000002.12:g.71570704G>A	NM_001130978.1:c.3137G>A	NP_001124450.1:p.Arg1046His		21714	CM994326	rs121908958	"Limb-girdle muscular dystrophy, type 2B"	3137G>A	AMR	0.000119282	DYSF	8291
VSR9N788KX	chr2	71589615	71589617	TG	T	NC_000002.12:g.71589617delG	NM_003494.3:c.3373delG	NP_003485.1:p.Glu1125fs			CD994335		"Limb-girdle muscular dystrophy, type 2B"	3373delG			DYSF	8291
VS9LVRA7RY	chr2	71660635	71660637	AG	A	NC_000002.12:g.71660637delG	NM_003494.3:c.4872delG	NP_003485.1:p.Glu1624fs			CD043180	rs1156805286	"Limb-girdle muscular dystrophy, type 2B"	4872delG	NFE	8.96E-06	DYSF	8291
VS3RGQ15HY	chr2	71660636	71660641	GCCCG	CCCC	NC_000002.12:g.71660637_71660641delGCCCGinsCCCC	NM_003494.3:c.4872_4876delGCCCGinsCCCC	NP_003485.1:p.Glu1624fs		21708	CP984534	rs786200896	"Limb-girdle muscular dystrophy, type 2B"	4872_4876delGCCCGinsCCCC			DYSF	8291
VSC22L2N8K	chr2	85844541	85844542	G	A	NC_000002.12:g.85844542G>A	NM_003896.3:c.862C>T	NP_003887.3:p.Arg288*		20595	CM043092	rs104893668	Amish infantile epilepsy syndrome	862C>T	NFE	5.38E-05	ST3GAL5	8869
VSCXYSASIQ	chr2	98396754	98396755	G	A	NC_000002.12:g.98396755G>A	NM_001298.2:c.1585G>A	NP_001289.1:p.Val529Met		24519	CM980379	rs104893619	"Achromatopsia, CNGA3-related"	1585G>A	EAS	0.000289922	CNGA3	1261
VSX1Z1G2YE	chr2	108897109	108897110	C	T	NC_000002.12:g.108897110C>T	NM_022336.3:c.1144G>A	NP_071731.1:p.Gly382Ser		191278	CM052867	rs747806672	Hypohidrotic ectodermal dysplasia	1144G>A	AMR	0.000238535	EDAR	10913
VC94779896	chr2	151645754	151648257	CTGATCCAAAATTTCATTGAGTGTCTACTATGTGTCAGGCACGATTCTAGATAAGCACTGTAGATTCAATAAGAATTGCCTCTGCCTGCAAAGAGTGCCTGTCCACACTGGGAAGAGCAATATAAGCCACCTTATGATGATATGTATAACAACGGACTGCAAGGAACAGAGAATACAGACTCCCCATTCTGCCTGACATAGTGAGTACTAACATTTCGATATTCAATCTAAAAGCCACTAAATAAGGAATCTAAGTCATATGTAGTTAATTAATTAAAATAATTCAGGGATTCAGAGAACTTCTAGACAATTTCACTGATTTAGAAACAATTAAAATGAGCTTTCTGAAAACACATGCTGAATTTGAAAACTTACATCACTTGTGTTGATTAAGTTTGCTTTAGCCAGAACAATGTCAGGTGTATCAGGCATGATGTGGATCTGAGTCTTGTCTTTGTCCCAAGCTTCTCTATAAAGTCTCTAAAATAAGAAATAATAATTTTTCAGTGGTGTTGTTAGATTAGTGAATGATACAGTTGGCTTCAAACAGAATTGCTGAATTTATCTGAATTAAACATTATACAGAATTGATATAATAAGCAGACAACATAAGCAGAAAATAGATGCAATATTTCTTGACTTATCTGGGACATAACTGCCTTTCAACACAGAGATTATGGGTCACATTTTCAAAGTTACAGATAATCCTGCCTACAAGAAATCAATCTAGGTAATTACATGCCTTGCCAATATTATCAAATGAAACAGGCTTCTCCATCTTCTGGGTTGTGTCCCTCAGTGTTTAATTTAGAGGCAGCCCTTGCCTTTTCAAAAGATGTCTTATTCAAAGCATGCCTAGAAATCAGGAAGTTTTATTTCCTATGTGGCTTATTGTTATCACTATCATTATTTTGACACAGAGTCTTACACTGCTGCCCAGGCTGGAGTGCAATGGCGCAATCATGGCTCACTGCAACCTCTGCCTCCTGAGTTCAAGTGATTCTGGTGCCTCAGCCACCTGAGTAGCTAGGATTACAGGCATGTGCCACCATACCCGGCTAATTTTTGTATTTTTAGTAGAAACAGGGTTTCGCTACGTTGTGCAGGCTGGCCTTGAACTCCCCACCTCAGCCTCCCAAAGTGCTGGGATTACAGGTGTGAGCCACTGTGTCCAGCTTCTATGTGACTTAGTATTTATAGTTATGCCTCATAATCATTGTGAAGGATTAGGATTCCCAAAAGGATTTTTTGGGGGGGAATTTATCAAGATATCTTGGATGTCCCAGAGCCATCCTTATGTCTCTTCAACAGAAGACAAGGGGATCCAAACAAAAGTTTCACAGACTTACTAAAACTAATAATTTTTTTTTTTTGAGATGGAGTTTCACTCTTGTTGCCCATGCTGGAGTGCAATGGTGCAGTCTTAGCTCACTGTAATCTCCACCTCCCAGGTTCAAGCAATTCTCCTGCCTCAGCTTCCCAAGTAGCTGGGATTACAGGCACCCACCACATGCCCAGCTAATTTTTGTATTTTTAGTAGAGATGGGGTTTCACCATGTTGGCCAGGCTGGTCTCGAACTCCTGATCGCAGGTGATCCACCTGCCTCGGCCTCCCAAAGTGCTGGGATTACAGGTGTGAGCCATCGTGCCCGGCTAAAACTAGGAAAATTTGATTAAAAACAGAATATTTACACAGGGCAGAATATCTCCCTGCCAGATTACTTATCAATTACAAAGGATAAAATGGTTACTCAACAGTACAGCAACCTGGCACCATCACTTTAACCAAGTGTTTAAGTTATTAGTAATAGAACAAATTGATATCCTGTGCCTCCTGATATGAGGTACTGAGGAGGACACAATGTGTGATCTCCTGCTGAAAAGATAATCTGAGTCTATCACAGGAACCCACCAGAAAACCCAAATGGAGGGAGATTCTACAAAATAACTGACCTATGTTCTTTACGAATGTCAAAAACTTGGAAGGCAAAGAAACAGTGAGGAACTAGTCCAGAGTAAAGGAGACTAAAGACATAGCAAGTAATGCAACCTGTGGTCTTGGATTAAATCCTGAGCCAGAGAAAATATTTTCTTTTCTTATAAAGGATATTAGTGATAAAATTGAATAAATTCTGTAGACTAGCAGACCAGTGGAAATTAATTCTGTGATTTTAATCATCACAATGTGATTATGTGAGTATGTTCTTATTCTTGGGAAATACAGACGGAATATTTAGGCATCATGAAGCAATTTAATTTCTCATATAGATATATAGATATAGATCTGAGAGAAAGAAAGGGAGAAAAAGAGACAAAAAGAGAAAGCAAATGTGGTAAAATTTTAACATTTGGGGAATCTGGGTATATGTATGCACACACACATACACACATATGTGAATTACATGTACTATTTTTTCAACTTTTCTGAGTGCCTGAAATTATTTCAATAAAAAATTTTTTTGTCTCATTGATTCCTTAAACTTGTCCATTTCCCTTTGAGGTA	C	NC_000002.12:g.151645758_151648259del	NM_001271208.1:c.7431+1919_7536+374del			29091			Nemaline myopathy 2	p.R2478_D2512del			NEB	4703
VS25KZMGMU	chr2	165754930	165754931	C	T	NC_000002.12:g.165754931C>T	NM_004482.3:c.1524+1G>A			22830	CS041533	rs745655924	Hyperphosphatemic familial tumoral calcinosis	1524+1G>A	NFE	8.97E-06	GALNT3	2591
VS5WCFISIA	chr2	165765057	165765058	T	A	NC_000002.12:g.165765058T>A	NM_004482.3:c.516-2A>T			22833	CS054899	rs761396172	Hyperphosphatemic familial tumoral calcinosis	516-2A>T	AFR	0.000392824	GALNT3	2591
VSR2GA1IRZ	chr2	168970130	168970131	G	A	NC_000002.12:g.168970131G>A	NM_003742.2:c.1723C>T	NP_003733.2:p.Arg575*		21628	CM980248	rs72549401	"Progressive familial intrahepatic cholestasis, type II"	1723C>T	AMR	0.000268865	ABCB11	8647
VSV2E3HRJL	chr2	168990818	168990819	T	C	NC_000002.12:g.168990819T>C	NM_003742.2:c.890A>G	NP_003733.2:p.Glu297Gly		21629	CM980245	rs11568372	"Progressive familial intrahepatic cholestasis, type II"	890A>G	NFE	0.000484809	ABCB11	8647
VS6JTIPRUB	chr2	178529081	178529083	AT	A	NC_000002.12:g.178529086delT	NM_133378.4:c.98964delA	NP_596869.4:p.Lys32988fs		27699	CD072503	rs587776772	Early onset myopathy with fatal cardiomyopathy	106668delA			TTN	7273
VSDL1A3MF8	chr2	178531078	178531087	GTGGTCACT	G	NC_000002.12:g.178531084_178531091del	NM_133378.4:c.97824_97831del	NP_596869.4:p.Gln32608fs		27700	CD072504	rs199469665	Early onset myopathy with fatal cardiomyopathy	97824_97831delAGTGACCA			TTN	7273
VSJR8X2MTN	chr2	218661218	218661219	A	G	NC_000002.12:g.218661219A>G	NM_004328.4:c.232A>G	NP_004319.1:p.Ser78Gly		21206	CM022764	rs28937590	GRACILE syndrome	232A>G	FIN	0.00430609	BCS1L	617
VSICL7DVGA	chr2	227164727	227164728	T	C	NC_000002.12:g.227164728T>C	NM_000091.4:c.2T>C	NP_000082.2:p.Met1?		542106	CM131775		"Alport syndrome, COL4A3-related"	2T>C			COL4A3	1285
VS83C95AA5	chr2	227164754	227164779	AGGTGCTCCTGCTGCCGCTCCTGCT	A	NC_000002.12:g.227164766_227164789del	NM_000091.4:c.40_63del	NP_000082.2:p.Leu14_Leu21del		190092		rs1381723230	"Alport syndrome, COL4A3-related"	40del24	ASJ	0.00131096	COL4A3	1285
VSCFHD2FAN	chr2	227303903	227303904	G	A	NC_000002.12:g.227303904G>A	NM_000091.4:c.4001G>A	NP_000082.2:p.Gly1334Glu			CM014047	rs375290088	"Alport syndrome, COL4A3-related"	4001G>A	AFR	6.54E-05	COL4A3	1285
VSMKNQDUHC	chr2	233767921	233767922	A	G	NC_000002.12:g.233767922A>G	NM_000463.2:c.1070A>G	NP_000454.1:p.Gln357Arg		27322	CM941353	rs72551351	Crigler-Najjar syndrome	1070A>G	SAS	3.25E-05	UGT1A1	54658
TP2016031	chr2	240868889	240868890	A	AC	NC_000002.12:g.240868898dupC	NM_000030.2:c.33dupC	NP_000021.1:p.Lys12fs		150264	HI971435	rs1188924124	"Primary hyperoxaluria, type I"	33dupC	EAS	0.000240038	AGXT	189
VS9TY8T3KL	chr2	240868985	240868986	G	A	NC_000002.12:g.240868986G>A	NM_000030.2:c.121G>A	NP_000021.1:p.Gly41Arg		20683	CM930013	rs121908523	"Primary hyperoxaluria, type I"	121G>A	SAS	3.25E-05	AGXT	189
VS7PEFBT1U	chr2	240868986	240868987	G	T	NC_000002.12:g.240868987G>T	NM_000030.2:c.122G>T	NP_000021.1:p.Gly41Val		186652	HM971430	rs180177168	"Primary hyperoxaluria, type I"	122G>T			AGXT	189
VSYRRGJCC9	chr2	240869248	240869249	G	A	NC_000002.12:g.240869249G>A	NM_000030.2:c.245G>A	NP_000021.1:p.Gly82Glu		20682	CM920011	rs121908522	"Primary hyperoxaluria, type I"	245G>A	SAS	0.000162433	AGXT	189
VS20160202	chr2	240871378	240871379	T	A	NC_000002.12:g.240871379T>A	NM_000030.2:c.454T>A	NP_000021.1:p.Phe152Ile		20684	CM930014	rs121908524	"Primary hyperoxaluria, type I"	454T>A	NFE	0.000174348	AGXT	189
VSS1ZTY3YY	chr2	240871390	240871391	G	A	NC_000002.12:g.240871391G>A	NM_000030.2:c.466G>A	NP_000021.1:p.Gly156Arg		20689	HM971433	rs121908530	"Primary hyperoxaluria, type I"	466G>A	AFR	7.62E-05	AGXT	189
TP2016032	chr2	240871432	240871433	G	A	NC_000002.12:g.240871433G>A	NM_000030.2:c.508G>A	NP_000021.1:p.Gly170Arg		38436	CM910016	rs121908529	"Primary hyperoxaluria, type I"	508G>A	NFE	0.00108015	AGXT	189
VS5AGRKKDY	chr2	240875124	240875125	C	T	NC_000002.12:g.240875125C>T	NM_000030.2:c.697C>T	NP_000021.1:p.Arg233Cys		20686	CM970065	rs121908526	"Primary hyperoxaluria, type I"	697C>T	AFR	0.000392054	AGXT	189
VS20160201	chr2	240875158	240875159	T	C	NC_000002.12:g.240875159T>C	NM_000030.2:c.731T>C	NP_000021.1:p.Ile244Thr		20685	CM970066	rs121908525	"Primary hyperoxaluria, type I"	731T>C	AMR	0.00023828	AGXT	189
VSR3RJ3X7P	chr20	3228336	3228337	A	G	NC_000020.11:g.3228337A>G	NM_032034.3:c.2528T>C	NP_114423.1:p.Leu843Pro		16355	CM072054	rs121909394	Corneal dystrophy and perceptive deafness syndrome	2528T>C	NFE	2.69E-05	SLC4A11	83959
VSTWWRKZ6L	chr20	35434092	35434093	A	G	NC_000020.11:g.35434093A>G	NM_000557.4:c.1322T>C	NP_000548.2:p.Leu441Pro		23420	CM021270	rs28936683	Du Pan syndrome	1322T>C			GDF5	8200
VS1546YL6N	chr20	35434281	35434282	C	T	NC_000020.11:g.35434282C>T	NM_000557.4:c.1133G>A	NP_000548.2:p.Arg378Gln		23432	CM085446	rs121909350	Du Pan syndrome	1133G>A	NFE	9.00E-06	GDF5	8200
VSE1AY2LDQ	chr20	36904250	36904251	T	C	NC_000020.11:g.36904251T>C	NM_015474.3:c.1411-2A>G			131940	CS112236	rs515726141	"Aicardi-Goutieres syndrome, SAMHD1-related"	1411-2A>G	NFE	8.95E-06	SAMHD1	25939
VSUXIQL9F5	chr20	44620390	44620391	G	A	NC_000020.11:g.44620391G>A	NM_000022.3:c.986C>T	NP_000013.2:p.Ala329Val		16998	CM870001	rs121908715	Adenosine deaminase deficiency	986C>T	AFR	0.000718766	ADA	100
VSVWA2AZJ4	chr20	44625579	44625580	C	T	NC_000020.11:g.44625580C>T	NM_000022.3:c.467G>A	NP_000013.2:p.Arg156His		17023	CM930009	rs121908722	Adenosine deaminase deficiency	467G>A	EAS	6.97E-05	ADA	100
TP2016002	chr20	63695618	63695619	G	A	NC_000020.11:g.63695619G>A	NM_001283009.1:c.3791G>A	NP_001269938.1:p.Arg1264His		51186	CM133341	rs201540674	"Dyskeratosis congenita, RTEL1-related"	R1264H	ASJ	0.00327131	RTEL1	51750
VS9WIB55YN	chr21	36765043	36765044	C	T	NC_000021.9:g.36765044C>T	NM_000411.6:c.1648G>A	NP_000402.3:p.Val550Met		16950	CM960835	rs119103231	Holocarboxylase synthetase deficiency	1648G>A	AMR	2.98E-05	HLCS	3141
VSMKZQDQCQ	chr21	36765169	36765170	G	A	NC_000021.9:g.36765170G>A	NM_000411.6:c.1522C>T	NP_000402.3:p.Arg508Trp		16948	CM960833	rs119103229	Holocarboxylase synthetase deficiency	1522C>T	EAS	0.000231911	HLCS	3141
VS2GQFMLSJ	chr21	43060527	43060528	G	A	NC_000021.9:g.43060528G>A	NM_000071.2:c.1058C>T	NP_000062.1:p.Thr353Met		15170	CM970238	rs121964972	"Homocystinuria, CBS-related"	1058C>T	AFR	0.00041534	CBS	875
VST6R7S3WX	chr21	43062987	43062988	C	T	NC_000021.9:g.43062988C>T	NM_000071.2:c.919G>A	NP_000062.1:p.Gly307Ser		15156	CM930082	rs121964962	"Homocystinuria, CBS-related"	919G>A	NFE	0.000286441	CBS	875
VSSIU7A9BX	chr21	43063073	43063074	A	G	NC_000021.9:g.43063074A>G	NM_000071.2:c.833T>C	NP_000062.1:p.Ile278Thr		15159	CM920136	rs5742905	"Homocystinuria, CBS-related"	833T>C			CBS	875
VSXU9QERKB	chr21	44286677	44286678	A	G	NC_000021.9:g.44286678A>G	NM_000383.3:c.254A>G	NP_000374.1:p.Tyr85Cys		79113	CM000631	rs179363882	"Autoimmune polyglandular syndrome, type I"	254A>G			AIRE	326
VS20160203	chr21	44287084	44287085	C	T	NC_000021.9:g.44287085C>T	NM_000383.3:c.415C>T	NP_000374.1:p.Arg139*		18349	CM980042	rs121434256	"Autoimmune polyglandular syndrome, type I"	415C>T	AFR	7.18E-05	AIRE	326
VS3ZUGGDW7	chr21	44289772	44289773	C	T	NC_000021.9:g.44289773C>T	NM_000383.3:c.769C>T	NP_000374.1:p.Arg257*		18346	CM970074	rs121434254	"Autoimmune polyglandular syndrome, type I"	769C>T	FIN	0.00498652	AIRE	326
VSWWWTJSXT	chr21	44291178	44291192	TGCCTGTCCCCTCC	T	NC_000021.9:g.44291182_44291194del	NM_000383.3:c.967_979del	NP_000374.1:p.Leu323fs		18348	CD971970	rs1365551291	"Autoimmune polyglandular syndrome, type I"	967_979delCTGTCCCCTCCGC	NFE	0.000983275	AIRE	326
VSMZ2Z9B6G	chr22	50625255	50625267	GGTCACAGCTGC	G	NC_000022.11:g.50625260_50625270del	NM_000487.5:c.1408_1418del	NP_000478.3:p.Ala470fs		190193	CD910478	rs80338823	Metachromatic leukodystrophy	1408_1418delGCAGCTGTGAC			ARSA	410
VSBFU64YYK	chr22	50625391	50625392	G	A	NC_000022.11:g.50625392G>A	NM_000487.5:c.1283C>T	NP_000478.3:p.Pro428Leu		18091	CM940113	rs28940893	Metachromatic leukodystrophy	1283C>T	FIN	0.00087485	ARSA	410
VSNGKKBCZW	chr22	50625442	50625443	G	A	NC_000022.11:g.50625443G>A	NM_000487.5:c.1232C>T	NP_000478.3:p.Thr411Ile		18126	CM940112	rs74315481	Metachromatic leukodystrophy	1232C>T			ARSA	410
VSETND4FD9	chr22	50625652	50625653	G	A	NC_000022.11:g.50625653G>A	NM_000487.5:c.1136C>T	NP_000478.3:p.Pro379Leu		18122	CM940110	rs74315478	Metachromatic leukodystrophy	1136C>T	NFE	8.97E-06	ARSA	410
VS20160207	chr22	50626617	50626618	G	A	NC_000022.11:g.50626618G>A	NM_000487.5:c.827C>T	NP_000478.3:p.Thr276Met		18114	CM930042	rs74315472	Metachromatic leukodystrophy	p.T274M			ARSA	410
VSRS5W7G2L	chr22	50626675	50626676	C	G	NC_000022.11:g.50626676C>G	NM_000487.5:c.769G>C	NP_000478.3:p.Asp257His		34039	CM960078	rs80338819	Metachromatic leukodystrophy	769G>C	AMR	5.96E-05	ARSA	410
VSTXCRVB5V	chr22	50626705	50626706	C	T	NC_000022.11:g.50626706C>T	NM_000487.5:c.739G>A	NP_000478.3:p.Gly247Arg		18113	CM930041	rs74315471	Metachromatic leukodystrophy	739G>A	SAS	3.25E-05	ARSA	410
VSM3QWXUY8	chr22	50626876	50626877	G	A	NC_000022.11:g.50626877G>A	NM_000487.5:c.641C>T	NP_000478.3:p.Ala214Val		18109	CM930039	rs74315467	Metachromatic leukodystrophy	641C>T	NFE	4.49E-05	ARSA	410
VSDD9EJU3U	chr22	50626975	50626976	A	C	NC_000022.11:g.50626976A>C	NM_000487.5:c.542T>G	NP_000478.3:p.Ile181Ser		18096	CM910051	rs74315457	Metachromatic leukodystrophy	542T>G	FIN	0.000405625	ARSA	410
VS20160204	chr22	50627164	50627165	C	T	NC_000022.11:g.50627165C>T	NM_000487.5:c.465+1G>A			18090	CS910416	rs80338815	Metachromatic leukodystrophy	c.465+1G>A	NFE	0.00120985	ARSA	410
VS20160206	chr22	50627328	50627329	C	T	NC_000022.11:g.50627329C>T	NM_000487.5:c.302G>A	NP_000478.3:p.Gly101Asp		18092	CM910050	rs74315455	Metachromatic leukodystrophy	c.302G>A	EAS	7.13E-05	ARSA	410
VSS8WHRURY	chr22	50627337	50627338	G	A	NC_000022.11:g.50627338G>A	NM_000487.5:c.293C>T	NP_000478.3:p.Ser98Phe		18093	CM910049	rs74315456	Metachromatic leukodystrophy	293C>T	NFE	6.73E-05	ARSA	410
VSKSFNE2WZ	chr22	50627373	50627374	C	T	NC_000022.11:g.50627374C>T	NM_000487.5:c.257G>A	NP_000478.3:p.Arg86Gln		34038	CM940096	rs74315458	Metachromatic leukodystrophy	257G>A	FIN	0.000273943	ARSA	410
VSVH95KN11	chr3	4362235	4362236	G	A	NC_000003.12:g.4362236G>A	NM_182760.3:c.1033C>T	NP_877437.2:p.Arg345Cys		17714	CM031422	rs137852852	Multiple sulfatase deficiency	1033C>T			SUMF1	285362
VSQKJT2UM6	chr3	4417131	4417132	G	A	NC_000003.12:g.4417132G>A	NM_182760.3:c.836C>T	NP_877437.2:p.Ala279Val		17708	CM031419	rs137852849	Multiple sulfatase deficiency	836C>T	AFR	0.000196053	SUMF1	285362
VS746W3BPZ	chr3	4417179	4417180	C	A	NC_000003.12:g.4417180C>A	NM_182760.3:c.788G>T	NP_877437.2:p.Gly263Val		39646	CM051673	rs387906976	Multiple sulfatase deficiency	788G>T			SUMF1	285362
VSHN1X4MJ8	chr3	4449256	4449261	ATTAC	A	NC_000003.12:g.4449263_4449266delTACT	NM_182760.3:c.519+5_519+8delGTAA			17702	CD031566	rs775324176	Multiple sulfatase deficiency	519+5_519+8delGTAA	NFE	8.95E-06	SUMF1	285362
VSK6QUQNX8	chr3	4449321	4449322	A	G	NC_000003.12:g.4449322A>G	NM_182760.3:c.463T>C	NP_877437.2:p.Ser155Pro		17711	CM031417	rs137852850	Multiple sulfatase deficiency	463T>C	ASJ	0.00152284	SUMF1	285362
VSFYNUWA6U	chr3	14158147	14158148	G	A	NC_000003.12:g.14158148G>A	NM_004628.4:c.1735C>T	NP_004619.3:p.Arg579*		15298	CM001391	rs121965088	Xeroderma pigmentosum	1735C>T	EAS	5.80E-05	XPC	7508
VSB2DSQGVJ	chr3	14168388	14168389	A	T	NC_000003.12:g.14168389A>T	NM_004628.4:c.413-9T>A			15299	CS040563	rs794729656	Xeroderma pigmentosum	413-9T>A			XPC	7508
VSA7QUN8YN	chr3	14168403	14168404	T	C	NC_000003.12:g.14168404T>C	NM_004628.4:c.413-24A>G			15300	CS040564	rs794729657	Xeroderma pigmentosum	413-24A>G			XPC	7508
VS9SXUTYNM	chr3	15635476	15635483	GCGGCTG	TCC	NC_000003.12:g.15635477_15635483delinsTCC	NM_000060.3:c.98_104delinsTCC	NP_000051.1:p.Cys33fs		16934	CX952003	rs80338684	Biotinidase deficiency	98_104delGCGGCTGinsTCC			BTD	686
VS3G1TPJJI	chr3	15644610	15644611	A	G	NC_000003.12:g.15644611A>G	NM_000060.3:c.755A>G	NP_000051.1:p.Asp252Gly		16940	CM993555	rs28934601	Biotinidase deficiency	755A>G	AMR	8.93E-05	BTD	686
VSN4ITRXXK	chr3	15645223	15645224	A	C	NC_000003.12:g.15645224A>C	NM_000060.3:c.1368A>C	NP_000051.1:p.Gln456His		16941	CM970190	rs80338685	Biotinidase deficiency	1368A>C	NFE	0.000779165	BTD	686
VSYYSHK97R	chr3	15645450	15645451	C	T	NC_000003.12:g.15645451C>T	NM_000060.3:c.1595C>T	NP_000051.1:p.Thr532Met		16936	CM980260	rs104893688	Biotinidase deficiency	1595C>T	NFE	0.000129345	BTD	686
VS1QC5LDN3	chr3	15645467	15645468	C	T	NC_000003.12:g.15645468C>T	NM_000060.3:c.1612C>T	NP_000051.1:p.Arg538Cys		16937	CM970191	rs80338686	Biotinidase deficiency	1612C>T	NFE	0.000121999	BTD	686
VSI83IXVD9	chr3	33016742	33016743	C	T	NC_000003.12:g.33016743C>T	NM_000404.3:c.1445G>A	NP_000395.2:p.Arg482His		15971	CM910189	rs72555391	GM1-gangliosidosis	1445G>A	EAS	5.80E-05	GLB1	2720
VS6BZHAGRC	chr3	33058199	33058200	G	A	NC_000003.12:g.33058200G>A	NM_000404.3:c.622C>T	NP_000395.2:p.Arg208Cys		15978	CM930342	rs72555366	GM1-gangliosidosis	622C>T	AFR	0.000196412	GLB1	2720
VS57BT44GZ	chr3	33072612	33072613	C	T	NC_000003.12:g.33072613C>T	NM_000404.3:c.176G>A	NP_000395.2:p.Arg59His		15984	CM990696	rs72555392	GM1-gangliosidosis	176G>A	AMR	8.93E-05	GLB1	2720
VS3I14HPRM	chr3	33072636	33072637	A	G	NC_000003.12:g.33072637A>G	NM_000404.3:c.152T>C	NP_000395.2:p.Ile51Thr		15965	CM910182	rs72555390	GM1-gangliosidosis	152T>C			GLB1	2720
VSYTSI3LYF	chr3	48466995	48466996	G	A	NC_000003.12:g.48466996G>A	NM_033629.4:c.341G>A	NP_338599.1:p.Arg114His		19218	CM063221	rs72556554	"Aicardi-Goutieres syndrome, TREX1-related"	341G>A	NFE	0.000352164	TREX1	11277
VSWSPF26VJ	chr3	48467144	48467145	C	T	NC_000003.12:g.48467145C>T	NM_033629.4:c.490C>T	NP_338599.1:p.Arg164*		19219	CM063222	rs78218009	"Aicardi-Goutieres syndrome, TREX1-related"	490C>T			TREX1	11277
VSY2N9NPBC	chr3	48573863	48573864	A	AG	NC_000003.12:g.48573870dupG	NM_000094.3:c.6527dupC	NP_000085.1:p.Gly2177fs		359567	CI972584	rs768128088	"Dystrophic epidermolysis bullosa, COL7A1-related"	6527dupC	AMR	0.000417014	COL7A1	1294
TP2016026	chr3	48575235	48575236	G	A	NC_000003.12:g.48575236G>A	NM_000094.3:c.6187C>T	NP_000085.1:p.Arg2063Trp		32495	CM970381	rs121912849	"Dystrophic epidermolysis bullosa, COL7A1-related"	p.Arg2063Trp	NFE	1.79E-05	COL7A1	1294
VS20160210	chr3	48581258	48581259	C	T	NC_000003.12:g.48581259C>T	NM_000094.3:c.4899+1G>A				CS051249	rs766168993	"Dystrophic epidermolysis bullosa, COL7A1-related"	c.4899+1G>A			COL7A1	1294
VSCD1I2HEW	chr3	48589326	48589336	CAGTCCTCAC	AA	NC_000003.12:g.48589327_48589336delinsAA	NM_000094.3:c.2305_2314delinsTT	NP_000085.1:p.Val769fs			CX096555		"Dystrophic epidermolysis bullosa, COL7A1-related"	2305_2314delGTGAGGACTGinsTT			COL7A1	1294
VS2CEQGPS5	chr3	49417891	49417892	C	T	NC_000003.12:g.49417892C>T	NM_000481.3:c.959G>A	NP_000472.2:p.Arg320His		27018	CM940064	rs121964985	"Glycine encephalopathy, AMT-related"	959G>A	NFE	0.000161412	AMT	275
VS4TWN92KB	chr3	49417973	49417974	C	T	NC_000003.12:g.49417974C>T	NM_000481.3:c.878-1G>A			27020	CS003178	rs181134220	"Glycine encephalopathy, AMT-related"	878-1G>A	AMR	9.40E-05	AMT	275
VSSP8KD6K3	chr3	49422222	49422223	C	T	NC_000003.12:g.49422223C>T	NM_000481.3:c.139G>A	NP_000472.2:p.Gly47Arg		27014	CM940062	rs121964982	"Glycine encephalopathy, AMT-related"	139G>A	AMR	8.93E-05	AMT	275
VS1ZFTIWWF	chr3	49422236	49422237	T	C	NC_000003.12:g.49422237T>C	NM_000481.3:c.125A>G	NP_000472.2:p.His42Arg		27015	CM980083	rs121964983	"Glycine encephalopathy, AMT-related"	125A>G			AMT	275
VS4CG4ZB41	chr3	58431594	58431595	T	C	NC_000003.12:g.58431595T>C	NM_000925.3:c.301A>G	NP_000916.2:p.Met101Val			CM0910758	rs747573712	"Pyruvate dehydrogenase deficiency, PDHB-related"	301A>G	NFE	5.37E-05	PDHB	5162
VS3DIFNB1G	chr3	81642786	81642787	T	G	NC_000003.12:g.81642787T>G	NM_000158.3:c.986A>C	NP_000149.3:p.Tyr329Ser		17816	CM960705	rs80338671	"Glycogen storage disease, type IV"	986A>C	ASJ	0.00641548	GBE1	2632
VS5UY9RI6W	chr3	120633222	120633223	T	TG	NC_000003.12:g.120633229dupG	NM_000187.3:c.1111dupC	NP_000178.2:p.His371fs		76481	CI992287	rs397515516	Alkaptonuria	1111dupC	NFE	8.97E-06	HGD	3081
VSZ25XRP4P	chr3	120633232	120633233	T	C	NC_000003.12:g.120633233T>C	NM_000187.3:c.1102A>G	NP_000178.2:p.Met368Val		18212	CM980982	rs120074173	Alkaptonuria	1102A>G	NFE	0.000340734	HGD	3081
VSAS4DV4XE	chr3	120641659	120641660	C	T	NC_000003.12:g.120641660C>T	NM_000187.3:c.808G>A	NP_000178.2:p.Gly270Arg		18214	CM992169	rs120074174	Alkaptonuria	808G>A	AFR	0.000196027	HGD	3081
VSBGKTV5RG	chr3	120647040	120647041	C	T	NC_000003.12:g.120647041C>T	NM_000187.3:c.481G>A	NP_000178.2:p.Gly161Arg		18207	CM970726	rs28941783	Alkaptonuria	481G>A	NFE	0.000188584	HGD	3081
VS2YX7YMC1	chr3	120647887	120647888	T	TC	NC_000003.12:g.120647892dupC	NM_000187.3:c.457dupG	NP_000178.2:p.Asp153fs		18208	CI972623	rs397515346	Alkaptonuria	457dupG	AMR	8.93E-05	HGD	3081
VSST4KUPU5	chr3	120650847	120650848	A	C	NC_000003.12:g.120650848A>C	NM_000187.3:c.360T>G	NP_000178.2:p.Cys120Trp		76486	CM023390	rs149165166	Alkaptonuria	360T>G			HGD	3081
VSJCN9Y2WZ	chr3	136255951	136255952	G	T	NC_000003.12:g.136255952G>T	NM_000532.4:c.280G>T	NP_000523.2:p.Gly94*		47485	CM034106	rs202247817	"Propionic acidemia, PCCB-related"	280G>T			PCCB	5096
VSQF66YJ89	chr3	136256585	136256586	G	A	NC_000003.12:g.136256586G>A	NM_000532.4:c.335G>A	NP_000523.2:p.Gly112Asp		47486	CM003601	rs202247818	"Propionic acidemia, PCCB-related"	335G>A			PCCB	5096
VSISIA256X	chr3	136261978	136261979	G	C	NC_000003.12:g.136261979G>C	NM_000532.4:c.457G>C	NP_000523.2:p.Ala153Pro		47487	CM043325	rs202247819	"Propionic acidemia, PCCB-related"	457G>C			PCCB	5096
VSV9B9SJ3Y	chr3	136262023	136262024	G	A	NC_000003.12:g.136262024G>A	NM_000532.4:c.502G>A	NP_000523.2:p.Glu168Lys		27054	CM981490	rs121964960	"Propionic acidemia, PCCB-related"	502G>A	NFE	1.58E-05	PCCB	5096
VSXCV9DTTA	chr3	136327173	136327187	GGGCATCATCCGGC	TAGAGCACAGGA	NC_000003.12:g.136327174_136327187delinsTAGAGCACAGGA	NM_000532.4:c.1218_1231delinsTAGAGCACAGGA	NP_000523.2:p.Gly407fs		47478	CX941939	rs397507445	"Propionic acidemia, PCCB-related"	1218_1231delGGGCATCATCCGGCinsTAGAGCACAGGA			PCCB	5096
VSD19DZVFC	chr3	136327183	136327184	C	T	NC_000003.12:g.136327184C>T	NM_000532.4:c.1228C>T	NP_000523.2:p.Arg410Trp		27050	CM930577	rs121964959	"Propionic acidemia, PCCB-related"	1228C>T	SAS	6.50E-05	PCCB	5096
VSQU6GWQCP	chr3	136327238	136327239	C	T	NC_000003.12:g.136327239C>T	NM_000532.4:c.1283C>T	NP_000523.2:p.Thr428Ile		27055	CM930578	rs111033542	"Propionic acidemia, PCCB-related"	1283C>T	EAS	0.000232315	PCCB	5096
VSEATS5CJ1	chr3	136328853	136328854	C	T	NC_000003.12:g.136328854C>T	NM_000532.4:c.1495C>T	NP_000523.2:p.Arg499*		47481	CM930579	rs202247820	"Propionic acidemia, PCCB-related"	1495C>T	NFE	8.97E-06	PCCB	5096
VS8Y2891Q1	chr3	136329939	136329940	C	T	NC_000003.12:g.136329940C>T	NM_000532.4:c.1534C>T	NP_000523.2:p.Arg512Cys		47482	CM981493	rs186710233	"Propionic acidemia, PCCB-related"	1534C>T	NFE	8.97E-06	PCCB	5096
VSJTTETHXD	chr3	136329942	136329943	G	GCCC	NC_000003.12:g.136329944_136329946dupCCC	NM_000532.4:c.1538_1540dupCCC	NP_000523.2:p.Ala513_Arg514insPro		27056	CI001945	rs202247821	"Propionic acidemia, PCCB-related"	1538_1540dupCCC			PCCB	5096
VSB8M2JFLE	chr3	136330011	136330012	A	G	NC_000003.12:g.136330012A>G	NM_000532.4:c.1606A>G	NP_000523.2:p.Asn536Asp		47484	CM941148	rs202247823	"Propionic acidemia, PCCB-related"	1606A>G	NFE	3.59E-05	PCCB	5096
VSQEYBD46X	chr3	149145546	149145547	G	A	NC_000003.12:g.149145547G>A	NM_032383.4:c.1163+1G>A			19648	CS013456	rs201227603	"Hermansky-Pudlak syndrome, type III"	1163+1G>A	ASJ	0.0016247	HPS3	84343
VSLXXE6AGJ	chr3	149150623	149150624	C	T	NC_000003.12:g.149150624C>T	NM_032383.4:c.1189C>T	NP_115759.2:p.Arg397Trp		19652	CM013270	rs121908316	"Hermansky-Pudlak syndrome, type III"	1189C>T	AFR	6.54E-05	HPS3	84343
VS4EJTX15X	chr3	149157532	149157533	T	G	NC_000003.12:g.149157533T>G	NM_032383.4:c.1691+2T>G			19649	CS013457	rs281865093	"Hermansky-Pudlak syndrome, type III"	1691+2T>G			HPS3	84343
VSC8W8IIX3	chr3	150928106	150928107	A	C	NC_000003.12:g.150928107A>C	NM_174878.2:c.528T>G	NP_777367.1:p.Tyr176*		19431	CM013798	rs121908140	"Usher syndrome, type III"	528T>G	FIN	0.00704415	CLRN1	7401
VS397C9517	chr3	150972564	150972565	A	C	NC_000003.12:g.150972565A>C	NM_174878.2:c.144T>G	NP_777367.1:p.Asn48Lys		19434	CM021360	rs111033258	"Usher syndrome, type III"	p.N48K	ASJ	0.00538071	CLRN1	7401
VSZ9NWCK36	chr3	165830740	165830741	T	C	NC_000003.12:g.165830741T>C	NM_000055.2:c.293A>G	NP_000046.1:p.Asp98Gly		28254	CM890021	rs1799807	Pseudocholinesterase deficiency	293A>G	NFE	0.0177665	BCHE	590
VSVZYECRPC	chr3	185519291	185519292	A	T	NC_000003.12:g.185519292A>T	NM_139248.2:c.736T>A	NP_640341.1:p.Cys246Ser		227256	CM098213	rs201249971	Autosomal recessive woolly hair/hypotrichosis	736T>A	EAS	0.00214518	LIPH	200879
TP2016018	chr4	987841	987842	C	A	NC_000004.12:g.987842C>A	NM_000203.4:c.192C>A	NP_000194.2:p.Tyr64*		26953	CM930423	rs121965022	"Mucopolysaccharidosis, type I - Hurler syndrome"	192C>A			IDUA	3425
VS20160221	chr4	987857	987858	C	T	NC_000004.12:g.987858C>T	NM_000203.4:c.208C>T	NP_000194.2:p.Gln70*		26948	CM930424	rs121965020	"Mucopolysaccharidosis, type I - Hurler syndrome"	p.Q70X	FIN	0.00200602	IDUA	3425
VS20160220	chr4	987915	987916	G	A	NC_000004.12:g.987916G>A	NM_000203.4:c.266G>A	NP_000194.2:p.Arg89Gln		26961	CM950677	rs121965029	"Mucopolysaccharidosis, type I - Hurler syndrome"	p.R89Q	EAS	6.46E-05	IDUA	3425
VS31ZP6JNU	chr4	1002274	1002275	G	C	NC_000004.12:g.1002275G>C	NM_000203.4:c.979G>C	NP_000194.2:p.Ala327Pro		177221	CM950680	rs199801029	"Mucopolysaccharidosis, type I - Hurler syndrome"	979G>C	NFE	0.000111934	IDUA	3425
TP2016029	chr4	1002746	1002747	G	A	NC_000004.12:g.1002747G>A	NM_000203.4:c.1205G>A	NP_000194.2:p.Trp402*		26947	CM920372	rs121965019	"Mucopolysaccharidosis, type I - Hurler syndrome"	Trp402Ter	NFE	0.00123845	IDUA	3425
VSD6DKEHBZ	chr4	1003417	1003418	C	G	NC_000004.12:g.1003418C>G	NM_000203.4:c.1598C>G	NP_000194.2:p.Pro533Arg		26949	CM920373	rs121965021	"Mucopolysaccharidosis, type I - Hurler syndrome"	1598C>G	AMR	0.000170605	IDUA	3425
TP2016003	chr4	3473636	3473637	G	T	NC_000004.12:g.3473637G>T	NM_173660.4:c.331+1G>T			443612	CS083895	rs1349476281	"Fetal akinesia deformation sequence, DOK7-related"	331+1G>T	NFE	2.69E-05	DOK7	285489
VSFKIRLZA2	chr4	52029721	52029722	C	CTCCTACTG	NC_000004.12:g.52029724_52029731dup	NM_000232.4:c.377_384dup	NP_000223.1:p.Gly129fs			CI951975	rs751427729	"Limb-girdle muscular dystrophy, type 2E"	377_384dupCAGTAGGA	NFE	8.95E-06	SGCB	6443
VS2HZYHXR4	chr4	52029765	52029766	G	A	NC_000004.12:g.52029766G>A	NM_000232.4:c.341C>T	NP_000223.1:p.Ser114Phe		51200	CM971349	rs150518260	"Limb-girdle muscular dystrophy, type 2E"	341C>T	NFE	0.000555078	SGCB	6443
VSZP9ANE4Q	chr4	99622755	99622756	G	T	NC_000004.12:g.99622756G>T	NM_000253.3:c.2593G>T	NP_000244.2:p.Gly865*		29282	CM952028	rs146064714	Abetalipoproteinemia	2593G>T	ASJ	0.00274167	MTTP	4547
VSEIYYX7NM	chr4	122742954	122742955	C	T	NC_000004.12:g.122742955C>T	NM_152618.2:c.1063C>T	NP_689831.2:p.Arg355*		16186	CM070035	rs121918327	"Bardet-Biedl syndrome, BBS12-related"	1063C>T	EAS	5.80E-05	BBS12	166379
VS8JCEZ6FY	chr4	122743004	122743007	ATT	A	NC_000004.12:g.122743007_122743008delTT	NM_152618.2:c.1115_1116delTT	NP_689831.2:p.Phe372fs		16190	CD070440	rs1238631265	"Bardet-Biedl syndrome, BBS12-related"	1115_1116delTT	NFE	0.000170132	BBS12	166379
VS2Q9162NM	chr4	127930799	127930800	G	T	NC_000004.12:g.127930800G>T	NM_152778.2:c.881C>A	NP_689991.1:p.Thr294Lys		16045	CM091346	rs140948465	"Neuronal ceroid-lipofuscinosis, MFSD8-related"	881C>A	NFE	9.00E-06	MFSD8	256471
VSKZTSPQXF	chr4	127938780	127938781	A	T	NC_000004.12:g.127938781A>T	NM_152778.2:c.754+2T>A			76805	CS073501	rs587778809	"Neuronal ceroid-lipofuscinosis, MFSD8-related"	754+2T>A	AMR	2.99E-05	MFSD8	256471
VSB66RPWTU	chr4	145639202	145639203	C	T	NC_000004.12:g.145639203C>T	NM_172250.2:c.64C>T	NP_758454.1:p.Arg22*		216025	CM042745	rs765799472	"Methylmalonic aciduria, cblA type"	64C>T	NFE	4.48E-05	MMAA	166785
VSBAUYZM4D	chr4	145639299	145639300	G	A	NC_000004.12:g.145639300G>A	NM_172250.2:c.161G>A	NP_758454.1:p.Trp54*		216026	CM043522	rs864309725	"Methylmalonic aciduria, cblA type"	161G>A			MMAA	166785
VS9M378KL4	chr4	145639404	145639405	T	C	NC_000004.12:g.145639405T>C	NM_172250.2:c.266T>C	NP_758454.1:p.Leu89Pro		216027	CM043523	rs864309726	"Methylmalonic aciduria, cblA type"	266T>C	NFE	8.96E-06	MMAA	166785
VSEQYWKNX9	chr4	145639421	145639422	C	T	NC_000004.12:g.145639422C>T	NM_172250.2:c.283C>T	NP_758454.1:p.Gln95*		18197	CM043524	rs104893846	"Methylmalonic aciduria, cblA type"	283C>T	NFE	0.000170233	MMAA	166785
VSIX68KSMR	chr4	145639496	145639497	C	T	NC_000004.12:g.145639497C>T	NM_172250.2:c.358C>T	NP_758454.1:p.Gln120*		216028	CM050663	rs864309727	"Methylmalonic aciduria, cblA type"	358C>T			MMAA	166785
VSYQC4Z3TC	chr4	145639535	145639536	C	T	NC_000004.12:g.145639536C>T	NM_172250.2:c.397C>T	NP_758454.1:p.Gln133*		216029	CM050664	rs754545360	"Methylmalonic aciduria, cblA type"	397C>T	NFE	8.99E-06	MMAA	166785
VSPAG5I2E4	chr4	145642424	145642426	AC	A	NC_000004.12:g.145642426delC	NM_172250.2:c.503delC	NP_758454.1:p.Thr168fs		216030	CD042875	rs864309728	"Methylmalonic aciduria, cblA type"	503delC			MMAA	166785
VSABFU16BD	chr4	145642484	145642485	G	C	NC_000004.12:g.145642485G>C	NM_172250.2:c.562G>C	NP_758454.1:p.Gly188Arg		216031	CM081335	rs864309729	"Methylmalonic aciduria, cblA type"	562G>C			MMAA	166785
VSALXA9J1W	chr4	145646072	145646073	T	A	NC_000004.12:g.145646073T>A	NM_172250.2:c.650T>A	NP_758454.1:p.Leu217*		216033	CM042747	rs140356252	"Methylmalonic aciduria, cblA type"	650T>A			MMAA	166785
VS83MVVX4B	chr4	145646075	145646076	G	A	NC_000004.12:g.145646076G>A	NM_172250.2:c.653G>A	NP_758454.1:p.Gly218Glu		216034	CM043529	rs864309730	"Methylmalonic aciduria, cblA type"	653G>A			MMAA	166785
VSFX3DPUAX	chr4	145646156	145646157	G	A	NC_000004.12:g.145646157G>A	NM_172250.2:c.733+1G>A			216035	CS043646	rs779939886	"Methylmalonic aciduria, cblA type"	733+1G>A	NFE	8.96E-06	MMAA	166785
VS418N5QJQ	chr4	145655164	145655165	C	T	NC_000004.12:g.145655165C>T	NM_172250.2:c.988C>T	NP_758454.1:p.Arg330*		200055	CM043532	rs571038432	"Methylmalonic aciduria, cblA type"	988C>T	SAS	3.25E-05	MMAA	166785
VSLN2W2GAZ	chr4	145655252	145655253	G	A	NC_000004.12:g.145655253G>A	NM_172250.2:c.1076G>A	NP_758454.1:p.Arg359Gln		216036	CM043533	rs864309731	"Methylmalonic aciduria, cblA type"	1076G>A			MMAA	166785
VSCPLUMTM4	chr4	177438763	177438764	C	G	NC_000004.12:g.177438764C>G	NM_000027.3:c.488G>C	NP_000018.2:p.Cys163Ser		15258	CM910011	rs121964904	Aspartylglycosaminuria	488G>C	FIN	0.00825482	AGA	175
VSWQRGCELX	chr4	177440339	177440340	A	G	NC_000004.12:g.177440340A>G	NM_000027.3:c.214T>C	NP_000018.2:p.Ser72Pro		15268	CM960014	rs121964909	Aspartylglycosaminuria	214T>C			AGA	175
VSTFS98RAF	chr4	177440351	177440354	GCT	G	NC_000004.12:g.177440360_177440361delTC	NM_000027.3:c.200_201delAG	NP_000018.2:p.Glu67fs		70578	CD951560	rs386833420	Aspartylglycosaminuria	200_201delAG	NFE	1.79E-05	AGA	175
VSX7AX7HBP	chr5	38511871	38511872	C	CA	NC_000005.10:g.38511873dupA	NM_002310.5:c.653dupT	NP_002301.1:p.Glu219fs		265681	CI040632	rs886042160	Stuve-Wiedemann syndrome	653dupT			LIFR	3977
VSH7CKDAQA	chr5	74689473	74689474	G	A	NC_000005.10:g.74689474G>A	NM_000521.3:c.445+1G>A				CS941497		Sandhoff disease	445+1G>A			HEXB	3074
VSXZ5QNVL2	chr5	74713583	74713584	C	T	NC_000005.10:g.74713584C>T	NM_000521.3:c.850C>T	NP_000512.1:p.Arg284*		18926	CM940931	rs121907986	Sandhoff disease	850C>T	SAS	0.000227406	HEXB	3074
VSPN5SZPVQ	chr5	74718929	74718930	A	C	NC_000005.10:g.74718930A>C	NM_000521.3:c.1376A>C	NP_000512.1:p.Asp459Ala			CM087535		Sandhoff disease	1376A>C			HEXB	3074
VSW5FTGMRT	chr5	78839426	78839427	C	G	NC_000005.10:g.78839427C>G	NM_000046.3:c.1143-1G>C			15926	CS075071	rs431905495	"Mucopolysaccharidosis, type VI"	1143-1G>C			ARSB	411
VS6ZGKUPK6	chr5	78839433	78839434	A	C	NC_000005.10:g.78839434A>C	NM_000046.3:c.1143-8T>G			15927	CS055564	rs431905496	"Mucopolysaccharidosis, type VI"	1143-8T>G	AMR	2.98E-05	ARSB	411
VSQXDXIEPA	chr5	78964476	78964477	T	C	NC_000005.10:g.78964477T>C	NM_000046.3:c.629A>G	NP_000037.2:p.Tyr210Cys		15924	CM960081	rs118203943	"Mucopolysaccharidosis, type VI"	629A>G	NFE	0.000582719	ARSB	411
VSGT1K9AR2	chr5	119452620	119452621	G	A	NC_000005.10:g.119452621G>A	NM_000414.3:c.46G>A	NP_000405.1:p.Gly16Ser		22694	CM981006	rs137853096	D-bifunctional protein deficiency	46G>A	NFE	0.000416501	HSD17B4	3295
VS9LJVEW4H	chr5	119509175	119509176	A	T	NC_000005.10:g.119509176A>T	NM_000414.3:c.1369A>T	NP_000405.1:p.Asn457Tyr		22695	CM990741	rs137853097	D-bifunctional protein deficiency	1369A>T	AMR	5.96E-05	HSD17B4	3295
VSGIJ5EMGB	chr5	149960980	149960981	T	C	NC_000005.10:g.149960981T>C	NM_000112.3:c.-26+2T>C			19136	CS992255	rs386833492	Sulfate transporter-related osteochondrodysplasia	-26+2T>C			SLC26A2	1836
VSTYDVMLJV	chr5	149978183	149978184	C	T	NC_000005.10:g.149978184C>T	NM_000112.3:c.532C>T	NP_000103.2:p.Arg178*		19131	CM960496	rs104893919	Sulfate transporter-related osteochondrodysplasia	532C>T	AMR	0.000297921	SLC26A2	1836
VSYT2ILMNB	chr5	149980427	149980428	C	T	NC_000005.10:g.149980428C>T	NM_000112.3:c.835C>T	NP_000103.2:p.Arg279Trp		19128	CM960498	rs104893915	Sulfate transporter-related osteochondrodysplasia	835C>T	ASJ	0.00193168	SLC26A2	1836
VS279Y826W	chr5	149980601	149980605	CTTG	C	NC_000005.10:g.149980613_149980615delTGT	NM_000112.3:c.1020_1022delTGT	NP_000103.2:p.Val341del		76466	CD961963	rs121908077	Sulfate transporter-related osteochondrodysplasia	1020_1022delTGT	EAS	0.000289889	SLC26A2	1836
VSHL1XUW22	chr5	149981549	149981550	T	A	NC_000005.10:g.149981550T>A	NM_000112.3:c.1957T>A	NP_000103.2:p.Cys653Ser		19137	CM010437	rs104893924	Sulfate transporter-related osteochondrodysplasia	1957T>A	NFE	0.000251126	SLC26A2	1836
VSQKNQAA8N	chr5	179272925	179272926	G	A	NC_000005.10:g.179272926G>A	NM_014244.4:c.673C>T	NP_055059.2:p.Gln225*		20541	CM993490	rs137853146	"Ehlers-Danlos syndrome, type VIIC"	673C>T	ASJ	0.0030525	ADAMTS2	9509
VSSJDFPE13	chr6	26090950	26090951	C	G	NC_000006.12:g.26090951C>G	NM_000410.3:c.187C>G	NP_000401.1:p.His63Asp		15049	CM960827	rs1799945	"Hereditary hemochromatosis, HFE-related"	187C>G	NFE	0.144081995	HFE	3077
VSPZVG5PHD	chr6	26092912	26092913	G	A	NC_000006.12:g.26092913G>A	NM_000410.3:c.845G>A	NP_000401.1:p.Cys282Tyr		15048	CM960828	rs1800562	"Hereditary hemochromatosis, HFE-related"	845G>A	NFE	0.0572928	HFE	3077
VSU37YJ15L	chr6	42978334	42978349	AAGCGCCAGTCCGTC	A	NC_000006.12:g.42978340_42978353del	NM_000287.3:c.802_815del	NP_000278.3:p.Asp268fs		544100	CD013197	rs63749004	"Zellweger syndrome spectrum, PEX6-related"	802_815delGACGGACTGGCGCT	NFE	2.69E-05	PEX6	5190
VSYEKZ25PN	chr6	49431830	49431831	C	A	NC_000006.12:g.49431831C>A	NM_000255.3:c.2150G>T	NP_000246.2:p.Gly717Val		16920	CM920488	rs121918252	"Methylmalonic aciduria, MUT-related"	2150G>T	AFR	0.000719048	MUT	4594
VSUH6S2776	chr6	49435525	49435526	A	C	NC_000006.12:g.49435526A>C	NM_000255.3:c.2054T>G	NP_000246.2:p.Leu685Arg		216040	CM981321	rs864309739	"Methylmalonic aciduria, MUT-related"	2054T>G			MUT	4594
VSE2LNKMRW	chr6	49435568	49435569	T	C	NC_000006.12:g.49435569T>C	NM_000255.3:c.2011A>G	NP_000246.2:p.Ile671Val		98592	CM0911477	rs8589	fingerprint variant		SAS	0.646643996	MUT	4594
VSWLK15R5J	chr6	49440294	49440295	C	T	NC_000006.12:g.49440295C>T	NM_000255.3:c.1867G>A	NP_000246.2:p.Gly623Arg		16923	CM941075	rs121918254	"Methylmalonic aciduria, MUT-related"	1867G>A	AFR	6.54E-05	MUT	4594
VSAZW756IR	chr6	49451517	49451518	C	T	NC_000006.12:g.49451518C>T	NM_000255.3:c.1280G>A	NP_000246.2:p.Gly427Asp		216044	CM060371	rs753288303	"Methylmalonic aciduria, MUT-related"	1280G>A	EAS	0.000347987	MUT	4594
VS6X6HD3D3	chr6	49451691	49451692	C	T	NC_000006.12:g.49451692C>T	NM_000255.3:c.1106G>A	NP_000246.2:p.Arg369His		200114	CM990882	rs564069299	"Methylmalonic aciduria, MUT-related"	1106G>A	EAS	0.000173994	MUT	4594
VS8HGEQEVA	chr6	49451692	49451693	G	A	NC_000006.12:g.49451693G>A	NM_000255.3:c.1105C>T	NP_000246.2:p.Arg369Cys		216045	CM050683	rs772552898	"Methylmalonic aciduria, MUT-related"	1105C>T	AFR	6.54E-05	MUT	4594
VSD9TZD95D	chr6	49451700	49451701	T	C	NC_000006.12:g.49451701T>C	NM_000255.3:c.1097A>G	NP_000246.2:p.Asn366Ser		216046	CM071009	rs864309737	"Methylmalonic aciduria, MUT-related"	1097A>G			MUT	4594
VS6H8FW9RD	chr6	49453732	49453733	C	A	NC_000006.12:g.49453733C>A	NM_000255.3:c.935G>T	NP_000246.2:p.Gly312Val		216047	CM981319	rs864309734	"Methylmalonic aciduria, MUT-related"	935G>T			MUT	4594
VSD6ZM44MA	chr6	49457752	49457753	A	T	NC_000006.12:g.49457753A>T	NM_000255.3:c.691T>A	NP_000246.2:p.Tyr231Asn		216048	CM971004	rs864309736	"Methylmalonic aciduria, MUT-related"	691T>A			MUT	4594
VSM5UDZDMU	chr6	49457788	49457789	T	A	NC_000006.12:g.49457789T>A	NM_000255.3:c.655A>T	NP_000246.2:p.Asn219Tyr		16925	CM012408	rs121918256	"Methylmalonic aciduria, MUT-related"	655A>T	NFE	0.000152423	MUT	4594
VS4B9M8U1A	chr6	49457800	49457801	C	T	NC_000006.12:g.49457801C>T	NM_000255.3:c.643G>A	NP_000246.2:p.Gly215Ser		16927	CM050673	rs121918258	"Methylmalonic aciduria, MUT-related"	643G>A			MUT	4594
VSXKILHKBE	chr6	49457836	49457837	C	T	NC_000006.12:g.49457837C>T	NM_000255.3:c.607G>A	NP_000246.2:p.Gly203Arg		216050	CM002067	rs778702777	"Methylmalonic aciduria, MUT-related"	607G>A	AMR	2.98E-05	MUT	4594
TP2016028	chr6	49457871	49457872	G	T	NC_000006.12:g.49457872G>T	NM_000255.3:c.572C>A	NP_000246.2:p.Ala191Glu		200124	CM981317	rs760782399	"Methylmalonic aciduria, MUT-related"	572C>A	NFE	8.07E-05	MUT	4594
VS76HPS6F5	chr6	49457922	49457923	A	G	NC_000006.12:g.49457923A>G	NM_000255.3:c.521T>C	NP_000246.2:p.Phe174Ser		216051	CM002066	rs864309733	"Methylmalonic aciduria, MUT-related"	521T>C			MUT	4594
VSWYHZFDH8	chr6	49459144	49459145	G	A	NC_000006.12:g.49459145G>A	NM_000255.3:c.322C>T	NP_000246.2:p.Arg108Cys		16926	CM060359	rs121918257	"Methylmalonic aciduria, MUT-related"	322C>T	AMR	0.000834177	MUT	4594
VSKCFPT8RM	chr6	49459153	49459154	A	G	NC_000006.12:g.49459154A>G	NM_000255.3:c.313T>C	NP_000246.2:p.Trp105Arg		16917	CM900166	rs121918249	"Methylmalonic aciduria, MUT-related"	313T>C	AMR	5.96E-05	MUT	4594
VSMJUGM85X	chr6	49459167	49459168	T	C	NC_000006.12:g.49459168T>C	NM_000255.3:c.299A>G	NP_000246.2:p.Tyr100Cys		216052	CM071014	rs864309735	"Methylmalonic aciduria, MUT-related"	299A>G	NFE	8.95E-06	MUT	4594
TP2016014	chr6	49459185	49459186	C	A	NC_000006.12:g.49459186C>A	NM_000255.3:c.281G>T	NP_000246.2:p.Gly94Val			CM973221	rs535411418	"Methylmalonic aciduria, MUT-related"	281G>T	AFR	0.000130685	MUT	4594
TP2016020	chr6	49459188	49459189	C	T	NC_000006.12:g.49459189C>T	NM_000255.3:c.278G>A	NP_000246.2:p.Arg93His		16919	CM910267	rs121918251	"Methylmalonic aciduria, MUT-related"	278G>A	FIN	0.000448471	MUT	4594
VSLZRG4W3R	chr6	51659713	51659714	A	C	NC_000006.12:g.51659714A>C	NM_138694.3:c.10412T>G	NP_619639.3:p.Val3471Gly		19154	CM032335	rs137852950	Autosomal recessive polycystic kidney disease	10412T>G	FIN	0.00071794	PKHD1	5314
VS8EX8D3R1	chr6	52058348	52058349	G	A	NC_000006.12:g.52058349G>A	NM_138694.3:c.1486C>T	NP_619639.3:p.Arg496*		19153	CM032309	rs137852949	Autosomal recessive polycystic kidney disease	1486C>T	FIN	0.0067713	PKHD1	5314
VSFZI6PE6T	chr6	52083200	52083201	G	A	NC_000006.12:g.52083201G>A	NM_138694.3:c.107C>T	NP_619639.3:p.Thr36Met		19147	CM020490	rs137852944	Autosomal recessive polycystic kidney disease	107C>T	NFE	0.00081569	PKHD1	5314
VSCFLBBNXB	chr6	57194816	57194817	A	T	NC_000006.12:g.57194817A>T	NM_183227.2:c.434T>A	NP_899050.1:p.Leu145*		19630	CM071964	rs121908171	Carpenter syndrome	434T>A	NFE	0.000575467	RAB23	51715
VSWVFITDCS	chr6	73644582	73644583	G	A	NC_000006.12:g.73644583G>A	NM_012434.4:c.115C>T	NP_036566.1:p.Arg39Cys		20654	CM993211	rs80338794	Salla disease	115C>T	FIN	0.0059652	SLC17A5	26503
VSKT16IKR2	chr6	79487620	79487621	G	GT	NC_000006.12:g.79487622dupT	NM_181714.3:c.1476dupA	NP_859065.2:p.Pro493fs		16006	CI073756	rs386834253	"Leber congenital amaurosis, LCA5-related"	1476dupA			LCA5	167691
VSUCEK6WDX	chr6	79489162	79489164	TG	T	NC_000006.12:g.79489166delG	NM_181714.3:c.1151delC	NP_859065.2:p.Pro384fs		16005	CD073659	rs386834252	"Leber congenital amaurosis, LCA5-related"	1151delC	SAS	3.25E-05	LCA5	167691
VSR1JXH2LV	chr6	79493635	79493636	G	A	NC_000006.12:g.79493636G>A	NM_181714.3:c.835C>T	NP_859065.2:p.Gln279*		16007	CM073175	rs121918165	"Leber congenital amaurosis, LCA5-related"	835C>T	ASJ	0.00213458	LCA5	167691
VS8CA7211A	chr6	80168944	80168945	G	C	NC_000006.12:g.80168945G>C	NM_183050.3:c.548G>C	NP_898871.1:p.Arg183Pro		26976	CM014511	rs79761867	"Maple syrup urine disease, type IB"	p.R183P	ASJ	0.004671	BCKDHB	594
VS36B6252C	chr6	80201022	80201023	G	A	NC_000006.12:g.80201023G>A	NM_183050.3:c.832G>A	NP_898871.1:p.Gly278Ser		76679	CM014512	rs386834233	"Maple syrup urine disease, type IB"	p.G278S	FIN	0.00300637	BCKDHB	594
VSE4B2A47D	chr6	80343738	80343739	G	T	NC_000006.12:g.80343739G>T	NM_183050.3:c.1114G>T	NP_898871.1:p.Glu372*		76678	CM014513	rs386834234	"Maple syrup urine disease, type IB"	p.E372X			BCKDHB	594
VS8Q44HA31	chr6	136898212	136898213	T	A	NC_000006.12:g.136898213T>A	NM_000288.3:c.875T>A	NP_000279.1:p.Leu292*		22819	CM971147	rs1805137	"Rhizomelic chondrodysplasia punctata, type I"	875T>A	NFE	0.000654309	PEX7	5191
VSQ4WCLXZQ	chr7	66082933	66082934	C	T	NC_000007.14:g.66082934C>T	NM_000048.3:c.346C>T	NP_000039.2:p.Gln116*		34106	CM022314	rs367543006	Argininosuccinic aciduria	346C>T			ASL	435
VS20160208	chr7	66089692	66089693	C	T	NC_000007.14:g.66089693C>T	NM_000048.3:c.1060C>T	NP_000039.2:p.Gln354*		34105	CM055096	rs367543005	Argininosuccinic aciduria	c.1060C>T			ASL	435
VSR485FCEW	chr7	66092565	66092566	C	T	NC_000007.14:g.66092566C>T	NM_000048.3:c.1153C>T	NP_000039.2:p.Arg385Cys		17440	CM022198	rs28940286	Argininosuccinic aciduria	1153C>T	ASJ	0.000712541	ASL	435
TP2016016	chr7	66994209	66994210	A	G	NC_000007.14:g.66994210A>G	NM_016038.2:c.258+2T>C			18235	CS030125	rs113993993	Shwachman-Diamond syndrome	258+2T>C	FIN	0.00979071	SBDS	51119
VSM5UM2BQR	chr7	93101614	93101615	T	C	NC_000007.14:g.93101615T>C	NM_017654.3:c.4483A>G	NP_060124.2:p.Lys1495Glu		16268	CM064252	rs121918554	"Tumoral calcinosis, normophosphatemic"	4483A>G			SAMD9	54809
VS8LS3PJKM	chr7	93105067	93105068	G	A	NC_000007.14:g.93105068G>A	NM_017654.3:c.1030C>T	NP_060124.2:p.Arg344*			CM083089	rs543007243	"Tumoral calcinosis, normophosphatemic"	1030C>T	SAS	9.75E-05	SAMD9	54809
VSHKUT54EL	chr7	93105137	93105138	A	G	NC_000007.14:g.93105138A>G	NM_017654.3:c.960T>C	NP_060124.2:p.Tyr320Tyr				rs6965201	fingerprint variant		AFR	0.774321973	SAMD9	54809
VS7ZKY3R43	chr7	100626829	100626830	T	G	NC_000007.14:g.100626830T>G	NM_003227.3:c.2069A>C	NP_003218.2:p.Gln690Pro		20423	CM024599	rs80338889	"Hereditary hemochromatosis, TFR2-related"	2069A>C			TFR2	7036
VSMDXLXS6Q	chr7	100633099	100633100	G	C	NC_000007.14:g.100633100G>C	NM_003227.3:c.750C>G	NP_003218.2:p.Tyr250*		20419	CM000834	rs80338880	"Hereditary hemochromatosis, TFR2-related"	750C>G			TFR2	7036
VSGBVRPRZY	chr7	100633514	100633515	A	T	NC_000007.14:g.100633515A>T	NM_001206855.1:c.2T>A	NP_001193784.1:p.Met1?		20421	CM011819	rs80338879	"Hereditary hemochromatosis, TFR2-related"	515T>A	NFE	1.88E-05	TFR2	7036
VSBDXZLBYC	chr7	101157374	101157375	A	G	NC_000007.14:g.101157375A>G	NM_001283.3:c.183-2A>G			48453	CS088076	rs751430853	MEDNIK syndrome	183-2A>G	NFE	4.08E-05	AP1S1	1174
VSXMJ3BP9W	chr7	107683452	107683453	A	G	NC_000007.14:g.107683453A>G	NM_000441.1:c.919-2A>G			19879	CS991479	rs111033313	Pendred syndrome	919-2A>G	EAS	0.00446636	SLC26A4	5172
VSXE25VW5U	chr7	107683537	107683538	G	A	NC_000007.14:g.107683538G>A	NM_000441.1:c.1001+1G>A			19858	CS982315	rs80338849	Pendred syndrome	1001+1G>A	NFE	0.000388276	SLC26A4	5172
VSZQ216DXD	chr7	107690124	107690125	A	G	NC_000007.14:g.107690125A>G	NM_000441.1:c.1151A>G	NP_000432.1:p.Glu384Gly		19859	CM981502	rs111033244	Pendred syndrome	1151A>G	NFE	0.000224513	SLC26A4	5172
VSVGUP32QJ	chr7	107690219	107690220	A	C	NC_000007.14:g.107690220A>C	NM_000441.1:c.1246A>C	NP_000432.1:p.Thr416Pro		19857	CM981505	rs28939086	Pendred syndrome	1246A>C	NFE	0.000405055	SLC26A4	5172
VS62YIMSP9	chr7	107696034	107696035	C	A	NC_000007.14:g.107696035C>A	NM_000441.1:c.1540C>A	NP_000432.1:p.Gln514Lys		19880	CM083155	rs121908366	Pendred syndrome	1540C>A			SLC26A4	5172
VS78VYTBV8	chr7	107710131	107710132	A	G	NC_000007.14:g.107710132A>G	NM_000441.1:c.2168A>G	NP_000432.1:p.His723Arg		19864	CM981513	rs121908362	Pendred syndrome	2168A>G	EAS	0.00168155	SLC26A4	5172
VS2A2D40DC	chr7	107893262	107893263	T	TA	NC_000007.14:g.107893264dupA	NM_000108.4:c.104dupA	NP_000099.2:p.Tyr35fs		357557	CI962265	rs1057516213	Dihydrolipoamide dehydrogenase deficiency	p.Y35X	AMR	3.01E-05	DLD	1738
VSFA3BD200	chr7	107915505	107915506	G	T	NC_000007.14:g.107915506G>T	NM_000108.4:c.685G>T	NP_000099.2:p.Gly229Cys		27005	CM990485	rs121964990	Dihydrolipoamide dehydrogenase deficiency	p.G229C	ASJ	0.00559057	DLD	1738
VS3A29724A	chr7	117480094	117480095	A	G	NC_000007.14:g.117480095A>G	NM_000492.3:c.1A>G	NP_000483.3:p.Met1?		68091	CM930094	rs397508328	Cystic Fibrosis	M1V	NFE	4.48E-05	CFTR	1080
VSD4040B9A	chr7	117480094	117480095	A	C	NC_000007.14:g.117480095A>C	NM_000492.3:c.1A>C	NP_000483.3:p.Met1?					Cystic Fibrosis	M1L			CFTR	1080
VS072017F0	chr7	117480095	117480096	T	C	NC_000007.14:g.117480096T>C	NM_000492.3:c.2T>C	NP_000483.3:p.Met1?		68290	CM994781	rs397508476	Cystic Fibrosis	M1T	SAS	6.50E-05	CFTR	1080
VS55FD538C	chr7	117480095	117480096	T	A	NC_000007.14:g.117480096T>A	NM_000492.3:c.2T>A	NP_000483.3:p.Met1?		68289	CM930093	rs397508476	Cystic Fibrosis	M1K			CFTR	1080
VSFQ1PBFX2	chr7	117480097	117480098	C	T	NC_000007.14:g.117480098C>T	NM_000492.3:c.4C>T	NP_000483.3:p.Gln2*		68647	CM940232	rs397508740	Cystic Fibrosis	Q2X	EAS	5.80E-05	CFTR	1080
VSUNEE3Y78	chr7	117480104	117480105	C	A	NC_000007.14:g.117480105C>A	NM_000492.3:c.11C>A	NP_000483.3:p.Ser4*		67879	CM930095	rs397508173	Cystic Fibrosis	S4X			CFTR	1080
VSDV5T83XL	chr7	117480112	117480113	G	T	NC_000007.14:g.117480113G>T	NM_000492.3:c.19G>T	NP_000483.3:p.Glu7*		22274	CM031655	rs121909045	Cystic Fibrosis	E7X			CFTR	1080
VS6PI5T6UK	chr7	117480133	117480134	A	T	NC_000007.14:g.117480134A>T	NM_000492.3:c.40A>T	NP_000483.3:p.Lys14*			CM931138	rs397508673	Cystic Fibrosis	K14X			CFTR	1080
VCE6E04FAC	chr7	117498307	117519388	TCTTTAGCGAGCATATACTCCCTAAAGTTGATTAAGCTGACCAAGTGATTACTGCTTATAAATTCACCATTTTATGGAGAAGAAGCAAACACTGCTAAATACCTTGTGGAATCAGAGGAGGGGAAATTAGTAACTTGACCCCAATACTGCGATTTTAAATTGAATTCTTGAAGCCTACAAGTTTTACACAGGACTTTAGAGAGCTGGATAGTATCACTTTGTCAAGTCCTACTTTTACTATGATTCTTTGAGAAAAATACATCTGACTAAATAACTCTGAATCTAAATTGGATAAAATAAATGTGACATTCAAAATGTTATTTATGATTTTAGAAAAATATCCTTATAGACACTAGATGAGTTTTAGTCTCAAATCAATCCTCCCTATCATAGTCACTTATCAAAATAACTAAAGCAAAGTGGTAGAGCTGTGCTCTAGAAGTTTGGGATTTATGATCACAATCTTTTCCAATGAGTCCCCTCTTTCCTCTGCCTGTCTTCAACATTTGTTTTTTTTTTTTTTTGGTTAGGACTATCCAGATTGTGTGGCCTATTTCAAACTCATGGCAAATACATTGGATGATCAGAAATTTTCTAATGTATTTGAATTTGTCTACACAAACTAGAGTAATTGCTATTAATTCCTCAAGTGTTAATTATTTCATGCAAAAAGGAAAAAGGCTATTAGTCTTTAAGTGTATTAGTATGTCAATATTTGGGAGAAGTGTCATGCAATTAGTGGTTTGAATTTCCTATTTTATTTTATTGCATTTTATTTTATTTGCCTAGTCAAATAAAAAGTAATGTTAAATACATGGAAGCATGATTGTTTTCTACACTAAAAATCATTTTGACTTGAAAAGATCTGATATCCATGACCTTCATCTGAAGTTTTGGCAGATGAAAATGTCAGATGCGTCTTTTGGATTAATAAAAGGCAAAAGTCAGATCGAAAAATGAGTATAAGCTTTAATTATATGACTTTAGGAGGATATGTTATGAAAATCAAAGCTTTAATAGTGATTATAATTGGCAAGTTCTTTTTTTATAAGGAATTACAAGTCACTCTATACAAAAATTGGAATTTTTGTCCTAAGAAATGAAATTTACTATAGTTTCATCTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTTTAAAAAATCAAGTGATAGGGCTTTTCCTCAATAAAATCTGAAATCTCTTATAGTTAAGTGAACAGAACAGTGTATCTAGGATGCTAGACTTTTTTTTCAAAGTTAGTTTAAAACTTATACATAGTAAAATCTGTATGCCTTAGGGATCTCTGTTTGCTATCCCATAGTGAATGATTAATTAGTTTCTGTTAGAAATAGTCAGAACTAGGCTGGGTGTGGTGGTGGCTCATGCCTGTAATTCCAGGACTTTGGGAGGCCAAGGCAGGAGGATCTCTTAAGCCCAGGAATTTGCAACCAGCTTGGGCAGGCTGGTGAGATCCTATCTCTACAAAAACAAACAAACAAACAAAGGACAATAAGAAAGAAAGAAATAGCCAGAGCTTTGAACAAAATTTCTAAGTAGACCAATGTAAAAGTCTGTCGTCAATATGTAGTGGCTATGAATGGAGGTTATGAATGAAAGAGAAGGATAAGATGAACTAGAGGTGAGAGGGGAAGACAGCAGGCCCAAGTGAAAGGCAGAGCCGAGTTTATTGCTTTTTGGTTATTCCAGGTGTGTCTGCTTTGTCTCATGAAACACCTGGATGATCACTGATTTCTAGTGGAAGAAATGCTGAAAAGTCCTTACTGTGCATTTAAACATTCTAGGTTTAATATACTCAGGGTTTTTCAAAAGAAAGGGTGGCTGGAGTTTTGCACTAACTAATATTTCATAAAGTGTCTAAGTATAGATGTCTGGTTTTTTTTTGTATTTCTAAGACTGGCTTGAGGTAGGCATGGAGAATTCTTTGATGGGACATAATTTTCTTCCTTTCTTTTTTTTTTTTTTTTTTTTTTTTTGAGACGGAGTTTTGCTCTTGTTGCCCAGGCTGGAGTGCAATGGCACAATCTCGGCTCACTGCAACCTCCGCCTCCCAGGTTCAAGCAATTCTCCCACCTCAGCCTCCCGCGTAGCTGGGATTACAGGCATGTGCCCCCATGCCTGGCTAATTTTTTTTGTATTTTTAGTAGAGATGGGGTTTCTCCATGTTGGTCAGGCTGGTCTCGAACTCCTTACCTCAGGTGATCCACCCACCTCGGCCTCCCAAAGTGCTGGGATTACAGGCGTGAGCCACCGCGCCTGGCCTGATGGGACATATTTTTCATTCAATTTTATTGATTTAACCTCACAAAATAAAATATTTCCTTAAGATGACTCTGTGGTCATTGTTGGGCAGCATAAGCTTAATGGATTTTAGTTATCATAATTTACCTTAAACCCAATTTGTATTTCAGGATATAAATAGAGGTTTATTGTAGTGAATCTTCCAGGAAATACTAAGTGATACTAATAATTATAGATGGTGAACTTAAGTCTTTATATTACTGAATTTGTTTGGTTTGATGATGCTAGGCTATGGCATTCTTGCTAATCAAAACGATGTGTCATGGTGTAACATAACTTATTAAAATGGGCACAGATAACACAGGAAGCTTTTTATAAAAGCAGCTCACAAATTGTGTTACTTTGAACTGAACTGGCCATTTATGGGAAAGGTCACTGGGTTGTAAATAAGGACCAAAAGAGTTACGTTTATATTTTTTAAAAGAGATTGAGGAGATTTATTTTTACATTTCTTGAAAATGCCTTATTTTGGTATGGTATTGACAGATAGTGAAATTCTGCTCATTTGTAAATATAGTGTCATATTTTAATAATTTCAAACATATTGAAAATGCAGAATTTATTAATAGTGGGAGCACATTTTCCTTTTTACTAAATGTTCTACAGGTTCTTTTCTTTCCATCCACACACAGTGCCATTACCCTCATTCTAAGCCTTTCAAACATCTGGCAGTAAGTGATCTGCTGCACTTAGCTCTTTCCAGCTGAGCTGATTTTTAAATTTTCAGAAAATTTGTGAGCTAATTGTTAAACATGGCCATTATTAAAAATTAAATTATTTCAACTTATAATTAAATAAATTATATTAAAACAAAAGTATTAAAAACTCAAAAGTTGGCTGGGCGCACTGGCTCACGTCTGTAATCCCAGCACTTTGGGAGACCGAGGCAGGTGGATTGCCTGAAGTCAGGGGTTCGAGACCAACCTGACCAACATGGAGAAACCCTGTCTCTACTAAAAATATAAAAAAATAGCCGGGCATGGTGGTGCATGCCTGTAATCCCAGCTACTCAGGAGGCTGAGGCAGGAGAATTGCTTGAACCCAGGAGGTGGAGGTTGTGGTGAGCTGAGATTGCGCCATTGCGCTCCAGCCTGGGCAACAAGAGTGAAACTCTGTCTCAAAAAAAAAAAAAAAAAAAAAAAAGAAACAAAAAAAAAAAAAAAACAAAAAGCAAACAAACAAAAAAACAAAAATTATCACTTCCTAATTATTTTGCATTTTACTATTATCTATGCTATTAACGTTATTTGCCTTCATTGTATTTGAAAGGTGGACTATATTCTATTGCACTTTCATTGTACTATATTCTAATATGCAACTGTGTATCCCTTCCCAACTCTGTGTTCAATGACTTTATATTTGGTTGCTTTAAAATGATGACGATGAGAGTATTTATATCATAGAAATTGGCAAATGCCGTAAGTCAGTTTTTGTTTTTGTTTTTGTTTTCCGGAGAGGGGATTGTTAAATATTTGCCTGCATGCAACACCACTACATGCAGTCTGCTATCTTTTGTTCTTCCTGCTTTCAGGCTCCTCTCCCAGCTGTCTGTCTAGCACAACCCAGCATACCAAATTTTCTTAAATAGGGAAAGTTGAACATGGTAAAAGAATGAATGAAGTCAAAAGAATGTGGAAAGACCTAGGCTTTGCCATTTAGTAAAGTTTAGCATCTCTAAGCCTCCATCTCTTTATCAATAAAATTGAGCAATGATCCCTTTTAGTTCTACCCATTTAAGAAGATTTTCAAATGAAAACCACAACCTGCTCATGTTTATGAAGGCACTTTGGAAAGCGCTAAATACACGGGTTTTTATTAGTAGTAAACACTTACTTCACCTTTTTCACTTCTTGACTTTAGTTTACAAGGGCTCATAATCTAAATTATATCATAAATTGCTGTCCCAGATTTTTTTACAGCCTAATTGCCACCTGTATGTTCGACTTTCCTTCTGTTCTTTATGTTAGATACTGGGATAGTATGCACCAGGTGGGTGTGCCATCACTTTCTCAGATGATGTCCACTGAAGACCTTGCATGATCATGGCATTCATTTTCCTGCTGTATTCAGACTGGCCTCAACTATTTTCTTTATTGCTCTCCAGGAAAAATTACAAATGAATCAGACTGGGCAATGAAGGGTAAACCTAATTATCGCTCTTTGTTAAAGACAGCTCTTGTTAAAATGCGGATATTGCAAATTAATGGAAAAAATATGACATAGTAAACCATACTCACTTATTAATATCTTAGTAAGGAATAATTGATGAAGTTACTTAACCTTAGAGCCCTAATTCAGTTAAGTTTTAATGAAGGACAAGTTGTAGAGATATCGAGAACCCAGGGCAGGTGCCTACTGAAGAAGTTCCAGACCAAGGAAGTATAAAGAAGGACCTGGGTGGGAGCAGTGAGATTGGATATGAGGGCCACTGGCAAAGTTTTGCCCCAGAACAGTGTCAAAATGTTTGCATTTGGCATAGCCCTTTCTCTTTTTGTTCTGAATGGCTTTGCTAGAATATCTTTTCTATAATGAATTTATCCTGCTTCTCAGATATTGCTAAAGCACTCCCTTTTGAATTTTGGTGCTTTAACATGCATTTTGATACATTACCAAATAAGGTCTGAATGACACAAATTTTAGAACTCTCCAGAGAAAAGAAAGATGCTGAGGGAAAAAGCATAGGTTTGGGACTCACTAAATCCCAGTTCAATTCCTTTCTTTAATAAATATATTCAATTTTACCTGAGAAAGCTCTCGTGCTCTCGAATTTTATTTAGAAATTTCTCTTTGTACATGATTGATTTCACAATCCTTCTTCTGCCTCCTCTTCTACTTTCTTCTTTCTAGATTTTCCTATCTTTATGAAGATTATTCTGCCTTATCCTCAACAGTTAGAAACAATATTTTTGAAAATCACTACGGTATCCTGCATAGTGATTTCCCATGCCAACTTTACTAATTTCCATTATAAATTATTATTTATTGATGCCTAGAGGGCAGATGAGTGTAGCTGCTATGGAGTGAGGAGACAAAACATAAGAAAGTTATGATCCTACCCTCAGGTAATGATTCAGACATGATAATTAAGTCAACAAATTGATAGAAACTAATCACTAACTCTCTGGCTATAGTCATTCTTTCAATGAATAGCTCATTACTGAGTATGCATGCTACAGTAACAAAATTATATAAGGCTGTTGATTAAATGTTGATTAAGTGCATGTCTTATTCAGAGTTTTTTTATATTTGAAATGGAAGAGGCTGGACTTCAGTAATTTGCTATAAACTGCTAGTATATGATTATTTGGGGGCAGTTATTTTTTAAAGAATAATTTAAATATGGAATGTTTAGCAGTTTGTTTTTTCCCTGGGAAAAACCATACTATTATTCCCTCCCAATCCCTTTGACAAAGTGACAGTCACATTAGTTCAGAGATATTGATGTTTTATACAGGTGTAGCCTGTAAGAGATGAAGCCTGGTATTTATAGAAATTGACTTATTTTATTCTCATATTTACATGTGCATAATTTTCCATATGCCAGAAAAGTTGAATAGTATCAGATTCCAAATCTGTATGGAGACCAAATCAAGTGAATATCTGTTCCTCCTCTCTTTATTTTAGCTGGACCAGACCAATTTTGAGGAAAGGATACAGACAGCGCCTGGAATTGTCAGACATATACCAAATCCCTTCTGTTGATTCTGCTGACAATCTATCTGAAAAATTGGAAAGGTATGTTCATGTACATTGTTTAGTTGAAGAGAGAAATTCATATTATTAATTATTTAGAGAAGAGAAAGCAAACATATTATAAGTTTAATTCTTATATTTAAAAATAGGAGCCAAGTATGGTGGCTAATGCCTGTAATCCCAACTATTTGGGAGGCCAAGATGAGAGGATTGCTTGAGACCAGGAGTTTGATACCAGCCTGGGCAACATAGCAAGATGTTATCTCTACACAAAATAAAAAAGTTAGCTGGGAATGGTAGTGCATGCTTGTATTCCCAGCTACTCAGGAGGCTGAAGCAGGAGGGTTACTTGAGCCCAGGAGTTTGAGGTTGCAGTGAGCTATGATTGTGCCACTGCACTCCAGCTTGGGTGACACAGCAAAACCCTCTCTCTCTAAAAAAAAAAAAAAAAAGGAACATCTCATTTTCACACTGAAATGTTGACTGAAATCATTAAACAATAAAATCATAAAAGAAAAATAATCAGTTTCCTAAGAAATGATTTTTTTTCCTGAAAAATACACATTTGGTTTCAGAGAATTTGTCTTATTAGAGACCATGAGATGGATTTTGTGAAAACTAAAGTAACACCATTATGAAGTAAATCGTGTATATTTGCTTTCAAAACCTTTATATTTGAATACAAATGTACTCCCTGGGAAGTCTTAAGGTAATGGCTACTGGTTATCAAACAAATGTAAAAATTGTATATTTTTGAGTACCTGTTACATGCCAGGTAGAATATCTCCTCTCAGCCACTCTGAGTGGAAAGCATCATTATCTCTATTTTACAGAAAAGCAAACTGAGGCTCAGAGAGATAATATACTTTGCCAGTTAATGAATGATGGAGCCATGATTCCAGCTGAGGTCTGTATTGCCTTGCTCTCTAGGAATGGTAGTCCCCCCCATAAAGAATCTCTCAGTTTCCTTTCCAATCAAAAGGTTAGGATCCTTTTGATTGCCAGTGACAGAAACCCAATTTACTAGCTTAAGTAAATAAAAGGAACGAATTTATTGGCTCATGAAGCCTGAACTATGTGAAGACCTAGGTGGAGAACTGGCCTTAGGAACTCAATGGGACCAAGGACTCAAATGCCACCTGGTGGCATTTGCCTTATGCTGGTTTTATTTTCTCAGACCGGACCAGCTTTCTACATAAAGTGGGTCCCTGGTTAGAACTCTTTGCTCCTATCTTTAAGGACCACGAAAGAAGGAGCCCTTTGTCCTTGGCTAAATGTGAAAAATCCCAGAGACTCTTGAGTCATAGTGCTTACCCCTTGGGCCACTCATAGTCTAGAATGAACTAGGCTGAGTCTCGTGCCAACAGCACAGGCCTGATGCCAGATAAAAGGGTGAGTGAAGGGGGATAAAAAATAAGACATAGCTACTAAATTATTGCACCAAAGTAAAAACATTGAGTTGACTTGCAATTTGTTTCTTTTAATTAAATTCATTTCCTTTTTTTGGCATTTTGAAGGCAAAGTAAGATATTAAACTTTATTTTTATTGATTTTATTCAAAGAATTAAGCTAGTGGGAGTAGCAGATTCACACTTCTAAGATCAAGGGCCAGCTTCTATTATTGAACACTTGGTGTGTGCAAATGCCATGAGGTAGGGATACTTTGTTTTGTTTTTTATTTTTTATTGGGTTCGATCTCTTTTGTTTATGATGTATCCCCAAGTGCCTAGAATAGGGCCTGGCATATGGTATATACTCAATAAATATTTGTTGAATGAATCCATGATGGAATGTGAAATGGCTAGCATTACATAGAAACCTGTAGCATTGCTGGAGAGATAAAATATATAAACATAATCCATTGCAGGTATATTGACAAGTTCAAAATAATATAATGGGTATTGAATATCTAAATGTTTGTTGTTGTTGTTGCTGTTGTTTTTGAGACAGAGTCTTGCTCTGTTGCCCAGGCTGGAGTGTAATGGTGCAATTTTGGCTCACTGCAAACTTCGTCTCCTGGGTTCAAGTGATTCTCCTGCCTCAGCCTCTCGAGTAGCTGGGTTTACAGGCACTCGCCACAATGCCTGGCTAATTTTTGTATTTTAGTAGATGTGGAGTTTCGCCATGTTGGCCAGGCTGGTCTTGAACTCCTGACCTCAAGTGATCTGCCCACCTTGGCCTCCCAAAATGCTGGGATTATAGGTGTGAGCCACTATGCCCAGCTTTGAATATCTAAGTTTTAATTGGATGCTGAGGGAATGATTAATCAGAGTAGGGCTGGGTTAATTGAAAAATGTGATACATTTGTATTTATGGCCAGATAGAGAACATGAATCTGAATTTGCAGAATTATCTGGCTTAACATTTTTTTCTTTCCAGTTTTCACTGTATCCCCCATGTTGATTCAATTTAAAAAATATACCTATTTTACTTCAATTCAACAATGCTATGCCAGTACAAACCCATACGTTCTATTATTTTTGTTTTGTTTTGTTTTTGTATCTCCACCCTGTTACTTCTTTTCTTATAAAATTGGTATTTGAAATTTATTGAAATATTTTGGAAGAGTGACATACCATTTTTGGTACTTTGTACCTCTGCACCCTTGGGAAGTGACCCTGGCTTCACATTTCATAACTGCCTTGTGACCATGGCCCTCAAGTGGTTGCCAGATGGTTGAAGAACATTAACCTATCTGGCTCAATTTTGTGACCATGGATTGAATCCTCTACATAACTGCAGTGTGCAAACCACACATCCGTTCCAAGATTGTAGTCAGGATATGAACTTTTTAAGAATAAAACTTCTTCCCTTCTGATCTGGGCCTGGTATGTGGTCCTACTAGAACCACATCACCTACTCTTGGTGCTAACAATTTGTGGCACCAAGTTGTTCAAGTTTCACCCATTAAAGAAATTCCCCGACCTTGCCTTCTCCTCAGGTAACTACCCCATTCTATTTTTTCTTTCATAGCTAACATTCTCTGCTCTCCTGGTCTCTCTACTTCACTTTCATTTACATCTCAGCTCCTGAAGTATGGTTTCCACCATGTTCCTAAAACTACATTGCCCAGGGTCACTAGAGACCTCTTATGAAATATAACAACACCTTTCTACATTACTTCCGTGTGGACCACTTTTTCACATTGAACCCATTTTGTTGGTTTATGTACACACCCCTTCCTTGGCTTTCCCATCTGATCCATTTCTCCTTTGATGGAGAAGGTGAGTCTGCTCCATATTTAGCTTCTTACTCTGAGTAACCAAATGTTATGGATGGGAGGTTAGCTCTGTGTGTGAGAGAAAGGTGGAGAAGCATGTGGGGAGGGAAATAGATGGGAAAAGGTAATTAGGCTTTATAGAAGGGCTCTCATTAGCAAGCTTCTAGGGGATGCCAAGATCCATGCTTAGAGATTGCCAGGCTTGTCTTCAAATCTCAGCTGTGTATTACTCCTTTATGTTTTTTGTTTGTTTGTGTTGTTTGTTTTTGAGACAGAGTCTCGCTGTGTCACCCAGGCTGGAGTGTAGTGGTGTGATCTCAGCTCACTGCAAACTCTGCCTCCTGGGTTCAAGCGAATCTCAGTCTCCTGAGTAGCTGGGACTACAGGCATGCACCACCAGGCCTGGCTAATTTTTGTAGAGACGGGGTTTTGCTATGCTGGCCAGGCTGGTCTTGAACTCCTGACCTCAAGTGATCTGCCCGCCTTGGCCTCCCAAAGTGTTGGGATTAGTGGCGTGAGCCACTGCCCCGGCCTATTACTCCTTTAGAGTGATTTAGAGCCATGTTTACTTATGGTAACTTGACAGTAATGGGAATAACCACTGATGAAACGTAAAGCCTTTGTCTAATTGTTTACCTAGTTCTTCCTTGTGGTTCATGAAATTTTTCATCTCTGTACAGTTTGAAAATTAAGATGATAATATTTAGAGATATTTTATTCCTTTGTGAAGAGAAAAAAGGCTTTCATTAACAGAAATCAGTGGCAATAACTTAATAAATACAATCAGCTGGTGTTCCTATAGTATTTAAAAGAAAACAGAAAGTTTACTAGATTTCAGCCAGTTTTCAGACTATTTAATGTCTATTCTTACTATAATAGAAAATATATAATTTGATCTTGTTCTCATTTTTCAAAGACCTTTAATACATGATTTTAGTAGTTGAAAATGAAGTTTAATGATAGTTTATGCCTCTACTTTTAAAAACAAAGTCTAACAGATTTTTCTCATGTTAAATCACAGAAAAAGCCACCTGACATTTTAACTTGTTTTTGATTTGACAGTGAAATCTTATAAATCTGCCACAGTTCTAAACCAATAAAGATCAAGGTATAAGGGAAAAATGTAGAATGTTTGTGTGTTTATTTTTTCCACCTTGTTCTAAGCACAGCAATGAGCATTCGTAAAAGCCTTACTTTATTTGTCCACCCTTTTCATTGTTTTTTAGAAGCCCAACACTTTTCTTTAACACATACAATGTGGCCTTTTCATGAAATCAATTCCCTGCACAGTGATATATGGCAGAGCATTGAATTCTGCCAAATATCTGGCTGAGTGTTTGGTGTTGTATGGTCTCCATGAGATTTTGTCTCTATAATACTTGGGTTAATCTCCTTGGATATACTTGTGTGAATCAAACTATGTTAAGGGAAATAGGACAACTAAAATATTTGCACATGCAACTTATTGGTCCCACTTTTTATTCTTTTGCAGAGAATGGGATAGAGAGCTGGCTTCAAAGAAAAATCCTAAACTCATTAATGCCCTTCGGCGATGTTTTTTCTGGAGATTTATGTTCTATGGAATCTTTTTATATTTAGGGGTAAGGATCTCATTTGTACATTCATTATGTATCACATAACTATATTCATTTTTGTGATTATGAAAAGACTACGAAATCTGGTGAATAGGTGTAAAAATATAAAGGATGAATCCAACTCCAAACACTAAGAAACCACCTAAAACTCTAGTAAGGATAAGTAAAAATCCTTTGGAACTAAAATGTCCTGGAACACGGGTGGCAATTTACAATCTCAATGGGCTCAGCAAAATAAATTGCTTGCTTAAAAAATTATTTTCTGTTATGATTCCAAATCACATTATCTTACTAGTACATGAGATTACTGGTGCCTTTATTTTGCTGTATTCAACAGGAGAGTGTCAGGAGACAATGTCAGCAGAATTAGGTCAAATGCAGCTAATTACATATATGAATGTTTGTAATATTTTGAAATCATATCTGCATGGTGAATTGTTTCAAAGAAAAACACTAAAAATTTAAAGTATAGCAGCTTTAAATACTAAATAAATAATACTAAAAATTTAAAGTTCTCTTGCAATATATTTTCTTAATATCTTACATCTCATCAGTGTGAAAAGTTGCACACCTGAAAATCCAGGCTTTGTGGTGTTTAAGTGCCTTGTATGTTCCCCAGTTGCTGTCCAATGTGACTCTGATTTATTATTTTCTACATCATGAAAGCATTATTTGAATCCTTGGTTGTAACCTATAAAAGGAGACAGATTCAAGACTTGTTTAATCTTCTTGTTAAAGCTGTGCACAATATTTGCTTTGGGGCGTTTACTTATCATATGGATTGACTTGTGTTTATATTGGTCTTTATGCCTCAGGGAGTTAAACAGTGTCTCCCAGAGAAATGCCATTTGTGTTACATTGCTTGAAAAATTTCAGTTCATACACCCCCATGAAAAATACATTTAAAACTTATCTTAACAAAGATGAGTACACTTAGGCCCAGAATGTTCTCTAATGCTCTTGATAATTTCCTAGAAGAAATTTTTCTGACTTTTGAAATAATAGATCCATAATATATATTCTTATGGAAATCTGAAACCATTTGGGCATTTGGGGGTAAAAAGTATTTTATTAGTAAATTTAAATGAGGTAGCTGGATAATTAAATTACTTTTAAGTTACCTTTGAGATGATTTTTCTCAATCAGAGCACCACCCAGAGCTTTGAGAAACAATTTTATTCACAGCTTCTGATTCTATTTGATGTAATTTTTAGAAAATAAGTTTTGCTGGTTGCTTTGAATCAGGGTATGGAGTACAGTTCACTCTGATCCTATCATATAAATCATGTAAGTATATAACATTTTCAATAAGTGATTGTTGGATTGAAGTGAATGATATTTCAAGTAATTGTTATGTCATGGCCAAGATTTCAGTGAAACTCAAAATTTCTCCTGGTTGTGTTCTCCATTGCATGCTGCTTCTATTGATTAACCTAAGCACTACTGAGTAGAAGCTGGAAGAGGGGTCTAATTAGAAGGCCCCTTTCTATGCTCTGCTTGGCTTGTAAAATAATTTATTTCTCTAGATCCCACCAACATAGTAGTTTCATGTATGCAAAAACACCCACCTAAATGTCAAAGTTTGTATGATACATGGACATATCTATAGAATTTTTTTTGGTCTGGTGCATGCCAAAAAATAAACATGATATAGAAGAATTTAATATTTATTGAGTACCTAATCTGTTCCAGTTCAATATGAAGGTCTTTATGCAGATTATTTTACTTAATTTTCCTAGTAACTCCATGGAGCAAAAATTATCTCTAATTTATATAACAGGAAGTTGAGCGTGAGGCAAATTAAGTAACTTTCCCAAAGTTACACATATGGTAAGTTTGAGAGATATCCCAGTCTCTTTAGCTCCAAAGCCTTTGACCCTTTCACCATACCAGATTATGATTGCTATTAATATATAATTATAATTATAATGATTGTATTTAGGTACTCAACAGAATGGTGACTCTAGTAACCAGCCTTGGTTCTGCTGAGCTTCTCTGCGTCTTCTCAGGAGACACAGGCTACAGAGCTTGAAGGCTGAGGATTCTTCCAGGGTCACTTCAGGGGCAAATCTGAAACTTTCTTCAGGACAGGAATCAACGAGATCTTCTCACTTACTTATACCTGGGGGAGGAACTGTATGAAATCCACCCAAGAACCAGTCATGCTAAGGGCCAAACCTATAGACAAAAAAAGGGATAGGAGAATGGAGTATGTATGGAGAAAGACTAAATTGTTCTTAAACTTCTCAAGCTTAAAAATATCCCAGCAAAAGAGATCGTAAAAGCCCTTCATGGCGTATTAATTATCCATGCATGGGGGTGAGTGGAAAGGTACTCCTGAGCCCGAGGCTACAGCTTTGGAACTAGCAGCACCTTTGAAGGGGAAAGCGTGTTTCCATCATCTCAACTCCTACTGATAACCAATGGAATATTGGTGAGTAAAGGATCCTGGGGGAAGAAGCAGCTGAAATGTGTAGGTGAGAAGGCAGAGAGAAGAATATTTATATTGGGAATGGCACAAGTGTGATGAGGCTGCAGGTTTTTCACCCTTGTCATAGAGAAAAAACCACGCTGACACCATGCAGTTTTAAATAGTGAGAAATTTGCAAATTGTTAGATCTTAAATAATTTAGATAAACATAGTGGCCATTTAGATTATTGCAGTTTTTTCAGGATATCTGATCTCTTGATTTCATTCTTTTTGTCTCTTATAAGAATAAAAGGGGGGGAGAAAATTTAGCCATTATAGTATTTCTCTACATTTTCTCTGTCCTTTTACATAACTTACACCAGTGCCTTCCTATTTATGGTATTATTTATGGGTATTTCTTCTTTTCTTTCACTGAGCAAGGATAAATGAGCCAGGGATTCTTGAAACTACTGTAACACTTCTCTTAGAAATAGATGGTCATACTTTCAGAATCTCTACACATTCTTAGTCCCTCTAAACAATGATAGTTGTGGCATAAAAATATTTGCTTGGTTTCAGGACTGATAGAGAAAAGTACTATAAAATTTGCTGTTAACTGTGAAAGGTTAAAAAAAAGGAGGTGCCATCATGAAGGAGCTAATCTTTCTGAAGTACTGCTGTAGTTTTAAATATTATTAGCTATGACTTCTCACCATTAACTATGCACTTGCTTTTTCTTCATCTGACTCAGCAGCCAGATAGATGCAACATTGTCTTTAACATTTAAGACTCCTAGCAAGTCCGGGCACGGGGGCTCACACCTGTAATCCCAGCACTTTGGGAGGCCGAGGTGGGCAAATCACAAGGTCAGGAGTTTGAGACCAGCCTGGCCAATATGGTGAAACCCTGTCTCTACTAAAAGTACAAAAATCAGCCAGGTGTGGTGGCGTGGTGGCGGGCACCTGTGGTCCCAGCTACTTGGGAGGCTGAGGCAGGAGAATAGCTTGAACCTGGGAGGCAGAGGTTGCAGTGAGCTGAGATCGCACCACTGCACTCCAGCCTGGGTGACAGAGCGAGACTCCATCTCAAAAAAAAAAAAAAAAAAAAAGACTCCTAGCATGGAAGAGAAACTGGCTGTTGAAAACCTGAATGTGAGAGTCAGTCAAGGATAGTTTGAGGGAAGCCAAGTAGAGGAAGCTCTCACAAGCAGATTGGTGAGAGAATATGATTATACAATGCATTTATTATGATAAGAAATTCACAAGCATTCATTCAAAATACTCTTGATTCCTAGGCAGCTCTGGGCATATTTCCACCAACAAATTGAGGCATATGTCAGTGCAGCCTAGGTCAGACTACCTTTTTTCATTAAACCTCACAAAATTAAAGGACATACAGGAGAAGTCCTGGTACTCATGTTGCAGACTACAGTCTATATGGCAAAGGAGGATCTCTGTCCCTTATGTTTGGATGAAAACATTGGGTAGGCATTTGAATACAAGCCTACTGCTAATATGGGGCTAAGGTCTTTGGCCCCCTAAAGGTTTGCTGAAATATTACTGACAGGAGGCAGATTGATAAGAGGAAAAGCACATAAATGTATTTGACATGTATACATGGGAGCCTTCAGGATGAAGACCTACCCTCTCAGTGCAGTATGGAAGCTTGTATACCATCTTGAGGTTACAGAAAGAATGGGGGTTTGGATCTTTGTAAAACAGGTTTCAGTGGCAAGACAGGTTATGAGAAGGAGAAAGGAAGAGACTTGGGTAGCAAAGGGGGTCTTGTTTTGTAGGTAAATCGTTGGCAGCCCACAGAGAAAATAGATGGAGAATGTTTCTTTTCAGACCTTGGCAGGTGTCAGATTCTCAGTTAATCTCTCCTAGATTTGAAAAAAAAAAAAAAGGTCTAGAAAGGGAGAGCCTGGCTGCACTAACACATTTTCTACAGATGCAAATTTCTCCCACAAAATACAGCTTTGCAGGTCCACTTCTATCTGCTGGGCCTGTGGCAACCATTTCAAAATATGTGAATGAAATATATGTGGGGGTAAACTATTTTTATTTACTTCCCTAAAGAAGGGATGGTGTTCTCTCGGGAATTCTGTGCATAGAGAGCCTGTGGCTTAGGCACTTTGATTTATGTATATCTCTTCCTGTGATTGGCTATCTAGGGACTGCTATCTCCAGCAAATCTTCTAAATGTCTGCCATGTAGAATTCCTTTCTCATCTTTCTGTCTCACCCCCTTATCTAGCTGCTTCTCTAACCCTAGAGTGACACTGCACTCCCCACAATCTCCTATGTCCTGAATATTTTACCCCATCCTAAACTCCATCTCTAACACAGATGCACTTTCTTGTGCTGCCTACTGCATTGTACATCTTCCCCTTAGTTCCCATGATGCAACTCTGCCCTACCCCAGAAAATGTAATTTAATTGGTCTGGGATAAAACCTGGGACACTATCATTCTTGAAATATTCCCCAAGCGATTCTAATTATATAGCCAAAGTTGAGAACTATTTGTAGACAGGCATCAGCATGATCACTTAATGATTTGACTTTTGCTAGATCTAAGGTGAGGAAATTGGAGAGTGGTATCCATAGGAAGAACTGTTTAGTTTAATTTTTTTTTTATTTTTTCTTCTAAAAAAAAATCCAACAACGAGATACATGTGCGGAACATGCAGGTTTGTTACATAGGTATAATGTGCCATGGTAGTTTGTTGCACCTATTGACCCATCCTCTAAGTTCCCTCCCCTACTCCTTACTTCCCAACAGGCCCTGGTGTATGTTGTTCCCCTCTCTGGGTCCACCTGTTCTCAATGTTCAACTCCCTTTTACGAGTGAGAACACATGGTGTTTGATTTTCTGTTCCTGTGTTAATTTGCTGAGGATGATAGTTTCCAGCTTCATCCACGTCCCTGCAAAGGACATGATCTCATTCCTTTTTATGGCTGCATAGTATTCCATGATGTATATGTACCACATTTTCTTTATCCAGTCTGTCATTGATGGGCATTTGGGTTGGTTCCATGTCTTTGCTATTGTAAATAGTTCTGCAGTAAACATATATGTCCATGTGTCTTTATAGTAGAATGATTTATATTACTTTGGGTATATACCCAGTAATGAGATTGCTGGGTCAAATGGCATTTCTGGTTCTAGATACTTGAGGAATCGCCACACTGTCTTCCACAATGGTTGAACTAATTTACACTCCCACTAACAGTGTAAAAGCGTTCCTATTTCTCCACAGCCTCACCAGCATCTATTGTTTCCTAACATTTTAATAACTGCTATTCTGACTGGCATGAGATGGTATCTCATTGTGGTTTTGATTTGCATTTATCTGATGATCAGTGATGCTGAGATTTTTAAAATATGTTTGTTGGCCATGTAAATGTCTTTTGTGAAGTGTCTGTTCATATCCTTTGCCCACCTTAATAGGGTTTTTTTTTTCTTGTGAATTTGTTTAAGTGCCTTGTAAATTCTGGAAATTAGATCTTTGTCAGATGGATAGATTGCAAAAATTTTCTCCCATTTTGTAGGTTGCCTGTTCACTCTGATGATAGGTTCTTTTGCTGTGCAGAAGCTCTTTAGTTTAATTAGATCCAATTTGTCAATTTTGGCTTTTTTTGCAATTGCTTTTGGCATTTTCCTCGTGAAGTCTTTGCCCGTGCCTATGTCCTGAATGGTATTGCGTAGGTTTTCTTCTAGGGTTTTTATAGTTTTGGGTTTTACATTTAAGTCTTTAATACATCTTGAGTTAATTTTTGTATAAGGTATAAGGAAGGGGTCCAGTTTCAGTTTTATGCATAATGGCTAGGCAGTTTTCCCACCACCATTTACTGAATAGGAGATCTTTTCCTCATTGCTTGTTTTTGTCAGATTTGTCGAAGATCAGATGGTTGTAGATGTGTGGTGTTATTTCTGAGGTCTCTGTTCTGCACCATTGGTCTATATGTCTGTTATCGTACCAGTCCCATGCTGTTTTGGTTACCGTAGCCTTGTAGTATATTTTGAAGTCTGGTAGCGTGATGCCTCCAGCTTTGTTCTTTTTGCTTAGGATTGTCTTGGCTATATGGAGTCTTCTTTGATTCCATATGAAATTTAAAATAATTTTTTTTTATTCTGTGAAGAATGTCAATGGTAGTTTGATGGGAATAGCATTGAAATTATAAATTACTTTGGGCAGTATAGCCATGTTCACAATATTGATTCTTTCTATCCGTAAGGACGACACTTTTTCCATTTGTTTGTGTTCTCTCTTATTTCCTTGAGCAGTGGTTTGTAGTTCTCCTTAAAGAGGTCTTTCACATCCTTTGTTAGCTGTGTTCCTAGGTATTTTGTTCTCTTTGTAGTGATTGTGAATGGGAATTCATTCTTGATTTGCCTCTCTGCTGCCTGTTGTTGGTGTAAACAAAATTCATTTCTTGTTCTTATTTGTGAAATTTTGGAACCAAATCTATTTTCAAATTAGAAATTGCTTGTGATAATGGTTTTGCAACTTAGACTGGATATGAGACGATGAGATATTAGTTCTTTCATTCCTTTGTAGGAATATGGTGCATCTTGCATTATTTTAGCTAACTAGTGTCCTTTAATGACTAATGAATATGACATGGTGAAACAAAGTAAAATATATATGATGCACTAAGTATGCATTGTTTCCAAAGGTTCAGCATTTTTTTTTTGTTAACTCTGCTGGGATCTGCTTTATGCACTGATAACATAACTTATTTTATGATCTTAAGCAAATAAAAACACTTATCTGGACCTCAGTTTCCTTAACTGTACAACTGAGGGAAACTGTATAGTATAGCTATAGTACAGTATACCATCTTTACCGTCACTTCCATCTTTTAAATTATGTGTATATAAGATAGGGCCTAGATAAATGGTATTTATCTTAAATTACAGTGATACTAGCTTATAACTTAATTTGCTAGGTCATGTTGAACTGATAACAATGTGTGAACTGATGAGCAACTGAGAAGTAACCAGGTTGTGTTATAACAGTTTGTTTTTGATTTAGGGTTATCAGTGAGGGTGGCGGTGGGGAGGGGACTTTGGAGTCTAACTGTCTAGTTCAAATATTAGTTTTTGTTTATTTTTATTTTTAATTTTTGTGGGTACATAGTAGATGTATATATTTATGGGGTACATGTGATGTTTTCATATAGGCATGCAATGTGAAATAAGCACATCATAGAGAATGGGGTATCCATCCCCTCAAACACTTATCTTTTGAGTTACCAACAATCCAATGACACTCTTTAAGTTATCAAATCACAGTTTTGCCAGCTACTAGCCATGTGATTTTGGGTAGGTTACTTAAATTCTCTTCATCTCAATTTCATTATTGTAAAGTGGAGATAATGATAGCACATTTTTTCTTTTTCTTTTTTCTTTTATTTTTTATTATTATACTTTAAGTTGTGTGATACATGTGCAGAATGTGCAGGTTTGTTACATAGGTATCAACAACTCTATAAAACATGTTCTATCCAGGAAAAGAAACTATCATCAGAGTGAACAGGCAACTTACGGAATGGGAGAAAATGTTTGCAATCTAGATGGCGATTGCAATGGCGGTTCGCTGCATCCATCAGCCCATCATCTACATTAGGTATTTCTCCTAATGCTATCCCTCCCCTTGCTCCCCACCCCCTCACAGGCCCCTGTGTGTGATGTTCCCCTCCCTGTGTCCATGTGTTCTCATTGTTCAACTCCCACTTATGAGTGAGAACATGTGGTGTTTGGTTTTCTGTTCTTGTGTTAGTTTGCTGAGAATGATGGTTTCCAGCTTCATCCATGTTCCTGCAAGGACATGAACTCATCCTTTTTTATGGCTGTATAGTATTCCATGGTATATATGTGCCACATTTTCTTTATCCAGTCTATCATTGGTGGACATTTGGGTTGGTTCCAAGTCTTTGCTATTGTGAACGCTGCAGCAATGAACATACATAAGCATATGTCTTTCTAGTCAAATAAGTTATAATCCTTTGGGTATGTACCCAGTAATGGGATTGCTGGGTCAAATGGTATTTCTGGTTCTAGATTCTTGAGGAATCGCCACACTGTCTTCCACAATGGTTGAATTAATTTACACTCCCACCAACAGTGTAGAAGCATTCCTATTTCTCCACATCCGCTCCAGCATCTGTTGTTTCCTGACTTTTTAATGATCACCATTCTAACTGGTGTGAGATGGTATCTCATTGTGGTTTTGATTTGCATTTCTCTAATGACTAGTGATGATGAGCTTCTTTTCATGTTTGTTGGCTGCATAAATGTCTTCTTTTGAGAAGTGTCTGTTCATATCCTTTCCCCACTTTTTGATGGGGTTGTTTTTTTCCTGTAAATTTGTTTAAGTTCCTTGTAGATTTTGGATATTAGCCCTTTGTCAGGTGGATAGATTGCAAACATTTTCTCCCATTCTGTAAGTTGCCTGTTCACTCTGATGATAGTTTCTTTTGCTGGATAGAACATGTTTTATAGAGTTGTTGTGAGAATTAAATGCATTAAGCACATAGAATAGATTCTGGTACATAGCAAGTGCTCTCTCTATATATGGAACTCTATATGTAGTTGGTGCAAAAGTAATTGTGGTTTTCACCATTGAAAGTAATGGCAAAGACCATCATTACCTTTTCACCAATTTAAATATATGGAAGGAATATATATATAAAACCTATATATATATGTCACATATATGTCTCTAACCCATTATTATAATATATAATACAATATATATTATAATTATAATTGTATATAACATATGTTATATAATAATATAGTAATATTTATTCTAAATAAATATATAATACTATAAATAATATAATAATTTATATATATGATTATAATATATAATAGGCTATATTATATATTATTAACATATACATATGTGTATATATATGTCTTTCATAGACTTAAATATATAGAGCAATAATAGGTTAGAAAATAGCAAACATGTATATATAAACATATATACATATAGAAAACATATATAAAAACATATATATATATATATATATGTGTGTTTTCTGCCTTTCATTTTTAGAGACAGGGTCTCATCATGTTGCCCAGGCTGGTCTCAAACTCCTGGGCTCAAGTGATCCTACTGCTTTGGACTCCCGAAGTGCTGGGATTTCAGACATGAGACACTGCACCCAGTCCAGTCCCTGTCTTTTTAAATAGACTCTCTACCTAAGTGCACAAATACTCATTATTTACATTTAGTTATTTCTGTATATATGCTATAAGCAAATCTTGTAGCACCAGTTTGATTTTTATAAGGCACAAGAATATATTTTACTAATGCTTTAAAATGGCAGCTAGATTCTAGTATTACTTTAGAAATTAAAATTAATATTTTAACACATCTTTCATTATTGTGTTATCTGAACCAAACCTATTATTGCTGCTATTTCAGCAAATCCAGGGGCTTTTTCTTATAAAATATGAAGAATATAGCTTAGATTTCTAGTGAAGATGTTACCAGTAATAATTAATAAAATCAGTAAGCACTAAAAGGAAAATACCAAAACTAAAGCATTTTGAATTAGTCATTGAATCTAAAAGAAAGGTAGATTTTTTTCTGAGATTCTGTTCTAGGTGTGGTATATGTGTATTTTTGCAAAAACTATAAACAATTGTGGCAAAATGAAGGAAATATTTAAAAACAAACCTCTTAATTCTTCAGTGGATTAAGCGTGAATATGTTTTTATTTTCTATGATGAATATGGAAAAATTCATTTCCTTAGCAATTTGTATGAGCCCAAAAACTATTGTCAGACTCTGCTGTATCAAAATAGACAAAAAATTGACACTCA	T	NC_000007.14:g.117498313_117519392del	NM_000492.3:c.54-5940_273+10250del		Deletion of exons 2 and 3				Cystic Fibrosis	CFTRdele2.3			CFTR	1080
VSZKSHA17E	chr7	117504276	117504278	AG	A	NC_000007.14:g.117504279delG	NM_000492.3:c.80delG	NP_000483.3:p.Gly27fs		68730	CD941996	rs397508798	Cystic Fibrosis	211delG			CFTR	1080
VS13CFCK21	chr7	117504277	117504278	G	T	NC_000007.14:g.117504278G>T	NM_000492.3:c.79G>T	NP_000483.3:p.Gly27*		68728	CM920138	rs397508796	Cystic Fibrosis	G27X	NFE	8.99E-06	CFTR	1080
VSN8L92L7E	chr7	117504282	117504283	C	G	NC_000007.14:g.117504283C>G	NM_000492.3:c.84C>G	NP_000483.3:p.Tyr28*					Cystic Fibrosis	Y28X			CFTR	1080
VSLNH53MKW	chr7	117504283	117504284	A	T	NC_000007.14:g.117504284A>T	NM_000492.3:c.85A>T	NP_000483.3:p.Arg29*					Cystic Fibrosis	R29X			CFTR	1080
VSR312JGDH	chr7	117504286	117504287	C	T	NC_000007.14:g.117504287C>T	NM_000492.3:c.88C>T	NP_000483.3:p.Gln30*		68748	CM940235	rs397508815	Cystic Fibrosis	Q30X			CFTR	1080
VS9LMKD3FG	chr7	117504295	117504296	G	T	NC_000007.14:g.117504296G>T	NM_000492.3:c.97G>T	NP_000483.3:p.Glu33*			CM132377		Cystic Fibrosis	E33X			CFTR	1080
VS1X9JCJZQ	chr7	117504299	117504300	T	A	NC_000007.14:g.117504300T>A	NM_000492.3:c.101T>A	NP_000483.3:p.Leu34*					Cystic Fibrosis	L34X			CFTR	1080
VS9LMUAZ3F	chr7	117504302	117504303	C	G	NC_000007.14:g.117504303C>G	NM_000492.3:c.104C>G	NP_000483.3:p.Ser35*					Cystic Fibrosis	S35X (TGA)			CFTR	1080
VSLQA5HC5E	chr7	117504302	117504303	C	A	NC_000007.14:g.117504303C>A	NM_000492.3:c.104C>A	NP_000483.3:p.Ser35*					Cystic Fibrosis	S35X			CFTR	1080
VSRY391W2E	chr7	117504302	117504303	C	CA	NC_000007.14:g.117504304dupA	NM_000492.3:c.105dupA	NP_000483.3:p.Asp36fs		67845	CI952069	rs397508149	Cystic Fibrosis	237insA			CFTR	1080
VSZRYX81PW	chr7	117504306	117504309	CAT	C	NC_000007.14:g.117504311_117504312delTA	NM_000492.3:c.112_113delTA	NP_000483.3:p.Tyr38fs		67866	CD920839	rs397508162	Cystic Fibrosis	241delAT			CFTR	1080
VS34939JKU	chr7	117504312	117504313	C	G	NC_000007.14:g.117504313C>G	NM_000492.3:c.114C>G	NP_000483.3:p.Tyr38*		44481		rs193922498	Cystic Fibrosis	Y38X			CFTR	1080
VS4F8B1904	chr7	117504313	117504314	C	T	NC_000007.14:g.117504314C>T	NM_000492.3:c.115C>T	NP_000483.3:p.Gln39*		67872	CM920139	rs397508168	Cystic Fibrosis	Q39X			CFTR	1080
VSSBBC4IQ8	chr7	117504335	117504336	C	A	NC_000007.14:g.117504336C>A	NM_000492.3:c.137C>A	NP_000483.3:p.Ala46Asp		67906	CM970258	rs151020603	Cystic Fibrosis	A46D			CFTR	1080
VSA33P22L2	chr7	117504349	117504351	GA	G	NC_000007.14:g.117504355delA	NM_000492.3:c.156delA	NP_000483.3:p.Lys52fs			CD931164		Cystic Fibrosis	284delA			CFTR	1080
VSM4611WRH	chr7	117504349	117504350	G	T	NC_000007.14:g.117504350G>T	NM_000492.3:c.151G>T	NP_000483.3:p.Glu51*					Cystic Fibrosis	E51X			CFTR	1080
VSZUL8NS3D	chr7	117504350	117504351	A	AAAAATTGG	NC_000007.14:g.117504355_117504362dup	NM_000492.3:c.156_163dup	NP_000483.3:p.Arg55fs			CI962517		Cystic Fibrosis	295ins8			CFTR	1080
VSE93MVVMQ	chr7	117504352	117504353	A	T	NC_000007.14:g.117504353A>T	NM_000492.3:c.154A>T	NP_000483.3:p.Lys52*					Cystic Fibrosis	K52X			CFTR	1080
VSM4MUHZFE	chr7	117504358	117504359	G	T	NC_000007.14:g.117504359G>T	NM_000492.3:c.160G>T	NP_000483.3:p.Glu54*					Cystic Fibrosis	E54X			CFTR	1080
VSTTHEF932	chr7	117509032	117509033	G	A	NC_000007.14:g.117509033G>A	NM_000492.3:c.165-1G>A			67982	CS000849	rs397508249	Cystic Fibrosis	297-1G>A			CFTR	1080
VS988NXGMD	chr7	117509034	117509035	G	T	NC_000007.14:g.117509035G>T	NM_000492.3:c.166G>T	NP_000483.3:p.Glu56*		610296			Cystic Fibrosis	E56X			CFTR	1080
VSQRJPSPQA	chr7	117509034	117509036	GA	G	NC_000007.14:g.117509037delA	NM_000492.3:c.168delA	NP_000483.3:p.Glu56fs		68011	CD930918	rs397508269	Cystic Fibrosis	300delA			CFTR	1080
VSTWX2CFCA	chr7	117509038	117509039	G	A	NC_000007.14:g.117509039G>A	NM_000492.3:c.170G>A	NP_000483.3:p.Trp57*		68023	CM930096	rs397508279	Cystic Fibrosis	W57X(TAG)			CFTR	1080
VS19HSQZPY	chr7	117509039	117509044	GGATA	G	NC_000007.14:g.117509043_117509046delTAGA	NM_000492.3:c.174_177delTAGA	NP_000483.3:p.Asp58fs		68041	CD972121	rs397508295	Cystic Fibrosis	306delTAGA			CFTR	1080
VS7P46N7K9	chr7	117509039	117509040	G	A	NC_000007.14:g.117509040G>A	NM_000492.3:c.171G>A	NP_000483.3:p.Trp57*		22218	CM994782	rs121909025	Cystic Fibrosis	W57X (TGA)			CFTR	1080
VSIUIJMY2S	chr7	117509040	117509041	G	GA	NC_000007.14:g.117509042dupA	NM_000492.3:c.173dupA	NP_000483.3:p.Asp58fs			CI942007		Cystic Fibrosis	306insA			CFTR	1080
VS5UUNV2RB	chr7	117509043	117509044	A	T	NC_000007.14:g.117509044A>T	NM_000492.3:c.175A>T	NP_000483.3:p.Arg59*			CM1213091		Cystic Fibrosis	R59X			CFTR	1080
VS4184378A	chr7	117509046	117509047	G	T	NC_000007.14:g.117509047G>T	NM_000492.3:c.178G>T	NP_000483.3:p.Glu60*		47335	CM920141	rs77284892	Cystic Fibrosis	E60X	NFE	5.39E-05	CFTR	1080
VSDLP313ZL	chr7	117509056	117509057	C	G	NC_000007.14:g.117509057C>G	NM_000492.3:c.188C>G	NP_000483.3:p.Ser63*					Cystic Fibrosis	S63X			CFTR	1080
VSJ3VZ6CFI	chr7	117509058	117509059	A	T	NC_000007.14:g.117509059A>T	NM_000492.3:c.190A>T	NP_000483.3:p.Lys64*					Cystic Fibrosis	K64X			CFTR	1080
VSW2FM2MXG	chr7	117509061	117509062	A	T	NC_000007.14:g.117509062A>T	NM_000492.3:c.193A>T	NP_000483.3:p.Lys65*					Cystic Fibrosis	K65X			CFTR	1080
VSF4FQU5D7	chr7	117509064	117509070	AATCCT	A	NC_000007.14:g.117509067_117509071delTCCTA	NM_000492.3:c.198_202delTCCTA	NP_000483.3:p.Asn66fs					Cystic Fibrosis	c.198_202delTCCTA			CFTR	1080
VS0A325DF5	chr7	117509068	117509069	C	T	NC_000007.14:g.117509069C>T	NM_000492.3:c.200C>T	NP_000483.3:p.Pro67Leu		68093	CM930097	rs368505753	Cystic Fibrosis	P67L	NFE	7.18E-05	CFTR	1080
VSLNDADUW6	chr7	117509070	117509071	A	T	NC_000007.14:g.117509071A>T	NM_000492.3:c.202A>T	NP_000483.3:p.Lys68*					Cystic Fibrosis	K68X			CFTR	1080
VSDSXTWL76	chr7	117509082	117509084	GC	G	NC_000007.14:g.117509086delC	NM_000492.3:c.217delC	NP_000483.3:p.Leu73fs			CD952063	rs397508348	Cystic Fibrosis	347delC			CFTR	1080
VSF4685E71	chr7	117509091	117509092	C	T	NC_000007.14:g.117509092C>T	NM_000492.3:c.223C>T	NP_000483.3:p.Arg75*		57834	CM940236	rs121908749	Cystic Fibrosis	R75X	AMR	8.94E-05	CFTR	1080
VS29VYU8VQ	chr7	117509095	117509097	GT	G	NC_000007.14:g.117509102delT	NM_000492.3:c.233delT	NP_000483.3:p.Phe78fs			CD983595	rs397508367	Cystic Fibrosis	360delT			CFTR	1080
VSDHNCAS6M	chr7	117509095	117509096	G	GT	NC_000007.14:g.117509102dupT	NM_000492.3:c.233dupT	NP_000483.3:p.Trp79fs		68143	CI942008	rs397508360	Cystic Fibrosis	360_365insT	AMR	2.98E-05	CFTR	1080
VSLGFRXGNT	chr7	117509096	117509097	T	A	NC_000007.14:g.117509097T>A	NM_000492.3:c.228T>A	NP_000483.3:p.Cys76*					Cystic Fibrosis	C76X			CFTR	1080
VSN178MZB6	chr7	117509101	117509103	TC	T	NC_000007.14:g.117509103delC	NM_000492.3:c.234delC	NP_000483.3:p.Trp79fs					Cystic Fibrosis	c.234delC			CFTR	1080
VS5GTZDJXY	chr7	117509104	117509105	G	A	NC_000007.14:g.117509105G>A	NM_000492.3:c.236G>A	NP_000483.3:p.Trp79*		68150	CM931141	rs397508371	Cystic Fibrosis	W79X (TGA)			CFTR	1080
VSW529EG1D	chr7	117509105	117509106	G	A	NC_000007.14:g.117509106G>A	NM_000492.3:c.237G>A	NP_000483.3:p.Trp79*					Cystic Fibrosis	W79X			CFTR	1080
VSBMBX2RCQ	chr7	117509106	117509107	A	T	NC_000007.14:g.117509107A>T	NM_000492.3:c.238A>T	NP_000483.3:p.Arg80*					Cystic Fibrosis	R80X			CFTR	1080
VSC8Z8C2QT	chr7	117509114	117509115	G	GT	NC_000007.14:g.117509117dupT	NM_000492.3:c.248dupT	NP_000483.3:p.Tyr84fs			CI042895		Cystic Fibrosis	379_381insT			CFTR	1080
VSX66A3M5K	chr7	117509120	117509121	T	G	NC_000007.14:g.117509121T>G	NM_000492.3:c.252T>G	NP_000483.3:p.Tyr84*					Cystic Fibrosis	Y84X			CFTR	1080
VS6XBHY2KS	chr7	117509121	117509122	G	T	NC_000007.14:g.117509122G>T	NM_000492.3:c.253G>T	NP_000483.3:p.Gly85*					Cystic Fibrosis	G85X			CFTR	1080
VS4F9C856A	chr7	117509122	117509123	G	A	NC_000007.14:g.117509123G>A	NM_000492.3:c.254G>A	NP_000483.3:p.Gly85Glu		22182	CM910068	rs75961395	Cystic Fibrosis	G85E	NFE	9.88E-05	CFTR	1080
VS85A7764B	chr7	117509126	117509129	CTT	C	NC_000007.14:g.117509131_117509132delTT	NM_000492.3:c.262_263delTT	NP_000483.3:p.Leu88fs		22271	CD930919	rs121908769	Cystic Fibrosis	394delTT	FIN	0.00140107	CFTR	1080
VSCFY2GGT7	chr7	117509129	117509135	TTTATA	T	NC_000007.14:g.117509133_117509137delATATT	NM_000492.3:c.264_268delATATT	NP_000483.3:p.Leu88fs					Cystic Fibrosis	c.264_268delATATT			CFTR	1080
VSC9WJ8R1X	chr7	117509131	117509132	T	G	NC_000007.14:g.117509132T>G	NM_000492.3:c.263T>G	NP_000483.3:p.Leu88*		68202	CM920142	rs397508412	Cystic Fibrosis	L88X (T>G)			CFTR	1080
VSG7SDSJLB	chr7	117509131	117509132	T	A	NC_000007.14:g.117509132T>A	NM_000492.3:c.263T>A	NP_000483.3:p.Leu88*		68200	CM940238	rs397508412	Cystic Fibrosis	L88X (T>A)			CFTR	1080
VSGI15JBUD	chr7	117509135	117509136	T	A	NC_000007.14:g.117509136T>A	NM_000492.3:c.267T>A	NP_000483.3:p.Tyr89*					Cystic Fibrosis	Y89X			CFTR	1080
VSKICSJALU	chr7	117509137	117509138	T	A	NC_000007.14:g.117509138T>A	NM_000492.3:c.269T>A	NP_000483.3:p.Leu90*					Cystic Fibrosis	L90X (TAA)			CFTR	1080
VSZUSIJ32Z	chr7	117509137	117509138	T	G	NC_000007.14:g.117509138T>G	NM_000492.3:c.269T>G	NP_000483.3:p.Leu90*					Cystic Fibrosis	L90X			CFTR	1080
VS7F7E0E7B	chr7	117509142	117509143	G	A	NC_000007.14:g.117509143G>A	NM_000492.3:c.273+1G>A			68217	CS930763	rs121908791	Cystic Fibrosis	405+1G>A	NFE	9.00E-06	CFTR	1080
VS77C5AC6E	chr7	117530897	117530898	G	A	NC_000007.14:g.117530898G>A	NM_000492.3:c.274-1G>A			57842	CS000850	rs121908792	Cystic Fibrosis	406-1G>A	AMR	0.000119911	CFTR	1080
VS3B1F671A	chr7	117530898	117530899	G	T	NC_000007.14:g.117530899G>T	NM_000492.3:c.274G>T	NP_000483.3:p.Glu92*		22225	CM940239	rs121908751	Cystic Fibrosis	E92X	NFE	8.98E-06	CFTR	1080
VS794C7EC3	chr7	117530898	117530899	G	A	NC_000007.14:g.117530899G>A	NM_000492.3:c.274G>A	NP_000483.3:p.Glu92Lys		22220	CM920143	rs121908751	Cystic Fibrosis	E92K			CFTR	1080
VSHT1D9R8R	chr7	117530904	117530911	ACCAAAG	TA	NC_000007.14:g.117530905_117530911delinsTA	NM_000492.3:c.280_286delinsTA	NP_000483.3:p.Thr94fs			CX962523		Cystic Fibrosis	412del7- >TA			CFTR	1080
VSDXJ2QX2H	chr7	117530907	117530908	A	T	NC_000007.14:g.117530908A>T	NM_000492.3:c.283A>T	NP_000483.3:p.Lys95*					Cystic Fibrosis	L94X			CFTR	1080
VS43F6AF8D	chr7	117530916	117530917	C	T	NC_000007.14:g.117530917C>T	NM_000492.3:c.292C>T	NP_000483.3:p.Gln98*		68268	CM980332	rs397508461	Cystic Fibrosis	Q98X	AFR	0.000130753	CFTR	1080
VS8LWUK8VX	chr7	117530926	117530927	T	TA	NC_000007.14:g.117530928dupA	NM_000492.3:c.303dupA	NP_000483.3:p.Leu102fs		68305	CI920927	rs397508486	Cystic Fibrosis	435insA			CFTR	1080
VSDIBBLYHI	chr7	117530926	117530927	T	G	NC_000007.14:g.117530927T>G	NM_000492.3:c.302T>G	NP_000483.3:p.Leu101*		68301	CM962451	rs397508484	Cystic Fibrosis	L101X	SAS	3.25E-05	CFTR	1080
VSJFNGZ28I	chr7	117530926	117530927	T	A	NC_000007.14:g.117530927T>A	NM_000492.3:c.302T>A	NP_000483.3:p.Leu101*					Cystic Fibrosis	L101X (TAA)			CFTR	1080
VSNW8RTYDJ	chr7	117530931	117530932	G	T	NC_000007.14:g.117530932G>T	NM_000492.3:c.307G>T	NP_000483.3:p.Gly103*			CM920981		Cystic Fibrosis	G103X			CFTR	1080
VSBN27NZNX	chr7	117530932	117530934	GA	G	NC_000007.14:g.117530935delA	NM_000492.3:c.310delA	NP_000483.3:p.Arg104fs		68321	CD951650	rs397508499	Cystic Fibrosis	441delA			CFTR	1080
VSBYKIEIDS	chr7	117530934	117530935	A	T	NC_000007.14:g.117530935A>T	NM_000492.3:c.310A>T	NP_000483.3:p.Arg104*					Cystic Fibrosis	R104X			CFTR	1080
VSD0123047	chr7	117530935	117530937	GA	G	NC_000007.14:g.117530938delA	NM_000492.3:c.313delA	NP_000483.3:p.Ile105fs		57846	CD910487	rs121908801	Cystic Fibrosis	444delA	AFR	6.54E-05	CFTR	1080
VSDGA4KPTM	chr7	117530940	117530949	ATAGCTTCC	A	NC_000007.14:g.117530944_117530951del	NM_000492.3:c.319_326del	NP_000483.3:p.Ala107fs		68348	CD991667	rs397508516	Cystic Fibrosis	451del8			CFTR	1080
VSCDHFVBM3	chr7	117530948	117530951	CTA	C	NC_000007.14:g.117530951_117530952delAT	NM_000492.3:c.326_327delAT	NP_000483.3:p.Tyr109fs			CD920989	rs397508526	Cystic Fibrosis	458delAT			CFTR	1080
VS4F03325E	chr7	117530949	117530952	TAT	G	NC_000007.14:g.117530950_117530952delTATinsG	NM_000492.3:c.325_327delTATinsG	NP_000483.3:p.Tyr109fs		68364	CX931109	rs121908798	Cystic Fibrosis	457TAT>G			CFTR	1080
VS7W6D83RE	chr7	117530951	117530952	T	A	NC_000007.14:g.117530952T>A	NM_000492.3:c.327T>A	NP_000483.3:p.Tyr109*		68370	CM040400	rs397508528	Cystic Fibrosis	Y109X			CFTR	1080
VSHLIUAJFH	chr7	117530951	117530953	TG	T	NC_000007.14:g.117530953delG	NM_000492.3:c.328delG	NP_000483.3:p.Asp110fs		68374	CD961884	rs397508530	Cystic Fibrosis	460delG			CFTR	1080
VSD57F472C	chr7	117530952	117530953	G	C	NC_000007.14:g.117530953G>C	NM_000492.3:c.328G>C	NP_000483.3:p.Asp110His		22147	CM900042	rs113993958	Cystic Fibrosis	D110H	NFE	3.59E-05	CFTR	1080
VS32CUN2MW	chr7	117530964	117530965	A	T	NC_000007.14:g.117530965A>T	NM_000492.3:c.340A>T	NP_000483.3:p.Lys114*			CM043459	rs397508554	Cystic Fibrosis	K114X			CFTR	1080
VSCR3KL4BL	chr7	117530967	117530968	G	T	NC_000007.14:g.117530968G>T	NM_000492.3:c.343G>T	NP_000483.3:p.Glu115*			CM001648		Cystic Fibrosis	E115X			CFTR	1080
VS4EGTAUX2	chr7	117530970	117530971	G	T	NC_000007.14:g.117530971G>T	NM_000492.3:c.346G>T	NP_000483.3:p.Glu116*			CM066753		Cystic Fibrosis	E116X			CFTR	1080
VSB05AB754	chr7	117530973	117530974	C	T	NC_000007.14:g.117530974C>T	NM_000492.3:c.349C>T	NP_000483.3:p.Arg117Cys		57850	CM940241	rs77834169	Cystic Fibrosis	R117C	NFE	0.000430887	CFTR	1080
VSF4716976	chr7	117530974	117530975	G	A	NC_000007.14:g.117530975G>A	NM_000492.3:c.350G>A	NP_000483.3:p.Arg117His	R117H	22148	CM900043	rs78655421	Cystic Fibrosis	R117H	NFE	0.0025763	CFTR	1080
VSYG5KMFJZ	chr7	117530980	117530982	TC	T	NC_000007.14:g.117530982delC	NM_000492.3:c.357delC	NP_000483.3:p.Ile119fs			CD043669	rs397508583	Cystic Fibrosis	489delC			CFTR	1080
VS3C3F76D3	chr7	117530990	117530991	T	A	NC_000007.14:g.117530991T>A	NM_000492.3:c.366T>A	NP_000483.3:p.Tyr122*		47438	CM920144	rs79660178	Cystic Fibrosis	Y122X			CFTR	1080
VSHQFB85ZN	chr7	117531004	117531005	T	G	NC_000007.14:g.117531005T>G	NM_000492.3:c.380T>G	NP_000483.3:p.Leu127*		68482	CM962453	rs397508611	Cystic Fibrosis	L127X			CFTR	1080
VSUM6T31YJ	chr7	117531004	117531005	T	A	NC_000007.14:g.117531005T>A	NM_000492.3:c.380T>A	NP_000483.3:p.Leu127*					Cystic Fibrosis	L127X (TAA)			CFTR	1080
VS5YCY4CFM	chr7	117531008	117531009	C	A	NC_000007.14:g.117531009C>A	NM_000492.3:c.384C>A	NP_000483.3:p.Cys128*				rs1388235792	Cystic Fibrosis	C128X			CFTR	1080
VSIG45MKF9	chr7	117531009	117531011	CT	C	NC_000007.14:g.117531012delT	NM_000492.3:c.387delT	NP_000483.3:p.Leu130fs		68503	CD135527	rs397508627	Cystic Fibrosis	519delT			CFTR	1080
VSMF1R96AN	chr7	117531014	117531016	CT	C	NC_000007.14:g.117531018delT	NM_000492.3:c.393delT	NP_000483.3:p.Phe131fs		68526	CD983596	rs397508647	Cystic Fibrosis	525delT			CFTR	1080
VSVHYXWY6B	chr7	117531026	117531027	G	GAC	NC_000007.14:g.117531030_117531031dupAC	NM_000492.3:c.405_406dupAC	NP_000483.3:p.Leu136fs		544130	CI129619		Cystic Fibrosis	c.405_406dupAC			CFTR	1080
VSPVNJBM8H	chr7	117531032	117531034	GC	G	NC_000007.14:g.117531034delC	NM_000492.3:c.409delC	NP_000483.3:p.Leu137fs		68554	CD920840	rs397508672	Cystic Fibrosis	541delC			CFTR	1080
VST8M2Z6PD	chr7	117531032	117531037	GCTCC	G	NC_000007.14:g.117531034_117531037delCTCC	NM_000492.3:c.409_412delCTCC	NP_000483.3:p.Leu137fs		68553	CD931165	rs397508671	Cystic Fibrosis	541del4			CFTR	1080
VS2SSKELK2	chr7	117531035	117531036	C	CCTA	NC_000007.14:g.117531038_117531040dupTAC	NM_000492.3:c.413_415dupTAC	NP_000483.3:p.Leu138dup		68572	CI972569	rs1263192252	Cystic Fibrosis	546insCTA	FIN	4.49E-05	CFTR	1080
VSI86YLIFK	chr7	117531036	117531037	C	CTA	NC_000007.14:g.117531038_117531039dupTA	NM_000492.3:c.413_414dupTA	NP_000483.3:p.His139fs					Cystic Fibrosis	547insTA			CFTR	1080
VSCJ214FZP	chr7	117531037	117531038	T	TAG	NC_000007.14:g.117531039_117531040insGA	NM_000492.3:c.414_415insGA	NP_000483.3:p.His139fs					Cystic Fibrosis	547insGA			CFTR	1080
VSHWG5A5JG	chr7	117531047	117531049	CA	C	NC_000007.14:g.117531049delA	NM_000492.3:c.424delA	NP_000483.3:p.Ile142fs		22185	CD910488	rs387906363	Cystic Fibrosis	556delA			CFTR	1080
VS6DSG4ITS	chr7	117531048	117531050	AT	A	NC_000007.14:g.117531054delT	NM_000492.3:c.429delT	NP_000483.3:p.Phe143fs		22186	CD920841	rs387906364	Cystic Fibrosis	557delT			CFTR	1080
VSF61XFJZH	chr7	117531055	117531057	GC	G	NC_000007.14:g.117531058delC	NM_000492.3:c.433delC	NP_000483.3:p.Leu145fs			CD962506		Cystic Fibrosis	565delC			CFTR	1080
VS55133E69	chr7	117531065	117531067	CA	C	NC_000007.14:g.117531067delA	NM_000492.3:c.442delA	NP_000483.3:p.Ile148fs		68615	CD920842	rs121908770	Cystic Fibrosis	574delA			CFTR	1080
VS8QTRDG93	chr7	117531069	117531070	G	T	NC_000007.14:g.117531070G>T	NM_000492.3:c.445G>T	NP_000483.3:p.Gly149*		544131	CM086804		Cystic Fibrosis	G149X			CFTR	1080
VS2T39F9SM	chr7	117531097	117531098	G	GT	NC_000007.14:g.117531101dupT	NM_000492.3:c.476dupT	NP_000483.3:p.Leu159fs			CI942009	rs397508726	Cystic Fibrosis	605insT			CFTR	1080
VS89VVFUK1	chr7	117531100	117531101	T	A	NC_000007.14:g.117531101T>A	NM_000492.3:c.476T>A	NP_000483.3:p.Leu159*			CM003240	rs397508727	Cystic Fibrosis	L159X			CFTR	1080
VSSBNRQPKD	chr7	117531107	117531108	T	A	NC_000007.14:g.117531108T>A	NM_000492.3:c.483T>A	NP_000483.3:p.Tyr161*					Cystic Fibrosis	Y161X (TAA)			CFTR	1080
VSVVXNYSQK	chr7	117531107	117531108	T	G	NC_000007.14:g.117531108T>G	NM_000492.3:c.483T>G	NP_000483.3:p.Tyr161*					Cystic Fibrosis	Y161X			CFTR	1080
VSSKDV9NJ1	chr7	117531108	117531109	A	T	NC_000007.14:g.117531109A>T	NM_000492.3:c.484A>T	NP_000483.3:p.Lys162*					Cystic Fibrosis	K162X			CFTR	1080
VS1VGCSRM5	chr7	117531111	117531112	A	T	NC_000007.14:g.117531112A>T	NM_000492.3:c.487A>T	NP_000483.3:p.Lys163*					Cystic Fibrosis	K163X			CFTR	1080
VS0EA3AD35	chr7	117531114	117531115	G	T	NC_000007.14:g.117531115G>T	NM_000492.3:c.489+1G>T			47058	CS910419	rs78756941	Cystic Fibrosis	621+1G>T	NFE	0.00017563	CFTR	1080
VSZK4U922K	chr7	117534305	117534306	A	T	NC_000007.14:g.117534306A>T	NM_000492.3:c.520A>T	NP_000483.3:p.Lys174*					Cystic Fibrosis	K174X			CFTR	1080
VS215MYCUM	chr7	117534309	117534311	TA	T	NC_000007.14:g.117534312delA	NM_000492.3:c.526delA	NP_000483.3:p.Ser176fs			CD962507	rs397508745	Cystic Fibrosis	657delA			CFTR	1080
VS883CC39A	chr7	117534314	117534316	AT	A	NC_000007.14:g.117534317delT	NM_000492.3:c.531delT	NP_000483.3:p.Ile177fs		68658	CD983597	rs1056702558	Cystic Fibrosis	663delT			CFTR	1080
VS4NPPEHTE	chr7	117534317	117534318	G	T	NC_000007.14:g.117534318G>T	NM_000492.3:c.532G>T	NP_000483.3:p.Gly178*			CM1510237		Cystic Fibrosis	G178X			CFTR	1080
VS6251ADC3	chr7	117534317	117534318	G	A	NC_000007.14:g.117534318G>A	NM_000492.3:c.532G>A	NP_000483.3:p.Gly178Arg		57854	CM910069	rs80282562	Cystic Fibrosis	G178R	NFE	2.69E-05	CFTR	1080
VS2317C3C7	chr7	117534320	117534321	C	A	NC_000007.14:g.117534321C>A	NM_000492.3:c.535C>A	NP_000483.3:p.Gln179Lys		68660	CM003242	rs367850319	Cystic Fibrosis	Q179K	NFE	1.80E-05	CFTR	1080
VSM51HALUX	chr7	117534320	117534321	C	T	NC_000007.14:g.117534321C>T	NM_000492.3:c.535C>T	NP_000483.3:p.Gln179*				rs367850319	Cystic Fibrosis	Q179X	SAS	3.25E-05	CFTR	1080
VSTZ7TYUTY	chr7	117534325	117534330	TGTTA	T	NC_000007.14:g.117534329_117534332delTAGT	NM_000492.3:c.543_546delTAGT	NP_000483.3:p.Leu183fs		68663	CD983598	rs397508750	Cystic Fibrosis	675del4			CFTR	1080
VSVQA75Y6I	chr7	117534333	117534335	TC	T	NC_000007.14:g.117534336delC	NM_000492.3:c.550delC	NP_000483.3:p.Leu184fs		68666	CD951654	rs397508752	Cystic Fibrosis	681delC			CFTR	1080
VSXPPYK5CD	chr7	117534353	117534354	A	T	NC_000007.14:g.117534354A>T	NM_000492.3:c.568A>T	NP_000483.3:p.Lys190*					Cystic Fibrosis	K190X			CFTR	1080
VSSZSGAA6L	chr7	117534359	117534367	GATGAAGT	G	NC_000007.14:g.117534364_117534370del	NM_000492.3:c.578_579+5del	NP_000483.3:p.Glu193fs			CD136198	rs397508760	Cystic Fibrosis	710_711+5del7			CFTR	1080
VSVGGMY64Z	chr7	117534362	117534363	G	T	NC_000007.14:g.117534363G>T	NM_000492.3:c.577G>T	NP_000483.3:p.Glu193*		68674	CM941970	rs397508759	Cystic Fibrosis	E193X			CFTR	1080
VSD408173B	chr7	117534365	117534366	G	T	NC_000007.14:g.117534366G>T	NM_000492.3:c.579+1G>T			47059	CS910420	rs77188391	Cystic Fibrosis	711+1G>T	AMR	0.0001492	CFTR	1080
VSB084265B	chr7	117534367	117534368	A	G	NC_000007.14:g.117534368A>G	NM_000492.3:c.579+3A>G			68677	CS941439	rs397508761	Cystic Fibrosis	711+3A>G	NFE	3.60E-05	CFTR	1080
VS10379430	chr7	117534369	117534370	G	A	NC_000007.14:g.117534370G>A	NM_000492.3:c.579+5G>A			68679	CS941440	rs78440224	Cystic Fibrosis	711+5G>A			CFTR	1080
VS3EAF2836	chr7	117535246	117535247	G	T	NC_000007.14:g.117535247G>T	NM_000492.3:c.580-1G>T			68681	CS971649	rs121908793	Cystic Fibrosis	712-1G>T	NFE	8.96E-06	CFTR	1080
VSBXQ96C58	chr7	117535247	117535248	G	T	NC_000007.14:g.117535248G>T	NM_000492.3:c.580G>T	NP_000483.3:p.Gly194*					Cystic Fibrosis	G194X			CFTR	1080
VS9PVXHJBS	chr7	117535257	117535258	T	A	NC_000007.14:g.117535258T>A	NM_000492.3:c.590T>A	NP_000483.3:p.Leu197*					Cystic Fibrosis	L197X			CFTR	1080
VSE60277C6	chr7	117535262	117535263	C	T	NC_000007.14:g.117535263C>T	NM_000492.3:c.595C>T	NP_000483.3:p.His199Tyr		68685	CM940246	rs121908802	Cystic Fibrosis	H199Y			CFTR	1080
VS7DX1GSUB	chr7	117535267	117535269	CG	C	NC_000007.14:g.117535269delG	NM_000492.3:c.601delG	NP_000483.3:p.Val201fs			CD151454	rs397508767	Cystic Fibrosis	733delG			CFTR	1080
VS1B82F9D4	chr7	117535280	117535281	C	T	NC_000007.14:g.117535281C>T	NM_000492.3:c.613C>T	NP_000483.3:p.Pro205Ser		68693	CM930101	rs121908803	Cystic Fibrosis	P205S	AMR	2.98E-05	CFTR	1080
VSA10EE0AB	chr7	117535284	117535285	T	G	NC_000007.14:g.117535285T>G	NM_000492.3:c.617T>G	NP_000483.3:p.Leu206Trp		22229	CM930102	rs121908752	Cystic Fibrosis	L206W	AMR	0.000536065	CFTR	1080
VSJRZLUSWP	chr7	117535284	117535285	T	A	NC_000007.14:g.117535285T>A	NM_000492.3:c.617T>A	NP_000483.3:p.Leu206*					Cystic Fibrosis	L206X			CFTR	1080
VS5HIFUMSS	chr7	117535286	117535287	C	T	NC_000007.14:g.117535287C>T	NM_000492.3:c.619C>T	NP_000483.3:p.Gln207*			CM931143	rs397508771	Cystic Fibrosis	Q207X			CFTR	1080
VSQQQPCHJV	chr7	117535314	117535315	G	A	NC_000007.14:g.117535315G>A	NM_000492.3:c.647G>A	NP_000483.3:p.Trp216*		68700	CM993850	rs397508775	Cystic Fibrosis	W216X	AMR	2.98E-05	CFTR	1080
VS46EZY287	chr7	117535316	117535317	G	T	NC_000007.14:g.117535317G>T	NM_000492.3:c.649G>T	NP_000483.3:p.Glu217*					Cystic Fibrosis	E217X			CFTR	1080
VS5QIJTGWI	chr7	117535316	117535327	GAGTTGTTACA	G	NC_000007.14:g.117535318_117535327del	NM_000492.3:c.650_659del	NP_000483.3:p.Glu217fs			CD113213		Cystic Fibrosis	c.650_659delAGTTGTTACA			CFTR	1080
VSC74C7GGM	chr7	117535320	117535321	T	A	NC_000007.14:g.117535321T>A	NM_000492.3:c.653T>A	NP_000483.3:p.Leu218*		68702	CM962458	rs397508777	Cystic Fibrosis	L218X	SAS	0.000259892	CFTR	1080
VS45TNJ7UT	chr7	117535323	117535324	T	A	NC_000007.14:g.117535324T>A	NM_000492.3:c.656T>A	NP_000483.3:p.Leu219*					Cystic Fibrosis	L219X (T>A)			CFTR	1080
VS489VZVUD	chr7	117535323	117535324	T	G	NC_000007.14:g.117535324T>G	NM_000492.3:c.656T>G	NP_000483.3:p.Leu219*					Cystic Fibrosis	L219X (T>G)			CFTR	1080
VS0314F8F2	chr7	117535325	117535326	C	T	NC_000007.14:g.117535326C>T	NM_000492.3:c.658C>T	NP_000483.3:p.Gln220*		68703	CM940247	rs397508778	Cystic Fibrosis	Q220X	NFE	8.96E-06	CFTR	1080
VS1G5QW6JD	chr7	117535342	117535343	T	A	NC_000007.14:g.117535343T>A	NM_000492.3:c.675T>A	NP_000483.3:p.Cys225*		68706	CM962459	rs397508781	Cystic Fibrosis	C225X			CFTR	1080
VS988NR6LP	chr7	117535343	117535344	G	T	NC_000007.14:g.117535344G>T	NM_000492.3:c.676G>T	NP_000483.3:p.Gly226*					Cystic Fibrosis	G226X			CFTR	1080
VSFD77GB4C	chr7	117535370	117535372	CT	C	NC_000007.14:g.117535376delT	NM_000492.3:c.708delT	NP_000483.3:p.Gln237fs				rs1299250440	Cystic Fibrosis	c.708delT			CFTR	1080
VSVFW7D42N	chr7	117535376	117535377	C	T	NC_000007.14:g.117535377C>T	NM_000492.3:c.709C>T	NP_000483.3:p.Gln237*					Cystic Fibrosis	Q237X			CFTR	1080
VSFYA85NKG	chr7	117535380	117535382	CT	C	NC_000007.14:g.117535382delT	NM_000492.3:c.714delT	NP_000483.3:p.Leu240fs		68712	CD000925	rs397508787	Cystic Fibrosis	c.714delT			CFTR	1080
VSGR3GX5T2	chr7	117535381	117535383	TG	T	NC_000007.14:g.117535385delG	NM_000492.3:c.717delG	NP_000483.3:p.Leu240fs		480436			Cystic Fibrosis	c.717delG			CFTR	1080
VSF1C7B01D	chr7	117535386	117535409	TAGGGAGAATGATGATGAAGTAC	T	NC_000007.14:g.117535391_117535412del	NM_000492.3:c.723_743+1del	NP_000483.3:p.Arg242_Arg248del		22184		rs121908804	Cystic Fibrosis	852del22			CFTR	1080
VSKP31LXGZ	chr7	117535391	117535392	A	T	NC_000007.14:g.117535392A>T	NM_000492.3:c.724A>T	NP_000483.3:p.Arg242*					Cystic Fibrosis	R242X			CFTR	1080
VSG6KLTR8E	chr7	117535403	117535404	A	T	NC_000007.14:g.117535404A>T	NM_000492.3:c.736A>T	NP_000483.3:p.Lys246*					Cystic Fibrosis	K246X			CFTR	1080
VSASZAIF5E	chr7	117535405	117535406	G	GTACA	NC_000007.14:g.117535407_117535410dupTACA	NM_000492.3:c.739_742dupTACA	NP_000483.3:p.Arg248fs		357563	CI056209	rs1057517342	Cystic Fibrosis	874insTACA			CFTR	1080
VSGAPHL9QL	chr7	117535408	117535409	C	A	NC_000007.14:g.117535409C>A	NM_000492.3:c.741C>A	NP_000483.3:p.Tyr247*					Cystic Fibrosis	Y247X			CFTR	1080
VSTAPEMSVF	chr7	117535408	117535409	C	G	NC_000007.14:g.117535409C>G	NM_000492.3:c.741C>G	NP_000483.3:p.Tyr247*		68717	CM970268	rs1800082	Cystic Fibrosis	Y247X			CFTR	1080
VSACXKVEPI	chr7	117536563	117536564	A	T	NC_000007.14:g.117536564A>T	NM_000492.3:c.760A>T	NP_000483.3:p.Lys254*					Cystic Fibrosis	K254X			CFTR	1080
VSIL9EHCBL	chr7	117536572	117536573	G	T	NC_000007.14:g.117536573G>T	NM_000492.3:c.769G>T	NP_000483.3:p.Glu257*			CM063902		Cystic Fibrosis	E257X			CFTR	1080
VS25IUDCL3	chr7	117536575	117536576	A	T	NC_000007.14:g.117536576A>T	NM_000492.3:c.772A>T	NP_000483.3:p.Arg258*					Cystic Fibrosis	R258X			CFTR	1080
VSQHATB4U5	chr7	117536575	117536577	AG	A	NC_000007.14:g.117536577delG	NM_000492.3:c.773delG	NP_000483.3:p.Arg258fs		68723	CD931166	rs397508794	Cystic Fibrosis	905delG			CFTR	1080
VS1NV9XTRW	chr7	117536591	117536592	C	A	NC_000007.14:g.117536592C>A	NM_000492.3:c.788C>A	NP_000483.3:p.Ser263*					Cystic Fibrosis	S263X			CFTR	1080
VSGZIRBPRT	chr7	117536591	117536592	C	G	NC_000007.14:g.117536592C>G	NM_000492.3:c.788C>G	NP_000483.3:p.Ser263*					Cystic Fibrosis	S263X			CFTR	1080
VS6MP5L2EX	chr7	117536593	117536594	G	T	NC_000007.14:g.117536594G>T	NM_000492.3:c.790G>T	NP_000483.3:p.Glu264*					Cystic Fibrosis	E264X			CFTR	1080
VS31ZH5R9T	chr7	117536602	117536603	G	T	NC_000007.14:g.117536603G>T	NM_000492.3:c.799G>T	NP_000483.3:p.Glu267*					Cystic Fibrosis	E267X			CFTR	1080
VS601B7270	chr7	117536602	117536604	GA	G	NC_000007.14:g.117536607delA	NM_000492.3:c.803delA	NP_000483.3:p.Asn268fs		57862	CD000926	rs121908772	Cystic Fibrosis	935delA	AMR	0.000120265	CFTR	1080
VSZ8QYW6Z8	chr7	117536611	117536612	C	T	NC_000007.14:g.117536612C>T	NM_000492.3:c.808C>T	NP_000483.3:p.Gln270*					Cystic Fibrosis	Q270X			CFTR	1080
VSG1YDPRSJ	chr7	117536620	117536621	A	T	NC_000007.14:g.117536621A>T	NM_000492.3:c.817A>T	NP_000483.3:p.Lys273*					Cystic Fibrosis	K273X			CFTR	1080
VSY7PJYF83	chr7	117536628	117536629	C	G	NC_000007.14:g.117536629C>G	NM_000492.3:c.825C>G	NP_000483.3:p.Tyr275*		44554	CM001962	rs193922532	Cystic Fibrosis	c.825C>G			CFTR	1080
VSX25IGNQU	chr7	117536631	117536632	C	A	NC_000007.14:g.117536632C>A	NM_000492.3:c.828C>A	NP_000483.3:p.Cys276*		68731	CM950243	rs397508799	Cystic Fibrosis	C276X	NFE	9.01E-06	CFTR	1080
VSXN1JJLZT	chr7	117536633	117536634	G	A	NC_000007.14:g.117536634G>A	NM_000492.3:c.830G>A	NP_000483.3:p.Trp277*		171722	CM162717	rs672601317	Cystic Fibrosis	W277X			CFTR	1080
VSGEBU3AXF	chr7	117536659	117536660	G	T	NC_000007.14:g.117536660G>T	NM_000492.3:c.856G>T	NP_000483.3:p.Glu286*					Cystic Fibrosis	E286X			CFTR	1080
VSIKJ7VGC3	chr7	117536659	117536660	G	GA	NC_000007.14:g.117536664dupA	NM_000492.3:c.860dupA	NP_000483.3:p.Asn287fs		22275	CI031895	rs387906380	Cystic Fibrosis	989_992insA			CFTR	1080
VSEQ6Z9ZCU	chr7	117536661	117536667	AAACTT	A	NC_000007.14:g.117536665_117536669delCTTAA	NM_000492.3:c.861_865delCTTAA	NP_000483.3:p.Asn287fs		68739	CD962508	rs397508805	Cystic Fibrosis	991del5	NFE	9.00E-06	CFTR	1080
VSNWE4UVNT	chr7	117536666	117536667	T	G	NC_000007.14:g.117536667T>G	NM_000492.3:c.863T>G	NP_000483.3:p.Leu288*					Cystic Fibrosis	L288X			CFTR	1080
VSZ5R3CC63	chr7	117536666	117536667	T	A	NC_000007.14:g.117536667T>A	NM_000492.3:c.863T>A	NP_000483.3:p.Leu288*					Cystic Fibrosis	L288X			CFTR	1080
VSSEJEL39F	chr7	117536668	117536669	A	T	NC_000007.14:g.117536669A>T	NM_000492.3:c.865A>T	NP_000483.3:p.Arg289*		357565	CM1511150	rs1057516619	Cystic Fibrosis	R289X			CFTR	1080
VSUDZW9SM1	chr7	117536671	117536672	C	T	NC_000007.14:g.117536672C>T	NM_000492.3:c.868C>T	NP_000483.3:p.Gln290*			CM952046	rs397508808	Cystic Fibrosis	Q290X	EAS	5.82E-05	CFTR	1080
VSYS1U7GIC	chr7	117540103	117540104	G	T	NC_000007.14:g.117540104G>T	NM_000492.3:c.874G>T	NP_000483.3:p.Glu292*					Cystic Fibrosis	E292X			CFTR	1080
VSLRLJW3K8	chr7	117540108	117540111	GAA	G	NC_000007.14:g.117540111_117540112delAA	NM_000492.3:c.881_882delAA	NP_000483.3:p.Lys294fs		68746	CD941632	rs397508813	Cystic Fibrosis	1013delAA			CFTR	1080
VSIDLBPKP4	chr7	117540109	117540110	A	T	NC_000007.14:g.117540110A>T	NM_000492.3:c.880A>T	NP_000483.3:p.Lys294*					Cystic Fibrosis	K294X			CFTR	1080
VSK3K1PJD5	chr7	117540121	117540122	A	T	NC_000007.14:g.117540122A>T	NM_000492.3:c.892A>T	NP_000483.3:p.Lys298*					Cystic Fibrosis	K298X			CFTR	1080
VS5DZBLJNU	chr7	117540132	117540133	T	G	NC_000007.14:g.117540133T>G	NM_000492.3:c.903T>G	NP_000483.3:p.Tyr301*					Cystic Fibrosis	Y301X			CFTR	1080
VSUNSECYRI	chr7	117540136	117540137	A	T	NC_000007.14:g.117540137A>T	NM_000492.3:c.907A>T	NP_000483.3:p.Arg303*					Cystic Fibrosis	R303X			CFTR	1080
VSB247IAZU	chr7	117540141	117540142	C	G	NC_000007.14:g.117540142C>G	NM_000492.3:c.912C>G	NP_000483.3:p.Tyr304*			CM962460	rs397508816	Cystic Fibrosis	Y304X			CFTR	1080
VSK8JAZ85J	chr7	117540152	117540153	C	G	NC_000007.14:g.117540153C>G	NM_000492.3:c.923C>G	NP_000483.3:p.Ser308*					Cystic Fibrosis	S308X			CFTR	1080
VSDYQDXIWH	chr7	117540154	117540156	GC	G	NC_000007.14:g.117540157delC	NM_000492.3:c.927delC	NP_000483.3:p.Phe310fs			CD952064		Cystic Fibrosis	1058delC			CFTR	1080
VS102A1203	chr7	117540155	117540159	CCTT	C	NC_000007.14:g.117540165_117540167delTCT	NM_000492.3:c.935_937delTCT	NP_000483.3:p.Phe312del		57866	CD930921	rs121908768	Cystic Fibrosis	[delta]F311	AMR	0.000357867	CFTR	1080
VSRWMATQ6J	chr7	117540167	117540168	C	G	NC_000007.14:g.117540168C>G	NM_000492.3:c.938C>G	NP_000483.3:p.Ser313*					Cystic Fibrosis	S313X			CFTR	1080
VS6FE44C17	chr7	117540174	117540176	CT	C	NC_000007.14:g.117540178delT	NM_000492.3:c.948delT	NP_000483.3:p.Phe316fs		22202	CD920843	rs121908744	Cystic Fibrosis	1078delT	AFR	6.54E-05	CFTR	1080
VSJS87B3MC	chr7	117540188	117540189	T	A	NC_000007.14:g.117540189T>A	NM_000492.3:c.959T>A	NP_000483.3:p.Leu320*			CM015354	rs397508820	Cystic Fibrosis	L320X			CFTR	1080
VSZGSN3SUJ	chr7	117540188	117540189	T	G	NC_000007.14:g.117540189T>G	NM_000492.3:c.959T>G	NP_000483.3:p.Leu320*					Cystic Fibrosis	L320X			CFTR	1080
VSFLYZB4FA	chr7	117540204	117540205	T	A	NC_000007.14:g.117540205T>A	NM_000492.3:c.975T>A	NP_000483.3:p.Tyr325*					Cystic Fibrosis	Y325X			CFTR	1080
VSR7EIWEJA	chr7	117540213	117540215	CA	C	NC_000007.14:g.117540217delA	NM_000492.3:c.987delA	NP_000483.3:p.Gly330fs		68764	CD972122	rs397508824	Cystic Fibrosis	1119delA			CFTR	1080
VSB51YXTQ4	chr7	117540214	117540215	A	T	NC_000007.14:g.117540215A>T	NM_000492.3:c.985A>T	NP_000483.3:p.Lys329*					Cystic Fibrosis	K329X			CFTR	1080
VS93E901F0	chr7	117540217	117540218	G	T	NC_000007.14:g.117540218G>T	NM_000492.3:c.988G>T	NP_000483.3:p.Gly330*		57870	CM970272	rs79031340	Cystic Fibrosis	G330X			CFTR	1080
VS9E636C2B	chr7	117540229	117540230	C	T	NC_000007.14:g.117540230C>T	NM_000492.3:c.1000C>T	NP_000483.3:p.Arg334Trp		22178	CM910070	rs121909011	Cystic Fibrosis	R334W	AMR	0.000178795	CFTR	1080
VS7STJZ1F2	chr7	117540234	117540235	A	AG	NC_000007.14:g.117540235_117540236insG	NM_000492.3:c.1005_1006insG	NP_000483.3:p.Ile336fs					Cystic Fibrosis	1138insG			CFTR	1080
VS3407AC22	chr7	117540236	117540237	T	A	NC_000007.14:g.117540237T>A	NM_000492.3:c.1007T>A	NP_000483.3:p.Ile336Lys		67830	CM930103	rs397508139	Cystic Fibrosis	I336K	NFE	8.97E-06	CFTR	1080
VS8BA79F26	chr7	117540242	117540243	C	T	NC_000007.14:g.117540243C>T	NM_000492.3:c.1013C>T	NP_000483.3:p.Thr338Ile		22232	CM930104	rs77409459	Cystic Fibrosis	T338I	NFE	5.38E-05	CFTR	1080
VSW56PTHB6	chr7	117540246	117540248	CA	C	NC_000007.14:g.117540248delA	NM_000492.3:c.1018delA	NP_000483.3:p.Ile340fs			CD941997	rs397508143	Cystic Fibrosis	1150delA			CFTR	1080
VSB3262B85	chr7	117540247	117540248	A	ATC	NC_000007.14:g.117540251_117540252dupTC	NM_000492.3:c.1021_1022dupTC	NP_000483.3:p.Phe342fs		22173	CI910565	rs1131692275	Cystic Fibrosis	1154insTC	NFE	6.28E-05	CFTR	1080
VS48A816C1	chr7	117540250	117540251	T	C	NC_000007.14:g.117540251T>C	NM_000492.3:c.1021T>C	NP_000483.3:p.Ser341Pro		67835	CM057576	rs397508144	Cystic Fibrosis	S341P			CFTR	1080
VS5HGCGZS8	chr7	117540251	117540252	C	G	NC_000007.14:g.117540252C>G	NM_000492.3:c.1022C>G	NP_000483.3:p.Ser341*					Cystic Fibrosis	S341X			CFTR	1080
VSDJIGLZPQ	chr7	117540256	117540257	T	TG	NC_000007.14:g.117540258dupG	NM_000492.3:c.1028dupG	NP_000483.3:p.Cys343fs					Cystic Fibrosis	1161insG			CFTR	1080
VSIWMJGQ6N	chr7	117540257	117540259	GC	G	NC_000007.14:g.117540259delC	NM_000492.3:c.1029delC	NP_000483.3:p.Cys343fs		67838	CD982537	rs121908774	Cystic Fibrosis	1161delC	SAS	0.000519784	CFTR	1080
VS6X6TXI78	chr7	117540258	117540259	C	A	NC_000007.14:g.117540259C>A	NM_000492.3:c.1029C>A	NP_000483.3:p.Cys343*					Cystic Fibrosis	C343X			CFTR	1080
VS83C8C942	chr7	117540269	117540270	G	C	NC_000007.14:g.117540270G>C	NM_000492.3:c.1040G>C	NP_000483.3:p.Arg347Pro		22149	CM900044	rs77932196	Cystic Fibrosis	R347P	NFE	5.39E-05	CFTR	1080
VSDD8AFC1F	chr7	117540269	117540270	G	A	NC_000007.14:g.117540270G>A	NM_000492.3:c.1040G>A	NP_000483.3:p.Arg347His		22221	CM920152	rs77932196	Cystic Fibrosis	R347H	NFE	3.59E-05	CFTR	1080
VS0075C5AB	chr7	117540284	117540285	G	A	NC_000007.14:g.117540285G>A	NM_000492.3:c.1055G>A	NP_000483.3:p.Arg352Gln		22237	CM920153	rs121908753	Cystic Fibrosis	R352Q	SAS	0.000129955	CFTR	1080
VS2QQ4MIL3	chr7	117540286	117540287	C	T	NC_000007.14:g.117540287C>T	NM_000492.3:c.1057C>T	NP_000483.3:p.Gln353*			CM003243	rs397508148	Cystic Fibrosis	Q353X			CFTR	1080
VS1LXNIBL3	chr7	117540295	117540297	TG	T	NC_000007.14:g.117540299delG	NM_000492.3:c.1069delG	NP_000483.3:p.Ala357fs		67847	CD992497	rs397508151	Cystic Fibrosis	1199delG			CFTR	1080
VSC534Z58T	chr7	117540296	117540297	G	A	NC_000007.14:g.117540297G>A	NM_000492.3:c.1067G>A	NP_000483.3:p.Trp356*					Cystic Fibrosis	W356X (TAG)			CFTR	1080
VSWJ4GTFZ3	chr7	117540297	117540298	G	A	NC_000007.14:g.117540298G>A	NM_000492.3:c.1068G>A	NP_000483.3:p.Trp356*			CM983547	rs397508150	Cystic Fibrosis	W356X			CFTR	1080
VS8IUQ6AJK	chr7	117540304	117540305	C	T	NC_000007.14:g.117540305C>T	NM_000492.3:c.1075C>T	NP_000483.3:p.Gln359*					Cystic Fibrosis	Q359X			CFTR	1080
VS4AC03656	chr7	117540309	117540311	AT	A	NC_000007.14:g.117540311delT	NM_000492.3:c.1081delT	NP_000483.3:p.Trp361fs		22174	CD910489	rs387906361	Cystic Fibrosis	1213delT			CFTR	1080
VS2JRSX242	chr7	117540310	117540312	TG	T	NC_000007.14:g.117540313delG	NM_000492.3:c.1083delG	NP_000483.3:p.Trp361fs		22252	CD941633	rs387906375	Cystic Fibrosis	1215delG			CFTR	1080
VSLJXVVXWM	chr7	117540311	117540312	G	A	NC_000007.14:g.117540312G>A	NM_000492.3:c.1082G>A	NP_000483.3:p.Trp361*					Cystic Fibrosis	W361X			CFTR	1080
VSB4WQHGKQ	chr7	117540315	117540316	T	G	NC_000007.14:g.117540316T>G	NM_000492.3:c.1086T>G	NP_000483.3:p.Tyr362*		67854	CM021069	rs397508155	Cystic Fibrosis	c.1086T>G			CFTR	1080
VSTBMUQAUP	chr7	117540315	117540316	T	A	NC_000007.14:g.117540316T>A	NM_000492.3:c.1086T>A	NP_000483.3:p.Tyr362*		67853	CM104904	rs397508155	Cystic Fibrosis	c.1086T>A			CFTR	1080
VSQ7IYNGZK	chr7	117540325	117540326	G	T	NC_000007.14:g.117540326G>T	NM_000492.3:c.1096G>T	NP_000483.3:p.Gly366*					Cystic Fibrosis	G366X			CFTR	1080
VSUEH22PM1	chr7	117540336	117540337	C	CA	NC_000007.14:g.117540341dupA	NM_000492.3:c.1111dupA	NP_000483.3:p.Ile371fs					Cystic Fibrosis	c.1111dupA			CFTR	1080
VSSHXV1H86	chr7	117540337	117540338	A	T	NC_000007.14:g.117540338A>T	NM_000492.3:c.1108A>T	NP_000483.3:p.Lys370*					Cystic Fibrosis	K370X			CFTR	1080
VSF7YWBH7J	chr7	117540343	117540344	C	T	NC_000007.14:g.117540344C>T	NM_000492.3:c.1114C>T	NP_000483.3:p.Gln372*			CM1212240	rs1478315064	Cystic Fibrosis	c.1114C>T	AMR	2.98E-05	CFTR	1080
VS4826B622	chr7	117540346	117540347	G	A	NC_000007.14:g.117540347G>A	NM_000492.3:c.1116+1G>A			67858	CS001827	rs397508158	Cystic Fibrosis	1248+1G>A	NFE	9.01E-06	CFTR	1080
VSB775RC56	chr7	117542022	117542023	T	A	NC_000007.14:g.117542023T>A	NM_000492.3:c.1124T>A	NP_000483.3:p.Leu375*					Cystic Fibrosis	L375X			CFTR	1080
VS84AA3804	chr7	117542024	117542025	C	CA	NC_000007.14:g.117542029dupA	NM_000492.3:c.1130dupA	NP_000483.3:p.Gln378fs		480438	CI972570	rs397508163	Cystic Fibrosis	1259insA			CFTR	1080
VSQX8Q41N3	chr7	117542024	117542025	C	T	NC_000007.14:g.117542025C>T	NM_000492.3:c.1126C>T	NP_000483.3:p.Gln376*		610318			Cystic Fibrosis	Q376X			CFTR	1080
VSE1315F8B	chr7	117542027	117542028	A	T	NC_000007.14:g.117542028A>T	NM_000492.3:c.1129A>T	NP_000483.3:p.Lys377*					Cystic Fibrosis	K377X			CFTR	1080
VS5VMMNK7I	chr7	117542030	117542031	C	T	NC_000007.14:g.117542031C>T	NM_000492.3:c.1132C>T	NP_000483.3:p.Gln378*			CM1510238		Cystic Fibrosis	Q378X			CFTR	1080
VS7WDKR7H6	chr7	117542033	117542034	G	T	NC_000007.14:g.117542034G>T	NM_000492.3:c.1135G>T	NP_000483.3:p.Glu379*		67868	CM003245	rs397508165	Cystic Fibrosis	E379X	NFE	8.98E-06	CFTR	1080
VSCV3S7PQJ	chr7	117542038	117542039	T	G	NC_000007.14:g.117542039T>G	NM_000492.3:c.1140T>G	NP_000483.3:p.Tyr380*					Cystic Fibrosis	Y380X			CFTR	1080
VSHVFZ5PQF	chr7	117542039	117542040	A	T	NC_000007.14:g.117542040A>T	NM_000492.3:c.1141A>T	NP_000483.3:p.Lys381*		485739			Cystic Fibrosis	K381X			CFTR	1080
VS3DVWWJQ9	chr7	117542046	117542047	T	A	NC_000007.14:g.117542047T>A	NM_000492.3:c.1148T>A	NP_000483.3:p.Leu383*					Cystic Fibrosis	L383X			CFTR	1080
VS6FL7FLF8	chr7	117542048	117542050	GA	G	NC_000007.14:g.117542051delA	NM_000492.3:c.1152delA	NP_000483.3:p.Glu384fs		67870	CD972123	rs397508167	Cystic Fibrosis	1283delA			CFTR	1080
VSA45AEU1X	chr7	117542048	117542049	G	T	NC_000007.14:g.117542049G>T	NM_000492.3:c.1150G>T	NP_000483.3:p.Glu384*					Cystic Fibrosis	E384X			CFTR	1080
VSYGKNFZ9B	chr7	117542049	117542050	A	AAT	NC_000007.14:g.117542054_117542055dupTA	NM_000492.3:c.1155_1156dupTA	NP_000483.3:p.Asn386fs		480439	CI042896	rs121908785	Cystic Fibrosis	1289insTA	AMR	8.95E-05	CFTR	1080
VSDDYIWCW4	chr7	117542053	117542054	T	A	NC_000007.14:g.117542054T>A	NM_000492.3:c.1155T>A	NP_000483.3:p.Tyr385*					Cystic Fibrosis	Y385X			CFTR	1080
VSS27QEKIC	chr7	117542053	117542054	T	G	NC_000007.14:g.117542054T>G	NM_000492.3:c.1155T>G	NP_000483.3:p.Tyr385*					Cystic Fibrosis	Y385X			CFTR	1080
VS6MM3516G	chr7	117542056	117542059	CTT	C	NC_000007.14:g.117542058_117542059delTT	NM_000492.3:c.1159_1160delTT	NP_000483.3:p.Leu387fs			CD024715		Cystic Fibrosis	1291delTT			CFTR	1080
VS49IY5VFT	chr7	117542058	117542059	T	A	NC_000007.14:g.117542059T>A	NM_000492.3:c.1160T>A	NP_000483.3:p.Leu387*					Cystic Fibrosis	L387X (TAA)			CFTR	1080
VSN1P3T3I5	chr7	117542058	117542059	T	G	NC_000007.14:g.117542059T>G	NM_000492.3:c.1160T>G	NP_000483.3:p.Leu387*					Cystic Fibrosis	L387X			CFTR	1080
VSQYSIZBB6	chr7	117542060	117542062	AC	TA	NC_000007.14:g.117542061_117542062delACinsTA	NM_000492.3:c.1162_1163delACinsTA	NP_000483.3:p.Thr388*			CP931366		Cystic Fibrosis	T388X			CFTR	1080
VSJSLJU1YS	chr7	117542069	117542070	G	T	NC_000007.14:g.117542070G>T	NM_000492.3:c.1171G>T	NP_000483.3:p.Glu391*					Cystic Fibrosis	E391X			CFTR	1080
VSDAACPGML	chr7	117542073	117542075	TA	T	NC_000007.14:g.117542075delA	NM_000492.3:c.1176delA	NP_000483.3:p.Val393fs					Cystic Fibrosis	1309delG			CFTR	1080
VSX2DJ285M	chr7	117542081	117542082	G	T	NC_000007.14:g.117542082G>T	NM_000492.3:c.1183G>T	NP_000483.3:p.Glu395*					Cystic Fibrosis	E395X			CFTR	1080
VSVWIR6CP7	chr7	117542088	117542089	T	TA	NC_000007.14:g.117542091dupA	NM_000492.3:c.1192dupA	NP_000483.3:p.Thr398fs			CI983614		Cystic Fibrosis	1323insA			CFTR	1080
VSB98E24FD	chr7	117542100	117542101	G	A	NC_000007.14:g.117542101G>A	NM_000492.3:c.1202G>A	NP_000483.3:p.Trp401*		67880	CM972944	rs397508174	Cystic Fibrosis	W401X			CFTR	1080
VS500F9EE9	chr7	117542101	117542102	G	A	NC_000007.14:g.117542102G>A	NM_000492.3:c.1203G>A	NP_000483.3:p.Trp401*		67881	CM930111	rs397508175	Cystic Fibrosis	W401X (TGA)	NFE	8.99E-06	CFTR	1080
VSRDGG8FGA	chr7	117542102	117542103	G	T	NC_000007.14:g.117542103G>T	NM_000492.3:c.1204G>T	NP_000483.3:p.Glu402*					Cystic Fibrosis	E402X			CFTR	1080
VSSFM2HIYB	chr7	117542105	117542106	G	T	NC_000007.14:g.117542106G>T	NM_000492.3:c.1207G>T	NP_000483.3:p.Glu403*					Cystic Fibrosis	E403X			CFTR	1080
VS2DED8592	chr7	117542108	117542109	G	A	NC_000007.14:g.117542109G>A	NM_000492.3:c.1209+1G>A			67882	CS962492	rs397508176	Cystic Fibrosis	1341+1G>A			CFTR	1080
VS727A4C3A	chr7	117548627	117548628	G	GTT	NC_000007.14:g.117548634_117548635dupTT	NM_000492.3:c.1210-7_1210-6dupTT		9T	171032		rs200454589	Cystic Fibrosis	9T	FIN	0.104258001	CFTR	1080
VS889D2CB9	chr7	117548627	117548630	GTT	G	NC_000007.14:g.117548634_117548635delTT	NM_000492.3:c.1210-7_1210-6delTT		5T	205614	CD1716966	rs1491448762	Cystic Fibrosis	5T	AFR	0.0664474	CFTR	1080
VSSJTPV3QG	chr7	117548640	117548641	G	T	NC_000007.14:g.117548641G>T	NM_000492.3:c.1210G>T	NP_000483.3:p.Gly404*					Cystic Fibrosis	G404X			CFTR	1080
VSJS7NLGV4	chr7	117548649	117548650	G	T	NC_000007.14:g.117548650G>T	NM_000492.3:c.1219G>T	NP_000483.3:p.Glu407*		487125			Cystic Fibrosis	E407X			CFTR	1080
VSKP1NEJRZ	chr7	117548653	117548654	T	A	NC_000007.14:g.117548654T>A	NM_000492.3:c.1223T>A	NP_000483.3:p.Leu408*					Cystic Fibrosis	L408X			CFTR	1080
VSRR7TEW8N	chr7	117548653	117548654	T	G	NC_000007.14:g.117548654T>G	NM_000492.3:c.1223T>G	NP_000483.3:p.Leu408*					Cystic Fibrosis	L408X			CFTR	1080
VSVLM691YS	chr7	117548654	117548656	AT	A	NC_000007.14:g.117548658delT	NM_000492.3:c.1227delT	NP_000483.3:p.Phe409fs					Cystic Fibrosis	c.1227delT			CFTR	1080
VSG6FCXNIM	chr7	117548658	117548659	G	T	NC_000007.14:g.117548659G>T	NM_000492.3:c.1228G>T	NP_000483.3:p.Glu410*					Cystic Fibrosis	E410X			CFTR	1080
VSUZBSVKVS	chr7	117548661	117548662	A	T	NC_000007.14:g.117548662A>T	NM_000492.3:c.1231A>T	NP_000483.3:p.Lys411*					Cystic Fibrosis	K411X			CFTR	1080
VSMUDD4KZ3	chr7	117548663	117548665	AG	A	NC_000007.14:g.117548665delG	NM_000492.3:c.1234delG	NP_000483.3:p.Ala412fs		67888	CD972971	rs397508181	Cystic Fibrosis	1366delG			CFTR	1080
VS572QPCA5	chr7	117548664	117548670	GCAAAA	G	NC_000007.14:g.117548674_117548678delAACAA	NM_000492.3:c.1243_1247delAACAA	NP_000483.3:p.Asn415fs			CD993887	rs397508184	Cystic Fibrosis	1367del5			CFTR	1080
VSWC6XJBDW	chr7	117548664	117548666	GC	G	NC_000007.14:g.117548666delC	NM_000492.3:c.1235delC	NP_000483.3:p.Ala412fs		67889	CD993886	rs397508182	Cystic Fibrosis	1367delC			CFTR	1080
VSAHS7STFH	chr7	117548667	117548668	A	T	NC_000007.14:g.117548668A>T	NM_000492.3:c.1237A>T	NP_000483.3:p.Lys413*					Cystic Fibrosis	K413X			CFTR	1080
VSWKEZV2BB	chr7	117548670	117548671	C	T	NC_000007.14:g.117548671C>T	NM_000492.3:c.1240C>T	NP_000483.3:p.Gln414*		67890	CM940249	rs397508183	Cystic Fibrosis	Q414X			CFTR	1080
VSWE4YJRPW	chr7	117548731	117548732	C	G	NC_000007.14:g.117548732C>G	NM_000492.3:c.1301C>G	NP_000483.3:p.Ser434*		544156	CM983551		Cystic Fibrosis	S434X			CFTR	1080
VS1Q7BQ1WL	chr7	117548754	117548755	A	T	NC_000007.14:g.117548755A>T	NM_000492.3:c.1324A>T	NP_000483.3:p.Lys442*			CM155027		Cystic Fibrosis	K442X			CFTR	1080
VSC72F45BD	chr7	117548755	117548756	A	AAGAT	NC_000007.14:g.117548758_117548761dupGATA	NM_000492.3:c.1327_1330dupGATA	NP_000483.3:p.Ile444fs		186745	CI951922	rs1403089710	Cystic Fibrosis	1461ins4	NFE	6.57E-05	CFTR	1080
VSWRH6WG2Y	chr7	117548757	117548760	GAT	G	NC_000007.14:g.117548761_117548762delAT	NM_000492.3:c.1330_1331delAT	NP_000483.3:p.Ile444fs		67899	CD961885	rs397508190	Cystic Fibrosis	1460delAT			CFTR	1080
VS2KEURV5D	chr7	117548768	117548770	CA	C	NC_000007.14:g.117548771delA	NM_000492.3:c.1340delA	NP_000483.3:p.Lys447fs		67901	CD993888	rs1455236122	Cystic Fibrosis	1471delA	NFE	9.35E-06	CFTR	1080
VSWTEQ81CJ	chr7	117548769	117548770	A	T	NC_000007.14:g.117548770A>T	NM_000492.3:c.1339A>T	NP_000483.3:p.Lys447*					Cystic Fibrosis	K447X			CFTR	1080
VSZVZXYCDR	chr7	117548775	117548776	G	T	NC_000007.14:g.117548776G>T	NM_000492.3:c.1345G>T	NP_000483.3:p.Glu449*					Cystic Fibrosis	E449X			CFTR	1080
VSSDPAK8CG	chr7	117548778	117548779	A	T	NC_000007.14:g.117548779A>T	NM_000492.3:c.1348A>T	NP_000483.3:p.Arg450*					Cystic Fibrosis	R450X			CFTR	1080
VSG7UVZYCZ	chr7	117548781	117548782	G	T	NC_000007.14:g.117548782G>T	NM_000492.3:c.1351G>T	NP_000483.3:p.Gly451*					Cystic Fibrosis	G451X			CFTR	1080
VSSDKF4IAX	chr7	117548782	117548783	G	GT	NC_000007.14:g.117548783_117548784insT	NM_000492.3:c.1352_1353insT	NP_000483.3:p.Gln452fs					Cystic Fibrosis	c.1353_1354insT			CFTR	1080
VSDJF7Z2G6	chr7	117548784	117548785	C	T	NC_000007.14:g.117548785C>T	NM_000492.3:c.1354C>T	NP_000483.3:p.Gln452*					Cystic Fibrosis	Q452X			CFTR	1080
VS7CR49FN2	chr7	117548788	117548789	T	A	NC_000007.14:g.117548789T>A	NM_000492.3:c.1358T>A	NP_000483.3:p.Leu453*					Cystic Fibrosis	L453X			CFTR	1080
VS271RDBR8	chr7	117548791	117548792	T	A	NC_000007.14:g.117548792T>A	NM_000492.3:c.1361T>A	NP_000483.3:p.Leu454*					Cystic Fibrosis	L454X			CFTR	1080
VS69FCEFBE	chr7	117548794	117548795	C	A	NC_000007.14:g.117548795C>A	NM_000492.3:c.1364C>A	NP_000483.3:p.Ala455Glu		22150	CM900045	rs74551128	Cystic Fibrosis	A455E	ASJ	0.000103734	CFTR	1080
VSHDU9RSIC	chr7	117548794	117548797	CGG	C	NC_000007.14:g.117548796_117548797delGG	NM_000492.3:c.1365_1366delGG	NP_000483.3:p.Val456fs		205615	CD024716	rs797045161	Cystic Fibrosis	1497delGG			CFTR	1080
VS92SN7VYG	chr7	117548801	117548803	TG	T	NC_000007.14:g.117548804delG	NM_000492.3:c.1373delG	NP_000483.3:p.Gly458fs		67905	CD972125	rs1425243442	Cystic Fibrosis	1504delG	AFR	6.84E-05	CFTR	1080
VSCRRMJGSI	chr7	117548802	117548803	G	T	NC_000007.14:g.117548803G>T	NM_000492.3:c.1372G>T	NP_000483.3:p.Gly458*					Cystic Fibrosis	G458X			CFTR	1080
VS3SJZJ7H8	chr7	117548811	117548812	G	T	NC_000007.14:g.117548812G>T	NM_000492.3:c.1381G>T	NP_000483.3:p.Gly461*					Cystic Fibrosis	G461X			CFTR	1080
VSF2D99FC3	chr7	117559462	117559463	G	A	NC_000007.14:g.117559463G>A	NM_000492.3:c.1393-1G>A			67910	CS930767	rs397508200	Cystic Fibrosis	1525-1G>A	SAS	0.000259909	CFTR	1080
VS85123591	chr7	117559467	117559468	C	A	NC_000007.14:g.117559468C>A	NM_000492.3:c.1397C>A	NP_000483.3:p.Ser466*		67912	CM960278	rs121908805	Cystic Fibrosis	S466X			CFTR	1080
VS921DAF7C	chr7	117559467	117559468	C	G	NC_000007.14:g.117559468C>G	NM_000492.3:c.1397C>G	NP_000483.3:p.Ser466*		44486	CM940251	rs121908805	Cystic Fibrosis	S466X	AFR	6.54E-05	CFTR	1080
VS013A3F71	chr7	117559470	117559471	T	C	NC_000007.14:g.117559471T>C	NM_000492.3:c.1400T>C	NP_000483.3:p.Leu467Pro		44487	CM107799	rs139573311	Cystic Fibrosis	L467P	AFR	0.000130804	CFTR	1080
VSUI3B8GZ7	chr7	117559476	117559487	TGGTGATTATG	T	NC_000007.14:g.117559480_117559489del	NM_000492.3:c.1409_1418del	NP_000483.3:p.Val470fs		67918	CD983602	rs397508204	Cystic Fibrosis	1540del10			CFTR	1080
VS2CJ12KCY	chr7	117559478	117559479	G	A	NC_000007.14:g.117559479G>A	NM_000492.3:c.1408G>A	NP_000483.3:p.Val470Met		22169	CM034388	rs213950	fingerprint variant		AFR	0.873839021	CFTR	1080
VSB947F533	chr7	117559485	117559487	TG	T	NC_000007.14:g.117559489delG	NM_000492.3:c.1418delG	NP_000483.3:p.Gly473fs		67919	CD972126	rs397508205	Cystic Fibrosis	1548delG			CFTR	1080
VSRD1D76EW	chr7	117559487	117559488	G	T	NC_000007.14:g.117559488G>T	NM_000492.3:c.1417G>T	NP_000483.3:p.Gly473*					Cystic Fibrosis	G473X			CFTR	1080
VS2YVI8G6R	chr7	117559490	117559491	G	T	NC_000007.14:g.117559491G>T	NM_000492.3:c.1420G>T	NP_000483.3:p.Glu474*					Cystic Fibrosis	E474X			CFTR	1080
VST21JLA8H	chr7	117559496	117559497	G	T	NC_000007.14:g.117559497G>T	NM_000492.3:c.1426G>T	NP_000483.3:p.Glu476*					Cystic Fibrosis	E476X			CFTR	1080
VSYPARPCEQ	chr7	117559502	117559505	TCA	T	NC_000007.14:g.117559504_117559505delCA	NM_000492.3:c.1433_1434delCA	NP_000483.3:p.Ser478fs			CD067860	rs397508206	Cystic Fibrosis	1565delCA			CFTR	1080
VS8AVFLPSL	chr7	117559503	117559504	C	A	NC_000007.14:g.117559504C>A	NM_000492.3:c.1433C>A	NP_000483.3:p.Ser478*					Cystic Fibrosis	S478X			CFTR	1080
VSATY5T96G	chr7	117559503	117559504	C	G	NC_000007.14:g.117559504C>G	NM_000492.3:c.1433C>G	NP_000483.3:p.Ser478*					Cystic Fibrosis	S478X			CFTR	1080
VSC1K64L6T	chr7	117559505	117559506	G	T	NC_000007.14:g.117559506G>T	NM_000492.3:c.1435G>T	NP_000483.3:p.Glu479*			CM074728	rs397508207	Cystic Fibrosis	E479X			CFTR	1080
VSNSCK5LPA	chr7	117559506	117559508	AG	A	NC_000007.14:g.117559510delG	NM_000492.3:c.1439delG	NP_000483.3:p.Gly480fs			CD931167		Cystic Fibrosis	1571delG			CFTR	1080
VSJIM8Q5S5	chr7	117559511	117559512	A	T	NC_000007.14:g.117559512A>T	NM_000492.3:c.1441A>T	NP_000483.3:p.Lys481*					Cystic Fibrosis	K481X			CFTR	1080
VSESFIBI2A	chr7	117559514	117559515	A	AT	NC_000007.14:g.117559517dupT	NM_000492.3:c.1446dupT	NP_000483.3:p.Lys483fs		67924		rs397508209	Cystic Fibrosis	1576insT			CFTR	1080
VS1X6TAUZK	chr7	117559517	117559518	A	T	NC_000007.14:g.117559518A>T	NM_000492.3:c.1447A>T	NP_000483.3:p.Lys483*					Cystic Fibrosis	K483X			CFTR	1080
VSRAI673TR	chr7	117559526	117559527	G	T	NC_000007.14:g.117559527G>T	NM_000492.3:c.1456G>T	NP_000483.3:p.Gly486*			CM952050		Cystic Fibrosis	G486X			CFTR	1080
VSSNKSWYZV	chr7	117559529	117559530	A	T	NC_000007.14:g.117559530A>T	NM_000492.3:c.1459A>T	NP_000483.3:p.Arg487*					Cystic Fibrosis	R487X			CFTR	1080
VS75675066	chr7	117559536	117559537	C	A	NC_000007.14:g.117559537C>A	NM_000492.3:c.1466C>A	NP_000483.3:p.Ser489*		67927	CM970276	rs397508211	Cystic Fibrosis	S489X	NFE	8.96E-06	CFTR	1080
VS7VKB2TJW	chr7	117559537	117559539	AT	A	NC_000007.14:g.117559540delT	NM_000492.3:c.1469delT	NP_000483.3:p.Phe490fs		432617		rs775663783	Cystic Fibrosis	c.1469delT	AMR	2.98E-05	CFTR	1080
VS6LIRU9Q4	chr7	117559538	117559541	TTC	T	NC_000007.14:g.117559541_117559542delCT	NM_000492.3:c.1470_1471delCT	NP_000483.3:p.Phe490fs			CD962511	rs397508212	Cystic Fibrosis	1601delTC			CFTR	1080
VSJUUA95JQ	chr7	117559543	117559544	T	A	NC_000007.14:g.117559544T>A	NM_000492.3:c.1473T>A	NP_000483.3:p.Cys491*					Cystic Fibrosis	C491X			CFTR	1080
VS85991402	chr7	117559545	117559546	C	T	NC_000007.14:g.117559546C>T	NM_000492.3:c.1475C>T	NP_000483.3:p.Ser492Phe		22194	CM920156	rs121909017	Cystic Fibrosis	S492F	AMR	2.98E-05	CFTR	1080
VS92755F46	chr7	117559547	117559548	C	T	NC_000007.14:g.117559548C>T	NM_000492.3:c.1477C>T	NP_000483.3:p.Gln493*		22146	CM900046	rs77101217	Cystic Fibrosis	Q493X	NFE	4.48E-05	CFTR	1080
VSVZS9FL2P	chr7	117559577	117559578	A	T	NC_000007.14:g.117559578A>T	NM_000492.3:c.1507A>T	NP_000483.3:p.Lys503*					Cystic Fibrosis	K503X			CFTR	1080
VSV4K9XTKW	chr7	117559580	117559581	G	T	NC_000007.14:g.117559581G>T	NM_000492.3:c.1510G>T	NP_000483.3:p.Glu504*		67942	CM972947	rs397508223	Cystic Fibrosis	E504X			CFTR	1080
VS4C47BFBA	chr7	117559585	117559589	TATC	T	NC_000007.14:g.117559590_117559592delATC	NM_000492.3:c.1519_1521delATC	NP_000483.3:p.Ile507del		22145	CD900275	rs121908745	Cystic Fibrosis	[delta]I507	AFR	0.000130702	CFTR	1080
VS62BC7AED	chr7	117559589	117559593	ATCT	A	NC_000007.14:g.117559592_117559594delCTT	NM_000492.3:c.1521_1523delCTT	NP_000483.3:p.Phe508del	[delta]F508	22144	CD890142	rs113993960	Cystic Fibrosis	[delta]F508	NFE	0.0120356	CFTR	1080
VS623D79D7	chr7	117559593	117559594	T	G	NC_000007.14:g.117559594T>G	NM_000492.3:c.1523T>G	NP_000483.3:p.Phe508Cys	F508C	22165	CM900048	rs74571530	Cystic Fibrosis	F508C	NFE	0.00176299	CFTR	1080
VS9RRJ7U8A	chr7	117559597	117559599	TG	T	NC_000007.14:g.117559599delG	NM_000492.3:c.1528delG	NP_000483.3:p.Val510fs			CD067859		Cystic Fibrosis	1660delG			CFTR	1080
VSMKSWPWGJ	chr7	117559606	117559607	T	G	NC_000007.14:g.117559607T>G	NM_000492.3:c.1536T>G	NP_000483.3:p.Tyr512*					Cystic Fibrosis	Y512X			CFTR	1080
VSHJ9TTPUL	chr7	117559610	117559611	G	T	NC_000007.14:g.117559611G>T	NM_000492.3:c.1540G>T	NP_000483.3:p.Glu514*					Cystic Fibrosis	E514X			CFTR	1080
VSECC6F2C3	chr7	117559611	117559614	AAT	A	NC_000007.14:g.117559616_117559617delTA	NM_000492.3:c.1545_1546delTA	NP_000483.3:p.Tyr515fs		22179	CD910490	rs121908776	Cystic Fibrosis	1677delTA			CFTR	1080
VSAAIA55M4	chr7	117559616	117559617	A	T	NC_000007.14:g.117559617A>T	NM_000492.3:c.1546A>T	NP_000483.3:p.Arg516*					Cystic Fibrosis	R516X			CFTR	1080
VSABA590CE	chr7	117559628	117559629	G	T	NC_000007.14:g.117559629G>T	NM_000492.3:c.1558G>T	NP_000483.3:p.Val520Phe		22189	CM920158	rs77646904	Cystic Fibrosis	V520F	NFE	8.97E-06	CFTR	1080
VS1FD8E50F	chr7	117587730	117587731	G	A	NC_000007.14:g.117587731G>A	NM_000492.3:c.1585-8G>A			44492	CS941441	rs193922503	Cystic Fibrosis	1717-8G>A			CFTR	1080
VS052B70BF	chr7	117587737	117587738	G	A	NC_000007.14:g.117587738G>A	NM_000492.3:c.1585-1G>A			22151	CS900233	rs76713772	Cystic Fibrosis	1717-1G>A	ASJ	0.000203169	CFTR	1080
VSZL4W8VY5	chr7	117587747	117587748	A	T	NC_000007.14:g.117587748A>T	NM_000492.3:c.1594A>T	NP_000483.3:p.Lys532*					Cystic Fibrosis	R532X			CFTR	1080
VS3VS4ZT1S	chr7	117587756	117587757	G	T	NC_000007.14:g.117587757G>T	NM_000492.3:c.1603G>T	NP_000483.3:p.Glu535*					Cystic Fibrosis	E535X			CFTR	1080
VSWZ84Z8G6	chr7	117587759	117587760	A	T	NC_000007.14:g.117587760A>T	NM_000492.3:c.1606A>T	NP_000483.3:p.Lys536*		67965	CM065997	rs148173473	Cystic Fibrosis	K536X			CFTR	1080
VSGUZRQHD6	chr7	117587762	117587765	GAC	G	NC_000007.14:g.117587765_117587766delCA	NM_000492.3:c.1611_1612delCA	NP_000483.3:p.Asp537fs		67966	CD983603	rs397508239	Cystic Fibrosis	1742delAC			CFTR	1080
VSZ8L5MPA8	chr7	117587765	117587766	A	AAT	NC_000007.14:g.117587770_117587771dupTA	NM_000492.3:c.1616_1617dupTA	NP_000483.3:p.Val540fs			CI003301		Cystic Fibrosis	1749insTA			CFTR	1080
VSF41ED101	chr7	117587777	117587778	G	T	NC_000007.14:g.117587778G>T	NM_000492.3:c.1624G>T	NP_000483.3:p.Gly542*		22154	CM900049	rs113993959	Cystic Fibrosis	G542X	ASJ	0.00142248	CFTR	1080
VSPBD31S8E	chr7	117587780	117587781	G	T	NC_000007.14:g.117587781G>T	NM_000492.3:c.1627G>T	NP_000483.3:p.Glu543*					Cystic Fibrosis	E543X			CFTR	1080
VSYFEXNR8Z	chr7	117587786	117587787	G	T	NC_000007.14:g.117587787G>T	NM_000492.3:c.1633G>T	NP_000483.3:p.Gly545*					Cystic Fibrosis	G545X			CFTR	1080
VS2F6RPVTE	chr7	117587794	117587797	ACT	A	NC_000007.14:g.117587796_117587797delCT	NM_000492.3:c.1642_1643delCT	NP_000483.3:p.Leu548fs			CD941999	rs397508246	Cystic Fibrosis	1774delCT			CFTR	1080
VS5IB7TC33	chr7	117587795	117587800	CTGAG	C	NC_000007.14:g.117587799_117587802delAGTG	NM_000492.3:c.1645_1648delAGTG	NP_000483.3:p.Ser549fs					Cystic Fibrosis	c.1645_1648delAGTG			CFTR	1080
VS13ACE37F	chr7	117587798	117587799	A	C	NC_000007.14:g.117587799A>C	NM_000492.3:c.1645A>C	NP_000483.3:p.Ser549Arg		47338	CM910071	rs121908757	Cystic Fibrosis	S549R	NFE	8.98E-06	CFTR	1080
VSDE5BEF69	chr7	117587799	117587800	G	A	NC_000007.14:g.117587800G>A	NM_000492.3:c.1646G>A	NP_000483.3:p.Ser549Asn		22155	CM900050	rs121908755	Cystic Fibrosis	S549N	SAS	0.000357561	CFTR	1080
VS8DF78295	chr7	117587800	117587801	T	G	NC_000007.14:g.117587801T>G	NM_000492.3:c.1647T>G	NP_000483.3:p.Ser549Arg		22157	CM900052	rs121909005	Cystic Fibrosis	S549R	AMR	5.98E-05	CFTR	1080
VSZPJM6UWL	chr7	117587801	117587802	G	T	NC_000007.14:g.117587802G>T	NM_000492.3:c.1648G>T	NP_000483.3:p.Gly550*		67980	CM920984	rs397508247	Cystic Fibrosis	G550X			CFTR	1080
VSU9LH8BKL	chr7	117587802	117587804	GA	G	NC_000007.14:g.117587804delA	NM_000492.3:c.1650delA	NP_000483.3:p.Gly551fs		67987	CD942000	rs397508251	Cystic Fibrosis	1782delA			CFTR	1080
VSGKDDVDT9	chr7	117587803	117587805	AG	A	NC_000007.14:g.117587806delG	NM_000492.3:c.1652delG	NP_000483.3:p.Gly551fs		67988	CD910491	rs397508252	Cystic Fibrosis	1784delG			CFTR	1080
VS5WUWUVXS	chr7	117587804	117587805	G	A	NC_000007.14:g.117587805G>A	NM_000492.3:c.1651G>A	NP_000483.3:p.Gly551Ser		22181	CM920160	rs121909013	Cystic Fibrosis	G551S	AMR	2.99E-05	CFTR	1080
VSCBE4E150	chr7	117587805	117587806	G	A	NC_000007.14:g.117587806G>A	NM_000492.3:c.1652G>A	NP_000483.3:p.Gly551Asp		22159	CM900053	rs75527207	Cystic Fibrosis	G551D	NFE	0.000395314	CFTR	1080
VS3EB76C43	chr7	117587807	117587808	C	T	NC_000007.14:g.117587808C>T	NM_000492.3:c.1654C>T	NP_000483.3:p.Gln552*		22240	CM910072	rs76554633	Cystic Fibrosis	Q552X			CFTR	1080
VSGU6KD8WV	chr7	117587807	117587809	CA	C	NC_000007.14:g.117587810delA	NM_000492.3:c.1656delA	NP_000483.3:p.Gln552fs		67989	CD993889	rs397508253	Cystic Fibrosis	1787delA			CFTR	1080
VS06379F0F	chr7	117587810	117587811	C	T	NC_000007.14:g.117587811C>T	NM_000492.3:c.1657C>T	NP_000483.3:p.Arg553*		22161	CM900054	rs74597325	Cystic Fibrosis	R553X	NFE	0.00013481	CFTR	1080
VS19NMNYM5	chr7	117587811	117587812	G	GA	NC_000007.14:g.117587813dupA	NM_000492.3:c.1659dupA	NP_000483.3:p.Ala554fs					Cystic Fibrosis	c.1660_1661insA			CFTR	1080
VSYTMIE77C	chr7	117587816	117587817	A	T	NC_000007.14:g.117587817A>T	NM_000492.3:c.1663A>T	NP_000483.3:p.Arg555*					Cystic Fibrosis	R555X			CFTR	1080
VSM5YE157M	chr7	117587822	117587824	TC	T	NC_000007.14:g.117587824delC	NM_000492.3:c.1670delC	NP_000483.3:p.Ser557fs		67994	CD962512	rs397508257	Cystic Fibrosis	1802delC			CFTR	1080
VSJVY1X1U5	chr7	117587826	117587828	TA	T	NC_000007.14:g.117587828delA	NM_000492.3:c.1674delA	NP_000483.3:p.Ala559fs			CD931168	rs397508258	Cystic Fibrosis	1806delA			CFTR	1080
VSUS15IPF7	chr7	117587826	117587827	T	A	NC_000007.14:g.117587827T>A	NM_000492.3:c.1673T>A	NP_000483.3:p.Leu558*					Cystic Fibrosis	L558X (TAA)			CFTR	1080
VSVTFELMGZ	chr7	117587826	117587827	T	G	NC_000007.14:g.117587827T>G	NM_000492.3:c.1673T>G	NP_000483.3:p.Leu558*					Cystic Fibrosis	L558X			CFTR	1080
VS04829F58	chr7	117587828	117587829	G	A	NC_000007.14:g.117587829G>A	NM_000492.3:c.1675G>A	NP_000483.3:p.Ala559Thr		22162	CM900055	rs75549581	Cystic Fibrosis	A559T	AFR	0.000261883	CFTR	1080
VSA8391BAB	chr7	117587832	117587833	G	A	NC_000007.14:g.117587833G>A	NM_000492.3:c.1679G>A	NP_000483.3:p.Arg560Lys		22195	CM920163	rs80055610	Cystic Fibrosis	R560K			CFTR	1080
VSB51D412E	chr7	117587832	117587833	G	C	NC_000007.14:g.117587833G>C	NM_000492.3:c.1679G>C	NP_000483.3:p.Arg560Thr		22152	CM900056	rs80055610	Cystic Fibrosis	R560T	NFE	4.50E-05	CFTR	1080
VS1UFPYZ4V	chr7	117587833	117587834	G	C	NC_000007.14:g.117587834G>C	NM_000492.3:c.1679+1G>C			68003	CS961504	rs397508263	Cystic Fibrosis	1811+1G>C			CFTR	1080
VS5A699F32	chr7	117589466	117589467	A	G	NC_000007.14:g.117589467A>G	NM_000492.3:c.1680-886A>G			68006	CS951372	rs397508266	Cystic Fibrosis	1811+1.6kbA>G			CFTR	1080
VS5FN9VIQG	chr7	117589482	117589483	T	A	NC_000007.14:g.117589483T>A	NM_000492.3:c.1680-870T>A			68000		rs213965	fingerprint variant				CFTR	1080
VS61BFD731	chr7	117590351	117590352	G	A	NC_000007.14:g.117590352G>A	NM_000492.3:c.1680-1G>A			57843	CS941442	rs121908794	Cystic Fibrosis	1812-1G>A	AMR	2.98E-05	CFTR	1080
VS2BCR6LTF	chr7	117590353	117590354	G	GC	NC_000007.14:g.117590355dupC	NM_000492.3:c.1682dupC	NP_000483.3:p.Val562fs			CI962521	rs397508268	Cystic Fibrosis	1813insC			CFTR	1080
VS1N12YT1D	chr7	117590354	117590355	C	A	NC_000007.14:g.117590355C>A	NM_000492.3:c.1682C>A	NP_000483.3:p.Ala561Glu		22279	CM970278	rs121909047	Cystic Fibrosis	A561E	AMR	8.95E-05	CFTR	1080
VS92F7A2S4	chr7	117590361	117590362	C	G	NC_000007.14:g.117590362C>G	NM_000492.3:c.1689C>G	NP_000483.3:p.Tyr563*					Cystic Fibrosis	Y563X			CFTR	1080
VSKZ6XP7PB	chr7	117590361	117590363	CA	C	NC_000007.14:g.117590365delA	NM_000492.3:c.1692delA	NP_000483.3:p.Asp565fs		44495	CD1516642	rs193922505	Cystic Fibrosis	1824delA	AFR	0.000131113	CFTR	1080
VSWTE9YLE3	chr7	117590362	117590363	A	T	NC_000007.14:g.117590363A>T	NM_000492.3:c.1690A>T	NP_000483.3:p.Lys564*					Cystic Fibrosis	K564X			CFTR	1080
VSNT6X395E	chr7	117590372	117590374	AT	A	NC_000007.14:g.117590376delT	NM_000492.3:c.1703delT	NP_000483.3:p.Leu568fs		68017	CD920991	rs397508274	Cystic Fibrosis	1833delT			CFTR	1080
VS5M2XYKRH	chr7	117590375	117590376	T	A	NC_000007.14:g.117590376T>A	NM_000492.3:c.1703T>A	NP_000483.3:p.Leu568*		68016	CM970280	rs397508273	Cystic Fibrosis	L568X			CFTR	1080
VSC756AF33	chr7	117590377	117590378	T	G	NC_000007.14:g.117590378T>G	NM_000492.3:c.1705T>G	NP_000483.3:p.Tyr569Asp		68020	CM980339	rs397508276	Cystic Fibrosis	Y569D	SAS	0.000780589	CFTR	1080
VSV4UJJ3JP	chr7	117590379	117590380	T	A	NC_000007.14:g.117590380T>A	NM_000492.3:c.1707T>A	NP_000483.3:p.Tyr569*		68022	CM931149	rs397508278	Cystic Fibrosis	Y569X			CFTR	1080
VS4WMYKHT9	chr7	117590381	117590382	T	G	NC_000007.14:g.117590382T>G	NM_000492.3:c.1709T>G	NP_000483.3:p.Leu570*					Cystic Fibrosis	L570X (TGA)			CFTR	1080
VSFTHS6V5B	chr7	117590381	117590382	T	A	NC_000007.14:g.117590382T>A	NM_000492.3:c.1709T>A	NP_000483.3:p.Leu570*					Cystic Fibrosis	L570X			CFTR	1080
VSJJZ7MEH3	chr7	117590384	117590387	TAG	T	NC_000007.14:g.117590387_117590388delGA	NM_000492.3:c.1714_1715delGA	NP_000483.3:p.Asp572fs		68025	CD993890	rs397508281	Cystic Fibrosis	1845delAG/1846delGA			CFTR	1080
VSLF4D27PM	chr7	117590384	117590385	T	A	NC_000007.14:g.117590385T>A	NM_000492.3:c.1712T>A	NP_000483.3:p.Leu571*					Cystic Fibrosis	L571X (TAA)			CFTR	1080
VSQZIULM7S	chr7	117590384	117590385	T	G	NC_000007.14:g.117590385T>G	NM_000492.3:c.1712T>G	NP_000483.3:p.Leu571*					Cystic Fibrosis	L571X			CFTR	1080
VSEN6SHB2M	chr7	117590398	117590399	G	T	NC_000007.14:g.117590399G>T	NM_000492.3:c.1726G>T	NP_000483.3:p.Gly576*		68028	CM962466	rs397508284	Cystic Fibrosis	G576X			CFTR	1080
VSM84BRZ5Q	chr7	117590403	117590404	C	G	NC_000007.14:g.117590404C>G	NM_000492.3:c.1731C>G	NP_000483.3:p.Tyr577*					Cystic Fibrosis	Y577X (TAG)			CFTR	1080
VSP6VU5SDU	chr7	117590403	117590404	C	A	NC_000007.14:g.117590404C>A	NM_000492.3:c.1731C>A	NP_000483.3:p.Tyr577*					Cystic Fibrosis	Y577X			CFTR	1080
VSYGG7IVY7	chr7	117590409	117590411	TG	T	NC_000007.14:g.117590411delG	NM_000492.3:c.1738delG	NP_000483.3:p.Val580fs		68034	CD003290	rs397508289	Cystic Fibrosis	1870delG			CFTR	1080
VS1JEGUENG	chr7	117590410	117590411	G	GT	NC_000007.14:g.117590415dupT	NM_000492.3:c.1742dupT	NP_000483.3:p.Leu581fs		68035	CI962522	rs397508290	Cystic Fibrosis	1874insT			CFTR	1080
VSD6AVCR9Y	chr7	117590414	117590415	T	A	NC_000007.14:g.117590415T>A	NM_000492.3:c.1742T>A	NP_000483.3:p.Leu581*			CM1618010		Cystic Fibrosis	L581X (TAA)			CFTR	1080
VSIF7W5DPV	chr7	117590414	117590415	T	G	NC_000007.14:g.117590415T>G	NM_000492.3:c.1742T>G	NP_000483.3:p.Leu581*					Cystic Fibrosis	L581X			CFTR	1080
VS0D2F0ABC	chr7	117590425	117590426	G	T	NC_000007.14:g.117590426G>T	NM_000492.3:c.1753G>T	NP_000483.3:p.Glu585*		68042	CM920165	rs397508296	Cystic Fibrosis	E585X	SAS	9.77E-05	CFTR	1080
VSUP4JP9UU	chr7	117590434	117590435	G	T	NC_000007.14:g.117590435G>T	NM_000492.3:c.1762G>T	NP_000483.3:p.Glu588*			CM022335		Cystic Fibrosis	E588X			CFTR	1080
VS0283DD8A	chr7	117590439	117590440	G	A	NC_000007.14:g.117590440G>A	NM_000492.3:c.1766+1G>A			22207	CS920734	rs121908748	Cystic Fibrosis	1898+1G>A	NFE	7.21E-05	CFTR	1080
VS29C6A85E	chr7	117590439	117590440	G	C	NC_000007.14:g.117590440G>C	NM_000492.3:c.1766+1G>C			68044	CS930768	rs121908748	Cystic Fibrosis	1898+1G>C	NFE	9.01E-06	CFTR	1080
VS85E168EE	chr7	117590441	117590442	A	G	NC_000007.14:g.117590442A>G	NM_000492.3:c.1766+3A>G			68047	CS971651	rs397508298	Cystic Fibrosis	1898+3A>G			CFTR	1080
VS726CD71C	chr7	117590443	117590444	G	A	NC_000007.14:g.117590444G>A	NM_000492.3:c.1766+5G>A			68048	CS972967	rs121908796	Cystic Fibrosis	1898+5G>A			CFTR	1080
VSLJYQ6EVS	chr7	117590590	117590591	T	A	NC_000007.14:g.117590591T>A	NM_000492.3:c.1766+152T>A					rs4148711	fingerprint variant				CFTR	1080
VC1B65235D	chr7	117591982	117592067	AAAATGGAACATTTAAAGAAAGCTGACAAAATATTAATTTTGCATGAAGGTAGCAGCTATTTTTATGGGACATTTTCAGAACTCC	A	NC_000007.14:g.117591987_117592070del	NM_000492.3:c.1820_1903del	NP_000483.3:p.Met607_Gln634del		68064		rs121908777	Cystic Fibrosis	1949del84			CFTR	1080
VS695ZYXDK	chr7	117592066	117592067	C	T	NC_000007.14:g.117592067C>T	NM_000492.3:c.1900C>T	NP_000483.3:p.Gln634*			CM962764	rs397508319	Cystic Fibrosis	Q634X			CFTR	1080
VS7M4YRWV1	chr7	117592075	117592076	C	T	NC_000007.14:g.117592076C>T	NM_000492.3:c.1909C>T	NP_000483.3:p.Gln637*		68081	CM993860	rs397508320	Cystic Fibrosis	Q637X			CFTR	1080
VSB34ARTKD	chr7	117592083	117592086	CTT	C	NC_000007.14:g.117592086_117592087delTT	NM_000492.3:c.1919_1920delTT	NP_000483.3:p.Phe640fs		68083	CD983604	rs397508322	Cystic Fibrosis	2051delTT			CFTR	1080
VS3K58V1WM	chr7	117592132	117592133	G	T	NC_000007.14:g.117592133G>T	NM_000492.3:c.1966G>T	NP_000483.3:p.Glu656*		68084	CM972952	rs397508323	Cystic Fibrosis	E656X			CFTR	1080
VS23YYLDIE	chr7	117592145	117592147	CA	C	NC_000007.14:g.117592148delA	NM_000492.3:c.1981delA	NP_000483.3:p.Ile661fs		68087	CD972128	rs397508324	Cystic Fibrosis	2113delA			CFTR	1080
VSMUEA97AN	chr7	117592149	117592154	CCTAA	C	NC_000007.14:g.117592153_117592156delAACT	NM_000492.3:c.1986_1989delAACT	NP_000483.3:p.Thr663fs		68089	CD930924	rs397508325	Cystic Fibrosis	2116delCTAA			CFTR	1080
VSFRZEC1FR	chr7	117592156	117592157	G	T	NC_000007.14:g.117592157G>T	NM_000492.3:c.1990G>T	NP_000483.3:p.Glu664*		68090	CM970284	rs397508327	Cystic Fibrosis	E664X			CFTR	1080
VS147ALG39	chr7	117592175	117592176	C	CA	NC_000007.14:g.117592177dupA	NM_000492.3:c.2010dupA	NP_000483.3:p.Leu671fs			CI942010	rs397508329	Cystic Fibrosis	2141insA			CFTR	1080
VS1850A54B	chr7	117592176	117592178	AT	A	NC_000007.14:g.117592179delT	NM_000492.3:c.2012delT	NP_000483.3:p.Leu671fs		44500	CD920847	rs121908812	Cystic Fibrosis	2143delT	NFE	9.04E-06	CFTR	1080
VSCXR6369G	chr7	117592183	117592184	G	T	NC_000007.14:g.117592184G>T	NM_000492.3:c.2017G>T	NP_000483.3:p.Gly673*		68095	CM940260	rs397508331	Cystic Fibrosis	G673X	NFE	9.05E-06	CFTR	1080
VSUQNZLDIA	chr7	117592202	117592203	G	A	NC_000007.14:g.117592203G>A	NM_000492.3:c.2036G>A	NP_000483.3:p.Trp679*		68097	CM993861	rs397508333	Cystic Fibrosis	W679X			CFTR	1080
VST5KXH6W6	chr7	117592207	117592209	GA	G	NC_000007.14:g.117592211delA	NM_000492.3:c.2044delA	NP_000483.3:p.Thr682fs		544446	CD1212248		Cystic Fibrosis	c.2044delA			CFTR	1080
VSABZPYU6S	chr7	117592210	117592211	A	AC	NC_000007.14:g.117592212dupC	NM_000492.3:c.2045dupC	NP_000483.3:p.Gln685fs		68098	CI972571	rs397508334	Cystic Fibrosis	2176insC			CFTR	1080
VS9047EA50	chr7	117592211	117592212	C	CA	NC_000007.14:g.117592219dupA	NM_000492.3:c.2052dupA	NP_000483.3:p.Gln685fs		44502	CI941848	rs1131692276	Cystic Fibrosis	2184insA	SAS	6.51E-05	CFTR	1080
VSE0D3C8DA	chr7	117592211	117592213	CA	C	NC_000007.14:g.117592219delA	NM_000492.3:c.2052delA	NP_000483.3:p.Lys684fs		47057	CD910492	rs1164974840	Cystic Fibrosis	2184delA	NFE	0.000118021	CFTR	1080
VSC67AC258	chr7	117592217	117592219	AA	G	NC_000007.14:g.117592218_117592219delAAinsG	NM_000492.3:c.2051_2052delAAinsG	NP_000483.3:p.Lys684fs		44501	CX931110	rs121908799	Cystic Fibrosis	2183delAA>G			CFTR	1080
VSZHCPG68E	chr7	117592218	117592219	A	AC	NC_000007.14:g.117592220dupC	NM_000492.3:c.2053dupC	NP_000483.3:p.Gln685fs		480442	CI993896	rs797045162	Cystic Fibrosis	2185insC			CFTR	1080
VS2WPS58E6	chr7	117592219	117592220	C	T	NC_000007.14:g.117592220C>T	NM_000492.3:c.2053C>T	NP_000483.3:p.Gln685*		68102	CM940261	rs397508336	Cystic Fibrosis	Q685X			CFTR	1080
VSXHWCY7F4	chr7	117592228	117592229	A	T	NC_000007.14:g.117592229A>T	NM_000492.3:c.2062A>T	NP_000483.3:p.Lys688*			CM067765		Cystic Fibrosis	K688X			CFTR	1080
VS63CE3EA9	chr7	117592291	117592292	C	T	NC_000007.14:g.117592292C>T	NM_000492.3:c.2125C>T	NP_000483.3:p.Arg709*		68108	CM950248	rs121908760	Cystic Fibrosis	R709X	SAS	0.000129988	CFTR	1080
VS875C9A9D	chr7	117592294	117592295	A	T	NC_000007.14:g.117592295A>T	NM_000492.3:c.2128A>T	NP_000483.3:p.Lys710*		22242	CM920167	rs75115087	Cystic Fibrosis	K710X			CFTR	1080
VSCE860E7C	chr7	117592339	117592340	G	GA	NC_000007.14:g.117592342dupA	NM_000492.3:c.2175dupA	NP_000483.3:p.Glu726fs		22224	CI931071	rs121908787	Cystic Fibrosis	2307insA	AFR	0.000326883	CFTR	1080
VS14DB972C	chr7	117592361	117592362	T	G	NC_000007.14:g.117592362T>G	NM_000492.3:c.2195T>G	NP_000483.3:p.Leu732*		68119	CM970286	rs397508350	Cystic Fibrosis	L732X	NFE	8.96E-06	CFTR	1080
VSC382332F	chr7	117592380	117592382	AG	A	NC_000007.14:g.117592382delG	NM_000492.3:c.2215delG	NP_000483.3:p.Val739fs		68123	CD992498	rs397508353	Cystic Fibrosis	2347delG	SAS	3.25E-05	CFTR	1080
VSHGJ8SKK5	chr7	117592439	117592441	GC	G	NC_000007.14:g.117592444delC	NM_000492.3:c.2277delC	NP_000483.3:p.Thr760fs					Cystic Fibrosis	2409delC			CFTR	1080
VSTH41HS5K	chr7	117592439	117592442	GCC	G	NC_000007.14:g.117592443_117592444delCC	NM_000492.3:c.2276_2277delCC	NP_000483.3:p.Pro759fs			CD067858	rs397508358	Cystic Fibrosis	2406delCC			CFTR	1080
VS0FD5235A	chr7	117592456	117592457	C	T	NC_000007.14:g.117592457C>T	NM_000492.3:c.2290C>T	NP_000483.3:p.Arg764*		68139	CM960282	rs121908810	Cystic Fibrosis	R764X	FIN	4.80E-05	CFTR	1080
VSZLZSXKEX	chr7	117592485	117592488	GAC	G	NC_000007.14:g.117592491_117592492delAC	NM_000492.3:c.2324_2325delAC	NP_000483.3:p.His775fs			CD015372	rs397508364	Cystic Fibrosis	2456delAC			CFTR	1080
VSWZG3JF7V	chr7	117592493	117592494	C	G	NC_000007.14:g.117592494C>G	NM_000492.3:c.2327C>G	NP_000483.3:p.Ser776*		68142	CM972954	rs397508365	Cystic Fibrosis	S776X			CFTR	1080
VSXTX5VSZU	chr7	117592507	117592508	C	T	NC_000007.14:g.117592508C>T	NM_000492.3:c.2341C>T	NP_000483.3:p.Gln781*			CM972955	rs397508368	Cystic Fibrosis	Q781X			CFTR	1080
VSMKJ2VG5G	chr7	117592519	117592520	C	T	NC_000007.14:g.117592520C>T	NM_000492.3:c.2353C>T	NP_000483.3:p.Arg785*		68148	CM941979	rs374946172	Cystic Fibrosis	R785X	AFR	6.92E-05	CFTR	1080
VSK46IV6BV	chr7	117592540	117592541	C	T	NC_000007.14:g.117592541C>T	NM_000492.3:c.2374C>T	NP_000483.3:p.Arg792*		68151	CM930118	rs145449046	Cystic Fibrosis	R792X	AFR	6.93E-05	CFTR	1080
VS1QLEXHGD	chr7	117592545	117592547	AG	A	NC_000007.14:g.117592547delG	NM_000492.3:c.2380delG	NP_000483.3:p.Val794fs					Cystic Fibrosis	2512delG			CFTR	1080
VSDNZ1AYC3	chr7	117592555	117592556	G	GC	NC_000007.14:g.117592560dupC	NM_000492.3:c.2393dupC	NP_000483.3:p.Gln799fs		68152	CI910602	rs397508372	Cystic Fibrosis	2522insC			CFTR	1080
VSEQ9NEYRQ	chr7	117592582	117592583	G	GAT	NC_000007.14:g.117592590_117592591dupAT	NM_000492.3:c.2423_2424dupAT	NP_000483.3:p.Ser809fs		205617	CI900297	rs387906359	Cystic Fibrosis	2556insAT			CFTR	1080
VSIMGWBAZW	chr7	117592599	117592600	G	GT	NC_000007.14:g.117592602dupT	NM_000492.3:c.2435dupT	NP_000483.3:p.Leu812fs			CI962239	rs397508376	Cystic Fibrosis	2566insT			CFTR	1080
VSHW94MJI4	chr7	117592606	117592607	C	T	NC_000007.14:g.117592607C>T	NM_000492.3:c.2440C>T	NP_000483.3:p.Gln814*		68158	CM035676	rs397508377	Cystic Fibrosis	Q814X			CFTR	1080
VSD917A612	chr7	117592617	117592619	CT	C	NC_000007.14:g.117592620delT	NM_000492.3:c.2453delT	NP_000483.3:p.Leu818fs		77003	CD067861	rs397515498	Cystic Fibrosis	2585delT			CFTR	1080
VS479A045F	chr7	117592630	117592631	G	T	NC_000007.14:g.117592631G>T	NM_000492.3:c.2464G>T	NP_000483.3:p.Glu822*		68160	CM970287	rs397508378	Cystic Fibrosis	E822X	NFE	1.09E-05	CFTR	1080
VS89EUYMVP	chr7	117592633	117592634	G	T	NC_000007.14:g.117592634G>T	NM_000492.3:c.2467G>T	NP_000483.3:p.Glu823*			CM983563	rs397508379	Cystic Fibrosis	E823X			CFTR	1080
VS41HGUN1K	chr7	117592636	117592638	AT	A	NC_000007.14:g.117592639delT	NM_000492.3:c.2472delT	NP_000483.3:p.Asn825fs		68162	CD930926	rs1170237781	Cystic Fibrosis	2603delT			CFTR	1080
VSUULC85ZY	chr7	117592645	117592646	G	T	NC_000007.14:g.117592646G>T	NM_000492.3:c.2479G>T	NP_000483.3:p.Glu827*		22196	CM920168	rs121909018	Cystic Fibrosis	E827X			CFTR	1080
VSA8K1DHQG	chr7	117592654	117592655	A	T	NC_000007.14:g.117592655A>T	NM_000492.3:c.2488A>T	NP_000483.3:p.Lys830*		68164	CM930120	rs397508382	Cystic Fibrosis	K830X			CFTR	1080
VS4DAC6D90	chr7	117592657	117592658	G	A	NC_000007.14:g.117592658G>A	NM_000492.3:c.2490+1G>A			22214	CS930769	rs141158996	Cystic Fibrosis	2622+1G>A	NFE	2.18E-05	CFTR	1080
VS677A3EB3	chr7	117594929	117594930	G	T	NC_000007.14:g.117594930G>T	NM_000492.3:c.2491G>T	NP_000483.3:p.Glu831*		68169	CM960283	rs397508387	Cystic Fibrosis	E831X	NFE	5.38E-05	CFTR	1080
VS87Q68VTM	chr7	117594934	117594935	C	CT	NC_000007.14:g.117594941dupT	NM_000492.3:c.2502dupT	NP_000483.3:p.Asp835fs			CI983615	rs1216033218	Cystic Fibrosis	2634insT	NFE	8.96E-06	CFTR	1080
VSK5P11DIH	chr7	117594934	117594935	C	A	NC_000007.14:g.117594935C>A	NM_000492.3:c.2496C>A	NP_000483.3:p.Cys832*				rs397508388	Cystic Fibrosis	C831X			CFTR	1080
VSKKK1CTAU	chr7	117594934	117594936	CT	C	NC_000007.14:g.117594941delT	NM_000492.3:c.2502delT	NP_000483.3:p.Phe834fs			CD075348	rs397508390	Cystic Fibrosis	2634delT			CFTR	1080
VS3X3VPI2Y	chr7	117594945	117594947	AT	A	NC_000007.14:g.117594947delT	NM_000492.3:c.2508delT	NP_000483.3:p.Asp836fs			CD983606	rs397508391	Cystic Fibrosis	2640delT			CFTR	1080
VSPHHJ8422	chr7	117594950	117594951	G	T	NC_000007.14:g.117594951G>T	NM_000492.3:c.2512G>T	NP_000483.3:p.Glu838*					Cystic Fibrosis	E838X			CFTR	1080
VS6AA10BF0	chr7	117594975	117594976	G	A	NC_000007.14:g.117594976G>A	NM_000492.3:c.2537G>A	NP_000483.3:p.Trp846*		68176	CM930121	rs397508393	Cystic Fibrosis	W846X			CFTR	1080
VSJYXRKS3R	chr7	117594976	117594977	G	A	NC_000007.14:g.117594977G>A	NM_000492.3:c.2538G>A	NP_000483.3:p.Trp846*		22166	CM900059	rs267606722	Cystic Fibrosis	W846X (2670TGG>TGA)	NFE	8.96E-06	CFTR	1080
VSJAFILCKY	chr7	117594985	117594986	C	A	NC_000007.14:g.117594986C>A	NM_000492.3:c.2547C>A	NP_000483.3:p.Tyr849*		68177	CM994348	rs397508394	Cystic Fibrosis	Y849X			CFTR	1080
VS1071F57D	chr7	117594989	117594990	C	T	NC_000007.14:g.117594990C>T	NM_000492.3:c.2551C>T	NP_000483.3:p.Arg851*		22180	CM910073	rs121909012	Cystic Fibrosis	R851X			CFTR	1080
VSHI9T4NYG	chr7	117594991	117594992	A	AT	NC_000007.14:g.117594993dupT	NM_000492.3:c.2554dupT	NP_000483.3:p.Tyr852fs		357571	CI002201	rs1057517068	Cystic Fibrosis	c.2554dupT			CFTR	1080
VSSTB3G384	chr7	117594994	117594995	T	G	NC_000007.14:g.117594995T>G	NM_000492.3:c.2556T>G	NP_000483.3:p.Tyr852*			CM088455		Cystic Fibrosis	Y852X			CFTR	1080
VS67D5UZ4Z	chr7	117594999	117595001	CT	C	NC_000007.14:g.117595001delT	NM_000492.3:c.2562delT	NP_000483.3:p.Val855fs			CD003291	rs397508396	Cystic Fibrosis	2694delT			CFTR	1080
VSFMENYNMW	chr7	117595000	117595001	T	G	NC_000007.14:g.117595001T>G	NM_000492.3:c.2562T>G	NP_000483.3:p.Thr854Thr		52746	CM1710643	rs1042077	fingerprint variant		AFR	0.64943099	CFTR	1080
VSXTKJSYJK	chr7	117595003	117595004	C	CT	NC_000007.14:g.117595004_117595005insT	NM_000492.3:c.2565_2566insT	NP_000483.3:p.His856fs					Cystic Fibrosis	c.2566_2567insT			CFTR	1080
VSXUQ72XSL	chr7	117595007	117595008	A	T	NC_000007.14:g.117595008A>T	NM_000492.3:c.2569A>T	NP_000483.3:p.Lys857*					Cystic Fibrosis	K857X			CFTR	1080
VS7W7AX69U	chr7	117595014	117595015	T	A	NC_000007.14:g.117595015T>A	NM_000492.3:c.2576T>A	NP_000483.3:p.Leu859*					Cystic Fibrosis	L859X			CFTR	1080
VSFFN5WPLK	chr7	117595014	117595015	T	G	NC_000007.14:g.117595015T>G	NM_000492.3:c.2576T>G	NP_000483.3:p.Leu859*					Cystic Fibrosis	L859X (TGA)			CFTR	1080
VS97F5BBB0	chr7	117595016	117595018	AT	A	NC_000007.14:g.117595022delT	NM_000492.3:c.2583delT	NP_000483.3:p.Phe861fs		68183	CD951655	rs397508399	Cystic Fibrosis	2711delT			CFTR	1080
VSDPD47SXR	chr7	117595021	117595033	TGTGCTAATTTG	T	NC_000007.14:g.117595028_117595038del	NM_000492.3:c.2589_2599del	NP_000483.3:p.Ile864fs		68184	CD930927	rs397508400	Cystic Fibrosis	2721del11			CFTR	1080
VS882HATFK	chr7	117595028	117595031	ATT	A	NC_000007.14:g.117595031_117595032delTT	NM_000492.3:c.2592_2593delTT	NP_000483.3:p.Ile864fs		68185	CD962513	rs397508401	Cystic Fibrosis	2723delTT			CFTR	1080
VSNTL78VRR	chr7	117595032	117595033	G	A	NC_000007.14:g.117595033G>A	NM_000492.3:c.2594G>A	NP_000483.3:p.Trp865*					Cystic Fibrosis	W865X			CFTR	1080
VS3ECBNT5G	chr7	117595038	117595039	T	TA	NC_000007.14:g.117595040dupA	NM_000492.3:c.2601dupA	NP_000483.3:p.Val868fs		480446	CI003304	rs397508405	Cystic Fibrosis	2732insA			CFTR	1080
VSCE2WW8VC	chr7	117595038	117595039	T	A	NC_000007.14:g.117595039T>A	NM_000492.3:c.2600T>A	NP_000483.3:p.Leu867*			CM962469	rs397508404	Cystic Fibrosis	L867X			CFTR	1080
VSNHWFPZSV	chr7	117595040	117595041	G	AT	NC_000007.14:g.117595041delGinsAT	NM_000492.3:c.2602delGinsAT	NP_000483.3:p.Val868fs			CX972736		Cystic Fibrosis	2734G>AT			CFTR	1080
VSZNEYS3QT	chr7	117595052	117595054	GC	G	NC_000007.14:g.117595054delC	NM_000492.3:c.2615delC	NP_000483.3:p.Ala872fs			CD067857		Cystic Fibrosis	2747delC			CFTR	1080
VS527I6GU7	chr7	117595055	117595056	G	T	NC_000007.14:g.117595056G>T	NM_000492.3:c.2617G>T	NP_000483.3:p.Glu873*					Cystic Fibrosis	E883X			CFTR	1080
VS7LCL7Q19	chr7	117602838	117602847	TGGTTGTGC	T	NC_000007.14:g.117602840_117602847del	NM_000492.3:c.2634_2641del	NP_000483.3:p.Leu878fs				rs397508411	Cystic Fibrosis	2766del8			CFTR	1080
VSUV79I2FR	chr7	117602850	117602851	G	A	NC_000007.14:g.117602851G>A	NM_000492.3:c.2645G>A	NP_000483.3:p.Trp882*		68203	CM962470	rs397508413	Cystic Fibrosis	W882X			CFTR	1080
VS4RNAHABQ	chr7	117602858	117602859	G	T	NC_000007.14:g.117602859G>T	NM_000492.3:c.2653G>T	NP_000483.3:p.Gly885*					Cystic Fibrosis	G885X			CFTR	1080
VS4EA1BEF0	chr7	117602867	117602868	G	A	NC_000007.14:g.117602868G>A	NM_000492.3:c.2657+5G>A			47062	CS900235	rs80224560	Cystic Fibrosis	2789+5G>A	NFE	0.00015218	CFTR	1080
VSSG6QBNSL	chr7	117603530	117603531	G	C	NC_000007.14:g.117603531G>C	NM_000492.3:c.2658-1G>C			205619	CS931162	rs397508416	Cystic Fibrosis	2790-1G>C	SAS	3.25E-05	CFTR	1080
VSE6167BFE	chr7	117603541	117603542	C	T	NC_000007.14:g.117603542C>T	NM_000492.3:c.2668C>T	NP_000483.3:p.Gln890*		22243	CM920170	rs79633941	Cystic Fibrosis	Q890X			CFTR	1080
VSEMRG78Y9	chr7	117603557	117603558	G	GT	NC_000007.14:g.117603559dupT	NM_000492.3:c.2685dupT	NP_000483.3:p.Thr896fs					Cystic Fibrosis	c.2686_2687insT			CFTR	1080
VSENHKVVP8	chr7	117603577	117603579	AG	A	NC_000007.14:g.117603579delG	NM_000492.3:c.2705delG	NP_000483.3:p.Ser902fs			CD1212249		Cystic Fibrosis	c.2705delG			CFTR	1080
VSHHNJLV8C	chr7	117603608	117603609	C	A	NC_000007.14:g.117603609C>A	NM_000492.3:c.2735C>A	NP_000483.3:p.Ser912*		68218	CM930122	rs121909034	Cystic Fibrosis	S912X			CFTR	1080
VSNWSITT8P	chr7	117603612	117603613	T	A	NC_000007.14:g.117603613T>A	NM_000492.3:c.2739T>A	NP_000483.3:p.Tyr913*		68220	CM055926	rs149790377	Cystic Fibrosis	Y913X	AFR	0.000130719	CFTR	1080
VSPC3FFYAJ	chr7	117603634	117603635	G	GGA	NC_000007.14:g.117603637_117603638dupAG	NM_000492.3:c.2763_2764dupAG	NP_000483.3:p.Val922fs		68231	CI972572	rs397508431	Cystic Fibrosis	2896insAG	NFE	8.95E-06	CFTR	1080
VSHQZ5EW9M	chr7	117603647	117603649	CT	C	NC_000007.14:g.117603651delT	NM_000492.3:c.2777delT	NP_000483.3:p.Leu926fs		68235	CD910493	rs397508434	Cystic Fibrosis	2909delT			CFTR	1080
VSYLLA6T1V	chr7	117603647	117603650	CTT	C	NC_000007.14:g.117603650_117603651delTT	NM_000492.3:c.2776_2777delTT	NP_000483.3:p.Leu926fs		68234	CD930928	rs397508433	Cystic Fibrosis	2907delTT			CFTR	1080
VS11FFD22D	chr7	117603653	117603654	T	C	NC_000007.14:g.117603654T>C	NM_000492.3:c.2780T>C	NP_000483.3:p.Leu927Pro		68236	CM940265	rs397508435	Cystic Fibrosis	L927P			CFTR	1080
VSA7XUID4K	chr7	117603659	117603661	TG	T	NC_000007.14:g.117603663delG	NM_000492.3:c.2789delG	NP_000483.3:p.Gly930fs			CD1212250		Cystic Fibrosis	c.2789delG			CFTR	1080
VS72YEVLYY	chr7	117603672	117603684	AGGTCTACCACT	A	NC_000007.14:g.117603677_117603687del	NM_000492.3:c.2803_2813del	NP_000483.3:p.Leu935fs			CD1212251		Cystic Fibrosis	c.2803_2813delCTACCACTGGT			CFTR	1080
VSD948RBXQ	chr7	117603682	117603683	C	CT	NC_000007.14:g.117603684dupT	NM_000492.3:c.2810dupT	NP_000483.3:p.Val938fs		44513	CI993897	rs1222022172	Cystic Fibrosis	2942insT			CFTR	1080
VSS148T5QD	chr7	117603689	117603691	AT	C	NC_000007.14:g.117603690_117603691delATinsC	NM_000492.3:c.2816_2817delATinsC	NP_000483.3:p.His939fs			CX993898		Cystic Fibrosis	2948AT>C			CFTR	1080
VS12165100	chr7	117603707	117603708	C	T	NC_000007.14:g.117603708C>T	NM_000492.3:c.2834C>T	NP_000483.3:p.Ser945Leu		68243	CM930123	rs397508442	Cystic Fibrosis	S945L	FIN	0.000358809	CFTR	1080
VS8KHHCGWL	chr7	117603709	117603710	A	T	NC_000007.14:g.117603710A>T	NM_000492.3:c.2836A>T	NP_000483.3:p.Lys946*			CM962473	rs397508443	Cystic Fibrosis	K946X			CFTR	1080
VS69EBEBE0	chr7	117603747	117603749	AG	A	NC_000007.14:g.117603749delG	NM_000492.3:c.2875delG	NP_000483.3:p.Ala959fs		68251	CD941635	rs397508447	Cystic Fibrosis	3007delG	NFE	8.96E-06	CFTR	1080
VSQMCJZX1X	chr7	117603748	117603750	GC	G	NC_000007.14:g.117603750delC	NM_000492.3:c.2876delC	NP_000483.3:p.Ala959fs					Cystic Fibrosis	c.2876delC			CFTR	1080
VS9HL7ZGFN	chr7	117603768	117603770	CA	C	NC_000007.14:g.117603770delA	NM_000492.3:c.2896delA	NP_000483.3:p.Thr966fs		68255	CD962514	rs397508451	Cystic Fibrosis	3028delA			CFTR	1080
VS1A44EA29	chr7	117603781	117603782	G	C	NC_000007.14:g.117603782G>C	NM_000492.3:c.2908G>C	NP_000483.3:p.Gly970Arg		68258	CM930124	rs397508453	Cystic Fibrosis	G970R			CFTR	1080
VSQJIE494S	chr7	117606671	117606673	AG	A	NC_000007.14:g.117606674delG	NM_000492.3:c.2909delG	NP_000483.3:p.Gly970fs		68263	CD941636	rs397508458	Cystic Fibrosis	3041delG			CFTR	1080
VSYEAEBNLW	chr7	117606686	117606689	TAG	T	NC_000007.14:g.117606689_117606690delGA	NM_000492.3:c.2924_2925delGA	NP_000483.3:p.Arg975fs			CD931169		Cystic Fibrosis	3056delGA			CFTR	1080
VSWA2L8JT5	chr7	117606696	117606697	A	T	NC_000007.14:g.117606697A>T	NM_000492.3:c.2932A>T	NP_000483.3:p.Lys978*		44519		rs193922514	Cystic Fibrosis	K978X			CFTR	1080
VSFRXHA1NY	chr7	117606708	117606711	ATT	A	NC_000007.14:g.117606712_117606713delTT	NM_000492.3:c.2947_2948delTT	NP_000483.3:p.Leu983fs			CD972973		Cystic Fibrosis	3079delTT			CFTR	1080
VSQ5WWD2WN	chr7	117606731	117606732	T	TA	NC_000007.14:g.117606733dupA	NM_000492.3:c.2968dupA	NP_000483.3:p.Thr990fs			CI941849	rs397508466	Cystic Fibrosis	3100insA			CFTR	1080
VS85E7A307	chr7	117606752	117606753	G	A	NC_000007.14:g.117606753G>A	NM_000492.3:c.2988G>A	NP_000483.3:p.Gln996Gln		44521	CS941443	rs121908797	Cystic Fibrosis	3120G>A	NFE	8.98E-06	CFTR	1080
VSCAB3F9A4	chr7	117606753	117606754	G	A	NC_000007.14:g.117606754G>A	NM_000492.3:c.2988+1G>A			33858	CS971653	rs75096551	Cystic Fibrosis	3120+1G>A	AFR	0.00137381	CFTR	1080
VS08D4813A	chr7	117610517	117610518	G	A	NC_000007.14:g.117610518G>A	NM_000492.3:c.2989-1G>A			68281	CS118688	rs397508470	Cystic Fibrosis	3121-1G>A	NFE	8.97E-06	CFTR	1080
VS2I9P6NQF	chr7	117610522	117610527	TATTA	T	NC_000007.14:g.117610527_117610530delAATT	NM_000492.3:c.2997_3000delAATT	NP_000483.3:p.Ile1000fs		68286	CD931170	rs397508472	Cystic Fibrosis	3126del4			CFTR	1080
VS51YZYTVF	chr7	117610528	117610531	TTG	T	NC_000007.14:g.117610532_117610533delTG	NM_000492.3:c.3002_3003delTG	NP_000483.3:p.Val1001fs		68291	CD951656	rs397508477	Cystic Fibrosis	3132delTG			CFTR	1080
VS2P877BJP	chr7	117610536	117610537	G	T	NC_000007.14:g.117610537G>T	NM_000492.3:c.3007G>T	NP_000483.3:p.Gly1003*		68292	CM003251	rs397508478	Cystic Fibrosis	G1003X			CFTR	1080
VS91MQGBM7	chr7	117610565	117610566	A	AC	NC_000007.14:g.117610569dupC	NM_000492.3:c.3039dupC	NP_000483.3:p.Tyr1014fs		68303	CI941850	rs397508485	Cystic Fibrosis	3171insC			CFTR	1080
VSF41F3669	chr7	117610565	117610567	AC	A	NC_000007.14:g.117610569delC	NM_000492.3:c.3039delC	NP_000483.3:p.Tyr1014fs		68304	CD002163	rs121908781	Cystic Fibrosis	3171delC			CFTR	1080
VS8NB9J5UE	chr7	117610569	117610572	TAC	T	NC_000007.14:g.117610572_117610573delCA	NM_000492.3:c.3042_3043delCA	NP_000483.3:p.Ile1015fs			CD982538	rs397508487	Cystic Fibrosis	3173delAC			CFTR	1080
VS8214B974	chr7	117610591	117610598	CAGTGAT	C	NC_000007.14:g.117610597_117610602delATAGTG	NM_000492.3:c.3067_3072delATAGTG	NP_000483.3:p.Ile1023_Val1024del		46824	CD941637	rs121908767	Cystic Fibrosis	3199del6	AMR	0.000149325	CFTR	1080
VSMRXDQWU3	chr7	117610596	117610602	ATAGTG	A	NC_000007.14:g.117610598_117610602delTAGTG	NM_000492.3:c.3068_3072delTAGTG	NP_000483.3:p.Ile1023fs			CD136203	rs397508493	Cystic Fibrosis	3200_3204delTAGTG			CFTR	1080
VSSYDLC9P4	chr7	117610632	117610634	CA	C	NC_000007.14:g.117610636delA	NM_000492.3:c.3106delA	NP_000483.3:p.Thr1036fs			CD057606	rs397508497	Cystic Fibrosis	3238delA			CFTR	1080
VS10F2FE42	chr7	117611554	117611555	A	G	NC_000007.14:g.117611555A>G	NM_000492.3:c.3140-26A>G			44528	CS920740	rs76151804	Cystic Fibrosis	3272-26A>G	AMR	9.30E-05	CFTR	1080
VSG2UFB58P	chr7	117611600	117611602	CA	C	NC_000007.14:g.117611602delA	NM_000492.3:c.3161delA	NP_000483.3:p.His1054fs		22260	CD941638	rs387906377	Cystic Fibrosis	3293delA			CFTR	1080
VSNE9DJ4YY	chr7	117611600	117611601	C	G	NC_000007.14:g.117611601C>G	NM_000492.3:c.3160C>G	NP_000483.3:p.His1054Asp		68335	CM940268	rs397508510	Cystic Fibrosis	H1054D			CFTR	1080
VS2V9F4BPB	chr7	117611616	117611618	TA	T	NC_000007.14:g.117611621delA	NM_000492.3:c.3180delA	NP_000483.3:p.Gly1061fs					Cystic Fibrosis	c.3180delA			CFTR	1080
VSHC5111RM	chr7	117611616	117611617	T	G	NC_000007.14:g.117611617T>G	NM_000492.3:c.3176T>G	NP_000483.3:p.Leu1059*		68337	CM940269	rs397508512	Cystic Fibrosis	L1059X			CFTR	1080
VSXG7XQLEP	chr7	117611621	117611622	G	C	NC_000007.14:g.117611622G>C	NM_000492.3:c.3181G>C	NP_000483.3:p.Gly1061Arg		68340	CM930126	rs142394380	Cystic Fibrosis	G1061R			CFTR	1080
VSP2JPC6TX	chr7	117611623	117611624	A	ACTATG	NC_000007.14:g.117611625_117611629dupCTATG	NM_000492.3:c.3184_3188dupCTATG	NP_000483.3:p.Trp1063fs		22200	CI920930	rs387906366	Cystic Fibrosis	3320ins5			CFTR	1080
VSFDGIGB8V	chr7	117611629	117611630	G	A	NC_000007.14:g.117611630G>A	NM_000492.3:c.3189G>A	NP_000483.3:p.Trp1063*		68342	CM920172	rs397508514	Cystic Fibrosis	W1063X			CFTR	1080
VS96680FD5	chr7	117611634	117611635	T	C	NC_000007.14:g.117611635T>C	NM_000492.3:c.3194T>C	NP_000483.3:p.Leu1065Pro		22247	CM920173	rs121909036	Cystic Fibrosis	L1065P			CFTR	1080
VSD6CEB9D6	chr7	117611636	117611637	C	T	NC_000007.14:g.117611637C>T	NM_000492.3:c.3196C>T	NP_000483.3:p.Arg1066Cys		22201	CM920175	rs78194216	Cystic Fibrosis	R1066C	AMR	5.98E-05	CFTR	1080
VS09C2A0A3	chr7	117611637	117611638	G	A	NC_000007.14:g.117611638G>A	NM_000492.3:c.3197G>A	NP_000483.3:p.Arg1066His		22197	CM920174	rs121909019	Cystic Fibrosis	R1066H	AFR	6.54E-05	CFTR	1080
VSPKAMYRF9	chr7	117611651	117611652	C	T	NC_000007.14:g.117611652C>T	NM_000492.3:c.3211C>T	NP_000483.3:p.Gln1071*			CM034791	rs397508517	Cystic Fibrosis	Q1071X			CFTR	1080
VS38NN9AWK	chr7	117611662	117611663	T	A	NC_000007.14:g.117611663T>A	NM_000492.3:c.3222T>A	NP_000483.3:p.Phe1074Leu		68356	CM970295	rs186045772	Cystic Fibrosis	F1074L	NFE	8.97E-06	CFTR	1080
VSYUH5GQ3K	chr7	117611666	117611669	ACT	A	NC_000007.14:g.117611670_117611671delCT	NM_000492.3:c.3229_3230delCT	NP_000483.3:p.Leu1077fs		68357	CD930929	rs397508518	Cystic Fibrosis	3359delCT			CFTR	1080
VS0D1C3581	chr7	117611670	117611671	T	C	NC_000007.14:g.117611671T>C	NM_000492.3:c.3230T>C	NP_000483.3:p.Leu1077Pro		68358	CM920177	rs139304906	Cystic Fibrosis	L1077P	NFE	8.97E-06	CFTR	1080
VSDQKLQ2UW	chr7	117611701	117611702	C	CA	NC_000007.14:g.117611704dupA	NM_000492.3:c.3263dupA	NP_000483.3:p.Asn1088fs		68366	CI045353	rs397508524	Cystic Fibrosis	c.3263dupA			CFTR	1080
VS9XNFJBPX	chr7	117611703	117611705	AC	A	NC_000007.14:g.117611705delC	NM_000492.3:c.3264delC	NP_000483.3:p.Trp1089fs		68367	CD003292	rs397508525	Cystic Fibrosis	3396delC			CFTR	1080
VS7685A8C1	chr7	117611706	117611707	G	A	NC_000007.14:g.117611707G>A	NM_000492.3:c.3266G>A	NP_000483.3:p.Trp1089*		22233	CM920178	rs78802634	Cystic Fibrosis	W1089X	AMR	0.000179254	CFTR	1080
VS8D71FC94	chr7	117611716	117611717	C	G	NC_000007.14:g.117611717C>G	NM_000492.3:c.3276C>G	NP_000483.3:p.Tyr1092*		22250	CM941981	rs121908761	Cystic Fibrosis	Y1092X			CFTR	1080
VSE19EF6D2	chr7	117611716	117611717	C	A	NC_000007.14:g.117611717C>A	NM_000492.3:c.3276C>A	NP_000483.3:p.Tyr1092*		47333	CM920179	rs121908761	Cystic Fibrosis	Y1092X	NFE	2.69E-05	CFTR	1080
VS99T5DYAL	chr7	117611726	117611728	CT	C	NC_000007.14:g.117611728delT	NM_000492.3:c.3287delT	NP_000483.3:p.Leu1096fs			CD942003	rs397508529	Cystic Fibrosis	3419delT			CFTR	1080
VS9LNKQH6T	chr7	117611730	117611732	GC	G	NC_000007.14:g.117611732delC	NM_000492.3:c.3291delC	NP_000483.3:p.Trp1098fs			CD952066		Cystic Fibrosis	3423delC			CFTR	1080
VSS7U574YV	chr7	117611732	117611734	TG	T	NC_000007.14:g.117611735delG	NM_000492.3:c.3294delG	NP_000483.3:p.Trp1098fs			CD962516	rs397508534	Cystic Fibrosis	3425delG			CFTR	1080
VS36A2GCW2	chr7	117611733	117611734	G	A	NC_000007.14:g.117611734G>A	NM_000492.3:c.3293G>A	NP_000483.3:p.Trp1098*		68376	CM940272	rs397508532	Cystic Fibrosis	W1098X(TAG)			CFTR	1080
VSB3Z5VH9T	chr7	117611734	117611735	G	A	NC_000007.14:g.117611735G>A	NM_000492.3:c.3294G>A	NP_000483.3:p.Trp1098*		205620	CM962477	rs397508533	Cystic Fibrosis	W1098X (TGA)			CFTR	1080
VS7592A482	chr7	117611742	117611743	T	A	NC_000007.14:g.117611743T>A	NM_000492.3:c.3302T>A	NP_000483.3:p.Met1101Lys		48115	CM930130	rs36210737	Cystic Fibrosis	M1101K	NFE	3.59E-05	CFTR	1080
VS2H76JEXV	chr7	117611744	117611745	A	T	NC_000007.14:g.117611745A>T	NM_000492.3:c.3304A>T	NP_000483.3:p.Arg1102*		68381	CM043474	rs397508536	Cystic Fibrosis	R1102X			CFTR	1080
VS80C93377	chr7	117611750	117611751	G	T	NC_000007.14:g.117611751G>T	NM_000492.3:c.3310G>T	NP_000483.3:p.Glu1104*		68383	CM950255	rs397508538	Cystic Fibrosis	E1104X			CFTR	1080
VSSW7Q5EUN	chr7	117611754	117611756	TG	T	NC_000007.14:g.117611756delG	NM_000492.3:c.3315delG	NP_000483.3:p.Met1105fs		68385		rs397508540	Cystic Fibrosis	3447delG			CFTR	1080
VS7WSEXYLF	chr7	117614626	117614627	A	T	NC_000007.14:g.117614627A>T	NM_000492.3:c.3382A>T	NP_000483.3:p.Arg1128*			CM962478	rs397508549	Cystic Fibrosis	R1128X			CFTR	1080
VSX7LBLTQQ	chr7	117614644	117614646	AC	GTA	NC_000007.14:g.117614645_117614646delACinsGTA	NM_000492.3:c.3400_3401delACinsGTA	NP_000483.3:p.Thr1134fs			CX983619	rs397508552	Cystic Fibrosis	3532AC>GTA			CFTR	1080
VSMNH3HWZI	chr7	117614688	117614690	CT	C	NC_000007.14:g.117614690delT	NM_000492.3:c.3445delT	NP_000483.3:p.Ser1149fs			CD972974	rs397508566	Cystic Fibrosis	3577delT			CFTR	1080
VSB03AC481	chr7	117614698	117614699	G	C	NC_000007.14:g.117614699G>C	NM_000492.3:c.3454G>C	NP_000483.3:p.Asp1152His		44531	CM950256	rs75541969	Cystic Fibrosis	D1152H	ASJ	0.00284553	CFTR	1080
VS3E1381CB	chr7	117627524	117627525	C	T	NC_000007.14:g.117627525C>T	NM_000492.3:c.3472C>T	NP_000483.3:p.Arg1158*		22183	CM920180	rs79850223	Cystic Fibrosis	R1158X	SAS	0.000130064	CFTR	1080
VS4000CDF1	chr7	117627536	117627537	C	T	NC_000007.14:g.117627537C>T	NM_000492.3:c.3484C>T	NP_000483.3:p.Arg1162*		22176	CM910074	rs74767530	Cystic Fibrosis	R1162X	SAS	0.000227509	CFTR	1080
VSLN43Q9CF	chr7	117627536	117627539	CGA	C	NC_000007.14:g.117627539_117627540delAG	NM_000492.3:c.3486_3487delAG	NP_000483.3:p.Val1163fs		68427	CD002164	rs397508575	Cystic Fibrosis	3617delGA			CFTR	1080
VSP4XQGZA8	chr7	117627541	117627542	C	CT	NC_000007.14:g.117627545dupT	NM_000492.3:c.3492dupT	NP_000483.3:p.Lys1165fs		22269	CI001933	rs387906379	Cystic Fibrosis	3622insT			CFTR	1080
VS45WU877U	chr7	117627547	117627549	GT	G	NC_000007.14:g.117627550delT	NM_000492.3:c.3497delT	NP_000483.3:p.Phe1166fs			CD034850		Cystic Fibrosis	3629delT			CFTR	1080
VS1C4019BF	chr7	117627578	117627580	AC	A	NC_000007.14:g.117627581delC	NM_000492.3:c.3528delC	NP_000483.3:p.Lys1177fs		44532	CD900276	rs1198330014	Cystic Fibrosis	3659delC	FIN	0.000359066	CFTR	1080
VSILNJCDPH	chr7	117627580	117627582	CA	C	NC_000007.14:g.117627583delA	NM_000492.3:c.3530delA	NP_000483.3:p.Lys1177fs		68435	CD910494	rs397508579	Cystic Fibrosis	3662delA			CFTR	1080
VSYTDZ6PNW	chr7	117627581	117627582	A	T	NC_000007.14:g.117627582A>T	NM_000492.3:c.3529A>T	NP_000483.3:p.Lys1177*		68434	CM001653	rs397508578	Cystic Fibrosis	K1177X			CFTR	1080
VS8MISLGWU	chr7	117627583	117627584	G	GTCAA	NC_000007.14:g.117627585_117627588dupTCAA	NM_000492.3:c.3532_3535dupTCAA	NP_000483.3:p.Thr1179fs		22261	CI931072	rs387906378	Cystic Fibrosis	3667ins4			CFTR	1080
VS5R2ZLBCE	chr7	117627589	117627591	CA	C	NC_000007.14:g.117627593delA	NM_000492.3:c.3540delA	NP_000483.3:p.Lys1180fs			CD993893	rs397508580	Cystic Fibrosis	3670delA			CFTR	1080
VSCVM9E1DF	chr7	117627598	117627599	C	G	NC_000007.14:g.117627599C>G	NM_000492.3:c.3546C>G	NP_000483.3:p.Tyr1182*			CM941985	rs397508581	Cystic Fibrosis	Y1182X			CFTR	1080
VSX8V9BQUF	chr7	117627608	117627609	C	T	NC_000007.14:g.117627609C>T	NM_000492.3:c.3556C>T	NP_000483.3:p.Gln1186*			CM962480	rs397508582	Cystic Fibrosis	Q1186X			CFTR	1080
VSF721ABA3	chr7	117627639	117627640	C	G	NC_000007.14:g.117627640C>G	NM_000492.3:c.3587C>G	NP_000483.3:p.Ser1196*		57836	CM930132	rs121908763	Cystic Fibrosis	S1196X	NFE	1.80E-05	CFTR	1080
VSD9MMRRSN	chr7	117627643	117627645	CG	C	NC_000007.14:g.117627645delG	NM_000492.3:c.3592delG	NP_000483.3:p.Val1198fs		68443	CD941640	rs397508585	Cystic Fibrosis	3724delG			CFTR	1080
VS7C4MJMWX	chr7	117627649	117627651	GA	G	NC_000007.14:g.117627653delA	NM_000492.3:c.3600delA	NP_000483.3:p.Asp1201fs			CD920848		Cystic Fibrosis	3732delA			CFTR	1080
VSDHFEEWHM	chr7	117627656	117627658	GA	G	NC_000007.14:g.117627658delA	NM_000492.3:c.3605delA	NP_000483.3:p.Asp1202fs		68445	CD920849	rs397508587	Cystic Fibrosis	3737delA			CFTR	1080
VS7E3F6BFC	chr7	117627663	117627664	G	A	NC_000007.14:g.117627664G>A	NM_000492.3:c.3611G>A	NP_000483.3:p.Trp1204*		22251	CM920183	rs121908764	Cystic Fibrosis	W1204X (TAG)			CFTR	1080
VSE631198C	chr7	117627664	117627665	G	A	NC_000007.14:g.117627665G>A	NM_000492.3:c.3612G>A	NP_000483.3:p.Trp1204*		68447	CM067771	rs121908765	Cystic Fibrosis	W1204X	AMR	5.97E-05	CFTR	1080
VS23TDVBYL	chr7	117627669	117627670	C	A	NC_000007.14:g.117627670C>A	NM_000492.3:c.3617C>A	NP_000483.3:p.Ser1206*			CM141631	rs397508588	Cystic Fibrosis	S1206X (C>A)			CFTR	1080
VSHIGWZ48J	chr7	117627669	117627672	CAG	C	NC_000007.14:g.117627671_117627672delAG	NM_000492.3:c.3618_3619delAG	NP_000483.3:p.Gly1208fs		68450	CD930930	rs397508589	Cystic Fibrosis	3750delAG			CFTR	1080
VSZ3DXWSR4	chr7	117627669	117627670	C	G	NC_000007.14:g.117627670C>G	NM_000492.3:c.3617C>G	NP_000483.3:p.Ser1206*		68449	CM962481	rs397508588	Cystic Fibrosis	S1206X			CFTR	1080
VSL5NITA8H	chr7	117627670	117627672	AG	A	NC_000007.14:g.117627676delG	NM_000492.3:c.3623delG	NP_000483.3:p.Gly1208fs			CD983609	rs35396083	Cystic Fibrosis	3755delG			CFTR	1080
VSPQK9ZX9V	chr7	117627709	117627710	C	CA	NC_000007.14:g.117627711dupA	NM_000492.3:c.3658dupA	NP_000483.3:p.Thr1220fs			CI983617		Cystic Fibrosis	3789insA			CFTR	1080
VS8EE7929A	chr7	117627710	117627712	AC	A	NC_000007.14:g.117627712delC	NM_000492.3:c.3659delC	NP_000483.3:p.Thr1220fs		22163	CD972131	rs121908811	Cystic Fibrosis	3791delC	AFR	6.54E-05	CFTR	1080
VS0B8FF00A	chr7	117627740	117627742	AT	A	NC_000007.14:g.117627744delT	NM_000492.3:c.3691delT	NP_000483.3:p.Ser1231fs		44535	CD910495	rs121908783	Cystic Fibrosis	3821delT			CFTR	1080
VSIZ8ARAUL	chr7	117627759	117627761	CT	C	NC_000007.14:g.117627761delT	NM_000492.3:c.3708delT	NP_000483.3:p.Gly1237fs			CD1212252		Cystic Fibrosis	c.3708delT			CFTR	1080
VSE452AE4F	chr7	117639960	117639961	C	T	NC_000007.14:g.117639961C>T	NM_000492.3:c.3718-2477C>T			22205	CS941445	rs75039782	Cystic Fibrosis	3849+10kbC>T			CFTR	1080
VS98736171	chr7	117642450	117642451	G	A	NC_000007.14:g.117642451G>A	NM_000492.3:c.3731G>A	NP_000483.3:p.Gly1244Glu		68465	CM910075	rs267606723	Cystic Fibrosis	G1244E	NFE	1.80E-05	CFTR	1080
VS270DE970	chr7	117642462	117642464	CA	C	NC_000007.14:g.117642464delA	NM_000492.3:c.3744delA	NP_000483.3:p.Lys1250fs		22270	CD000474	rs121908784	Cystic Fibrosis	3876delA	AMR	8.94E-05	CFTR	1080
VSCGHFI49C	chr7	117642463	117642465	AG	A	NC_000007.14:g.117642467delG	NM_000492.3:c.3747delG	NP_000483.3:p.Lys1250fs		205621	CD993894	rs797045159	Cystic Fibrosis	3878delG			CFTR	1080
VS6B6DA66D	chr7	117642471	117642472	G	A	NC_000007.14:g.117642472G>A	NM_000492.3:c.3752G>A	NP_000483.3:p.Ser1251Asn		22256	CM920185	rs74503330	Cystic Fibrosis	S1251N	SAS	6.50E-05	CFTR	1080
VS18ZPZYIU	chr7	117642480	117642481	T	G	NC_000007.14:g.117642481T>G	NM_000492.3:c.3761T>G	NP_000483.3:p.Leu1254*		68472		rs397508604	Cystic Fibrosis	L1254X			CFTR	1080
VS0B27E3E5	chr7	117642482	117642483	T	C	NC_000007.14:g.117642483T>C	NM_000492.3:c.3763T>C	NP_000483.3:p.Ser1255Pro		22231	CM920187	rs121909041	Cystic Fibrosis	S1255P			CFTR	1080
VS80A95EAB	chr7	117642483	117642484	C	A	NC_000007.14:g.117642484C>A	NM_000492.3:c.3764C>A	NP_000483.3:p.Ser1255*		22164	CM920186	rs76649725	Cystic Fibrosis	S1255X	AFR	6.54E-05	CFTR	1080
VS80C95GCD	chr7	117642483	117642484	C	G	NC_000007.14:g.117642484C>G	NM_000492.3:c.3764C>G	NP_000483.3:p.Ser1255*					Cystic Fibrosis	S1255X			CFTR	1080
VSENS4I9GV	chr7	117642485	117642486	G	GC	NC_000007.14:g.117642487dupC	NM_000492.3:c.3767dupC	NP_000483.3:p.Leu1258fs		22217	CI931073	rs387906370	Cystic Fibrosis	3898insC			CFTR	1080
VS428D9B78	chr7	117642486	117642487	C	CT	NC_000007.14:g.117642493dupT	NM_000492.3:c.3773dupT	NP_000483.3:p.Leu1258fs		47331	CI941851	rs121908789	Cystic Fibrosis	3905insT	NFE	1.80E-05	CFTR	1080
VSS7D6EL1J	chr7	117642492	117642493	T	TG	NC_000007.14:g.117642494dupG	NM_000492.3:c.3774dupG	NP_000483.3:p.Arg1259fs			CI942011	rs397508608	Cystic Fibrosis	3906insG			CFTR	1080
VSRLXJVKIJ	chr7	117642530	117642533	GGT	G	NC_000007.14:g.117642536_117642537delGT	NM_000492.3:c.3816_3817delGT	NP_000483.3:p.Ser1273fs		68483	CD972975	rs397508612	Cystic Fibrosis	3944delGT			CFTR	1080
VSQLDSNFEL	chr7	117642541	117642542	G	A	NC_000007.14:g.117642542G>A	NM_000492.3:c.3822G>A	NP_000483.3:p.Trp1274*		68484	CM993870	rs397508613	Cystic Fibrosis	W1274X			CFTR	1080
VS4R4JGJE1	chr7	117642546	117642548	CA	C	NC_000007.14:g.117642549delA	NM_000492.3:c.3829delA	NP_000483.3:p.Ile1277fs		68485	CD042863	rs397508614	Cystic Fibrosis	3960_3961delA			CFTR	1080
VS5VRG4MAQ	chr7	117642552	117642555	CTT	C	NC_000007.14:g.117642555_117642556delTT	NM_000492.3:c.3835_3836delTT	NP_000483.3:p.Leu1279fs				rs1351410554	Cystic Fibrosis	c.3835_3836delTT	NFE	8.98E-06	CFTR	1080
VSXFUCSLH7	chr7	117642560	117642561	C	T	NC_000007.14:g.117642561C>T	NM_000492.3:c.3841C>T	NP_000483.3:p.Gln1281*		68486	CM970297	rs397508615	Cystic Fibrosis	Q1281X			CFTR	1080
VS9FE720E6	chr7	117642565	117642566	G	A	NC_000007.14:g.117642566G>A	NM_000492.3:c.3846G>A	NP_000483.3:p.Trp1282*		22168	CM900061	rs77010898	Cystic Fibrosis	W1282X	ASJ	0.00884146	CFTR	1080
VSTSPYMY16	chr7	117642572	117642574	GC	G	NC_000007.14:g.117642575delC	NM_000492.3:c.3855delC	NP_000483.3:p.Phe1286fs		68491	CD090065	rs397508618	Cystic Fibrosis	c.3855delC			CFTR	1080
VSJ72HDNDT	chr7	117642590	117642591	C	T	NC_000007.14:g.117642591C>T	NM_000492.3:c.3871C>T	NP_000483.3:p.Gln1291*		68493	CM003260	rs397508620	Cystic Fibrosis	Q1291X	ASJ	0.00010175	CFTR	1080
VS2CCAAC51	chr7	117642593	117642594	G	A	NC_000007.14:g.117642594G>A	NM_000492.3:c.3873+1G>A			22199	CS920737	rs143570767	Cystic Fibrosis	4005+1G>A			CFTR	1080
VSQY7EKLZM	chr7	117652840	117652842	GA	G	NC_000007.14:g.117652844delA	NM_000492.3:c.3876delA	NP_000483.3:p.Val1293fs			CD993895	rs397508626	Cystic Fibrosis	4006delA			CFTR	1080
VSYYTCNVN7	chr7	117652844	117652849	GTATT	G	NC_000007.14:g.117652851_117652854delATTT	NM_000492.3:c.3883_3886delATTT	NP_000483.3:p.Ile1295fs		68505	CD941642	rs387906373	Cystic Fibrosis	4010del4			CFTR	1080
VS587JQBUM	chr7	117652849	117652851	TA	T	NC_000007.14:g.117652851delA	NM_000492.3:c.3883delA	NP_000483.3:p.Ile1295fs		68506	CD942004	rs397508630	Cystic Fibrosis	4015delA			CFTR	1080
VS1E49A5D6	chr7	117652850	117652851	A	AT	NC_000007.14:g.117652857dupT	NM_000492.3:c.3889dupT	NP_000483.3:p.Ser1297fs		68508	CI931074	rs121908808	Cystic Fibrosis	4016insT	AFR	6.57E-05	CFTR	1080
VSKQXEKHY6	chr7	117652857	117652858	C	CT	NC_000007.14:g.117652859dupT	NM_000492.3:c.3891dupT	NP_000483.3:p.Gly1298fs		68510		rs397508633	Cystic Fibrosis	4022insT			CFTR	1080
VSCJ3JCRVK	chr7	117652869	117652870	G	GA	NC_000007.14:g.117652876dupA	NM_000492.3:c.3908dupA	NP_000483.3:p.Asn1303fs		68515	CI102312	rs397508638	Cystic Fibrosis	c.3908dupA	SAS	3.30E-05	CFTR	1080
VST7M14RQS	chr7	117652869	117652871	GA	G	NC_000007.14:g.117652876delA	NM_000492.3:c.3908delA	NP_000483.3:p.Asn1303fs		68514	CD920850	rs1322366387	Cystic Fibrosis	4040delA	NFE	9.05E-06	CFTR	1080
VS06E3B9A7	chr7	117652876	117652877	C	G	NC_000007.14:g.117652877C>G	NM_000492.3:c.3909C>G	NP_000483.3:p.Asn1303Lys		22175	CM910076	rs80034486	Cystic Fibrosis	N1303K	ASJ	0.000715454	CFTR	1080
VS9F1A6D4E	chr7	117652876	117652877	C	A	NC_000007.14:g.117652877C>A	NM_000492.3:c.3909C>A	NP_000483.3:p.Asn1303Lys					Cystic Fibrosis	N1303K			CFTR	1080
VSL79XUEMW	chr7	117652882	117652883	T	TCC	NC_000007.14:g.117652885_117652886dupCC	NM_000492.3:c.3917_3918dupCC	NP_000483.3:p.Tyr1307fs			CI931173		Cystic Fibrosis	4048insCC			CFTR	1080
VSUVNV12P5	chr7	117652888	117652889	T	A	NC_000007.14:g.117652889T>A	NM_000492.3:c.3921T>A	NP_000483.3:p.Tyr1307*		68520	CM993871	rs397508642	Cystic Fibrosis	Y1307X			CFTR	1080
VSW99IERK8	chr7	117652889	117652890	G	T	NC_000007.14:g.117652890G>T	NM_000492.3:c.3922G>T	NP_000483.3:p.Glu1308*		68521	CM972963	rs397508643	Cystic Fibrosis	E1308X			CFTR	1080
VSL4LE88UI	chr7	117652896	117652897	G	A	NC_000007.14:g.117652897G>A	NM_000492.3:c.3929G>A	NP_000483.3:p.Trp1310*		68523	CM920192	rs397508645	Cystic Fibrosis	W1310X			CFTR	1080
VS670E93B8	chr7	117652904	117652905	C	T	NC_000007.14:g.117652905C>T	NM_000492.3:c.3937C>T	NP_000483.3:p.Gln1313*		22219	CM930137	rs121909026	Cystic Fibrosis	Q1313X			CFTR	1080
VS1WID3HRZ	chr7	117652914	117652915	G	A	NC_000007.14:g.117652915G>A	NM_000492.3:c.3947G>A	NP_000483.3:p.Trp1316*		22172	CM900062	rs121909010	Cystic Fibrosis	W1316X			CFTR	1080
VSKMF3WCYB	chr7	117652923	117652924	C	CAGGG	NC_000007.14:g.117652926_117652927insGGAG	NM_000492.3:c.3958_3959insGGAG	NP_000483.3:p.Asp1320fs					Cystic Fibrosis	4089ins4			CFTR	1080
VC80765638	chr7	117664605	117666138	AACTCCTGTGTTTATTTTTAGAATGTCAACTGCTTGAGTGTTTTTAACTCTGTGGTATCTGAACTATCTTCTCTAACTGCAGGTTGGGCTCAGATCTGTGATAGAACAGTTTCCTGGGAAGCTTGACTTTGTCCTTGTGGATGGGGGCTGTGTCCTAAGCCATGGCCACAAGCAGTTGATGTGCTTGGCTAGATCTGTTCTCAGTAAGGCGAAGATCTTGCTGCTTGATGAACCCAGTGCTCATTTGGATCCAGTGTGAGTTTCAGATGTTCTGTTACTTAATAGCACAGTGGGAACAGAATCATTATGCCTGCTTCATGGTGACACATATTTCTATTAGGCTGTCATGTCTGCGTGTGGGGGTCTCCCCCAAGATATGAAATAATTGCCCAGTGGAAATGAGCATAAATGCATATTTCCTTGCTAAGAGTCTTGTGTTTTCTTCCGAAGATAGTTTTTAGTTTCATACAAACTCTTCCCCCTTGTCAACACATGATGAAGCTTTTAAATACATGGGCCTAATCTGATCCTTATGATTTGCCTTTGTATCCCATTTATACCATAAGCATGTTTATAGCCCCAAATAAAGAAGTACTGGTGATTCTACATAATGAAAAATGTACTCATTTATTAAAGTTTCTTTGAAATATTTGTCCTGTTTATTTATGGATACTTAGAGTCTACCCCATGGTTGAAAAGCTGATTGTGGCTAACGCTATATCAACATTATGTGAAAAGAACTTAAAGAAATAAGTAATTTAAAGAGATAATAGAACAATAGACATATTATCAAGGTAAATACAGATCATTACTGTTCTGTGATATTATGTGTGGTATTTTCTTTCTTTTCTAGAACATACCAAATAATTAGAAGAACTCTAAAACAAGCATTTGCTGATTGCACAGTAATTCTCTGTGAACACAGGATAGAAGCAATGCTGGAATGCCAACAATTTTTGGTGAGTCTTTATAACTTTACTTAAGATCTCATTGCCCTTGTAATTCTTGATAACAATCTCACATGTGATAGTTCCTGCAAATTGCAACAATGTACAAGTTCTTTTCAAAAATATGTATCATACAGCCATCCAGCTTTACTCAAAATAGCTGCACAAGTTTTTCACTTTGATCTGAGCCATGTGGTGAGGTTGAAATATAGTAAATCTAAAATGGCAGCATATTACTAAGTTATGTTTATAAATAGGATATATATACTTTTTGAGCCCTTTATTTGGGGACCAAGTCATACAAAATACTCTACTGTTTAAGATTTTAAAAAAGGTCCCTGTGATTCTTTCAATAACTAAATGTCCCATGGATGTGGTCTGGGACAGGCCTAGTTGTCTTACAGTCTGATTTATGGTATTAATGACAAAGTTGAGAGGCACATTTCATTTTTCTAGCCATGATTTGGGTTCAGGTAGTACCTTTCTCAACCACCTTCTCACTGTTCTTAAAAAAACTGTCACATGGCCAGGCACAGTGGCTTACATCTGTAATCCCAATACTTTGGGAGGCTGAGGTGGGGGGATT	A	NC_000007.14:g.117664610_117666141del	NM_000492.3:c.3964-78_4242+577del		Deletion of exons 22 and 23	77005			Cystic Fibrosis	CFTRdele22.23			CFTR	1080
VS43A6C736	chr7	117664769	117664770	G	A	NC_000007.14:g.117664770G>A	NM_000492.3:c.4046G>A	NP_000483.3:p.Gly1349Asp		44545	CM920193	rs193922525	Cystic Fibrosis	G1349D			CFTR	1080
VSL725SN17	chr7	117664794	117664797	TAG	AA	NC_000007.14:g.117664795_117664797delTAGinsAA	NM_000492.3:c.4071_4073delTAGinsAA	NP_000483.3:p.Arg1358fs			CX994790	rs397508667	Cystic Fibrosis	4203TAG>AA			CFTR	1080
VSF23BB756	chr7	117664800	117664804	TGTT	AA	NC_000007.14:g.117664801_117664804delTGTTinsAA	NM_000492.3:c.4077_4080delTGTTinsAA	NP_000483.3:p.Val1360fs		68550	CX057622	rs397508668	Cystic Fibrosis	4209TGTT>AA			CFTR	1080
VSJ5KRDSAE	chr7	117664808	117664809	G	GT	NC_000007.14:g.117664810dupT	NM_000492.3:c.4086dupT	NP_000483.3:p.Lys1363fs		480454	CI931075	rs397508669	Cystic Fibrosis	4218insT			CFTR	1080
VSMGLA1KLL	chr7	117664834	117664835	G	T	NC_000007.14:g.117664835G>T	NM_000492.3:c.4111G>T	NP_000483.3:p.Glu1371*		68558	CM920194	rs397508675	Cystic Fibrosis	E1371X	NFE	8.97E-06	CFTR	1080
VSD1558188	chr7	117666913	117666915	GA	G	NC_000007.14:g.117666916delA	NM_000492.3:c.4251delA	NP_000483.3:p.Glu1418fs		68600	CD930931	rs397508706	Cystic Fibrosis	4382delA			CFTR	1080
VSBL8DQH14	chr7	117666916	117666917	G	T	NC_000007.14:g.117666917G>T	NM_000492.3:c.4252G>T	NP_000483.3:p.Glu1418*		68601	CM043479	rs397508707	Cystic Fibrosis	E1418X			CFTR	1080
VSRITR8DN5	chr8	1771123	1771124	C	G	NC_000008.11:g.1771124C>G	NM_018941.3:c.70C>G	NP_061764.2:p.Arg24Gly		17841	CM992146	rs104894064	"Neuronal ceroid lipofuscinosis, CLN8-related"	70C>G	FIN	0.00112118	CLN8	2055
VSDHHV5WNU	chr8	1780494	1780495	G	C	NC_000008.11:g.1780495G>C	NM_018941.3:c.789G>C	NP_061764.2:p.Trp263Cys		17842	CM040704	rs28940569	"Neuronal ceroid lipofuscinosis, CLN8-related"	789G>C			CLN8	2055
VSL3NH81UP	chr8	19954221	19954222	G	A	NC_000008.11:g.19954222G>A	NM_000237.2:c.644G>A	NP_000228.1:p.Gly215Glu		16561	CM900162	rs118204057	Lipoprotein lipase deficiency	644G>A	NFE	0.000349206	LPL	4023
VSMJVXMXEM	chr8	38144358	38144359	G	A	NC_000008.11:g.38144359G>A	NM_000349.2:c.772C>T	NP_000340.2:p.Gln258*		24026	CM971427	rs104894085	Congenital lipoid adrenal hyperplasia	772C>T	EAS	0.000735925	STAR	6770
TP2016012	chr8	38148302	38148305	TAG	T	NC_000008.11:g.38148308_38148309delAG	NM_000349.2:c.201_202delCT	NP_000340.2:p.Tyr68fs		577060	CD054425		Congenital lipoid adrenal hyperplasia	201_202delCT			STAR	6770
VSDAR1N9V4	chr8	43147063	43147064	G	A	NC_000008.11:g.43147064G>A	NM_152419.2:c.234+1G>A			39789	CS065564	rs483352908	"Mucopolysaccharidosis, type IIIC"	234+1G>A	AMR	0.000168748	HGSNAT	138050
VSU2XMP2XG	chr8	43158920	43158921	A	G	NC_000008.11:g.43158921A>G	NM_152419.2:c.372-2A>G			16275	CS083231	rs483352896	"Mucopolysaccharidosis, type IIIC"	372-2A>G	AMR	0.000190985	HGSNAT	138050
VSTMKENNJS	chr8	43197681	43197682	C	T	NC_000008.11:g.43197682C>T	NM_152419.2:c.1553C>T	NP_689632.2:p.Ser518Phe		16277	CM071800	rs121908286	"Mucopolysaccharidosis, type IIIC"	1553C>T	NFE	8.95E-06	HGSNAT	138050
VSHV7HEACX	chr8	63061343	63061345	CT	C	NC_000008.11:g.63061346delT	NM_000370.3:c.744delA	NP_000361.1:p.Glu249fs		24175	CD951868	rs397515377	Ataxia with vitamin E deficiency	744delA	AMR	0.000148898	TTPA	7274
VS22MP5ZGX	chr8	63065940	63065941	G	GAA	NC_000008.11:g.63065941_63065942insAA	NM_000370.3:c.514_515insTT	NP_000361.1:p.Thr172fs					Ataxia with vitamin E deficiency	513_514insTT			TTPA	7274
VS3KUB55BR	chr8	63066055	63066056	G	A	NC_000008.11:g.63066056G>A	NM_000370.3:c.400C>T	NP_000361.1:p.Arg134*		24180	CM981965	rs121917851	Ataxia with vitamin E deficiency	400C>T	FIN	4.49E-05	TTPA	7274
VS3QQNMMY6	chr8	63072989	63072990	A	C	NC_000008.11:g.63072990A>C	NM_000370.3:c.303T>G	NP_000361.1:p.His101Gln		24176	CM951245	rs121917849	Ataxia with vitamin E deficiency	303T>G	EAS	5.80E-05	TTPA	7274
VSNWN291WJ	chr8	86632767	86632768	G	A	NC_000008.11:g.86632768G>A	NM_019098.4:c.1304C>T	NP_061971.3:p.Ser435Phe		20261	CM001816	rs121918344	"Achromatopsia, CNGB3-related"	1304C>T			CNGB3	54714
VS5JTKIYQV	chr8	86643779	86643781	AG	A	NC_000008.11:g.86643781delG	NM_019098.4:c.1148delC	NP_061971.3:p.Thr383fs		20264	CD001927	rs397515360	"Achromatopsia, CNGB3-related"	1148delC	NFE	0.00282613	CNGB3	54714
VSC4BLE3CC	chr8	89971212	89971218	ATTTGT	A	NC_000008.11:g.89971217_89971221delGTTTT	NM_002485.4:c.657_661delACAAA	NP_002476.2:p.Lys219fs		21979	CD982819	rs587776650	Nijmegen breakage syndrome	657_661delACAAA	NFE	0.000377115	NBN	4683
VS8YF5ZB22	chr8	144414726	144414731	TCTGA	T	NC_000008.11:g.144414731_144414734delACTG	NM_130849.3:c.970_973delTCAG	NP_570901.2:p.Ser324fs			CD021442		Acrodermatitis enteropathica	970_973delTCAG			SLC39A4	55630
TP2016022	chr8	144415294	144415295	G	A	NC_000008.11:g.144415295G>A	NM_130849.3:c.599C>T	NP_570901.2:p.Pro200Leu		18576	CM021338	rs121434287	Acrodermatitis enteropathica	599C>T	NFE	0.00020708	SLC39A4	55630
VSJIT9D26W	chr9	6554702	6554703	C	T	NC_000009.12:g.6554703C>T	NM_000170.2:c.2281G>A	NP_000161.2:p.Gly761Arg		545205	CM016186	rs386833549	"Glycine encephalopathy, GLDC-related"	2281G>A	FIN	0.00166547	GLDC	2731
VS2UDGI9EG	chr9	6554713	6554717	CAGA	C	NC_000009.12:g.6554717_6554719delAAG	NM_000170.2:c.2267_2269delTCT	NP_000161.2:p.Phe756del		70706	CD910524	rs121964975	"Glycine encephalopathy, GLDC-related"	2267_2269delTCT	SAS	3.27E-05	GLDC	2731
VSWRDZJZJB	chr9	6588416	6588417	C	A	NC_000009.12:g.6588417C>A	NM_000170.2:c.1691G>T	NP_000161.2:p.Ser564Ile		27021	CM920313	rs121964974	"Glycine encephalopathy, GLDC-related"	1691G>T	FIN	0.00237668	GLDC	2731
VSYGCA8KT1	chr9	6589229	6589230	C	G	NC_000009.12:g.6589230C>G	NM_000170.2:c.1545G>C	NP_000161.2:p.Arg515Ser		27024	CM002029	rs121964976	"Glycine encephalopathy, GLDC-related"	1545G>C	NFE	0.00018799	GLDC	2731
VS8IUAKHRQ	chr9	34647489	34647490	A	G	NC_000009.12:g.34647490A>G	NM_000155.3:c.253-2A>G			36476	CS013822	rs111033661	Galactosemia	253-2A>G	AMR	0.000327556	GALT	2592
VSWDGQQYTQ	chr9	34647857	34647858	C	T	NC_000009.12:g.34647858C>T	NM_000155.3:c.404C>T	NP_000146.2:p.Ser135Leu		18657	CM950546	rs111033690	Galactosemia	404C>T	AFR	0.00352849	GALT	2592
VSEH6Z9L68	chr9	34648118	34648119	T	C	NC_000009.12:g.34648119T>C	NM_000155.3:c.512T>C	NP_000146.2:p.Phe171Ser		18655	CM920294	rs111033715	Galactosemia	512T>C	AFR	6.53E-05	GALT	2592
VSJR4FSYTZ	chr9	34648169	34648170	A	G	NC_000009.12:g.34648170A>G	NM_000155.3:c.563A>G	NP_000146.2:p.Gln188Arg		18653	CM910169	rs75391579	Galactosemia	563A>G	NFE	0.00265843	GALT	2592
TP2016015	chr9	34648352	34648353	T	C	NC_000009.12:g.34648353T>C	NM_000155.3:c.584T>C	NP_000146.2:p.Leu195Pro		36556	CM920295	rs111033728	Galactosemia	584T>C	NFE	0.000152177	GALT	2592
VSCBYLMZLA	chr9	34648394	34648395	A	G	NC_000009.12:g.34648395A>G	NM_000155.3:c.626A>G	NP_000146.2:p.Tyr209Cys		36565	CM990656	rs111033744	Galactosemia	626A>G	SAS	3.25E-05	GALT	2592
VSN48MPP2B	chr9	34649031	34649032	G	T	NC_000009.12:g.34649032G>T	NM_000155.3:c.855G>T	NP_000146.2:p.Lys285Asn		18660	CM920296	rs111033773	Galactosemia	855G>T	AMR	0.000238223	GALT	2592
VS96U3Y7PV	chr9	35657755	35657756	C	A	NC_000009.12:g.35657756C>A	NR_003051.3:n.263G>T			29248	CR012677	rs727502774	Cartilage-hair hypoplasia	c.262G>T	FIN	0.000202184	RMRP	6023
VSPVFAS4VE	chr9	35657947	35657948	T	C	NC_000009.12:g.35657948T>C	NR_003051.3:n.71A>G			29247	CR011576	rs199476103	Cartilage-hair hypoplasia	g.70A>G	FIN	0.0086727	RMRP	6023
VSRZLX2L5A	chr9	36217398	36217399	A	G	NC_000009.12:g.36217399A>G	NM_001128227.2:c.2228T>C	NP_001121699.1:p.Met743Thr		21064	CM012822	rs28937594	"Inclusion body myopathy, type II"	2135T>C	NFE	4.48E-05	GNE	10020
VS7AZL523B	chr9	36219939	36219940	C	G	NC_000009.12:g.36219940C>G	NM_001128227.2:c.1807G>C	NP_001121699.1:p.Val603Leu		21072	CM021717	rs121908632	"Inclusion body myopathy, type II"	1714G>C	EAS	0.000173933	GNE	10020
VS2QZTMNSV	chr9	36249317	36249318	C	G	NC_000009.12:g.36249318C>G	NM_001128227.2:c.131G>C	NP_001121699.1:p.Cys44Ser		488371	CM040429	rs1209266607	"Inclusion body myopathy, type II"	38G>C			GNE	10020
VSC8P5G6GI	chr9	37424860	37424862	TG	T	NC_000009.12:g.37424864delG	NM_012203.1:c.103delG	NP_036335.1:p.Asp35fs		20675	CD992266	rs1222084400	"Primary hyperoxaluria, type II"	103delG	NFE	0.000500774	GRHPR	9380
VS6JFVH2YB	chr9	37426651	37426656	GAAGT	G	NC_000009.12:g.37426657_37426660delAAGT	NM_012203.1:c.404+3_404+6delAAGT			200629	CD002505	rs180177309	"Primary hyperoxaluria, type II"	404+3_404+6delAAGT	SAS	0.000129955	GRHPR	9380
VS9FFBC56A	chr9	95101741	95101742	G	A	NC_000009.12:g.95101742G>A	NM_000136.2:c.1642C>T	NP_000127.2:p.Arg548*		27086	CM930241	rs104886457	"Fanconi anemia, type C"	p.R548X	SAS	0.000129997	FANCC	2176
VS3AAF6F3E	chr9	95172032	95172033	T	A	NC_000009.12:g.95172033T>A	NM_000136.2:c.456+4A>T			27084	CS930803	rs104886456	"Fanconi anemia, type C"	IVS4+4A>T	ASJ	0.00589551	FANCC	2176
VSAEE745DC	chr9	95249223	95249225	TC	T	NC_000009.12:g.95249227delC	NM_000136.2:c.67delG	NP_000127.2:p.Asp23fs		27088	CD941677	rs104886459	"Fanconi anemia, type C"	c.322delG	NFE	0.000287119	FANCC	2176
VS19UKRGTT	chr9	96254905	96254906	C	T	NC_000009.12:g.96254906C>T	NM_000197.1:c.239G>A	NP_000188.1:p.Arg80Gln		19913	CM940950	rs119481075	"17-beta-hydroxysteroid dehydrogenase deficiency, type III"	239G>A	NFE	0.000143346	HSD17B3	3293
VSCUT4XBRL	chr9	101421898	101421899	G	C	NC_000009.12:g.101421899G>C	NM_000035.3:c.1005C>G	NP_000026.2:p.Asn335Lys		15508	CM900014	rs78340951	Hereditary fructose intolerance	1005C>G	NFE	0.000227198	ALDOB	229
VS8F266ZRZ	chr9	101427497	101427498	G	T	NC_000009.12:g.101427498G>T	NM_000035.3:c.524C>A	NP_000026.2:p.Ala175Asp		15504	CM900012	rs76917243	Hereditary fructose intolerance	524C>A	ASJ	0.00182852	ALDOB	229
VSW924NXFX	chr9	101427573	101427574	C	G	NC_000009.12:g.101427574C>G	NM_000035.3:c.448G>C	NP_000026.2:p.Ala150Pro		15503	CM880004	rs1800546	Hereditary fructose intolerance	448G>C	NFE	0.00460693	ALDOB	229
VSIFB4EPNF	chr9	101428483	101428488	CTTTG	C	NC_000009.12:g.101428491_101428494delTGTT	NM_000035.3:c.360_363delCAAA	NP_000026.2:p.Asn120fs		186778	CD900270	rs1221949847	Hereditary fructose intolerance	360_363delCAAA	EAS	0.000173933	ALDOB	229
VS7A4918EC	chr9	105620048	105620049	G	GA	NC_000009.12:g.105620056dupA	NM_001079802.1:c.1167dupA	NP_001073270.1:p.Phe390fs		18242	CI992789	rs1419512580	Walker-Warburg syndrome	p.F390X	ASJ	0.00782998	FKTN	2218
VS92589E1D	chr9	108899815	108899816	A	G	NC_000009.12:g.108899816A>G	NM_003640.4:c.2204+6T>C			21124	CS011046	rs111033171	Familial dysautonomia	IVS20+6T>C	ASJ	0.0134092	IKBKAP	8518
VS17AEE45C	chr9	108900302	108900303	C	G	NC_000009.12:g.108900303C>G	NM_003640.4:c.2087G>C	NP_003631.2:p.Arg696Pro		21125	CM010892	rs137853022	Familial dysautonomia	p.R696P			IKBKAP	8518
VSX3RF9D9E	chr9	130466722	130466723	A	G	NC_000009.12:g.130466723A>G	NM_000050.4:c.421-2A>G			195547	CS951349	rs751930594	"Citrullinemia, type I"	421-2A>G	EAS	0.000174014	ASS1	445
VSCYFAUU42	chr9	130489403	130489404	C	T	NC_000009.12:g.130489404C>T	NM_000050.4:c.910C>T	NP_000041.2:p.Arg304Trp		21369	CM900034	rs121908642	"Citrullinemia, type I"	910C>T	AMR	5.96E-05	ASS1	445
VSXRXEY5IF	chr9	130499544	130499545	G	A	NC_000009.12:g.130499545G>A	NM_000050.4:c.1168G>A	NP_000041.2:p.Gly390Arg		21368	CM900037	rs121908641	"Citrullinemia, type I"	1168G>A	SAS	0.00107914	ASS1	445
VS73L7JJIC	chrX	18647191	18647192	C	G	NC_000023.11:g.18647192C>G	NM_000330.3:c.325G>C	NP_000321.1:p.Gly109Arg		24930	CM971320	rs104894934	Juvenile retinoschisis (X-linked)	325G>C	FIN	0.000182571	RS1	6247
VSI779SQFK	chrX	18647295	18647296	C	A	NC_000023.11:g.18647296C>A	NM_000330.3:c.221G>T	NP_000321.1:p.Gly74Val		24929	CM981736	rs104894933	Juvenile retinoschisis (X-linked)	221G>T			RS1	6247
VS8NE2UXW7	chrX	18647302	18647303	C	T	NC_000023.11:g.18647303C>T	NM_000330.3:c.214G>A	NP_000321.1:p.Glu72Lys		24927	CM981735	rs104894928	Juvenile retinoschisis (X-linked)	214G>A	FIN	0.000121632	RS1	6247
VSSM33R4VB	chrX	19355359	19355360	C	A	NC_000023.11:g.19355360C>A	NM_000284.3:c.615C>A	NP_000275.1:p.Phe205Leu			CM920571		"Pyruvate dehydrogenase deficiency, PDHA1-related (X-linked)"	615C>A			PDHA1	5160
VSERIT65BJ	chrX	19355712	19355713	C	G	NC_000023.11:g.19355713C>G	NM_000284.3:c.787C>G	NP_000275.1:p.Arg263Gly		25917	CM920573	rs137853259	"Pyruvate dehydrogenase deficiency, PDHA1-related (X-linked)"	787C>G			PDHA1	5160
VSHPSB6S9I	chrX	19358919	19358920	C	T	NC_000023.11:g.19358920C>T	NM_000284.3:c.904C>T	NP_000275.1:p.Arg302Cys		25918	CM920575	rs137853252	"Pyruvate dehydrogenase deficiency, PDHA1-related (X-linked)"	904C>T			PDHA1	5160
VSED6KVVQ7	chrX	19359618	19359619	C	CCAAT	NC_000023.11:g.19359622_19359625dupATCA	NM_000284.3:c.1142_1145dupATCA	NP_000275.1:p.Trp383fs		25919	CI931102	rs606231189	"Pyruvate dehydrogenase deficiency, PDHA1-related (X-linked)"	4-BP INS: 1251ACTA			PDHA1	5160
VSMIVS9MFC	chrX	38352772	38352773	G	A	NC_000023.11:g.38352773G>A	NM_000531.5:c.77G>A	NP_000522.3:p.Arg26Gln		26032	CM910273	rs68031618	Ornithine transcarbamylase deficiency (X-linked)	77G>A			OTC	5009
VSJFP59WA7	chrX	38369852	38369853	C	T	NC_000023.11:g.38369853C>T	NM_000531.5:c.274C>T	NP_000522.3:p.Arg92*		103043	CM910276	rs67418243	Ornithine transcarbamylase deficiency (X-linked)	274C>T			OTC	5009
VSP4E3J3H8	chrX	38401308	38401309	C	T	NC_000023.11:g.38401309C>T	NM_000531.5:c.421C>T	NP_000522.3:p.Arg141*		26027	CM890089	rs67960011	Ornithine transcarbamylase deficiency (X-linked)	421C>T			OTC	5009
VS9YPZ1SF6	chrX	71108335	71108336	G	A	NC_000023.11:g.71108336G>A	NM_000206.2:c.865C>T	NP_000197.1:p.Arg289*		45052	CM930435	rs137852508	"Severe combined immunodeficiency, IL2RG-related (X-linked)"	865C>T			IL2RG	3561
VSWZKD3MMA	chrX	71108598	71108599	C	T	NC_000023.11:g.71108599C>T	NM_000206.2:c.854G>A	NP_000197.1:p.Arg285Gln		25065	CM950696	rs111033617	"Severe combined immunodeficiency, IL2RG-related (X-linked)"	854G>A			IL2RG	3561
VSWT6DSFII	chrX	71223749	71223750	C	T	NC_000023.11:g.71223750C>T	NM_000166.5:c.43C>T	NP_000157.1:p.Arg15Trp		33936	CM970654	rs116840815	"Charcot-Marie-Tooth disease, GJB1-related (X-linked)"	43C>T			GJB1	2705
VSVQNC983C	chrX	71223870	71223871	C	T	NC_000023.11:g.71223871C>T	NM_000166.5:c.164C>T	NP_000157.1:p.Thr55Ile		25485	CM990687	rs104894824	"Charcot-Marie-Tooth disease, GJB1-related (X-linked)"	164C>T			GJB1	2705
VSBKEFHXMH	chrX	71223893	71223894	G	A	NC_000023.11:g.71223894G>A	NM_000166.5:c.187G>A	NP_000157.1:p.Val63Ile		33933	CM940832	rs116840818	"Charcot-Marie-Tooth disease, GJB1-related (X-linked)"	187G>A			GJB1	2705
VS5V12CMRP	chrX	71223929	71223931	CG	C	NC_000023.11:g.71223932delG	NM_000166.5:c.225delG	NP_000157.1:p.Leu76fs		33935	CD073646	rs116840820	"Charcot-Marie-Tooth disease, GJB1-related (X-linked)"	225delG			GJB1	2705
VSPDWG4IU3	chrX	71223929	71223930	C	T	NC_000023.11:g.71223930C>T	NM_000166.5:c.223C>T	NP_000157.1:p.Arg75Trp		33934	CM970660	rs116840819	"Charcot-Marie-Tooth disease, GJB1-related (X-linked)"	223C>T			GJB1	2705
VSP4H83JVQ	chrX	71223989	71223990	G	A	NC_000023.11:g.71223990G>A	NM_000166.5:c.283G>A	NP_000157.1:p.Val95Met		25480	CM950582	rs104894821	"Charcot-Marie-Tooth disease, GJB1-related (X-linked)"	283G>A			GJB1	2705
VSDDMYBY36	chrX	71224121	71224122	G	A	NC_000023.11:g.71224122G>A	NM_000166.5:c.415G>A	NP_000157.1:p.Val139Met		25472	CM930319	rs104894812	"Charcot-Marie-Tooth disease, GJB1-related (X-linked)"	415G>A	NFE	1.36E-05	GJB1	2705
VS20160218	chrX	71224242	71224243	G	A	NC_000023.11:g.71224243G>A	NM_000166.5:c.536G>A	NP_000157.1:p.Cys179Tyr		33937	CM065229	rs116840822	"Charcot-Marie-Tooth disease, GJB1-related (X-linked)"	c.536G>A			GJB1	2705
VS20160219	chrX	71224262	71224263	G	A	NC_000023.11:g.71224263G>A	NM_000166.5:c.556G>A	NP_000157.1:p.Glu186Lys		33938	CM930323	rs116840821	"Charcot-Marie-Tooth disease, GJB1-related (X-linked)"	c.556G>A			GJB1	2705
VS38RDISDU	chrX	71224364	71224365	C	T	NC_000023.11:g.71224365C>T	NM_000166.5:c.658C>T	NP_000157.1:p.Arg220*		25474	CM940840	rs104894814	"Charcot-Marie-Tooth disease, GJB1-related (X-linked)"	658C>T			GJB1	2705
VSE3ZFBSDH	chrX	85878961	85878962	T	TA	NC_000023.11:g.85878963dupA	NM_000390.3:c.1609+2dupT			70863		rs386833676	Choroideremia (X-linked)	1609+2insT	FIN	0.000126944	CHM	1121
VS7YYT8QT5	chrX	101398073	101398074	C	T	NC_000023.11:g.101398074C>T	NM_000169.2:c.1025G>A	NP_000160.1:p.Arg342Gln		25781	CM940868	rs28935493	Fabry disease (X-linked)	1025G>A			GLA	2717
VSP4URIC6D	chrX	101398386	101398387	C	T	NC_000023.11:g.101398387C>T	NM_000169.2:c.982G>A	NP_000160.1:p.Gly328Arg		25761	CM920312	rs104894832	Fabry disease (X-linked)	982G>A			GLA	2717
VSBXUCP3N3	chrX	101398466	101398467	C	T	NC_000023.11:g.101398467C>T	NM_000169.2:c.902G>A	NP_000160.1:p.Arg301Gln		25754	CM900111	rs104894828	Fabry disease (X-linked)	902G>A			GLA	2717
VS44YY4K56	chrX	101398480	101398481	C	T	NC_000023.11:g.101398481C>T	NM_000169.2:c.888G>A	NP_000160.1:p.Met296Ile		25802	CM950590	rs104894846	Fabry disease (X-linked)	888G>A			GLA	2717
VSSW8YR6AU	chrX	101398905	101398906	C	T	NC_000023.11:g.101398906C>T	NM_000169.2:c.680G>A	NP_000160.1:p.Arg227Gln		25771	CM930328	rs104894840	Fabry disease (X-linked)	680G>A			GLA	2717
VSA1CLJR86	chrX	101398906	101398907	G	A	NC_000023.11:g.101398907G>A	NM_000169.2:c.679C>T	NP_000160.1:p.Arg227*		25772	CM930329	rs104894841	Fabry disease (X-linked)	679C>T			GLA	2717
VS55ZJH7RE	chrX	101398941	101398942	T	C	NC_000023.11:g.101398942T>C	NM_000169.2:c.644A>G	NP_000160.1:p.Asn215Ser		25769	CM930327	rs28935197	Fabry disease (X-linked)	644A>G	NFE	1.25E-05	GLA	2717
VSU6DVGTS2	chrX	101401751	101401752	C	G	NC_000023.11:g.101401752C>G	NM_000169.2:c.427G>C	NP_000160.1:p.Ala143Pro		25808	CM940852	rs104894845	Fabry disease (X-linked)	427G>C			GLA	2717
VS2ZF47RCF	chrX	101403842	101403843	A	G	NC_000023.11:g.101403843A>G	NM_000169.2:c.337T>C	NP_000160.1:p.Phe113Leu			CM972770	rs869312142	Fabry disease (X-linked)	337T>C			GLA	2717
VSUERH7714	chrX	101403844	101403845	C	T	NC_000023.11:g.101403845C>T	NM_000169.2:c.335G>A	NP_000160.1:p.Arg112His		192190	CM940850	rs372966991	Fabry disease (X-linked)	335G>A	NFE	3.75E-05	GLA	2717
VSKNUXQ1P8	chrX	101403907	101403908	A	G	NC_000023.11:g.101403908A>G	NM_000169.2:c.272T>C	NP_000160.1:p.Ile91Thr		224100	CM972767	rs869312141	Fabry disease (X-linked)	272T>C			GLA	2717
VSYIBV62Z7	chrX	101407802	101407803	T	C	NC_000023.11:g.101407803T>C	NM_000169.2:c.101A>G	NP_000160.1:p.Asn34Ser		25763	CM930324	rs104894835	Fabry disease (X-linked)	101A>G			GLA	2717
VS2TQ3GQQ6	chrX	107640938	107640939	T	C	NC_000023.11:g.107640939T>C	NM_002764.3:c.344T>C	NP_002755.1:p.Met115Thr		24974	CM073280	rs80338732	"Charcot-Marie-Tooth disease, PRPS1-related (X-linked)"	344T>C			PRPS1	5631
VSU5QBPXKB	chrX	107640992	107640993	A	C	NC_000023.11:g.107640993A>C	NM_002764.3:c.398A>C	NP_002755.1:p.Gln133Pro		24976	CM073281	rs80338675	Arts syndrome (X-linked)	398A>C			PRPS1	5631
VSIB8HIK48	chrX	107642414	107642415	T	C	NC_000023.11:g.107642415T>C	NM_002764.3:c.455T>C	NP_002755.1:p.Leu152Pro		24975	CM073282	rs80338676	Arts syndrome (X-linked)	455T>C			PRPS1	5631
VSQIWQQDZP	chrX	108695408	108695409	T	G	NC_000023.11:g.108695409T>G	NM_000495.4:c.4946T>G	NP_000486.1:p.Leu1649Arg		25505	CM960401	rs104886303	"Alport syndrome, COL4A5-related (X-linked)"	4946T>G			COL4A5	1287
VSJUXVJKI2	chrX	108696349	108696350	G	A	NC_000023.11:g.108696350G>A	NM_000495.4:c.5030G>A	NP_000486.1:p.Arg1677Gln		25506	CM970369	rs104886308	"Alport syndrome, COL4A5-related (X-linked)"	5030G>A	ASJ	0.000411466	COL4A5	1287
VSBVW225GA	chrX	139537143	139537144	C	T	NC_000023.11:g.139537144C>T	NM_000133.3:c.223C>T	NP_000124.1:p.Arg75*		25611	CM940433	rs137852227	Hemophilia B (X-linked)	223C>T			F9	2158
VSVHR2B3RM	chrX	139541113	139541114	G	A	NC_000023.11:g.139541114G>A	NM_000133.3:c.316G>A	NP_000124.1:p.Gly106Ser		25618	CM940466	rs137852233	Hemophilia B (X-linked)	316G>A	AFR	8.17E-05	F9	2158
VSYMXPQTH6	chrX	139561709	139561710	C	T	NC_000023.11:g.139561710C>T	NM_000133.3:c.1025C>T	NP_000124.1:p.Thr342Met		25646	CM940625	rs137852254	Hemophilia B (X-linked)	1025C>T			F9	2158
VSQ91YKA17	chrX	139562012	139562013	T	C	NC_000023.11:g.139562013T>C	NM_000133.3:c.1328T>C	NP_000124.1:p.Ile443Thr		25666	CM940736	rs137852268	Hemophilia B (X-linked)	1328T>C			F9	2158
VSJALBIQ1S	chrX	149482995	149482996	C	T	NC_000023.11:g.149482996C>T	NM_000202.7:c.1403G>A	NP_000193.1:p.Arg468Gln		25537	CM930422	rs113993946	"Mucopolysaccharidosis, type II - Hunter syndrome (X-linked)"	1403G>A			IDS	3423
VSYZ3CYMQX	chrX	149482995	149482996	C	A	NC_000023.11:g.149482996C>A	NM_000202.7:c.1403G>T	NP_000193.1:p.Arg468Leu		25539	CM950672	rs113993946	"Mucopolysaccharidosis, type II - Hunter syndrome (X-linked)"	1403G>T			IDS	3423
VSBTD4UMBT	chrX	149482996	149482997	G	A	NC_000023.11:g.149482997G>A	NM_000202.7:c.1402C>T	NP_000193.1:p.Arg468Trp		25536	CM920369	rs199422231	"Mucopolysaccharidosis, type II - Hunter syndrome (X-linked)"	1402C>T			IDS	3423
VSVW5UR6F5	chrX	149483071	149483072	G	A	NC_000023.11:g.149483072G>A	NM_000202.7:c.1327C>T	NP_000193.1:p.Arg443*		25525	CM920368	rs199422227	"Mucopolysaccharidosis, type II - Hunter syndrome (X-linked)"	1327C>T			IDS	3423
VSSHXJPUU8	chrX	149490321	149490322	G	A	NC_000023.11:g.149490322G>A	NM_000202.7:c.998C>T	NP_000193.1:p.Ser333Leu		25526	CM920367	rs104894853	"Mucopolysaccharidosis, type II - Hunter syndrome (X-linked)"	998C>T			IDS	3423
VSI9C1EMW4	chrX	150596542	150596543	C	T	NC_000023.11:g.150596543C>T	NM_000252.2:c.109C>T	NP_000243.1:p.Arg37*		169961	CM970982	rs587783753	"Myotubular myopathy, MTM1-related (X-linked)"	109C>T			MTM1	4534
VS5WNVT7NB	chrX	150598596	150598597	G	T	NC_000023.11:g.150598597G>T	NM_000252.2:c.142G>T	NP_000243.1:p.Glu48*			CM990869		"Myotubular myopathy, MTM1-related (X-linked)"	142G>T	NFE	1.27E-05	MTM1	4534
VS5NA48HHX	chrX	150598659	150598660	C	T	NC_000023.11:g.150598660C>T	NM_000252.2:c.205C>T	NP_000243.1:p.Arg69Cys		26094	CM970983	rs132630304	"Myotubular myopathy, MTM1-related (X-linked)"	205C>T			MTM1	4534
VSHWFSK3KX	chrX	150641353	150641354	C	T	NC_000023.11:g.150641354C>T	NM_000252.2:c.614C>T	NP_000243.1:p.Pro205Leu		170001	CM960998	rs587783841	"Myotubular myopathy, MTM1-related (X-linked)"	614C>T			MTM1	4534
VSWP4PDB94	chrX	150645724	150645725	C	T	NC_000023.11:g.150645725C>T	NM_000252.2:c.721C>T	NP_000243.1:p.Arg241Cys		26098	CM970993	rs132630305	"Myotubular myopathy, MTM1-related (X-linked)"	721C>T			MTM1	4534
VSQITMWB9P	chrX	150659653	150659654	A	G	NC_000023.11:g.150659654A>G	NM_000252.2:c.1261-10A>G			26097	CS971813	rs397518445	"Myotubular myopathy, MTM1-related (X-linked)"	1261-10A>G			MTM1	4534
VS59J37VRV	chrX	150659663	150659664	C	T	NC_000023.11:g.150659664C>T	NM_000252.2:c.1261C>T	NP_000243.1:p.Arg421*		170042	CM971000	rs587783771	"Myotubular myopathy, MTM1-related (X-linked)"	1261C>T	NFE	1.25E-05	MTM1	4534
VS8YBMMYVA	chrX	150659664	150659665	G	A	NC_000023.11:g.150659665G>A	NM_000252.2:c.1262G>A	NP_000243.1:p.Arg421Gln		170043	CM970999	rs587783772	"Myotubular myopathy, MTM1-related (X-linked)"	1262G>A			MTM1	4534
TP2016001	chrX	153693347	153693351	TCAA	T	NC_000023.11:g.153693356_153693358delAAC	NM_005629.3:c.1006_1008delAAC	NP_005620.1:p.Asn336del		260285	CD063616	rs782433037	"Creatine transporter defect, SLC6A8-related (X-linked)"	1006_1008delAAC			SLC6A8	6535
VS20160223	chrX	153693977	153693981	GTTC	G	NC_000023.11:g.153693985_153693987delTTC	NM_005629.3:c.1222_1224delTTC	NP_005620.1:p.Phe408del		26737	CD021847	rs80338740	"Creatine transporter defect, SLC6A8-related (X-linked)"	c.1222_1224delTTC			SLC6A8	6535
VS9BHZ9XIC	chrX	153725951	153725952	T	C	NC_000023.11:g.153725952T>C	NM_000033.3:c.686T>C	NP_000024.2:p.Leu229Pro			CM000640		Adrenoleukodystrophy (X-linked)	686T>C			ABCD1	215
VS20160213	chrX	154379736	154379737	C	T	NC_000023.11:g.154379737C>T	NM_000117.2:c.130C>T	NP_000108.1:p.Gln44*		26215	CM950353	rs132630262	Emery-Dreifuss muscular dystrophy (X-linked)	c.130C>T			EMD	2010
VSDCRQVNY9	chrX	154532268	154532269	C	G	NC_000023.11:g.154532269C>G	NM_001042351.2:c.1376G>C	NP_001035810.1:p.Arg459Pro		25461	CM930284	rs72554665	Glucose-6-phosphate dehydrogenase deficiency (X-linked)	1376G>C	NFE	1.26E-05	G6PD	2539
VSPZVQMHMI	chrX	154532268	154532269	C	A	NC_000023.11:g.154532269C>A	NM_001042351.2:c.1376G>T	NP_001035810.1:p.Arg459Leu		25419	CM910163	rs72554665	Glucose-6-phosphate dehydrogenase deficiency (X-linked)	1376G>T	EAS	0.0103777	G6PD	2539
VS9NBM233F	chrX	154532989	154532990	C	T	NC_000023.11:g.154532990C>T	NM_001042351.2:c.1003G>A	NP_001035810.1:p.Ala335Thr		25402	CM880033	rs5030869	Glucose-6-phosphate dehydrogenase deficiency (X-linked)	1003G>A	SAS	0.00130678	G6PD	2539
VSXJUDIXIY	chrX	154533121	154533122	C	T	NC_000023.11:g.154533122C>T	NM_001042351.2:c.871G>A	NP_001035810.1:p.Val291Met		25425	CM930275	rs137852327	Glucose-6-phosphate dehydrogenase deficiency (X-linked)	871G>A	EAS	0.00248911	G6PD	2539
VSBV2NWSLY	chrX	154534418	154534419	G	A	NC_000023.11:g.154534419G>A	NM_001042351.2:c.563C>T	NP_001035810.1:p.Ser188Phe		25407	CM880032	rs5030868	Glucose-6-phosphate dehydrogenase deficiency (X-linked)	563C>T	SAS	0.0174476	G6PD	2539
VS4K4JVI32	chrX	154534494	154534495	C	T	NC_000023.11:g.154534495C>T	NM_001042351.2:c.487G>A	NP_001035810.1:p.Gly163Ser		25406	CM890050	rs137852314	Glucose-6-phosphate dehydrogenase deficiency (X-linked)	487G>A	SAS	0.000365688	G6PD	2539
VSHN7EKLEY	chrX	154535276	154535277	T	C	NC_000023.11:g.154535277T>C	NM_001042351.2:c.376A>G	NP_001035810.1:p.Asn126Asp		25399	CM880030	rs1050829	Glucose-6-phosphate dehydrogenase deficiency (X-linked)	376A>G	AFR	0.317322999	G6PD	2539
VSGN59VTUC	chrX	154536001	154536002	C	T	NC_000023.11:g.154536002C>T	NM_001042351.2:c.202G>A	NP_001035810.1:p.Val68Met		25400	CM880029	rs1050828	Glucose-6-phosphate dehydrogenase deficiency (X-linked)	202G>A	AFR	0.115884997	G6PD	2539
VSI19RPAHH	chrX	154536167	154536168	G	C	NC_000023.11:g.154536168G>C	NM_001042351.2:c.131C>G	NP_001035810.1:p.Ala44Gly		25445	CM950496	rs78478128	Glucose-6-phosphate dehydrogenase deficiency (X-linked)	131C>G	SAS	0.00161956	G6PD	2539
VSGQTM4F6W	chrX	154765449	154765450	C	A	NC_000023.11:g.154765450C>A	NM_001363.4:c.91C>A	NP_001354.1:p.Gln31Lys		26633	CM058293	rs137854491	"Dyskeratosis congenita, DKC-related (X-linked)"	91C>A			DKC1	1736
VS5MYS9LTJ	chrX	154765464	154765468	TTTC	T	NC_000023.11:g.154765468_154765470delCTT	NM_001363.4:c.109_111delCTT	NP_001354.1:p.Leu37del		26622	CD982594	rs137854489	"Dyskeratosis congenita, DKC-related (X-linked)"	109_111delCTT			DKC1	1736
VSNVY6I5QG	chrX	154765504	154765505	C	T	NC_000023.11:g.154765505C>T	NM_001363.4:c.146C>T	NP_001354.1:p.Thr49Met		26630	CM014178	rs121912304	"Dyskeratosis congenita, DKC-related (X-linked)"	146C>T			DKC1	1736
VSBNP3Y5Q2	chrX	154767019	154767020	C	T	NC_000023.11:g.154767020C>T	NM_001363.4:c.472C>T	NP_001354.1:p.Arg158Trp		47553	CM011312	rs199422246	"Dyskeratosis congenita, DKC-related (X-linked)"	472C>T			DKC1	1736
VS9S1S1JJR	chrX	154773151	154773152	C	T	NC_000023.11:g.154773152C>T	NM_001363.4:c.1058C>T	NP_001354.1:p.Ala353Val		26626	CM990482	rs121912288	"Dyskeratosis congenita, DKC-related (X-linked)"	1058C>T			DKC1	1736
VSUMM6DLN1	chrX	154774650	154774651	G	A	NC_000023.11:g.154774651G>A	NM_001363.4:c.1205G>A	NP_001354.1:p.Gly402Glu		26625	CM980561	rs121912295	"Dyskeratosis congenita, DKC-related (X-linked)"	1205G>A			DKC1	1736
VS3QF5ZSZZ	chrX	154837685	154837686	G	A	NC_000023.11:g.154837686G>A	NM_000132.3:c.6967C>T	NP_000123.1:p.Arg2323Cys		25372	CM910153	rs137852473	Hemophilia A (X-linked)	6967C>T			F8	2157
VSSWXNP3BX	chrX	154860587	154860588	C	A	NC_000023.11:g.154860588C>A	NM_000132.3:c.6744G>T	NP_000123.1:p.Trp2248Cys		25366	CM910150	rs137852469	Hemophilia A (X-linked)	6744G>T			F8	2157
VS9H3P2LSC	chrX	154861757	154861758	C	T	NC_000023.11:g.154861758C>T	NM_000132.3:c.6683G>A	NP_000123.1:p.Arg2228Gln		25137	CM880027	rs137852358	Hemophilia A (X-linked)	6683G>A			F8	2157
VSJZ2G8CP3	chrX	154861758	154861759	G	A	NC_000023.11:g.154861759G>A	NM_000132.3:c.6682C>T	NP_000123.1:p.Arg2228*		25125	CM850003	rs137852355	Hemophilia A (X-linked)	6682C>T			F8	2157
VSKNJK1E7L	chrX	154861767	154861771	AAGG	A	NC_000023.11:g.154861771_154861773delGAG	NM_000132.3:c.6670_6672delCCT	NP_000123.1:p.Pro2224del			CD910501	rs1229477261	Hemophilia A (X-linked)	6670_6672delCCT			F8	2157
VS6FI2DUVM	chrX	154863111	154863112	C	T	NC_000023.11:g.154863112C>T	NM_000132.3:c.6545G>A	NP_000123.1:p.Arg2182His		25359	CM940403	rs137852466	Hemophilia A (X-linked)	6545G>A			F8	2157
VSAAVKRFG3	chrX	154863124	154863125	G	A	NC_000023.11:g.154863125G>A	NM_000132.3:c.6532C>T	NP_000123.1:p.Arg2178Cys		25357	CM910148	rs137852464	Hemophilia A (X-linked)	6532C>T			F8	2157
VSYTWGIITQ	chrX	154863150	154863151	C	T	NC_000023.11:g.154863151C>T	NM_000132.3:c.6506G>A	NP_000123.1:p.Arg2169His		25354	CM910147	rs137852461	Hemophilia A (X-linked)	6506G>A	NFE	1.25E-05	F8	2157
VSLX1E9WGR	chrX	154896092	154896093	G	T	NC_000023.11:g.154896093G>T	NM_000132.3:c.6413C>A	NP_000123.1:p.Ser2138Tyr		25350	CM910146	rs137852460	Hemophilia A (X-linked)	6413C>A			F8	2157
VSY4DI29VF	chrX	154896145	154896146	A	C	NC_000023.11:g.154896146A>C	NM_000132.3:c.6360T>G	NP_000123.1:p.Phe2120Leu		25348	CM910145	rs137852458	Hemophilia A (X-linked)	6360T>G			F8	2157
VSYQUUWR3J	chrX	154896227	154896228	T	C	NC_000023.11:g.154896228T>C	NM_000132.3:c.6278A>G	NP_000123.1:p.Asp2093Gly		25347	CM950417	rs137852457	Hemophilia A (X-linked)	6278A>G			F8	2157
VSQVKIN64H	chrX	154902119	154902120	G	A	NC_000023.11:g.154902120G>A	NM_000132.3:c.6046C>T	NP_000123.1:p.Arg2016Trp		25343	CM910144	rs137852453	Hemophilia A (X-linked)	6046C>T			F8	2157
VSKSU1476A	chrX	154903950	154903951	G	A	NC_000023.11:g.154903951G>A	NM_000132.3:c.5953C>T	NP_000123.1:p.Arg1985*		25339	CM930233	rs137852452	Hemophilia A (X-linked)	5953C>T			F8	2157
VSDVS1I8AX	chrX	154904025	154904026	G	A	NC_000023.11:g.154904026G>A	NM_000132.3:c.5878C>T	NP_000123.1:p.Arg1960*		25157	CM860007	rs137852363	Hemophilia A (X-linked)	5878C>T			F8	2157
VS1ZRYBXGC	chrX	154904081	154904082	T	C	NC_000023.11:g.154904082T>C	NM_000132.3:c.5822A>G	NP_000123.1:p.Asn1941Ser		25333	CM910143	rs28933682	Hemophilia A (X-linked)	5822A>G			F8	2157
VSQDW3EZLQ	chrX	154904860	154904861	T	A	NC_000023.11:g.154904861T>A	NM_000132.3:c.5536A>T	NP_000123.1:p.Lys1846*			CM930228	rs137852447	Hemophilia A (X-linked)	5536A>T			F8	2157
VSPP67R7YC	chrX	154904974	154904975	G	A	NC_000023.11:g.154904975G>A	NM_000132.3:c.5422C>T	NP_000123.1:p.Leu1808Phe		25317	CM920261	rs137852445	Hemophilia A (X-linked)	5422C>T			F8	2157
VSWTTZ17HS	chrX	154904997	154904998	C	T	NC_000023.11:g.154904998C>T	NM_000132.3:c.5399G>A	NP_000123.1:p.Arg1800His		25313	CM910139	rs137852442	Hemophilia A (X-linked)	5399G>A			F8	2157
VS8XAKFJCU	chrX	154906487	154906488	C	T	NC_000023.11:g.154906488C>T	NM_000132.3:c.5305G>A	NP_000123.1:p.Gly1769Arg		25309	CM950407	rs137852440	Hemophilia A (X-linked)	5305G>A			F8	2157
VS5FUV4MT4	chrX	154928646	154928647	G	A	NC_000023.11:g.154928647G>A	NM_000132.3:c.5143C>T	NP_000123.1:p.Arg1715*		25306	CM900094	rs137852439	Hemophilia A (X-linked)	5143C>T			F8	2157
VSRFVWP7L4	chrX	154928667	154928668	G	A	NC_000023.11:g.154928668G>A	NM_000132.3:c.5122C>T	NP_000123.1:p.Arg1708Cys		25153	CM880026	rs111033613	Hemophilia A (X-linked)	5122C>T			F8	2157
VSVGY92E5P	chrX	154931622	154931623	C	T	NC_000023.11:g.154931623C>T	NM_000132.3:c.2167G>A	NP_000123.1:p.Ala723Thr		25285	CM910135	rs137852436	Hemophilia A (X-linked)	2167G>A	SAS	5.24E-05	F8	2157
VSYG8BTI8S	chrX	154953960	154953961	G	A	NC_000023.11:g.154953961G>A	NM_000132.3:c.1834C>T	NP_000123.1:p.Arg612Cys		25275	CM910133	rs137852428	Hemophilia A (X-linked)	1834C>T	AMR	0.0001505	F8	2157
VSGKLPEVQ1	chrX	154953990	154953991	G	A	NC_000023.11:g.154953991G>A	NM_000132.3:c.1804C>T	NP_000123.1:p.Arg602*		25271	CM900089	rs137852424	Hemophilia A (X-linked)	1804C>T			F8	2157
VS82IBE5K1	chrX	154956958	154956959	G	T	NC_000023.11:g.154956959G>T	NM_000132.3:c.1750C>A	NP_000123.1:p.Gln584Lys		25269	CM910132	rs137852422	Hemophilia A (X-linked)	1750C>A			F8	2157
VSVL727QV7	chrX	154956979	154956980	A	G	NC_000023.11:g.154956980A>G	NM_000132.3:c.1729T>C	NP_000123.1:p.Ser577Pro		25270	CM062642	rs387906446	Hemophilia A (X-linked)	1729T>C			F8	2157
VS7YKS7CPA	chrX	154957060	154957061	G	A	NC_000023.11:g.154957061G>A	NM_000132.3:c.1648C>T	NP_000123.1:p.Arg550Cys		25262	CM910130	rs137852417	Hemophilia A (X-linked)	1648C>T			F8	2157
VSMHL4JT5P	chrX	154957072	154957073	G	A	NC_000023.11:g.154957073G>A	NM_000132.3:c.1636C>T	NP_000123.1:p.Arg546Trp		25261	CM910128	rs137852416	Hemophilia A (X-linked)	1636C>T			F8	2157
VSQABKGYPA	chrX	154966663	154966664	C	G	NC_000023.11:g.154966664C>G	NM_000132.3:c.1033G>C	NP_000123.1:p.Val345Leu			CM900086	rs137852371	Hemophilia A (X-linked)	1033G>C			F8	2157
VS9HTWBJK1	chrX	154969437	154969438	C	T	NC_000023.11:g.154969438C>T	NM_000132.3:c.902G>A	NP_000123.1:p.Arg301His		25231	CM910121	rs137852403	Hemophilia A (X-linked)	902G>A			F8	2157
VSG69JYTH6	chrX	155022509	155022510	G	A	NC_000023.11:g.155022510G>A	NM_000132.3:c.43C>T	NP_000123.1:p.Arg15*		25191	CM900085	rs387906432	Hemophilia A (X-linked)	43C>T			F8	2157
VSALPHATAI	chr16	149862	183313	G	<DEL>				#NAME?				Alpha Thalassemia	#NAME?				
VSALPHAFIL	chr16	151625	182302	G	<DEL>				#NAME?				Alpha Thalassemia	#NAME?				
VSALPH20P5	chr16	154301	177001	G	<DEL>				#NAME?				Alpha Thalassemia	#NAME?				
VSALPHAMED	chr16	162861	180270	G	<DEL>				#NAME?				Alpha Thalassemia	#NAME?				
VSALPHASEA	chr16	165396	184701	C	<DEL>				#NAME?				Alpha Thalassemia	#NAME?				
VSALPHA4P2	chr16	170154	174411	C	<DEL>				#NAME?				Alpha Thalassemia	#NAME?				
VSALPHA3P7	chr16	173301	177104	A	<DEL>				#NAME?				Alpha Thalassemia	#NAME?				
VSALPHANOS	chr16								Not Otherwise Specified				Alpha Thalassemia	Not Otherwise Specified				
